country,term,count
DZ,ISCHAEMIC STROKE,1
AR,BLOOD PRESSURE INCREASED,4
AR,PAIN,4
AR,HAEMORRHAGE,3
AR,NERVOUSNESS,3
AR,PNEUMONIA,3
AR,VISUAL ACUITY REDUCED,3
AR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,3
AR,ACUTE KIDNEY INJURY,2
AR,ARTHRALGIA,2
AR,ASTHENIA,2
AR,ATRIOVENTRICULAR BLOCK COMPLETE,2
AR,BONE DISORDER,2
AR,CELLULITIS,2
AR,CEREBROVASCULAR ACCIDENT,2
AR,CORONARY ARTERY DISEASE,2
AR,DIABETIC FOOT,2
AR,DRUG DEPENDENCE,2
AR,DRUG INEFFECTIVE,2
AR,FALL,2
AR,HIP FRACTURE,2
AR,HYPERSENSITIVITY,2
AR,HYPERTENSION,2
AR,MYOCARDIAL INFARCTION,2
AR,NASOPHARYNGITIS,2
AR,OSTEOARTHRITIS,2
AR,RENAL CANCER,2
AR,RENAL DISORDER,2
AR,RETINAL VASCULAR THROMBOSIS,2
AR,SPINAL CORD DISORDER,2
AR,VISUAL IMPAIRMENT,2
AR,ABASIA,1
AR,ABDOMINAL PAIN UPPER,1
AR,ALOPECIA,1
AR,ANAEMIA,1
AR,ANXIETY,1
AR,BACK PAIN,1
AR,BILE DUCT STENOSIS,1
AR,BLOOD PRESSURE DECREASED,1
AR,BLOOD SODIUM INCREASED,1
AR,BLOODY DISCHARGE,1
AR,BONE PAIN,1
AR,BRONCHITIS,1
AR,CARDIAC FAILURE,1
AR,CARDIAC FAILURE ACUTE,1
AR,CATARRH,1
AR,CHRONIC KIDNEY DISEASE,1
AR,COAGULATION TIME PROLONGED,1
AR,COAGULOPATHY,1
AR,COLON NEOPLASM,1
AR,CONJUNCTIVITIS,1
AR,COUGH,1
AR,DECREASED APPETITE,1
AR,DIZZINESS,1
AR,DRUG PRESCRIBING ERROR,1
AR,DYSPNOEA,1
AR,ERYSIPELAS,1
AR,FATIGUE,1
AR,FEMUR FRACTURE,1
AR,GASTRIC ULCER,1
AR,GASTROENTERITIS,1
AR,GASTROINTESTINAL PAIN,1
AR,HAEMATURIA,1
AR,HAEMORRHAGIC TRANSFORMATION STROKE,1
AR,HALLUCINATION,1
AR,HEADACHE,1
AR,HEPATIC PAIN,1
AR,HYPERTRIGLYCERIDAEMIA,1
AR,HYPOACUSIS,1
AR,HYPOTHERMIA,1
AR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AR,INCORRECT DOSE ADMINISTERED,1
AR,INFECTION,1
AR,ISCHAEMIC STROKE,1
AR,JOINT DISLOCATION,1
AR,LEUKOPENIA,1
AR,LIMB DISCOMFORT,1
AR,LOCALISED INFECTION,1
AR,LUNG NEOPLASM MALIGNANT,1
AR,MALAISE,1
AR,METASTASES TO ADRENALS,1
AR,MUSCLE NECROSIS,1
AR,MUSCULOSKELETAL PAIN,1
AR,MYALGIA,1
AR,MYOPATHY,1
AR,NON-CARDIAC CHEST PAIN,1
AR,OSTEOMYELITIS,1
AR,OSTEONECROSIS OF JAW,1
AR,PANCYTOPENIA,1
AR,PERIPHERAL ARTERY ANGIOPLASTY,1
AR,PERIPHERAL VASCULAR DISORDER,1
AR,POLYMYOSITIS,1
AR,PRODUCTIVE COUGH,1
AR,PROSTATE CANCER,1
AR,PRURITUS GENERALISED,1
AR,PSORIASIS,1
AR,PULMONARY MASS,1
AR,PURULENT DISCHARGE,1
AR,RENAL FAILURE,1
AR,RENAL FAILURE CHRONIC,1
AR,RESPIRATORY DISTRESS,1
AR,SKIN DISCOLOURATION,1
AR,SPEECH DISORDER,1
AR,SPINAL PAIN,1
AR,SURGERY,1
AR,SYNCOPE,1
AR,THROMBOCYTOPENIA,1
AR,THROMBOSIS,1
AR,TINNITUS,1
AR,UNDERDOSE,1
AR,URINARY INCONTINENCE,1
AR,VITREOUS DETACHMENT,1
AR,VOMITING,1
AR,VULVAL CANCER,1
AR,WEIGHT DECREASED,1
AR,WHITE BLOOD CELL COUNT INCREASED,1
AU,RHABDOMYOLYSIS,30
AU,ELECTROCARDIOGRAM QT PROLONGED,25
AU,HYPOTENSION,23
AU,TACHYCARDIA,21
AU,CHEST PAIN,19
AU,MYOPATHY,19
AU,COMA,18
AU,FALL,17
AU,DYSPNOEA,16
AU,CONGESTIVE CARDIOMYOPATHY,14
AU,DIZZINESS,13
AU,DEPRESSION,12
AU,INTENTIONAL OVERDOSE,12
AU,FATIGUE,11
AU,HYPONATRAEMIA,11
AU,MENTAL DISORDER,11
AU,NAUSEA,11
AU,SCHIZOPHRENIA,11
AU,SUICIDE ATTEMPT,11
AU,DIARRHOEA,10
AU,DRUG INEFFECTIVE,10
AU,DRUG-INDUCED LIVER INJURY,10
AU,ABNORMAL BEHAVIOUR,9
AU,CONSTIPATION,9
AU,INTENTIONAL SELF-INJURY,9
AU,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,9
AU,PERSONALITY DISORDER,9
AU,ATRIAL FIBRILLATION,8
AU,DEATH,8
AU,HAEMORRHAGE INTRACRANIAL,8
AU,MYALGIA,8
AU,VITAMIN D DECREASED,8
AU,VOMITING,8
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,7
AU,BLOOD GLUCOSE INCREASED,7
AU,CEREBROVASCULAR ACCIDENT,7
AU,COUGH,7
AU,LEFT VENTRICULAR DYSFUNCTION,7
AU,LYMPHADENOPATHY MEDIASTINAL,7
AU,MUSCULAR WEAKNESS,7
AU,MYOCARDIAL INFARCTION,7
AU,MYOCARDITIS,7
AU,OVERDOSE,7
AU,PNEUMONIA,7
AU,PYREXIA,7
AU,RENAL FAILURE ACUTE,7
AU,TOXICITY TO VARIOUS AGENTS,7
AU,URINARY INCONTINENCE,7
AU,ACUTE MYOCARDIAL INFARCTION,6
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,6
AU,ASTHENIA,6
AU,C-REACTIVE PROTEIN DECREASED,6
AU,CARDIAC ARREST,6
AU,CARDIAC FAILURE,6
AU,DEHYDRATION,6
AU,ERYTHEMA,6
AU,HYPERHIDROSIS,6
AU,MALAISE,6
AU,OEDEMA PERIPHERAL,6
AU,PERICARDITIS,6
AU,PNEUMONIA HAEMOPHILUS,6
AU,RESPIRATORY FAILURE,6
AU,SPLENOMEGALY,6
AU,WHITE BLOOD CELL COUNT INCREASED,6
AU,ACUTE KIDNEY INJURY,5
AU,ANAPHYLACTIC REACTION,5
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,5
AU,ATYPICAL FEMUR FRACTURE,5
AU,BASAL CELL CARCINOMA,5
AU,BLOOD CREATININE INCREASED,5
AU,COLITIS,5
AU,CONFUSIONAL STATE,5
AU,DEEP VEIN THROMBOSIS,5
AU,DIABETES MELLITUS,5
AU,EXTRAOCULAR MUSCLE DISORDER,5
AU,HYPERCHOLESTEROLAEMIA,5
AU,LETHARGY,5
AU,METABOLIC ACIDOSIS,5
AU,MYOGLOBINURIA,5
AU,PULMONARY EMBOLISM,5
AU,RASH,5
AU,RECTAL HAEMORRHAGE,5
AU,SQUAMOUS CELL CARCINOMA OF SKIN,5
AU,TREATMENT NONCOMPLIANCE,5
AU,UROSEPSIS,5
AU,WEIGHT DECREASED,5
AU,ABDOMINAL PAIN,4
AU,BLOOD IRON DECREASED,4
AU,CALCIPHYLAXIS,4
AU,CHRONIC KIDNEY DISEASE,4
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,4
AU,CIRCULATORY COLLAPSE,4
AU,COLONIC PSEUDO-OBSTRUCTION,4
AU,CONDITION AGGRAVATED,4
AU,DIABETIC ULCER,4
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
AU,DYSPHAGIA,4
AU,EJECTION FRACTION DECREASED,4
AU,HAEMOGLOBIN DECREASED,4
AU,HYPERKALAEMIA,4
AU,HYPERTENSION,4
AU,HYPERTRIGLYCERIDAEMIA,4
AU,INTERNATIONAL NORMALISED RATIO INCREASED,4
AU,LOWER RESPIRATORY TRACT INFECTION,4
AU,PAIN,4
AU,PULMONARY HYPERTENSION,4
AU,RENAL IMPAIRMENT,4
AU,VENTRICULAR HYPOKINESIA,4
AU,ABDOMINAL DISTENSION,3
AU,AMNESIA,3
AU,ANAEMIA,3
AU,ANXIETY,3
AU,ARTERIOSPASM CORONARY,3
AU,ARTHRALGIA,3
AU,BACK PAIN,3
AU,BLOOD SODIUM DECREASED,3
AU,BLOOD UREA INCREASED,3
AU,C-REACTIVE PROTEIN INCREASED,3
AU,CARDIAC DISORDER,3
AU,COGNITIVE DISORDER,3
AU,CONTUSION,3
AU,DELIRIUM,3
AU,DIVERTICULITIS,3
AU,FAECALOMA,3
AU,FUNCTIONAL GASTROINTESTINAL DISORDER,3
AU,HAEMATURIA,3
AU,HEAD INJURY,3
AU,HYPOPHOSPHATAEMIA,3
AU,INTESTINAL OBSTRUCTION,3
AU,KOUNIS SYNDROME,3
AU,LEUKOPENIA,3
AU,LOSS OF CONSCIOUSNESS,3
AU,MENTAL IMPAIRMENT,3
AU,MYELODYSPLASTIC SYNDROME,3
AU,NEUTROPENIA,3
AU,PANCYTOPENIA,3
AU,PLEURAL EFFUSION,3
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
AU,RENAL FAILURE,3
AU,RIB FRACTURE,3
AU,SKIN ULCER,3
AU,SQUAMOUS CELL CARCINOMA,3
AU,SYNCOPE,3
AU,TACHYPNOEA,3
AU,TROPONIN INCREASED,3
AU,TYPE 2 DIABETES MELLITUS,3
AU,URINARY TRACT INFECTION,3
AU,URTICARIA,3
AU,WALKING DISABILITY,3
AU,WEIGHT INCREASED,3
AU,WHEEZING,3
AU,WRIST FRACTURE,3
AU,ABNORMAL PRECORDIAL MOVEMENT,2
AU,ACTINIC KERATOSIS,2
AU,AGITATION,2
AU,ALANINE AMINOTRANSFERASE INCREASED,2
AU,ANGINA PECTORIS,2
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,2
AU,AORTIC DILATATION,2
AU,ASTHMA,2
AU,ATAXIA,2
AU,ATELECTASIS,2
AU,BACTERAEMIA,2
AU,BACTERIAL SEPSIS,2
AU,BEDRIDDEN,2
AU,BLOOD CALCIUM DECREASED,2
AU,BLOOD CREATINE INCREASED,2
AU,BLOOD POTASSIUM INCREASED,2
AU,BLOOD PROLACTIN INCREASED,2
AU,BLOOD TRIGLYCERIDES INCREASED,2
AU,BONE PAIN,2
AU,BREAST CANCER,2
AU,BURSITIS,2
AU,CAROTID ARTERY STENOSIS,2
AU,CELLULITIS,2
AU,CHEST DISCOMFORT,2
AU,CHILLS,2
AU,CHRONIC MYELOID LEUKAEMIA,2
AU,CLAVICLE FRACTURE,2
AU,COMA SCALE ABNORMAL,2
AU,COMPLICATIONS OF TRANSPLANTED KIDNEY,2
AU,CONCOMITANT DISEASE AGGRAVATED,2
AU,CORONARY ARTERY DISEASE,2
AU,DECREASED APPETITE,2
AU,DRUG DOSE OMISSION,2
AU,DYSARTHRIA,2
AU,ENTEROBACTER BACTERAEMIA,2
AU,ESCHERICHIA BACTERAEMIA,2
AU,EXTRAPYRAMIDAL DISORDER,2
AU,FAECAL INCONTINENCE,2
AU,FEMORAL NECK FRACTURE,2
AU,FLUID OVERLOAD,2
AU,GAIT DISTURBANCE,2
AU,GASTROINTESTINAL HAEMORRHAGE,2
AU,GASTROOESOPHAGEAL REFLUX DISEASE,2
AU,GENERAL PHYSICAL HEALTH DETERIORATION,2
AU,HEPATIC FUNCTION ABNORMAL,2
AU,HYPERSENSITIVITY,2
AU,HYPOGLYCAEMIA,2
AU,HYPOXIA,2
AU,IMMUNOGLOBULINS DECREASED,2
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
AU,INCORRECT DOSE ADMINISTERED,2
AU,INFECTION,2
AU,INSOMNIA,2
AU,INTERSTITIAL LUNG DISEASE,2
AU,INTESTINAL PERFORATION,2
AU,LABORATORY TEST ABNORMAL,2
AU,LUNG CONSOLIDATION,2
AU,LUNG DISORDER,2
AU,LUNG INFILTRATION,2
AU,MALIGNANT NEOPLASM PROGRESSION,2
AU,METASTASES TO BONE,2
AU,METASTASES TO LIVER,2
AU,MITRAL VALVE INCOMPETENCE,2
AU,MOBILITY DECREASED,2
AU,MUSCULOSKELETAL PAIN,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,NEPHROPATHY,2
AU,NERVOUS SYSTEM DISORDER,2
AU,NEUROPATHY PERIPHERAL,2
AU,ORTHOSTATIC HYPOTENSION,2
AU,OSTEOARTHRITIS,2
AU,OSTEOPOROSIS,2
AU,PANIC ATTACK,2
AU,PARESIS,2
AU,PERFORMANCE STATUS DECREASED,2
AU,PHOTOSENSITIVITY REACTION,2
AU,PNEUMONITIS,2
AU,PRURITUS,2
AU,PRURITUS GENERALISED,2
AU,PSORIASIS,2
AU,PULMONARY OEDEMA,2
AU,PYELONEPHRITIS,2
AU,RED BLOOD CELL COUNT DECREASED,2
AU,RENAL FAILURE CHRONIC,2
AU,RESPIRATORY MUSCLE WEAKNESS,2
AU,RHEUMATOID ARTHRITIS,2
AU,SEIZURE,2
AU,SEPSIS,2
AU,SERUM FERRITIN DECREASED,2
AU,SINUS TACHYCARDIA,2
AU,SKIN LESION,2
AU,SLEEP APNOEA SYNDROME,2
AU,STRESS FRACTURE,2
AU,SUBDURAL HAEMATOMA,2
AU,SUBDURAL HAEMORRHAGE,2
AU,TRANSFERRIN DECREASED,2
AU,TRANSIENT ISCHAEMIC ATTACK,2
AU,TREMOR,2
AU,URINARY TRACT OBSTRUCTION,2
AU,WRONG DRUG ADMINISTERED,2
AU,ABASIA,1
AU,ABDOMINAL DISCOMFORT,1
AU,ABDOMINAL PAIN UPPER,1
AU,ABDOMINAL SEPSIS,1
AU,ABDOMINAL WALL HAEMATOMA,1
AU,ABSCESS,1
AU,ABSCESS INTESTINAL,1
AU,ACCIDENTAL EXPOSURE TO PRODUCT,1
AU,ACUTE HEPATIC FAILURE,1
AU,ACUTE LYMPHOCYTIC LEUKAEMIA,1
AU,ACUTE PULMONARY OEDEMA,1
AU,ADENOCARCINOMA PANCREAS,1
AU,ADRENAL INSUFFICIENCY,1
AU,ADRENAL NEOPLASM,1
AU,ADVERSE EVENT,1
AU,AGRANULOCYTOSIS,1
AU,ALBUMINURIA,1
AU,AMMONIA INCREASED,1
AU,ANAL HAEMORRHAGE,1
AU,ANGINA UNSTABLE,1
AU,ANGIOEDEMA,1
AU,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
AU,ANURIA,1
AU,AORTIC VALVE INCOMPETENCE,1
AU,APHASIA,1
AU,APLASIA PURE RED CELL,1
AU,APPENDICEAL ABSCESS,1
AU,APPENDICITIS PERFORATED,1
AU,ARRHYTHMIA,1
AU,ARTHRITIS,1
AU,ARTHROPATHY,1
AU,ASCITES,1
AU,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,1
AU,ATROPHIC VULVOVAGINITIS,1
AU,AUTOIMMUNE NEPHRITIS,1
AU,BACK DISORDER,1
AU,BACTERIAL INFECTION,1
AU,BALANCE DISORDER,1
AU,BLADDER CANCER,1
AU,BLINDNESS,1
AU,BLINDNESS UNILATERAL,1
AU,BLISTER,1
AU,BLOOD ALBUMIN DECREASED,1
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AU,BLOOD CHLORIDE DECREASED,1
AU,BLOOD CHOLESTEROL INCREASED,1
AU,BLOOD ELECTROLYTES ABNORMAL,1
AU,BLOOD KETONE BODY,1
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,1
AU,BLOOD PRESSURE INCREASED,1
AU,BLOOD PRESSURE SYSTOLIC INCREASED,1
AU,BLOOD TEST ABNORMAL,1
AU,BLOOD URIC ACID INCREASED,1
AU,BODY HEIGHT DECREASED,1
AU,BODY TEMPERATURE INCREASED,1
AU,BONE CANCER METASTATIC,1
AU,BONE LESION,1
AU,CANCER SURGERY,1
AU,CARDIAC ASSISTANCE DEVICE USER,1
AU,CARDIAC FAILURE CONGESTIVE,1
AU,CARDIAC OUTPUT DECREASED,1
AU,CARDIAC SEPTAL HYPERTROPHY,1
AU,CARDIO-RESPIRATORY ARREST,1
AU,CARDIOGENIC SHOCK,1
AU,CARDIOMEGALY,1
AU,CARDIOVASCULAR DISORDER,1
AU,CAROTID ARTERIOSCLEROSIS,1
AU,CD4 LYMPHOCYTES DECREASED,1
AU,CEREBELLAR SYNDROME,1
AU,CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE,1
AU,CHOLANGITIS SCLEROSING,1
AU,CHOLELITHIASIS,1
AU,CHOLESTASIS,1
AU,CHONDROCALCINOSIS PYROPHOSPHATE,1
AU,CHROMATURIA,1
AU,CHRONIC HEPATITIS C,1
AU,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
AU,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
AU,CLUMSINESS,1
AU,COAGULATION TEST ABNORMAL,1
AU,COLON CANCER,1
AU,COLON CANCER METASTATIC,1
AU,COLONIC OBSTRUCTION,1
AU,COLOSTOMY,1
AU,CONVULSION,1
AU,COR PULMONALE,1
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,1
AU,DERMATOMYOSITIS,1
AU,DEVICE BREAKAGE,1
AU,DIABETIC KETOACIDOSIS,1
AU,DILATATION VENTRICULAR,1
AU,DIPLOPIA,1
AU,DISEASE RECURRENCE,1
AU,DISORIENTATION,1
AU,DIVERTICULAR PERFORATION,1
AU,DIZZINESS POSTURAL,1
AU,DRUG WITHDRAWAL SYNDROME,1
AU,DUODENAL ULCER,1
AU,DYSGEUSIA,1
AU,DYSLIPIDAEMIA,1
AU,DYSSTASIA,1
AU,ELDERLY,1
AU,ELECTROCARDIOGRAM CHANGE,1
AU,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
AU,EMPHYSEMA,1
AU,EOSINOPHIL COUNT INCREASED,1
AU,EXTRASYSTOLES,1
AU,EYELID OEDEMA,1
AU,FEMUR FRACTURE,1
AU,FIBULA FRACTURE,1
AU,FOOD ALLERGY,1
AU,FURUNCLE,1
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
AU,GASTRIC ULCER,1
AU,GASTROENTERITIS,1
AU,GASTROENTERITIS SALMONELLA,1
AU,GASTROINTESTINAL DISORDER,1
AU,GASTROINTESTINAL HYPOMOTILITY,1
AU,GLAUCOMA,1
AU,GLOMERULAR FILTRATION RATE DECREASED,1
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
AU,GOUT,1
AU,GOUTY TOPHUS,1
AU,HAEMATOCRIT DECREASED,1
AU,HAEMATOMA,1
AU,HAEMATOMA INFECTION,1
AU,HAEMORRHAGE,1
AU,HAEMORRHAGE URINARY TRACT,1
AU,HAEMORRHOIDS,1
AU,HALLUCINATION_ AUDITORY,1
AU,HEART RATE INCREASED,1
AU,HEART RATE IRREGULAR,1
AU,HEAT STROKE,1
AU,HEMIPARESIS,1
AU,HEPATIC CANCER,1
AU,HEPATIC CIRRHOSIS,1
AU,HEPATIC CONGESTION,1
AU,HEPATIC CYST,1
AU,HEPATIC FIBROSIS,1
AU,HEPATIC STEATOSIS,1
AU,HEPATITIS,1
AU,HEPATOMEGALY,1
AU,HERNIA,1
AU,HERNIA REPAIR,1
AU,HIGH DENSITY LIPOPROTEIN DECREASED,1
AU,HIP FRACTURE,1
AU,HYPERCALCAEMIA,1
AU,HYPERLIPIDAEMIA,1
AU,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
AU,HYPOCALCAEMIA,1
AU,HYPOPITUITARISM,1
AU,HYPOTHYROIDISM,1
AU,HYPOTONIA,1
AU,HYPOVENTILATION,1
AU,IMMUNODEFICIENCY,1
AU,IMMUNOSUPPRESSION,1
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
AU,INCONTINENCE,1
AU,INCORRECT STORAGE OF DRUG,1
AU,INDURATION,1
AU,INFUSION RELATED REACTION,1
AU,INJECTION SITE MASS,1
AU,INTERMITTENT CLAUDICATION,1
AU,INTESTINAL HAEMORRHAGE,1
AU,INTESTINAL MALROTATION,1
AU,INTRAVENTRICULAR HAEMORRHAGE,1
AU,ISCHAEMIC CARDIOMYOPATHY,1
AU,JAUNDICE,1
AU,JC VIRUS GRANULE CELL NEURONOPATHY,1
AU,JC VIRUS TEST POSITIVE,1
AU,KIDNEY FIBROSIS,1
AU,KIDNEY TRANSPLANT REJECTION,1
AU,KNEE OPERATION,1
AU,KYPHOSIS,1
AU,LACERATION,1
AU,LARGE INTESTINE POLYP,1
AU,LARYNGEAL HAEMORRHAGE,1
AU,LARYNGEAL OEDEMA,1
AU,LEFT VENTRICULAR FAILURE,1
AU,LEFT VENTRICULAR HYPERTROPHY,1
AU,LENTICULAR OPACITIES,1
AU,LEUKAEMIA,1
AU,LEUKOENCEPHALOPATHY,1
AU,LIMB INJURY,1
AU,LIPASE INCREASED,1
AU,LISTLESS,1
AU,LIVER FUNCTION TEST ABNORMAL,1
AU,LOBAR PNEUMONIA,1
AU,LOCAL SWELLING,1
AU,LOCALISED INFECTION,1
AU,LOW DENSITY LIPOPROTEIN INCREASED,1
AU,LUNG ABSCESS,1
AU,LUNG INFECTION,1
AU,LYMPHOEDEMA,1
AU,MANTLE CELL LYMPHOMA,1
AU,MEAN CELL VOLUME INCREASED,1
AU,MEDICATION ERROR,1
AU,MEDICATION MONITORING ERROR,1
AU,MELAENA,1
AU,MELANOCYTIC NAEVUS,1
AU,METASTASES TO LUNG,1
AU,METASTASES TO OVARY,1
AU,METASTATIC SQUAMOUS CELL CARCINOMA,1
AU,MIGRAINE,1
AU,MITRAL VALVE PROLAPSE,1
AU,MONOCYTE COUNT INCREASED,1
AU,MOVEMENT DISORDER,1
AU,MUCOUS MEMBRANE DISORDER,1
AU,MULTI-ORGAN DISORDER,1
AU,MULTI-ORGAN FAILURE,1
AU,MUSCLE RIGIDITY,1
AU,MUSCLE SPASMS,1
AU,MUSCULOSKELETAL CHEST PAIN,1
AU,MYIASIS,1
AU,MYOCARDIAL ISCHAEMIA,1
AU,MYOCARDIAL STRAIN,1
AU,MYOSITIS,1
AU,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
AU,NECK PAIN,1
AU,NECROTISING MYOSITIS,1
AU,NEOPLASM PROSTATE,1
AU,NEPHROLITHIASIS,1
AU,NERVE COMPRESSION,1
AU,NEUROLOGICAL DECOMPENSATION,1
AU,NEUTROPHIL COUNT DECREASED,1
AU,NEUTROPHIL COUNT INCREASED,1
AU,NIGHTMARE,1
AU,NO ADVERSE EVENT,1
AU,NOCTURIA,1
AU,NON-CARDIOGENIC PULMONARY OEDEMA,1
AU,NYSTAGMUS,1
AU,OBSESSIVE-COMPULSIVE DISORDER,1
AU,OEDEMA,1
AU,OESOPHAGEAL STENOSIS,1
AU,OLIGURIA,1
AU,OSTEITIS DEFORMANS,1
AU,OSTEOMYELITIS,1
AU,OSTEONECROSIS OF JAW,1
AU,OSTEOPENIA,1
AU,OXYGEN SATURATION ABNORMAL,1
AU,PAIN IN EXTREMITY,1
AU,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
AU,PALPITATIONS,1
AU,PANCREATIC CARCINOMA,1
AU,PANCREATIC ENZYMES INCREASED,1
AU,PANCREATITIS,1
AU,PARKINSONISM,1
AU,PATHOGEN RESISTANCE,1
AU,PERICARDIAL EFFUSION,1
AU,PERIPHERAL ARTERY ANEURYSM,1
AU,PERIPHERAL EMBOLISM,1
AU,PERIPHERAL ISCHAEMIA,1
AU,PERIPHERAL SWELLING,1
AU,PERITONITIS,1
AU,PHYSICAL ASSAULT,1
AU,PILONIDAL CYST,1
AU,PLASMA CELL MYELOMA,1
AU,POISONING DELIBERATE,1
AU,POLYDIPSIA,1
AU,POLYMYALGIA RHEUMATICA,1
AU,POLYURIA,1
AU,POST PROCEDURAL HAEMORRHAGE,1
AU,PRODUCT QUALITY ISSUE,1
AU,PROSTATE CANCER,1
AU,PROSTATOMEGALY,1
AU,PULMONARY ARTERIAL HYPERTENSION,1
AU,PULMONARY ARTERIAL WEDGE PRESSURE INCREASED,1
AU,PULMONARY MASS,1
AU,RED BLOOD CELL COUNT ABNORMAL,1
AU,RED BLOOD CELLS URINE POSITIVE,1
AU,RENAL AMYLOIDOSIS,1
AU,RENAL ARTERIOSCLEROSIS,1
AU,RENAL CANCER,1
AU,RENAL GRAFT INFECTION,1
AU,RENAL INJURY,1
AU,RENAL SURGERY,1
AU,RENAL TUBULAR ATROPHY,1
AU,RESPIRATORY DEPRESSION,1
AU,RESPIRATORY TRACT INFECTION,1
AU,RETINAL ARTERY OCCLUSION,1
AU,RETINAL DETACHMENT,1
AU,RIGHT VENTRICULAR FAILURE,1
AU,RIGHT VENTRICULAR HYPERTROPHY,1
AU,RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED,1
AU,ROTATOR CUFF SYNDROME,1
AU,SCAR,1
AU,SCOLIOSIS,1
AU,SEDATION,1
AU,SENSORY LOSS,1
AU,SEPTIC SHOCK,1
AU,SKIN CANCER,1
AU,SKIN CANDIDA,1
AU,SKIN GRAFT,1
AU,SKIN INFECTION,1
AU,SKIN NEOPLASM EXCISION,1
AU,SKIN PAPILLOMA,1
AU,SMALL CELL LUNG CANCER METASTATIC,1
AU,SMALL INTESTINE CARCINOMA,1
AU,SNORING,1
AU,SOMNOLENCE,1
AU,SPEECH DISORDER,1
AU,SPINAL COLUMN STENOSIS,1
AU,SPUTUM DISCOLOURED,1
AU,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,1
AU,STAPHYLOCOCCAL INFECTION,1
AU,STAPHYLOCOCCAL SEPSIS,1
AU,SUICIDAL BEHAVIOUR,1
AU,SUICIDAL IDEATION,1
AU,SYSTOLIC DYSFUNCTION,1
AU,TEMPERATURE INTOLERANCE,1
AU,TENDERNESS,1
AU,THIRST,1
AU,THROMBOCYTOPENIA,1
AU,THROMBOSIS,1
AU,THROMBOTIC STROKE,1
AU,TOE AMPUTATION,1
AU,TONGUE DRY,1
AU,TOOTH DISORDER,1
AU,TRANSFERRIN SATURATION DECREASED,1
AU,TRANSPLANT DYSFUNCTION,1
AU,TRANSPLANT REJECTION,1
AU,TRAUMATIC HAEMORRHAGE,1
AU,TRICUSPID VALVE INCOMPETENCE,1
AU,TROPONIN T INCREASED,1
AU,TRYPTASE INCREASED,1
AU,ULTRASOUND SCAN ABNORMAL,1
AU,UNDERDOSE,1
AU,UPPER LIMB FRACTURE,1
AU,URETERIC OBSTRUCTION,1
AU,URINARY RETENTION,1
AU,URINE ALBUMIN/CREATININE RATIO INCREASED,1
AU,URINE FLOW DECREASED,1
AU,URINE OUTPUT DECREASED,1
AU,VENTRICULAR EXTRASYSTOLES,1
AU,VICTIM OF SPOUSAL ABUSE,1
AU,VITAMIN D DEFICIENCY,1
AU,WEIGHT ABNORMAL,1
AU,WEIGHT BEARING DIFFICULTY,1
AU,WHITE BLOOD CELL COUNT ABNORMAL,1
AU,WHITE BLOOD CELL COUNT DECREASED,1
AU,WHITE BLOOD CELLS URINE POSITIVE,1
AU,WHITE MATTER LESION,1
AU,WOUND COMPLICATION,1
AU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
AT,ANAEMIA,21
AT,CEREBROVASCULAR ACCIDENT,15
AT,DIZZINESS,13
AT,DIARRHOEA,12
AT,GASTROINTESTINAL HAEMORRHAGE,12
AT,NAUSEA,12
AT,FATIGUE,10
AT,MOVEMENT DISORDER,10
AT,GENERAL PHYSICAL HEALTH DETERIORATION,9
AT,HAEMORRHAGE,9
AT,PNEUMONIA,9
AT,RENAL IMPAIRMENT,9
AT,DEATH,8
AT,MYALGIA,8
AT,SYNCOPE,8
AT,ARTHRALGIA,7
AT,HEADACHE,7
AT,INFECTION,7
AT,REDUCED FACIAL EXPRESSION,7
AT,SOMNOLENCE,7
AT,BLOOD PRESSURE DECREASED,6
AT,DELIRIUM,6
AT,DRUG INEFFECTIVE,6
AT,HYPERTENSION,6
AT,OEDEMA PERIPHERAL,6
AT,RASH,6
AT,TARDIVE DYSKINESIA,6
AT,THYROIDITIS,6
AT,ALTERED STATE OF CONSCIOUSNESS,5
AT,ASTHENIA,5
AT,CIRCULATORY COLLAPSE,5
AT,CONVULSION,5
AT,CORONARY ARTERY DISEASE,5
AT,DYSPNOEA,5
AT,GAIT DISTURBANCE,5
AT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
AT,RHABDOMYOLYSIS,5
AT,SEPSIS,5
AT,URINARY TRACT INFECTION,5
AT,VERTIGO,5
AT,ACUTE MYOCARDIAL INFARCTION,4
AT,APHASIA,4
AT,BLOOD CREATININE INCREASED,4
AT,BLOOD GLUCOSE INCREASED,4
AT,BLOOD LACTATE DEHYDROGENASE INCREASED,4
AT,C-REACTIVE PROTEIN INCREASED,4
AT,CARDIAC ARREST,4
AT,CARDIAC FAILURE,4
AT,CHRONIC GASTRITIS,4
AT,EPIDIDYMITIS,4
AT,FALL,4
AT,HAEMATOMA,4
AT,HYPERTHYROIDISM,4
AT,HYPOTHYROIDISM,4
AT,ISCHAEMIA,4
AT,ISCHAEMIC STROKE,4
AT,LEUKOPENIA,4
AT,MALAISE,4
AT,METASTASES TO LIVER,4
AT,OBESITY,4
AT,PSORIASIS,4
AT,PYREXIA,4
AT,RENAL FAILURE,4
AT,STOMATITIS,4
AT,THROMBOCYTOPENIA,4
AT,WEIGHT DECREASED,4
AT,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,3
AT,AMAUROSIS,3
AT,ARTERIOSCLEROSIS CORONARY ARTERY,3
AT,ASPIRATION,3
AT,ATRIAL FIBRILLATION,3
AT,BLOOD INSULIN ABNORMAL,3
AT,BLOOD PRESSURE INADEQUATELY CONTROLLED,3
AT,BLOOD PRESSURE INCREASED,3
AT,CEREBELLAR INFARCTION,3
AT,CEREBRAL HAEMORRHAGE,3
AT,CEREBRAL ISCHAEMIA,3
AT,CHEST PAIN,3
AT,COUGH,3
AT,DECREASED APPETITE,3
AT,DEHYDRATION,3
AT,DELUSIONAL DISORDER_ UNSPECIFIED TYPE,3
AT,DEMENTIA,3
AT,DEPRESSION,3
AT,DIPLOPIA,3
AT,DISORIENTATION,3
AT,ELECTROLYTE IMBALANCE,3
AT,FEELING ABNORMAL,3
AT,GASTROENTERITIS,3
AT,HEPATIC CIRRHOSIS,3
AT,HYPERCHOLESTEROLAEMIA,3
AT,HYPERHIDROSIS,3
AT,HYPERTENSIVE CRISIS,3
AT,HYPOTENSION,3
AT,INFLUENZA,3
AT,INSOMNIA,3
AT,MELAENA,3
AT,MITRAL VALVE INCOMPETENCE,3
AT,MUSCULAR WEAKNESS,3
AT,MYOCARDIAL INFARCTION,3
AT,OSTEITIS,3
AT,PANCREATIC CARCINOMA,3
AT,PORPHYRIA NON-ACUTE,3
AT,PROTHROMBIN TIME SHORTENED,3
AT,PRURITUS,3
AT,PULMONARY OEDEMA,3
AT,RENAL FAILURE ACUTE,3
AT,TACHYCARDIA,3
AT,TOXICITY TO VARIOUS AGENTS,3
AT,UROSEPSIS,3
AT,ABDOMINAL PAIN,2
AT,ABDOMINAL PAIN UPPER,2
AT,ACUTE KIDNEY INJURY,2
AT,ADENOCARCINOMA PANCREAS,2
AT,AGGRESSION,2
AT,AKATHISIA,2
AT,APLASTIC ANAEMIA,2
AT,ATAXIA,2
AT,BASAL CELL CARCINOMA,2
AT,BLADDER CANCER,2
AT,BLOOD CHOLESTEROL INCREASED,2
AT,BRAIN OEDEMA,2
AT,COGNITIVE DISORDER,2
AT,CONDUCT DISORDER,2
AT,CONGESTIVE CARDIOMYOPATHY,2
AT,CONJUNCTIVITIS,2
AT,CONSTIPATION,2
AT,CORONARY ARTERY STENOSIS,2
AT,DEEP VEIN THROMBOSIS,2
AT,DISSEMINATED INTRAVASCULAR COAGULATION,2
AT,DRUG-INDUCED LIVER INJURY,2
AT,DYSAESTHESIA,2
AT,DYSPNOEA EXERTIONAL,2
AT,ECZEMA,2
AT,EJECTION FRACTION DECREASED,2
AT,EMPHYSEMA,2
AT,EPILEPSY,2
AT,EPISTAXIS,2
AT,EYELID OEDEMA,2
AT,FEBRILE NEUTROPENIA,2
AT,GOUTY ARTHRITIS,2
AT,HEMIPARESIS,2
AT,HYPOKALAEMIA,2
AT,HYPONATRAEMIA,2
AT,IMPAIRED HEALING,2
AT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
AT,INDIFFERENCE,2
AT,INTERVERTEBRAL DISC PROTRUSION,2
AT,KERATITIS,2
AT,LEFT VENTRICULAR HYPERTROPHY,2
AT,LISTLESS,2
AT,LYMPHADENOPATHY,2
AT,MUSCLE RIGIDITY,2
AT,NASOPHARYNGITIS,2
AT,NON-ALCOHOLIC STEATOHEPATITIS,2
AT,PAIN IN EXTREMITY,2
AT,PALLOR,2
AT,PARANOIA,2
AT,PLATELET ANISOCYTOSIS,2
AT,PLATELET COUNT DECREASED,2
AT,PNEUMONITIS,2
AT,POST PROCEDURAL HAEMORRHAGE,2
AT,PROSTATE CANCER RECURRENT,2
AT,PSYCHOTIC DISORDER,2
AT,PULMONARY EMBOLISM,2
AT,RALES,2
AT,RECTAL ADENOCARCINOMA,2
AT,RESTLESS LEGS SYNDROME,2
AT,RETCHING,2
AT,SALIVARY HYPERSECRETION,2
AT,SEDATION,2
AT,SPEECH DISORDER,2
AT,SPINAL OSTEOARTHRITIS,2
AT,SPLENOMEGALY,2
AT,SUBDURAL HAEMATOMA,2
AT,SUICIDE ATTEMPT,2
AT,THROMBOSIS,2
AT,TRACHEAL PAIN,2
AT,TRANSFERRIN DECREASED,2
AT,TRANSIENT ISCHAEMIC ATTACK,2
AT,URINARY RETENTION,2
AT,URTICARIA,2
AT,VISUAL IMPAIRMENT,2
AT,VOMITING,2
AT,ABDOMINAL DISTENSION,1
AT,ABNORMAL BEHAVIOUR,1
AT,ABSCESS JAW,1
AT,ABSCESS ORAL,1
AT,ACNE PUSTULAR,1
AT,ACTINIC KERATOSIS,1
AT,ADENOCARCINOMA,1
AT,ALANINE AMINOTRANSFERASE INCREASED,1
AT,ALCOHOL POISONING,1
AT,ALCOHOLISM,1
AT,ALOPECIA,1
AT,AMAUROSIS FUGAX,1
AT,AMNESIA,1
AT,AMYLASE DECREASED,1
AT,ANAL FISTULA,1
AT,ANGINA PECTORIS,1
AT,ANGIOEDEMA,1
AT,ANXIETY,1
AT,AORTIC ARTERIOSCLEROSIS,1
AT,AORTIC DISORDER,1
AT,AORTIC STENOSIS,1
AT,AORTIC VALVE CALCIFICATION,1
AT,AORTIC VALVE INCOMPETENCE,1
AT,AORTIC VALVE SCLEROSIS,1
AT,APRAXIA,1
AT,ARTERIAL OCCLUSIVE DISEASE,1
AT,ARTERIOSCLEROSIS,1
AT,ARTERIOSCLEROSIS MOENCKEBERG-TYPE,1
AT,ATELECTASIS,1
AT,ATRIOVENTRICULAR BLOCK,1
AT,B-CELL LYMPHOMA,1
AT,BACK PAIN,1
AT,BENIGN PROSTATIC HYPERPLASIA,1
AT,BIFASCICULAR BLOCK,1
AT,BILE DUCT STONE,1
AT,BIPOLAR DISORDER,1
AT,BLADDER TRABECULATION,1
AT,BLADDER TRANSITIONAL CELL CARCINOMA,1
AT,BLINDNESS UNILATERAL,1
AT,BLOOD ALCOHOL INCREASED,1
AT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
AT,BLOOD BILIRUBIN INCREASED,1
AT,BLOOD CALCIUM DECREASED,1
AT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AT,BLOOD ELECTROLYTES ABNORMAL,1
AT,BLOOD GLUCOSE ABNORMAL,1
AT,BLOOD PHOSPHORUS DECREASED,1
AT,BLOOD PROLACTIN INCREASED,1
AT,BLOOD UREA DECREASED,1
AT,BONE GIANT CELL TUMOUR,1
AT,BRADYKINESIA,1
AT,BRAIN STEM HAEMORRHAGE,1
AT,BRAIN STEM INFARCTION,1
AT,BREAST CANCER METASTATIC,1
AT,BRONCHIAL CARCINOMA,1
AT,BRONCHIECTASIS,1
AT,BRONCHIOLITIS,1
AT,BRONCHITIS,1
AT,BRONCHITIS BACTERIAL,1
AT,BRONCHOPNEUMONIA,1
AT,BURNING SENSATION,1
AT,CANCER PAIN,1
AT,CANDIDA INFECTION,1
AT,CARBOHYDRATE ANTIGEN 15-3 INCREASED,1
AT,CARCINOEMBRYONIC ANTIGEN INCREASED,1
AT,CARCINOMA IN SITU,1
AT,CARDIAC DISORDER,1
AT,CARDIAC FAILURE CHRONIC,1
AT,CARDIAC FAILURE CONGESTIVE,1
AT,CARDIAC HYPERTROPHY,1
AT,CARDIAC MURMUR,1
AT,CARDIOMEGALY,1
AT,CAROTID ARTERY STENOSIS,1
AT,CARPAL TUNNEL SYNDROME,1
AT,CATATONIA,1
AT,CENTRAL NERVOUS SYSTEM LESION,1
AT,CHEST DISCOMFORT,1
AT,CHILLS,1
AT,CHOLANGITIS INFECTIVE,1
AT,CHOLECYSTECTOMY,1
AT,CHOLECYSTITIS,1
AT,CHOLELITHIASIS,1
AT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AT,CHRONIC SINUSITIS,1
AT,CLAVICLE FRACTURE,1
AT,COLITIS,1
AT,COLON ADENOMA,1
AT,COMA,1
AT,COMPLETED SUICIDE,1
AT,CONDITION AGGRAVATED,1
AT,CORONARY ARTERY INSUFFICIENCY,1
AT,CORONARY ARTERY OCCLUSION,1
AT,CREATININE RENAL CLEARANCE DECREASED,1
AT,CUTANEOUS LUPUS ERYTHEMATOSUS,1
AT,CYSTITIS,1
AT,CYTOMEGALOVIRUS INFECTION,1
AT,CYTOPENIA,1
AT,DEAFNESS,1
AT,DELUSION,1
AT,DEMENTIA ALZHEIMER^S TYPE,1
AT,DERMATITIS ALLERGIC,1
AT,DEVICE CONNECTION ISSUE,1
AT,DEVICE ISSUE,1
AT,DEVICE KINK,1
AT,DEVICE RELATED INFECTION,1
AT,DIABETES MELLITUS,1
AT,DIABETES MELLITUS INADEQUATE CONTROL,1
AT,DIABETIC KETOACIDOSIS,1
AT,DIABETIC NEPHROPATHY,1
AT,DIABETIC NEUROPATHY,1
AT,DIAPHRAGMATIC HERNIA,1
AT,DISCOMFORT,1
AT,DISEASE PROGRESSION,1
AT,DISTURBANCE IN ATTENTION,1
AT,DIVERTICULITIS,1
AT,DIZZINESS POSTURAL,1
AT,DRUG DOSE OMISSION,1
AT,DRUG ERUPTION,1
AT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
AT,DRUG INTOLERANCE,1
AT,DRUG LEVEL INCREASED,1
AT,DRY SKIN,1
AT,DUODENAL ULCER,1
AT,DYSARTHRIA,1
AT,DYSKINESIA,1
AT,DYSPHONIA,1
AT,ELECTROCARDIOGRAM QT PROLONGED,1
AT,EROSIVE DUODENITIS,1
AT,ERYSIPELAS,1
AT,ERYTHEMA,1
AT,ERYTHROLEUKAEMIA,1
AT,EXTRAPYRAMIDAL DISORDER,1
AT,EYE INFECTION,1
AT,FEMORAL NECK FRACTURE,1
AT,FIBRIN D DIMER,1
AT,FISTULA,1
AT,FLUID RETENTION,1
AT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
AT,GASTRITIS,1
AT,GASTRODUODENITIS,1
AT,GASTROENTERITIS SALMONELLA,1
AT,GASTROINTESTINAL INFECTION,1
AT,GENERAL PHYSICAL CONDITION ABNORMAL,1
AT,GLAUCOMA,1
AT,GLOMERULAR FILTRATION RATE DECREASED,1
AT,GOITRE,1
AT,GRAND MAL CONVULSION,1
AT,HAEMATOCHEZIA,1
AT,HAEMODIALYSIS,1
AT,HAEMOGLOBIN DECREASED,1
AT,HALLUCINATION,1
AT,HEMIPLEGIA,1
AT,HEPATIC ADENOMA,1
AT,HEPATIC ENZYME INCREASED,1
AT,HEPATIC LESION,1
AT,HEPATIC STEATOSIS,1
AT,HICCUPS,1
AT,HOSPITALISATION,1
AT,HYDROTHORAX,1
AT,HYPERGLYCAEMIA,1
AT,HYPERLIPIDAEMIA,1
AT,HYPERSENSITIVITY VASCULITIS,1
AT,HYPERTHERMIA,1
AT,HYPERTONIA,1
AT,HYPERTRIGLYCERIDAEMIA,1
AT,HYPERTROPHY,1
AT,HYPERURICAEMIA,1
AT,HYPOGLYCAEMIA,1
AT,HYPOKINESIA,1
AT,HYPOPHYSITIS,1
AT,HYPOXIA,1
AT,ILEITIS,1
AT,IMMOBILE,1
AT,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
AT,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
AT,INCISIONAL HERNIA,1
AT,INFECTION SUSCEPTIBILITY INCREASED,1
AT,INFERIOR VENA CAVA DILATATION,1
AT,INHIBITORY DRUG INTERACTION,1
AT,INTENTIONAL DOSE OMISSION,1
AT,INTERNATIONAL NORMALISED RATIO INCREASED,1
AT,INTESTINAL PERFORATION,1
AT,IRON DEFICIENCY ANAEMIA,1
AT,ISCHAEMIC CEREBRAL INFARCTION,1
AT,JAUNDICE,1
AT,JOINT DISLOCATION,1
AT,KERATOSIS FOLLICULAR,1
AT,KETOACIDOSIS,1
AT,KYPHOSIS,1
AT,LEFT VENTRICULAR FAILURE,1
AT,LETHARGY,1
AT,LEUKOCYTOSIS,1
AT,LIMB DEFORMITY,1
AT,LIVER DISORDER,1
AT,LUMBAR PUNCTURE,1
AT,LUNG ADENOCARCINOMA STAGE III,1
AT,LUNG CONSOLIDATION,1
AT,LUNG DISORDER,1
AT,LUNG INFECTION,1
AT,LUNG NEOPLASM MALIGNANT,1
AT,MALIGNANT NEOPLASM PROGRESSION,1
AT,MEDICAL DEVICE COMPLICATION,1
AT,MENTAL DISORDER,1
AT,METABOLIC ACIDOSIS,1
AT,METASTASES TO CENTRAL NERVOUS SYSTEM,1
AT,METASTASES TO LUNG,1
AT,MOOD ALTERED,1
AT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
AT,MUSCULOSKELETAL STIFFNESS,1
AT,MYOCARDIAL ISCHAEMIA,1
AT,NECK PAIN,1
AT,NECROSIS,1
AT,NEOPLASM MALIGNANT,1
AT,NEPHRITIS,1
AT,NEPHROTIC SYNDROME,1
AT,NEUROPATHY PERIPHERAL,1
AT,NEUTROPENIA,1
AT,NOCTURNAL DYSPNOEA,1
AT,NON-SMALL CELL LUNG CANCER,1
AT,OEDEMA,1
AT,OESOPHAGEAL ULCER,1
AT,ON AND OFF PHENOMENON,1
AT,OROPHARYNGEAL CANCER,1
AT,OSTEOMYELITIS,1
AT,OSTEONECROSIS OF JAW,1
AT,OVERDOSE,1
AT,PAIN,1
AT,PANCREATIC STEATOSIS,1
AT,PANCREATITIS,1
AT,PANCYTOPENIA,1
AT,PANOPHTHALMITIS,1
AT,PAPILLARY THYROID CANCER,1
AT,PARKINSONISM,1
AT,PARKINSON^S DISEASE,1
AT,PERICARDIAL EFFUSION,1
AT,PERIODONTITIS,1
AT,PERIPHERAL ARTERY STENOSIS,1
AT,PERIPHERAL ARTERY THROMBOSIS,1
AT,PERIPHERAL SENSORY NEUROPATHY,1
AT,PERITONITIS,1
AT,PHARYNGEAL HAEMORRHAGE,1
AT,PLEURAL EFFUSION,1
AT,PLEURISY,1
AT,POISONING,1
AT,POLYCYTHAEMIA,1
AT,POLYDIPSIA PSYCHOGENIC,1
AT,POLYNEUROPATHY,1
AT,POST PROCEDURAL HAEMATOMA,1
AT,PRERENAL FAILURE,1
AT,PRODUCT USE IN UNAPPROVED INDICATION,1
AT,PROTEIN TOTAL DECREASED,1
AT,PSEUDOPORPHYRIA,1
AT,PULMONARY ARTERY DILATATION,1
AT,PULMONARY CONGESTION,1
AT,PULMONARY FIBROSIS,1
AT,PULMONARY HAEMORRHAGE,1
AT,PULMONARY INFARCTION,1
AT,PULMONARY MASS,1
AT,PULMONARY VALVE INCOMPETENCE,1
AT,PYELOCYSTITIS,1
AT,RASH MACULO-PAPULAR,1
AT,RASH PUSTULAR,1
AT,RENAL CANCER,1
AT,RENAL COLIC,1
AT,RENAL FAILURE CHRONIC,1
AT,RENAL NEOPLASM,1
AT,RENAL TRANSPLANT FAILURE,1
AT,RESPIRATORY FATIGUE,1
AT,RESTLESSNESS,1
AT,RETINAL ISCHAEMIA,1
AT,REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT,1
AT,ROAD TRAFFIC ACCIDENT,1
AT,SCOLIOSIS,1
AT,SECOND PRIMARY MALIGNANCY,1
AT,SINUSITIS,1
AT,SKIN CANCER,1
AT,SKULL FRACTURE,1
AT,SNEEZING,1
AT,STAPHYLOCOCCAL SEPSIS,1
AT,SUICIDAL IDEATION,1
AT,TENDONITIS,1
AT,THERAPEUTIC RESPONSE DECREASED,1
AT,THROAT TIGHTNESS,1
AT,THROMBIN TIME PROLONGED,1
AT,TOE AMPUTATION,1
AT,TOOTH IMPACTED,1
AT,TOOTH LOSS,1
AT,TRANSAMINASES INCREASED,1
AT,TRICUSPID VALVE INCOMPETENCE,1
AT,TUBERCULOUS PLEURISY,1
AT,TYPE 2 DIABETES MELLITUS,1
AT,UPPER RESPIRATORY TRACT INFECTION,1
AT,URETEROLITHIASIS,1
AT,URETHRAL CARUNCLE,1
AT,UVEITIS,1
AT,VASCULAR ENCEPHALOPATHY,1
AT,VENOUS OCCLUSION,1
AT,VENTRICULAR ARRHYTHMIA,1
AT,VENTRICULAR HYPOKINESIA,1
AT,VENTRICULAR TACHYCARDIA,1
AT,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
AT,VISUAL ACUITY REDUCED,1
AT,VITAMIN B12 DEFICIENCY,1
AT,WEIGHT INCREASED,1
AT,WHITE BLOOD CELL COUNT DECREASED,1
BB,ACUTE MYOCARDIAL INFARCTION,1
BB,DRY SKIN,1
BB,MYOCARDIAL ISCHAEMIA,1
BB,PARAPSORIASIS,1
BB,RASH ERYTHEMATOUS,1
BB,RASH PAPULAR,1
BE,GENERAL PHYSICAL HEALTH DETERIORATION,23
BE,NAUSEA,17
BE,DIARRHOEA,16
BE,ACUTE KIDNEY INJURY,13
BE,ASTHENIA,13
BE,DEATH,13
BE,FALL,13
BE,VOMITING,13
BE,PYREXIA,12
BE,DECREASED APPETITE,11
BE,DYSPNOEA,11
BE,MALAISE,11
BE,WEIGHT DECREASED,11
BE,DYSKINESIA,10
BE,FATIGUE,10
BE,PNEUMONIA,10
BE,ANAEMIA,8
BE,CEREBROVASCULAR ACCIDENT,8
BE,CONFUSIONAL STATE,8
BE,RENAL FAILURE,8
BE,CARDIAC FAILURE,7
BE,MYOCARDIAL INFARCTION,7
BE,OSTEONECROSIS OF JAW,7
BE,SINUS BRADYCARDIA,7
BE,ENCEPHALOPATHY,6
BE,OESOPHAGITIS,6
BE,ABDOMINAL PAIN UPPER,5
BE,BRONCHITIS,5
BE,CHEST PAIN,5
BE,DRUG INEFFECTIVE,5
BE,GASTROINTESTINAL HAEMORRHAGE,5
BE,HAEMORRHAGE,5
BE,HEADACHE,5
BE,HEPATIC FAILURE,5
BE,HYPOTENSION,5
BE,LOSS OF CONSCIOUSNESS,5
BE,MYALGIA,5
BE,RHABDOMYOLYSIS,5
BE,FEBRILE NEUTROPENIA,4
BE,FREEZING PHENOMENON,4
BE,GAIT DISTURBANCE,4
BE,HEPATITIS TOXIC,4
BE,HYPERGLYCAEMIA,4
BE,HYPOKALAEMIA,4
BE,HYPONATRAEMIA,4
BE,INFECTION,4
BE,IRON DEFICIENCY ANAEMIA,4
BE,NEUTROPENIA,4
BE,ON AND OFF PHENOMENON,4
BE,RENAL IMPAIRMENT,4
BE,RESPIRATORY FAILURE,4
BE,SEPSIS,4
BE,SEPTIC SHOCK,4
BE,TOXICITY TO VARIOUS AGENTS,4
BE,TREMOR,4
BE,ABDOMINAL PAIN,3
BE,ACUTE MYOCARDIAL INFARCTION,3
BE,ADVERSE EVENT,3
BE,ALANINE AMINOTRANSFERASE INCREASED,3
BE,ANXIETY,3
BE,ASPARTATE AMINOTRANSFERASE INCREASED,3
BE,ATRIAL FIBRILLATION,3
BE,BACK PAIN,3
BE,BLOOD CREATININE INCREASED,3
BE,CARDIAC DISORDER,3
BE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
BE,COUGH,3
BE,DIZZINESS,3
BE,DYSPEPSIA,3
BE,DYSPHAGIA,3
BE,ELECTROCARDIOGRAM QT PROLONGED,3
BE,EPILEPSY,3
BE,HIP FRACTURE,3
BE,HYPERKALAEMIA,3
BE,HYPERTENSION,3
BE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
BE,INTERSTITIAL LUNG DISEASE,3
BE,MALIGNANT NEOPLASM PROGRESSION,3
BE,MUSCLE RIGIDITY,3
BE,PARANOIA,3
BE,POLYNEUROPATHY,3
BE,PRURITUS,3
BE,PULMONARY EMBOLISM,3
BE,SUDDEN DEATH,3
BE,TRANSIENT ISCHAEMIC ATTACK,3
BE,URINARY TRACT INFECTION,3
BE,AGITATION,2
BE,ALTERED STATE OF CONSCIOUSNESS,2
BE,ARTERIOSCLEROSIS,2
BE,ASCITES,2
BE,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
BE,BLOOD PARATHYROID HORMONE DECREASED,2
BE,BRADYCARDIA,2
BE,C-REACTIVE PROTEIN INCREASED,2
BE,CACHEXIA,2
BE,CARDIAC ARREST,2
BE,CARDIOGENIC SHOCK,2
BE,CARDIOMYOPATHY,2
BE,CEREBRAL HAEMORRHAGE,2
BE,CHRONIC KIDNEY DISEASE,2
BE,COGNITIVE DISORDER,2
BE,CROHN^S DISEASE,2
BE,CYSTITIS,2
BE,DEEP VEIN THROMBOSIS,2
BE,DEHYDRATION,2
BE,DERMATITIS ALLERGIC,2
BE,DEVICE DISLOCATION,2
BE,DEVICE OCCLUSION,2
BE,DIABETES MELLITUS,2
BE,DIPLOPIA,2
BE,DISCOMFORT,2
BE,DISSEMINATED INTRAVASCULAR COAGULATION,2
BE,DRUG ADMINISTRATION ERROR,2
BE,DRUG EFFECT INCOMPLETE,2
BE,DRUG INTOLERANCE,2
BE,DYSGEUSIA,2
BE,DYSPNOEA EXERTIONAL,2
BE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,2
BE,EPISTAXIS,2
BE,ERYTHEMA,2
BE,EXTRASYSTOLES,2
BE,FACIAL BONES FRACTURE,2
BE,FLUSHING,2
BE,GASTROINTESTINAL DISORDER,2
BE,GENERALISED TONIC-CLONIC SEIZURE,2
BE,HAEMATOMA,2
BE,HAEMATURIA,2
BE,HEMIPARESIS,2
BE,HEPATITIS,2
BE,HEPATITIS ACUTE,2
BE,HEPATOCELLULAR CARCINOMA,2
BE,HYPERHIDROSIS,2
BE,HYPOCALCAEMIA,2
BE,HYPOGLYCAEMIA,2
BE,HYPOKINESIA,2
BE,HYPOPHAGIA,2
BE,HYPOXIA,2
BE,INFLAMMATION,2
BE,INFLUENZA LIKE ILLNESS,2
BE,INSOMNIA,2
BE,INTERNATIONAL NORMALISED RATIO INCREASED,2
BE,INTESTINAL ISCHAEMIA,2
BE,ISCHAEMIC CARDIOMYOPATHY,2
BE,JAUNDICE,2
BE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
BE,LARGE INTESTINE PERFORATION,2
BE,LUNG DISORDER,2
BE,MEMORY IMPAIRMENT,2
BE,METABOLIC ACIDOSIS,2
BE,METASTASES TO LIVER,2
BE,METASTASES TO STOMACH,2
BE,MICROCYTIC ANAEMIA,2
BE,MOBILITY DECREASED,2
BE,MUSCULAR WEAKNESS,2
BE,MYASTHENIA GRAVIS,2
BE,NEPHRITIS,2
BE,NEPHROPATHY,2
BE,OEDEMA,2
BE,ORTHOSTATIC HYPOTENSION,2
BE,PAIN,2
BE,PAIN IN EXTREMITY,2
BE,PALLOR,2
BE,PANCREATIC CARCINOMA,2
BE,PANCREATITIS ACUTE,2
BE,PERITONITIS,2
BE,PNEUMONIA ASPIRATION,2
BE,PRESCRIBED UNDERDOSE,2
BE,PSYCHIATRIC DECOMPENSATION,2
BE,PULMONARY HAEMORRHAGE,2
BE,PULMONARY OEDEMA,2
BE,RENAL FAILURE ACUTE,2
BE,SEDATION,2
BE,SHOCK HAEMORRHAGIC,2
BE,SMALL INTESTINAL OBSTRUCTION,2
BE,SOMNOLENCE,2
BE,STOMA SITE DISCHARGE,2
BE,STOMA SITE INFECTION,2
BE,STRESS,2
BE,SYNCOPE,2
BE,TERMINAL STATE,2
BE,THROMBOCYTOPENIA,2
BE,TORSADE DE POINTES,2
BE,TREATMENT FAILURE,2
BE,TROPONIN INCREASED,2
BE,URINARY INCONTINENCE,2
BE,VAGINAL HAEMORRHAGE,2
BE,VENTRICULAR TACHYCARDIA,2
BE,VERTIGO,2
BE,VIRAL INFECTION,2
BE,VISION BLURRED,2
BE,5-HYDROXYINDOLACETIC ACID IN URINE DECREASED,1
BE,ABASIA,1
BE,ABDOMINAL ABSCESS,1
BE,ABDOMINAL DISCOMFORT,1
BE,ABDOMINAL DISTENSION,1
BE,ABNORMAL BEHAVIOUR,1
BE,ABNORMAL DREAMS,1
BE,ABNORMAL LOSS OF WEIGHT,1
BE,ABORTION INDUCED,1
BE,ABSCESS JAW,1
BE,ACCIDENTAL OVERDOSE,1
BE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
BE,ACUTE CORONARY SYNDROME,1
BE,ACUTE MYELOID LEUKAEMIA,1
BE,ACUTE PULMONARY OEDEMA,1
BE,ACUTE SINUSITIS,1
BE,ADENOCARCINOMA OF COLON,1
BE,ADENOCARCINOMA PANCREAS,1
BE,AGGRESSION,1
BE,ALANINE AMINOTRANSFERASE ABNORMAL,1
BE,AMAUROSIS,1
BE,AMNESIA,1
BE,AMYLOIDOSIS SENILE,1
BE,ANAPHYLACTIC REACTION,1
BE,ANGINA PECTORIS,1
BE,ANGINA UNSTABLE,1
BE,ANGIOEDEMA,1
BE,ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE,1
BE,ANURIA,1
BE,AORTIC ANEURYSM,1
BE,AORTIC THROMBOSIS,1
BE,APATHY,1
BE,APHASIA,1
BE,APHTHOUS STOMATITIS,1
BE,APRAXIA,1
BE,ARRHYTHMIA,1
BE,ARTHRALGIA,1
BE,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
BE,ASPHYXIA,1
BE,ATRIAL THROMBOSIS,1
BE,ATROPHY,1
BE,ATYPICAL PNEUMONIA,1
BE,AZOTAEMIA,1
BE,B-CELL LYMPHOMA,1
BE,BALANCE DISORDER,1
BE,BEDRIDDEN,1
BE,BILE DUCT STONE,1
BE,BILIARY TRACT DISORDER,1
BE,BLADDER NEOPLASM,1
BE,BLADDER TRANSITIONAL CELL CARCINOMA,1
BE,BLINDNESS,1
BE,BLISTER,1
BE,BLOOD ALBUMIN DECREASED,1
BE,BLOOD ALBUMIN INCREASED,1
BE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
BE,BLOOD BILIRUBIN ABNORMAL,1
BE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
BE,BLOOD GLUCAGON INCREASED,1
BE,BLOOD GLUCOSE INCREASED,1
BE,BLOOD IMMUNOGLOBULIN E INCREASED,1
BE,BLOOD MAGNESIUM DECREASED,1
BE,BLOOD POTASSIUM ABNORMAL,1
BE,BLOOD PRESSURE DECREASED,1
BE,BLOOD URIC ACID ABNORMAL,1
BE,BLOOD URINE PRESENT,1
BE,BRAIN OEDEMA,1
BE,BRAIN STEM HAEMORRHAGE,1
BE,BRAIN STEM ISCHAEMIA,1
BE,BREAST ENLARGEMENT,1
BE,BRONCHOPNEUMONIA,1
BE,BURNING SENSATION,1
BE,BURSITIS,1
BE,CALCIPHYLAXIS,1
BE,CARCINOID CRISIS,1
BE,CARDIAC PACEMAKER INSERTION,1
BE,CARDIAC VALVE DISEASE,1
BE,CARDIO-RESPIRATORY ARREST,1
BE,CATARACT,1
BE,CATHETER SITE INFECTION,1
BE,CATHETER SITE INFLAMMATION,1
BE,CENTRAL NERVOUS SYSTEM LESION,1
BE,CLONUS,1
BE,CLOSTRIDIUM DIFFICILE COLITIS,1
BE,CLOSTRIDIUM DIFFICILE INFECTION,1
BE,COLON CANCER,1
BE,COLORECTAL CANCER METASTATIC,1
BE,COMA,1
BE,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
BE,CONCOMITANT DISEASE AGGRAVATED,1
BE,CONCOMITANT DISEASE PROGRESSION,1
BE,CONSTIPATION,1
BE,CONTUSION,1
BE,CORONARY ARTERY STENOSIS,1
BE,CREATININE URINE INCREASED,1
BE,CYTOMEGALOVIRUS INFECTION,1
BE,DENTAL CARIES,1
BE,DENTAL NECROSIS,1
BE,DEPRESSED MOOD,1
BE,DEPRESSION,1
BE,DEVICE LEAKAGE,1
BE,DEVICE RELATED INFECTION,1
BE,DEVICE USE ISSUE,1
BE,DIABETES INSIPIDUS,1
BE,DIABETES MELLITUS INADEQUATE CONTROL,1
BE,DIARRHOEA HAEMORRHAGIC,1
BE,DIASTOLIC DYSFUNCTION,1
BE,DIFFUSE LARGE B-CELL LYMPHOMA,1
BE,DIVERTICULITIS,1
BE,DIVERTICULUM,1
BE,DRUG DOSE OMISSION,1
BE,DRUG HYPERSENSITIVITY,1
BE,DRUG RESISTANCE,1
BE,DRUG-INDUCED LIVER INJURY,1
BE,DUODENAL ULCER,1
BE,DYSARTHRIA,1
BE,DYSPHONIA,1
BE,DYSPHORIA,1
BE,DYSSTASIA,1
BE,DYSTONIA,1
BE,DYSURIA,1
BE,ECCHYMOSIS,1
BE,ECZEMA,1
BE,ELECTROCARDIOGRAM ABNORMAL,1
BE,ENTERAL NUTRITION,1
BE,ENTERITIS,1
BE,ENTEROBACTER SEPSIS,1
BE,EOSINOPHILIA,1
BE,EPSTEIN-BARR VIRUS INFECTION,1
BE,ERUCTATION,1
BE,EXCESSIVE GRANULATION TISSUE,1
BE,EYELIDS PRURITUS,1
BE,FACE OEDEMA,1
BE,FACIAL ASYMMETRY,1
BE,FAECAL CALPROTECTIN INCREASED,1
BE,FAECALOMA,1
BE,FAECES DISCOLOURED,1
BE,FAECES PALE,1
BE,FEMORAL NECK FRACTURE,1
BE,FILARIASIS,1
BE,FLATULENCE,1
BE,FLUID INTAKE REDUCED,1
BE,FLUID OVERLOAD,1
BE,FOOT FRACTURE,1
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BE,GASTRIC DISORDER,1
BE,GASTRIC HAEMORRHAGE,1
BE,GASTRIC ULCER,1
BE,GASTRITIS HAEMORRHAGIC,1
BE,GASTROENTERITIS,1
BE,GASTROINTESTINAL ANGIODYSPLASIA,1
BE,GASTROINTESTINAL PAIN,1
BE,GASTROINTESTINAL TELANGIECTASIA,1
BE,GASTROINTESTINAL TRACT ADENOMA,1
BE,GASTROOESOPHAGEAL REFLUX DISEASE,1
BE,GLOMERULAR FILTRATION RATE DECREASED,1
BE,GLYCOSYLATED HAEMOGLOBIN,1
BE,GRIMACING,1
BE,HAEMOGLOBIN DECREASED,1
BE,HALLUCINATION_ VISUAL,1
BE,HEPATIC ENCEPHALOPATHY,1
BE,HEPATIC ENZYME INCREASED,1
BE,HEPATIC FUNCTION ABNORMAL,1
BE,HEPATIC NECROSIS,1
BE,HEPATITIS CHOLESTATIC,1
BE,HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME,1
BE,HERPES ZOSTER,1
BE,HIATUS HERNIA,1
BE,HIP SURGERY,1
BE,HOSPITALISATION,1
BE,HOT FLUSH,1
BE,HYDROCEPHALUS,1
BE,HYPERAESTHESIA,1
BE,HYPERCALCAEMIA,1
BE,HYPERCREATINAEMIA,1
BE,HYPEROXALURIA,1
BE,HYPERSENSITIVITY VASCULITIS,1
BE,HYPERSOMNIA,1
BE,HYPERTENSIVE CRISIS,1
BE,HYPERTROPHIC CARDIOMYOPATHY,1
BE,HYPOCHLORAEMIA,1
BE,HYPOGLYCAEMIC COMA,1
BE,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
BE,HYPOINSULINAEMIA,1
BE,HYPOVENTILATION,1
BE,ILEAL PERFORATION,1
BE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
BE,INCISION SITE CELLULITIS,1
BE,INCORRECT DOSE ADMINISTERED,1
BE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
BE,INFECTED SKIN ULCER,1
BE,INFECTIOUS COLITIS,1
BE,INFLUENZA,1
BE,INTENSIVE CARE,1
BE,INTENTIONAL DRUG MISUSE,1
BE,INTESTINAL OBSTRUCTION,1
BE,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,1
BE,INTRAVENTRICULAR HAEMORRHAGE,1
BE,INVASIVE LOBULAR BREAST CARCINOMA,1
BE,ISCHAEMIC STROKE,1
BE,JOINT STIFFNESS,1
BE,KETOACIDOSIS,1
BE,LACTIC ACIDOSIS,1
BE,LARGE INTESTINAL STENOSIS,1
BE,LARGE INTESTINAL ULCER,1
BE,LEFT VENTRICULAR FAILURE,1
BE,LETHARGY,1
BE,LEUKOENCEPHALOPATHY,1
BE,LEUKOPENIA,1
BE,LIMB INJURY,1
BE,LIP INJURY,1
BE,LIPASE ABNORMAL,1
BE,LIVER DISORDER,1
BE,LOCAL SWELLING,1
BE,LOCALISED OEDEMA,1
BE,LUNG ADENOCARCINOMA METASTATIC,1
BE,LUNG INFECTION,1
BE,LUNG INFILTRATION,1
BE,LUNG NEOPLASM,1
BE,LUNG NEOPLASM MALIGNANT,1
BE,LUNG SQUAMOUS CELL CARCINOMA STAGE III,1
BE,LYMPHADENOPATHY,1
BE,LYMPHADENOPATHY MEDIASTINAL,1
BE,LYMPHOMA,1
BE,MACULAR DEGENERATION,1
BE,MATERNAL EXPOSURE DURING PREGNANCY,1
BE,MELAENA,1
BE,MENINGITIS ENTEROCOCCAL,1
BE,MENTAL IMPAIRMENT,1
BE,MESOTHELIOMA,1
BE,METABOLIC DISORDER,1
BE,METASTASES TO BONE,1
BE,METASTASES TO CENTRAL NERVOUS SYSTEM,1
BE,MODIFIED RANKIN SCORE,1
BE,MONOPARESIS,1
BE,MOOD ALTERED,1
BE,MOVEMENT DISORDER,1
BE,MUCOSAL INFLAMMATION,1
BE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
BE,MUSCLE CONTRACTIONS INVOLUNTARY,1
BE,MUSCLE HAEMORRHAGE,1
BE,MUSCLE RUPTURE,1
BE,MUSCLE SPASMS,1
BE,MUSCULOSKELETAL PAIN,1
BE,MUSCULOSKELETAL STIFFNESS,1
BE,MYDRIASIS,1
BE,MYOCARDIAL ISCHAEMIA,1
BE,NASOPHARYNGITIS,1
BE,NEPHROANGIOSCLEROSIS,1
BE,NEPHROLITHIASIS,1
BE,NEPHROPATHY TOXIC,1
BE,NEUROENDOCRINE CARCINOMA OF THE SKIN,1
BE,NEUTROPENIC COLITIS,1
BE,NO THERAPEUTIC RESPONSE,1
BE,NOCTURIA,1
BE,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
BE,OBSTRUCTIVE UROPATHY,1
BE,OEDEMA MOUTH,1
BE,OEDEMA PERIPHERAL,1
BE,OESOPHAGEAL SPASM,1
BE,ORAL DISORDER,1
BE,ORAL HERPES,1
BE,OSTEONECROSIS,1
BE,OVERDOSE,1
BE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BE,PALPITATIONS,1
BE,PANCREATIC DISORDER,1
BE,PANCREATIC MASS,1
BE,PANCREATIC NEOPLASM,1
BE,PANCREATOLITHIASIS,1
BE,PARAESTHESIA,1
BE,PARALYSIS,1
BE,PARKINSON^S DISEASE,1
BE,PELVIC FRACTURE,1
BE,PEMPHIGOID,1
BE,PERICARDITIS,1
BE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
BE,PERIPHERAL ARTERY THROMBOSIS,1
BE,PERIPHERAL EMBOLISM,1
BE,PERIPHERAL SWELLING,1
BE,PHARYNGEAL HAEMORRHAGE,1
BE,PLATELET COUNT DECREASED,1
BE,PLEURAL EFFUSION,1
BE,PNEUMONIA HAEMOPHILUS,1
BE,PNEUMONITIS,1
BE,POLLAKIURIA,1
BE,POLYARTHRITIS,1
BE,POST PROCEDURAL FISTULA,1
BE,POST PROCEDURAL HAEMORRHAGE,1
BE,POST PROCEDURAL SEPSIS,1
BE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
BE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
BE,PRERENAL FAILURE,1
BE,PRESYNCOPE,1
BE,PRODUCT USE IN UNAPPROVED INDICATION,1
BE,PRODUCTIVE COUGH,1
BE,PROSTATE CANCER,1
BE,PROTHROMBIN LEVEL DECREASED,1
BE,PROTHROMBIN TIME SHORTENED,1
BE,PRURITUS GENERALISED,1
BE,PSEUDOMONAL SEPSIS,1
BE,PSYCHOMOTOR HYPERACTIVITY,1
BE,PULMONARY ALVEOLAR HAEMORRHAGE,1
BE,PULMONARY FIBROSIS,1
BE,PULMONARY GRANULOMA,1
BE,PURULENT DISCHARGE,1
BE,PUSTULAR PSORIASIS,1
BE,PYELONEPHRITIS,1
BE,PYELONEPHRITIS ACUTE,1
BE,RASH,1
BE,RENAL ABSCESS,1
BE,RENAL COLIC,1
BE,RENAL DISORDER,1
BE,RESPIRATORY DISORDER,1
BE,RETINAL INFILTRATES,1
BE,REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT,1
BE,RHINITIS,1
BE,SCHWANNOMA,1
BE,SEPTIC ENCEPHALOPATHY,1
BE,SEROSITIS,1
BE,SICK SINUS SYNDROME,1
BE,SKIN DISCOLOURATION,1
BE,SKIN FISSURES,1
BE,SKIN HYPERTROPHY,1
BE,SKIN LESION,1
BE,SKIN REACTION,1
BE,SKIN SWELLING,1
BE,SKIN ULCER,1
BE,SMALL CELL LUNG CANCER,1
BE,SMALL INTESTINAL HAEMORRHAGE,1
BE,SOCIAL AVOIDANT BEHAVIOUR,1
BE,SPEECH DISORDER,1
BE,SPINAL COLUMN STENOSIS,1
BE,SPINAL COMPRESSION FRACTURE,1
BE,SPINAL CORD COMPRESSION,1
BE,SPINAL MENINGIOMA BENIGN,1
BE,SPLENOMEGALY,1
BE,SPUTUM DISCOLOURED,1
BE,SPUTUM INCREASED,1
BE,STOMATITIS,1
BE,STRONGYLOIDIASIS,1
BE,SUBARACHNOID HAEMORRHAGE,1
BE,SUBCUTANEOUS HAEMATOMA,1
BE,SUICIDAL IDEATION,1
BE,SUPERINFECTION,1
BE,SUPRAVENTRICULAR TACHYCARDIA,1
BE,SURGERY,1
BE,SWELLING,1
BE,SWELLING FACE,1
BE,TENDON DISORDER,1
BE,TENDONITIS,1
BE,THERAPEUTIC RESPONSE DECREASED,1
BE,THERAPEUTIC RESPONSE UNEXPECTED,1
BE,THROMBOSIS IN DEVICE,1
BE,TONGUE INJURY,1
BE,TOXIC ENCEPHALOPATHY,1
BE,TRANSAMINASES ABNORMAL,1
BE,TRANSITIONAL CELL CARCINOMA,1
BE,TRANSPLANT DYSFUNCTION,1
BE,TRANSURETHRAL PROSTATECTOMY,1
BE,TREATMENT NONCOMPLIANCE,1
BE,TUBULOINTERSTITIAL NEPHRITIS,1
BE,TUMOUR LYSIS SYNDROME,1
BE,TUMOUR NECROSIS,1
BE,TYPE 1 DIABETES MELLITUS,1
BE,UNDERDOSE,1
BE,UNRESPONSIVE TO STIMULI,1
BE,UPPER GASTROINTESTINAL HAEMORRHAGE,1
BE,URETERIC OBSTRUCTION,1
BE,URGE INCONTINENCE,1
BE,URINARY TRACT INFECTION FUNGAL,1
BE,URINARY TRACT INFECTION PSEUDOMONAL,1
BE,UROSEPSIS,1
BE,VENTRICLE RUPTURE,1
BE,VENTRICULAR ARRHYTHMIA,1
BE,VISUAL ACUITY REDUCED,1
BE,VISUAL EVOKED POTENTIALS ABNORMAL,1
BE,VITAMIN B12 DEFICIENCY,1
BE,VITAMIN D DEFICIENCY,1
BE,WEIGHT INCREASED,1
BE,WHEEZING,1
BE,WOUND,1
BE,WOUND DEHISCENCE,1
BA,DERMATITIS ALLERGIC,1
BA,DYSPNOEA,1
BA,GLAUCOMA,1
BA,RETINAL HAEMORRHAGE,1
BA,URTICARIA CHRONIC,1
BR,PAIN,235
BR,DRUG INEFFECTIVE,217
BR,MALAISE,215
BR,DYSPNOEA,186
BR,ARTHRALGIA,185
BR,PAIN IN EXTREMITY,182
BR,WEIGHT DECREASED,175
BR,HYPERTENSION,163
BR,FALL,157
BR,HEADACHE,149
BR,FATIGUE,141
BR,PNEUMONIA,140
BR,DIZZINESS,135
BR,BLOOD PRESSURE INCREASED,130
BR,CEREBROVASCULAR ACCIDENT,128
BR,GAIT DISTURBANCE,126
BR,DIABETES MELLITUS,125
BR,ASTHENIA,120
BR,BLOOD CHOLESTEROL INCREASED,111
BR,URINARY TRACT INFECTION,109
BR,VOMITING,104
BR,MEMORY IMPAIRMENT,102
BR,BLOOD GLUCOSE INCREASED,97
BR,DIARRHOEA,97
BR,NAUSEA,96
BR,CATARACT,91
BR,INFLUENZA,91
BR,PYREXIA,91
BR,WEIGHT INCREASED,91
BR,ANAEMIA,90
BR,DEPRESSION,87
BR,DECREASED APPETITE,86
BR,CHEST PAIN,85
BR,CARDIAC DISORDER,78
BR,COUGH,78
BR,FEELING ABNORMAL,78
BR,HYPERGLYCAEMIA,75
BR,HYPERSENSITIVITY,74
BR,VISUAL IMPAIRMENT,73
BR,BACK PAIN,72
BR,INSOMNIA,72
BR,INJECTION SITE PAIN,71
BR,MYOCARDIAL INFARCTION,71
BR,ABDOMINAL PAIN UPPER,67
BR,PERIPHERAL SWELLING,66
BR,NERVOUSNESS,65
BR,ARRHYTHMIA,64
BR,INFARCTION,64
BR,TREMOR,62
BR,PRURITUS,59
BR,SYNCOPE,59
BR,SWELLING,57
BR,ERYTHEMA,56
BR,HYPOAESTHESIA,55
BR,ANXIETY,53
BR,OSTEOARTHRITIS,53
BR,ABASIA,52
BR,CORONARY ARTERY OCCLUSION,52
BR,ARTHROPATHY,51
BR,RHEUMATOID ARTHRITIS,51
BR,HYPOTENSION,49
BR,IMMUNODEFICIENCY,49
BR,ABDOMINAL PAIN,48
BR,SPEECH DISORDER,45
BR,VISION BLURRED,45
BR,INJECTION SITE ERYTHEMA,44
BR,BLOOD PRESSURE DECREASED,43
BR,JOINT SWELLING,43
BR,SINUSITIS,43
BR,SOMNOLENCE,43
BR,OSTEOPOROSIS,42
BR,MOBILITY DECREASED,41
BR,RENAL DISORDER,41
BR,ABDOMINAL DISTENSION,40
BR,HYPOGLYCAEMIA,40
BR,HYPERHIDROSIS,38
BR,INTERVERTEBRAL DISC PROTRUSION,38
BR,LUNG DISORDER,38
BR,MUSCULAR WEAKNESS,38
BR,DRUG DOSE OMISSION,37
BR,SKIN DISCOLOURATION,37
BR,THROMBOSIS,37
BR,SPINAL PAIN,36
BR,VENOUS OCCLUSION,36
BR,ARTERIAL OCCLUSIVE DISEASE,35
BR,CONDITION AGGRAVATED,35
BR,CONSTIPATION,35
BR,INFECTION,35
BR,WOUND,35
BR,ANGINA PECTORIS,34
BR,BLOOD PRESSURE FLUCTUATION,34
BR,DYSPHONIA,33
BR,HAEMORRHAGE,33
BR,INFLAMMATION,33
BR,OEDEMA PERIPHERAL,33
BR,TACHYCARDIA,33
BR,CONFUSIONAL STATE,32
BR,GASTRITIS,32
BR,LABYRINTHITIS,32
BR,ARTHRITIS,31
BR,BLOOD TRIGLYCERIDES INCREASED,31
BR,DEATH,31
BR,DRY MOUTH,30
BR,LIVER DISORDER,30
BR,ASTHMA,29
BR,BLINDNESS,29
BR,CHOLELITHIASIS,29
BR,PSORIASIS,29
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,28
BR,MUSCULOSKELETAL STIFFNESS,28
BR,NASOPHARYNGITIS,28
BR,NECK PAIN,28
BR,PULMONARY OEDEMA,28
BR,BLOOD CHOLESTEROL ABNORMAL,27
BR,DYSSTASIA,27
BR,LOCAL SWELLING,27
BR,PRODUCT USE ISSUE,27
BR,CARDIAC ARREST,26
BR,DEMENTIA ALZHEIMER^S TYPE,26
BR,EATING DISORDER,26
BR,INJECTION SITE PRURITUS,26
BR,MUSCLE SPASMS,26
BR,MUSCULOSKELETAL PAIN,26
BR,ALOPECIA,25
BR,BODY HEIGHT DECREASED,25
BR,FEMUR FRACTURE,25
BR,GLAUCOMA,25
BR,SPINAL DISORDER,25
BR,BONE PAIN,24
BR,DEAFNESS,24
BR,DIABETES MELLITUS INADEQUATE CONTROL,24
BR,LUNG INFECTION,24
BR,PALPITATIONS,24
BR,PARAESTHESIA,24
BR,UPPER LIMB FRACTURE,24
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,24
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,24
BR,BEDRIDDEN,23
BR,BURNING SENSATION,23
BR,FEAR,23
BR,INTENTIONAL PRODUCT MISUSE,23
BR,LIMB DISCOMFORT,23
BR,RENAL FAILURE,23
BR,RENAL IMPAIRMENT,23
BR,SEIZURE,23
BR,CHILLS,22
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,22
BR,GASTRIC DISORDER,22
BR,INCORRECT DOSE ADMINISTERED,22
BR,NEPHROLITHIASIS,22
BR,STRESS,22
BR,VISUAL ACUITY REDUCED,22
BR,ABDOMINAL DISCOMFORT,21
BR,CHEST DISCOMFORT,21
BR,DENGUE FEVER,21
BR,DRUG HYPERSENSITIVITY,21
BR,EYE PAIN,21
BR,LIMB INJURY,21
BR,MYALGIA,21
BR,OROPHARYNGEAL PAIN,21
BR,TENDON RUPTURE,21
BR,DEPRESSED MOOD,20
BR,DRUG ADMINISTRATION ERROR,20
BR,DYSPHAGIA,20
BR,LOSS OF CONSCIOUSNESS,20
BR,RETCHING,20
BR,SEPSIS,20
BR,SEPTIC SHOCK,20
BR,VARICOSE VEIN,20
BR,BLISTER,19
BR,COMA,19
BR,DYSPEPSIA,19
BR,DYSURIA,19
BR,EYE IRRITATION,19
BR,FEELING HOT,19
BR,HAEMATOCHEZIA,19
BR,HEAD DISCOMFORT,19
BR,SWELLING FACE,19
BR,THROAT IRRITATION,19
BR,THYROID DISORDER,19
BR,ACUTE MYOCARDIAL INFARCTION,18
BR,APHASIA,18
BR,BLOOD GLUCOSE DECREASED,18
BR,BLOOD PRESSURE ABNORMAL,18
BR,BONE DISORDER,18
BR,DEHYDRATION,18
BR,DRUG INTOLERANCE,18
BR,EMPHYSEMA,18
BR,EYE DISORDER,18
BR,GASTROOESOPHAGEAL REFLUX DISEASE,18
BR,MOVEMENT DISORDER,18
BR,OCULAR HYPERAEMIA,18
BR,THYROID NEOPLASM,18
BR,TINNITUS,18
BR,AMNESIA,17
BR,BACTERIAL INFECTION,17
BR,BLOOD GLUCOSE ABNORMAL,17
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,17
BR,CARDIAC FAILURE,17
BR,DRY SKIN,17
BR,DYSGEUSIA,17
BR,FLUID RETENTION,17
BR,GAIT INABILITY,17
BR,HAEMOGLOBIN DECREASED,17
BR,HEAD INJURY,17
BR,HEPATIC STEATOSIS,17
BR,RESPIRATORY FAILURE,17
BR,ASTHMATIC CRISIS,16
BR,BALANCE DISORDER,16
BR,CARDIOMEGALY,16
BR,CONVULSION,16
BR,CRYING,16
BR,EYE HAEMORRHAGE,16
BR,GASTROINTESTINAL DISORDER,16
BR,GENERAL PHYSICAL HEALTH DETERIORATION,16
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,16
BR,HYPOKINESIA,16
BR,ISCHAEMIC STROKE,16
BR,PLEURAL EFFUSION,16
BR,AGITATION,15
BR,BRONCHITIS,15
BR,DEVICE MALFUNCTION,15
BR,DISEASE PROGRESSION,15
BR,DRUG EFFECT INCOMPLETE,15
BR,FEELING COLD,15
BR,HEART RATE INCREASED,15
BR,MEDICATION ERROR,15
BR,PARKINSON^S DISEASE,15
BR,RHEUMATIC DISORDER,15
BR,RHINITIS,15
BR,BLOOD CREATININE INCREASED,14
BR,BREAST CANCER,14
BR,DECREASED IMMUNE RESPONSIVENESS,14
BR,EMOTIONAL DISORDER,14
BR,HEART RATE DECREASED,14
BR,HYPOTHYROIDISM,14
BR,INFUSION RELATED REACTION,14
BR,JOINT INJURY,14
BR,NERVOUS SYSTEM DISORDER,14
BR,PARALYSIS,14
BR,PRODUCTIVE COUGH,14
BR,RETINAL DETACHMENT,14
BR,SKIN EXFOLIATION,14
BR,THROAT TIGHTNESS,14
BR,BLOOD GLUCOSE FLUCTUATION,13
BR,DIVERTICULITIS,13
BR,EPISTAXIS,13
BR,EYE SWELLING,13
BR,FEEDING DISORDER,13
BR,FOOT DEFORMITY,13
BR,GLUCOSE TOLERANCE IMPAIRED,13
BR,HEMIPLEGIA,13
BR,IMPAIRED HEALING,13
BR,LEUKOPENIA,13
BR,MASS,13
BR,PHARYNGITIS,13
BR,PLATELET COUNT DECREASED,13
BR,THERAPEUTIC RESPONSE DECREASED,13
BR,VIRAL INFECTION,13
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,12
BR,CARDIO-RESPIRATORY ARREST,12
BR,CAROTID ARTERY OCCLUSION,12
BR,DISCOMFORT,12
BR,EXOSTOSIS,12
BR,FLATULENCE,12
BR,HERPES ZOSTER,12
BR,HIATUS HERNIA,12
BR,HYPOACUSIS,12
BR,INJECTION SITE SWELLING,12
BR,ISCHAEMIA,12
BR,LOWER LIMB FRACTURE,12
BR,NOSOCOMIAL INFECTION,12
BR,PRURITUS GENERALISED,12
BR,PULMONARY EMBOLISM,12
BR,SKIN HAEMORRHAGE,12
BR,SLUGGISHNESS,12
BR,SPINAL FRACTURE,12
BR,THYROID MASS,12
BR,TOOTH DISORDER,12
BR,URINARY INCONTINENCE,12
BR,DRUG PRESCRIBING ERROR,11
BR,FINGER DEFORMITY,11
BR,FOOT FRACTURE,11
BR,HYPERTENSIVE CRISIS,11
BR,IRRITABILITY,11
BR,KIDNEY INFECTION,11
BR,LOCALISED INFECTION,11
BR,MULTI-ORGAN FAILURE,11
BR,OSTEOPENIA,11
BR,POLLAKIURIA,11
BR,PULMONARY FIBROSIS,11
BR,ROAD TRAFFIC ACCIDENT,11
BR,TENDONITIS,11
BR,YELLOW SKIN,11
BR,CHOKING,10
BR,CYST,10
BR,DRY EYE,10
BR,DRY THROAT,10
BR,HAEMATOCRIT DECREASED,10
BR,HAEMATOMA,10
BR,HALLUCINATION,10
BR,INJECTION SITE DISCOLOURATION,10
BR,INJECTION SITE INDURATION,10
BR,MULTIPLE SCLEROSIS RELAPSE,10
BR,NEOPLASM MALIGNANT,10
BR,PRODUCT QUALITY ISSUE,10
BR,RASH MACULAR,10
BR,SKIN CANCER,10
BR,SLEEP DISORDER,10
BR,TYPE 2 DIABETES MELLITUS,10
BR,UNEVALUABLE EVENT,10
BR,WHEEZING,10
BR,ANGIOPLASTY,9
BR,ATRIAL FIBRILLATION,9
BR,BLOOD SODIUM DECREASED,9
BR,BLOOD URIC ACID INCREASED,9
BR,CARPAL TUNNEL SYNDROME,9
BR,CHOLECYSTITIS,9
BR,COLD SWEAT,9
BR,DIABETIC RETINOPATHY,9
BR,DRUG-INDUCED LIVER INJURY,9
BR,DYSLIPIDAEMIA,9
BR,HEARING IMPAIRED,9
BR,HEPATIC NEOPLASM,9
BR,HERPES VIRUS INFECTION,9
BR,HYPOPHAGIA,9
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,9
BR,INJECTION SITE BRUISING,9
BR,INJECTION SITE HAEMORRHAGE,9
BR,LACRIMATION INCREASED,9
BR,NEOPLASM PROGRESSION,9
BR,NODULE,9
BR,OVERDOSE,9
BR,OXYGEN SATURATION DECREASED,9
BR,POLYMYOSITIS,9
BR,PRODUCT USE IN UNAPPROVED INDICATION,9
BR,PROSTATE CANCER,9
BR,RHINORRHOEA,9
BR,RIB FRACTURE,9
BR,THROMBOCYTOPENIA,9
BR,VEIN DISORDER,9
BR,ADVERSE EVENT,8
BR,AGEUSIA,8
BR,ANKYLOSING SPONDYLITIS,8
BR,AORTIC ANEURYSM,8
BR,APPARENT DEATH,8
BR,APPLICATION SITE ERYTHEMA,8
BR,BRADYCARDIA,8
BR,BREAST MASS,8
BR,CARDIOVASCULAR DISORDER,8
BR,CATARRH,8
BR,DEVICE RELATED INFECTION,8
BR,DYSENTERY,8
BR,EAR PAIN,8
BR,ERYSIPELAS,8
BR,EXPIRED PRODUCT ADMINISTERED,8
BR,FIBROMYALGIA,8
BR,GALLBLADDER DISORDER,8
BR,HAEMATURIA,8
BR,HAEMOPTYSIS,8
BR,HERNIA,8
BR,HYPERCHOLESTEROLAEMIA,8
BR,INJECTION SITE HAEMATOMA,8
BR,INTESTINAL HAEMORRHAGE,8
BR,INTRAOCULAR PRESSURE INCREASED,8
BR,JOINT EFFUSION,8
BR,MOTOR DYSFUNCTION,8
BR,OEDEMA,8
BR,RASH,8
BR,SECRETION DISCHARGE,8
BR,SKIN DISORDER,8
BR,TONGUE DISORDER,8
BR,URINARY RETENTION,8
BR,VITAMIN D DEFICIENCY,8
BR,AGGRESSION,7
BR,ANEURYSM,7
BR,ANKLE FRACTURE,7
BR,APHONIA,7
BR,ASCITES,7
BR,BLINDNESS UNILATERAL,7
BR,BLOOD GROWTH HORMONE INCREASED,7
BR,BLOOD POTASSIUM DECREASED,7
BR,BLOOD TEST ABNORMAL,7
BR,BRONCHOSPASM,7
BR,CARDIAC OPERATION,7
BR,CARTILAGE INJURY,7
BR,CHRONIC KIDNEY DISEASE,7
BR,CONCOMITANT DISEASE AGGRAVATED,7
BR,CYSTITIS,7
BR,DELIRIUM,7
BR,DISORIENTATION,7
BR,EMOTIONAL DISTRESS,7
BR,EYE PRURITUS,7
BR,FEBRILE NEUTROPENIA,7
BR,FORMICATION,7
BR,GASTROINTESTINAL INFECTION,7
BR,GINGIVAL PAIN,7
BR,HAEMATEMESIS,7
BR,HEPATITIS,7
BR,HIP FRACTURE,7
BR,HOSPITALISATION,7
BR,ILL-DEFINED DISORDER,7
BR,INCORRECT PRODUCT STORAGE,7
BR,INJECTION SITE MASS,7
BR,JOINT DISLOCATION,7
BR,JOINT STIFFNESS,7
BR,LARYNGEAL OEDEMA,7
BR,MENTAL DISORDER,7
BR,METASTATIC RENAL CELL CARCINOMA,7
BR,MOUTH INJURY,7
BR,MUSCLE RIGIDITY,7
BR,MUSCULOSKELETAL CHEST PAIN,7
BR,MUSCULOSKELETAL DISORDER,7
BR,ORAL PAIN,7
BR,PANCREATITIS ACUTE,7
BR,PANIC DISORDER,7
BR,POSTOPERATIVE WOUND INFECTION,7
BR,PULMONARY MASS,7
BR,RENAL CANCER,7
BR,RESPIRATORY DISTRESS,7
BR,RETINAL DISORDER,7
BR,SENSORY DISTURBANCE,7
BR,SKIN LESION,7
BR,SKIN SENSITISATION,7
BR,SPINAL OSTEOARTHRITIS,7
BR,UNDERDOSE,7
BR,URTICARIA,7
BR,VERTIGO,7
BR,VITAMIN D DECREASED,7
BR,ACUTE KIDNEY INJURY,6
BR,APHTHOUS ULCER,6
BR,ARTHRITIS INFECTIVE,6
BR,BONE MARROW TOXICITY,6
BR,CEREBELLAR ATAXIA,6
BR,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,6
BR,CONTUSION,6
BR,CORONARY ARTERY DISEASE,6
BR,DERMATOMYOSITIS,6
BR,DEVICE DISLOCATION,6
BR,DIABETIC NEUROPATHY,6
BR,DISTURBANCE IN ATTENTION,6
BR,EAR INFECTION,6
BR,ENTERITIS INFECTIOUS,6
BR,FISTULA,6
BR,FRACTURE,6
BR,GASTRIC HAEMORRHAGE,6
BR,GASTRIC ULCER,6
BR,GASTROINTESTINAL INFLAMMATION,6
BR,GASTROINTESTINAL MOTILITY DISORDER,6
BR,GENERALISED OEDEMA,6
BR,HEPATIC PAIN,6
BR,HEPATOMEGALY,6
BR,HYPONATRAEMIA,6
BR,IMMUNOSUPPRESSION,6
BR,INJECTION SITE HYPERSENSITIVITY,6
BR,INJECTION SITE REACTION,6
BR,JOINT RANGE OF MOTION DECREASED,6
BR,LIMB DEFORMITY,6
BR,MIGRAINE,6
BR,NEEDLE ISSUE,6
BR,NEOPLASM,6
BR,NEUROPATHY PERIPHERAL,6
BR,OBESITY,6
BR,OBSTRUCTIVE AIRWAYS DISORDER,6
BR,ORAL DISCOMFORT,6
BR,PAIN IN JAW,6
BR,PALLOR,6
BR,PHARYNGEAL OEDEMA,6
BR,PIGMENTATION DISORDER,6
BR,POLYURIA,6
BR,RESPIRATORY DISORDER,6
BR,SCIATICA,6
BR,SENSORY LOSS,6
BR,SKIN FISSURES,6
BR,SKIN ULCER,6
BR,STENT PLACEMENT,6
BR,STOMATITIS,6
BR,SUBCUTANEOUS ABSCESS,6
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,6
BR,THERAPEUTIC RESPONSE UNEXPECTED,6
BR,TOOTH FRACTURE,6
BR,WHITE BLOOD CELL COUNT DECREASED,6
BR,ABDOMINAL HERNIA,5
BR,ABNORMAL BEHAVIOUR,5
BR,ACCIDENT,5
BR,ANAPHYLACTIC SHOCK,5
BR,ANGINA UNSTABLE,5
BR,ANGIOPATHY,5
BR,APHAGIA,5
BR,ASPHYXIA,5
BR,ATAXIA,5
BR,ATYPICAL PNEUMONIA,5
BR,BACK DISORDER,5
BR,BREAST PAIN,5
BR,BURSITIS,5
BR,CATARACT OPERATION,5
BR,CEREBRAL HAEMORRHAGE,5
BR,CHOKING SENSATION,5
BR,CHROMATURIA,5
BR,COLITIS,5
BR,CORONARY ARTERY RESTENOSIS,5
BR,CROHN^S DISEASE,5
BR,DEVICE BREAKAGE,5
BR,DIPLOPIA,5
BR,DISEASE RECURRENCE,5
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,5
BR,DRUG DISPENSING ERROR,5
BR,DYSKINESIA,5
BR,DYSPNOEA EXERTIONAL,5
BR,EMBOLISM,5
BR,ERECTILE DYSFUNCTION,5
BR,ERYTHRODERMIC PSORIASIS,5
BR,FAECES DISCOLOURED,5
BR,FURUNCLE,5
BR,GASTROINTESTINAL HAEMORRHAGE,5
BR,GASTROINTESTINAL PAIN,5
BR,GINGIVITIS,5
BR,GOUT,5
BR,HAEMORRHAGIC STROKE,5
BR,HAEMORRHOIDS,5
BR,HAND DEFORMITY,5
BR,HEART RATE IRREGULAR,5
BR,HEMIPARESIS,5
BR,HEPATIC CIRRHOSIS,5
BR,HUNGER,5
BR,HYPOTONIA,5
BR,INFLUENZA LIKE ILLNESS,5
BR,INGUINAL HERNIA,5
BR,INJECTION SITE WARMTH,5
BR,KNEE OPERATION,5
BR,LEUKAEMIA,5
BR,LEUKOCYTOSIS,5
BR,LOW DENSITY LIPOPROTEIN INCREASED,5
BR,LUNG NEOPLASM MALIGNANT,5
BR,LYMPHADENOPATHY,5
BR,LYMPHOMA,5
BR,MALIGNANT NEOPLASM PROGRESSION,5
BR,MENISCUS INJURY,5
BR,MONOPLEGIA,5
BR,MOUTH HAEMORRHAGE,5
BR,MULTIPLE SCLEROSIS,5
BR,NEUTROPENIA,5
BR,NIGHTMARE,5
BR,OSTEOMYELITIS,5
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
BR,PAROSMIA,5
BR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,5
BR,PERIPHERAL EMBOLISM,5
BR,PNEUMONIA ASPIRATION,5
BR,PNEUMONIA BACTERIAL,5
BR,POOR QUALITY SLEEP,5
BR,POST PROCEDURAL COMPLICATION,5
BR,PRESYNCOPE,5
BR,PROCEDURAL PAIN,5
BR,PROTEINURIA,5
BR,PSORIATIC ARTHROPATHY,5
BR,PSYCHIATRIC SYMPTOM,5
BR,RED BLOOD CELL COUNT DECREASED,5
BR,RESPIRATORY ARREST,5
BR,RESTLESSNESS,5
BR,SEROTONIN SYNDROME,5
BR,SERUM FERRITIN INCREASED,5
BR,SKIN ATROPHY,5
BR,SKIN BURNING SENSATION,5
BR,SKIN INFECTION,5
BR,STAPHYLOCOCCAL INFECTION,5
BR,SUFFOCATION FEELING,5
BR,TOOTH INFECTION,5
BR,TRANSIENT ISCHAEMIC ATTACK,5
BR,TUBERCULOSIS,5
BR,ULCER,5
BR,UTERINE DISORDER,5
BR,VASCULAR GRAFT,5
BR,VENOUS THROMBOSIS,5
BR,ACUTE PULMONARY OEDEMA,4
BR,AMENORRHOEA,4
BR,AORTIC OCCLUSION,4
BR,APNOEA,4
BR,APPLICATION SITE HYPERSENSITIVITY,4
BR,APPLICATION SITE PRURITUS,4
BR,BIPOLAR DISORDER,4
BR,BLOOD DISORDER,4
BR,BLOOD POTASSIUM INCREASED,4
BR,BLOOD PRESSURE SYSTOLIC INCREASED,4
BR,BLOOD TRIGLYCERIDES ABNORMAL,4
BR,BLOOD UREA ABNORMAL,4
BR,BLOOD UREA INCREASED,4
BR,BODY TEMPERATURE DECREASED,4
BR,BONE EROSION,4
BR,BONE LOSS,4
BR,BRAIN NEOPLASM,4
BR,BREAST CANCER FEMALE,4
BR,BRUXISM,4
BR,CANDIDA INFECTION,4
BR,CAROTID ARTERIOSCLEROSIS,4
BR,CATHETER PLACEMENT,4
BR,CENTRAL NERVOUS SYSTEM LESION,4
BR,CEREBRAL ISCHAEMIA,4
BR,CEREBRAL THROMBOSIS,4
BR,CHIKUNGUNYA VIRUS INFECTION,4
BR,CLAVICLE FRACTURE,4
BR,COLITIS ULCERATIVE,4
BR,CONJUNCTIVITIS,4
BR,DEAFNESS UNILATERAL,4
BR,DECUBITUS ULCER,4
BR,DEFORMITY,4
BR,DERMATITIS,4
BR,DEVICE OCCLUSION,4
BR,DRUG DEPENDENCE,4
BR,DRUG EFFECT DECREASED,4
BR,EAR DISORDER,4
BR,EYE INFECTION,4
BR,FACE INJURY,4
BR,FRACTURED COCCYX,4
BR,FREQUENT BOWEL MOVEMENTS,4
BR,GASTROINTESTINAL CARCINOMA,4
BR,GLOSSODYNIA,4
BR,HELICOBACTER INFECTION,4
BR,HEPATIC ENZYME INCREASED,4
BR,HYPERKERATOSIS,4
BR,HYPERPHAGIA,4
BR,INJECTION SITE NODULE,4
BR,INJURY,4
BR,INTENTIONAL DRUG MISUSE,4
BR,INTENTIONAL PRODUCT USE ISSUE,4
BR,INTESTINAL OBSTRUCTION,4
BR,IRON DEFICIENCY ANAEMIA,4
BR,LACK OF INJECTION SITE ROTATION,4
BR,LEG AMPUTATION,4
BR,LEIOMYOMA,4
BR,LOOSE TOOTH,4
BR,LOSS OF CONTROL OF LEGS,4
BR,MALNUTRITION,4
BR,MEDICAL DEVICE COMPLICATION,4
BR,MELAENA,4
BR,MUSCLE ATROPHY,4
BR,MYOCARDIAL ISCHAEMIA,4
BR,MYOPIA,4
BR,NAIL DISORDER,4
BR,NECROSIS,4
BR,NO ADVERSE EVENT,4
BR,OESOPHAGITIS,4
BR,OLIGURIA,4
BR,OVERWEIGHT,4
BR,PANCREATITIS,4
BR,PARAPLEGIA,4
BR,PERICARDIAL EFFUSION,4
BR,PERIPHERAL COLDNESS,4
BR,PERIPHERAL VASCULAR DISORDER,4
BR,PETECHIAE,4
BR,PITUITARY TUMOUR BENIGN,4
BR,PLATELET COUNT INCREASED,4
BR,POOR QUALITY DRUG ADMINISTERED,4
BR,PRODUCT ADHESION ISSUE,4
BR,PRODUCT AVAILABILITY ISSUE,4
BR,PRODUCT PHYSICAL ISSUE,4
BR,PULMONARY CONGESTION,4
BR,PULMONARY HAEMORRHAGE,4
BR,PULMONARY HYPERTENSION,4
BR,PULPITIS DENTAL,4
BR,PURULENCE,4
BR,PYELONEPHRITIS,4
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
BR,RENAL CYST,4
BR,RENAL INJURY,4
BR,RESPIRATORY TRACT INFECTION,4
BR,RETINOPATHY,4
BR,SCREAMING,4
BR,SENSATION OF FOREIGN BODY,4
BR,SKIN INDURATION,4
BR,SKIN INJURY,4
BR,SKIN PLAQUE,4
BR,SURGERY,4
BR,THIRST,4
BR,THYROID CANCER,4
BR,THYROID FUNCTION TEST ABNORMAL,4
BR,URINE OUTPUT INCREASED,4
BR,UVEITIS,4
BR,VAGINAL HAEMORRHAGE,4
BR,WALKING DISABILITY,4
BR,WRIST FRACTURE,4
BR,ABNORMAL FAECES,3
BR,ABSCESS,3
BR,ABSCESS LIMB,3
BR,ACUTE RESPIRATORY FAILURE,3
BR,ANAL ABSCESS,3
BR,APATHY,3
BR,APHTHOUS STOMATITIS,3
BR,APPLICATION SITE PAIN,3
BR,APPLICATION SITE REACTION,3
BR,ARTERIAL DISORDER,3
BR,ARTERIOSCLEROSIS,3
BR,ASPIRATION,3
BR,BACK INJURY,3
BR,BASAL CELL CARCINOMA,3
BR,BENIGN PROSTATIC HYPERPLASIA,3
BR,BLADDER PAIN,3
BR,BLOOD BLISTER,3
BR,BLOOD CHOLESTEROL DECREASED,3
BR,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
BR,BLOOD IRON DECREASED,3
BR,BLOOD PROLACTIN INCREASED,3
BR,BLOOD URINE PRESENT,3
BR,BODY MASS INDEX INCREASED,3
BR,BONE DENSITY DECREASED,3
BR,BONE FISSURE,3
BR,BONE MARROW DISORDER,3
BR,BREAST DISORDER,3
BR,BRONCHIAL SECRETION RETENTION,3
BR,CARDIAC FAILURE CONGESTIVE,3
BR,CARDIAC FIBRILLATION,3
BR,CARDIAC VALVE DISEASE,3
BR,CARDIOMYOPATHY,3
BR,CARTILAGE ATROPHY,3
BR,CATHETERISATION CARDIAC,3
BR,CELLULITIS,3
BR,CHOLECYSTITIS ACUTE,3
BR,CHONDROPATHY,3
BR,CHRONIC GASTRITIS,3
BR,CHRONIC SINUSITIS,3
BR,COGNITIVE DISORDER,3
BR,CONCOMITANT DISEASE PROGRESSION,3
BR,COORDINATION ABNORMAL,3
BR,CUSHING^S SYNDROME,3
BR,CYANOSIS,3
BR,DAYDREAMING,3
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
BR,DEVICE FAILURE,3
BR,DEVICE ISSUE,3
BR,DIABETIC COMPLICATION,3
BR,DROOLING,3
BR,DYSARTHRIA,3
BR,DYSGRAPHIA,3
BR,EAR DISCOMFORT,3
BR,EAR HAEMORRHAGE,3
BR,ENDOCARDITIS,3
BR,EXPIRED DRUG ADMINISTERED,3
BR,EYE DISCHARGE,3
BR,EYE INJURY,3
BR,EYELID OEDEMA,3
BR,FAECES SOFT,3
BR,FEAR OF INJECTION,3
BR,FEELING JITTERY,3
BR,FEELING OF DESPAIR,3
BR,FLAVIVIRUS INFECTION,3
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,3
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,3
BR,GASTROENTERITIS,3
BR,GENERAL PHYSICAL CONDITION ABNORMAL,3
BR,HAEMODIALYSIS,3
BR,HALLUCINATION_ VISUAL,3
BR,HEPATIC CANCER,3
BR,HEPATITIS C,3
BR,HIGH DENSITY LIPOPROTEIN DECREASED,3
BR,HORMONE LEVEL ABNORMAL,3
BR,HUMERUS FRACTURE,3
BR,HYPERAEMIA,3
BR,HYPERAESTHESIA,3
BR,HYPERSOMNIA,3
BR,HYPERTHYROIDISM,3
BR,HYPOAESTHESIA ORAL,3
BR,HYPOKALAEMIA,3
BR,HYPOXIA,3
BR,INCONTINENCE,3
BR,INCREASED APPETITE,3
BR,INSULIN-LIKE GROWTH FACTOR INCREASED,3
BR,INTERNATIONAL NORMALISED RATIO INCREASED,3
BR,INTESTINAL POLYP,3
BR,INTRACRANIAL PRESSURE INCREASED,3
BR,IRRITABLE BOWEL SYNDROME,3
BR,JOINT DESTRUCTION,3
BR,JOINT LOCK,3
BR,KNEE DEFORMITY,3
BR,LACTOSE INTOLERANCE,3
BR,LETHARGY,3
BR,LIMB MASS,3
BR,LIP SWELLING,3
BR,LIPOMA,3
BR,LIVER FUNCTION TEST ABNORMAL,3
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,3
BR,LUMBAR VERTEBRAL FRACTURE,3
BR,LYMPHADENITIS BACTERIAL,3
BR,MACULAR DEGENERATION,3
BR,MATERNAL EXPOSURE DURING PREGNANCY,3
BR,MENORRHAGIA,3
BR,METASTASES TO BONE,3
BR,METASTASES TO LIVER,3
BR,METASTASES TO LUNG,3
BR,MITRAL VALVE CALCIFICATION,3
BR,MITRAL VALVE DISEASE,3
BR,MITRAL VALVE INCOMPETENCE,3
BR,MOOD ALTERED,3
BR,MUSCLE ABSCESS,3
BR,MUSCLE DISORDER,3
BR,MUSCLE FATIGUE,3
BR,NASAL CONGESTION,3
BR,NASAL DISCOMFORT,3
BR,NASAL DRYNESS,3
BR,NECK MASS,3
BR,NERVE COMPRESSION,3
BR,PAPULE,3
BR,PELVIC FRACTURE,3
BR,PETIT MAL EPILEPSY,3
BR,PHARYNGEAL DISORDER,3
BR,POISONING,3
BR,POOR PERIPHERAL CIRCULATION,3
BR,PREMATURE MENOPAUSE,3
BR,PROSTATE CANCER RECURRENT,3
BR,PROSTATOMEGALY,3
BR,PULMONARY FUNCTION TEST DECREASED,3
BR,PULMONARY SEPSIS,3
BR,PURULENT DISCHARGE,3
BR,RECTAL HAEMORRHAGE,3
BR,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,3
BR,RENAL COLIC,3
BR,RENAL FAILURE ACUTE,3
BR,RENAL MASS,3
BR,RENAL PAIN,3
BR,RETINAL DEGENERATION,3
BR,RETINAL HAEMORRHAGE,3
BR,RHEUMATOID FACTOR INCREASED,3
BR,SCOLIOSIS,3
BR,SEDATION,3
BR,SKIN HYPERTROPHY,3
BR,SKIN PAPILLOMA,3
BR,SLEEP APNOEA SYNDROME,3
BR,SNEEZING,3
BR,SPINAL COLUMN INJURY,3
BR,SPINAL CORD COMPRESSION,3
BR,SPINAL DEFORMITY,3
BR,SPINAL OPERATION,3
BR,SUBDURAL HAEMATOMA,3
BR,SUDDEN DEATH,3
BR,SUICIDAL IDEATION,3
BR,TIBIA FRACTURE,3
BR,TONSILLITIS,3
BR,TOXICITY TO VARIOUS AGENTS,3
BR,UMBILICAL HERNIA,3
BR,UNRESPONSIVE TO STIMULI,3
BR,URINARY TRACT DISORDER,3
BR,URINE OUTPUT DECREASED,3
BR,VASCULAR OCCLUSION,3
BR,VENTRICULAR HYPOKINESIA,3
BR,VIITH NERVE PARALYSIS,3
BR,VITAMIN B12 DEFICIENCY,3
BR,WEIGHT FLUCTUATION,3
BR,WHITE BLOOD CELL COUNT INCREASED,3
BR,WOUND COMPLICATION,3
BR,WOUND SECRETION,3
BR,WRONG DRUG ADMINISTERED,3
BR,ABDOMINAL INFECTION,2
BR,ABDOMINAL RIGIDITY,2
BR,ACNE,2
BR,ADRENAL INSUFFICIENCY,2
BR,ALANINE AMINOTRANSFERASE INCREASED,2
BR,ALLERGIC COUGH,2
BR,ALLERGY TO CHEMICALS,2
BR,ANKLE OPERATION,2
BR,ANOGENITAL WARTS,2
BR,ANOSMIA,2
BR,AORTIC CALCIFICATION,2
BR,AORTIC INJURY,2
BR,AORTIC VALVE CALCIFICATION,2
BR,APPENDICITIS,2
BR,APPLICATION SITE DISCOLOURATION,2
BR,ARTERIOSCLEROSIS CORONARY ARTERY,2
BR,ARTHRITIS BACTERIAL,2
BR,ASPIRATION BRONCHIAL,2
BR,ASTHENOPIA,2
BR,ATRIOVENTRICULAR BLOCK,2
BR,BACTERIAL TEST POSITIVE,2
BR,BLADDER CANCER,2
BR,BLADDER DISORDER,2
BR,BLADDER PROLAPSE,2
BR,BLEEDING TIME PROLONGED,2
BR,BLOOD POTASSIUM ABNORMAL,2
BR,BLOOD TRIGLYCERIDES DECREASED,2
BR,BONE CYST,2
BR,BONE GRAFT,2
BR,BONE LESION,2
BR,BRAIN HYPOXIA,2
BR,BRAIN NEOPLASM BENIGN,2
BR,BREAST CANCER RECURRENT,2
BR,BRONCHOPNEUMONIA,2
BR,BUNDLE BRANCH BLOCK BILATERAL,2
BR,BUNDLE BRANCH BLOCK LEFT,2
BR,BURNS THIRD DEGREE,2
BR,C-REACTIVE PROTEIN INCREASED,2
BR,CALCINOSIS,2
BR,CARDIAC MURMUR,2
BR,CARDIAC PACEMAKER INSERTION,2
BR,CARDIOGENIC SHOCK,2
BR,CARDIOPULMONARY FAILURE,2
BR,CAROTID ARTERY DISEASE,2
BR,CAROTID ARTERY STENOSIS,2
BR,CEREBRAL DISORDER,2
BR,COAGULOPATHY,2
BR,COCCYDYNIA,2
BR,COMPLICATION ASSOCIATED WITH DEVICE,2
BR,CONGESTIVE CARDIOMYOPATHY,2
BR,CONJUNCTIVAL HAEMORRHAGE,2
BR,CORNEAL DISORDER,2
BR,CORONARY ARTERY BYPASS,2
BR,CORONARY ARTERY INSUFFICIENCY,2
BR,CRANIOCEREBRAL INJURY,2
BR,CRYSTAL URINE PRESENT,2
BR,DENTAL CARIES,2
BR,DERMATITIS ALLERGIC,2
BR,DEVICE LOOSENING,2
BR,DEVICE MATERIAL ISSUE,2
BR,DIABETIC NEPHROPATHY,2
BR,DIASTOLIC DYSFUNCTION,2
BR,DRUG EFFECT DELAYED,2
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
BR,DRUG RESISTANCE,2
BR,ECCHYMOSIS,2
BR,ECZEMA,2
BR,ELECTROLYTE IMBALANCE,2
BR,ENCEPHALOPATHY,2
BR,ENDOMETRIOSIS,2
BR,ENURESIS,2
BR,ERYTHEMA OF EYELID,2
BR,EXTRAPULMONARY TUBERCULOSIS,2
BR,EXTRASYSTOLES,2
BR,EYE COLOUR CHANGE,2
BR,EYE INFLAMMATION,2
BR,EYE MOVEMENT DISORDER,2
BR,EYELID DISORDER,2
BR,EYELID PTOSIS,2
BR,FACE OEDEMA,2
BR,FACIAL BONES FRACTURE,2
BR,FACIAL PAIN,2
BR,FACIAL PARALYSIS,2
BR,FAECAL INCONTINENCE,2
BR,FEAR OF DEATH,2
BR,FUNGAL INFECTION,2
BR,FUNGAL SKIN INFECTION,2
BR,GALLBLADDER OPERATION,2
BR,GALLBLADDER PAIN,2
BR,GASTRIC CANCER,2
BR,GASTRIC INFECTION,2
BR,GASTROINTESTINAL BACTERIAL INFECTION,2
BR,GASTROINTESTINAL HYPOMOTILITY,2
BR,GASTROINTESTINAL NECROSIS,2
BR,GENERALISED ERYTHEMA,2
BR,GINGIVAL BLEEDING,2
BR,GINGIVAL DISORDER,2
BR,GUN SHOT WOUND,2
BR,HAEMATOCRIT INCREASED,2
BR,HAEMODYNAMIC INSTABILITY,2
BR,HAEMORRHAGE INTRACRANIAL,2
BR,HAEMORRHAGE SUBCUTANEOUS,2
BR,HAEMORRHAGIC ANAEMIA,2
BR,HAIR DISORDER,2
BR,HALLUCINATION_ AUDITORY,2
BR,HEAT ILLNESS,2
BR,HELICOBACTER GASTRITIS,2
BR,HEPATIC CYST,2
BR,HEPATIC FIBROSIS,2
BR,HEPATIC FUNCTION ABNORMAL,2
BR,HIGH DENSITY LIPOPROTEIN INCREASED,2
BR,HIP ARTHROPLASTY,2
BR,HOT FLUSH,2
BR,HYDROCEPHALUS,2
BR,HYDRONEPHROSIS,2
BR,HYPERCOAGULATION,2
BR,HYPERTENSIVE HEART DISEASE,2
BR,HYPERTRIGLYCERIDAEMIA,2
BR,HYPOVITAMINOSIS,2
BR,IMPAIRED SELF-CARE,2
BR,IMPLANT SITE PAIN,2
BR,INCISION SITE PAIN,2
BR,INCISIONAL HERNIA,2
BR,INCORRECT DRUG ADMINISTRATION DURATION,2
BR,INCREASED UPPER AIRWAY SECRETION,2
BR,INFECTED SKIN ULCER,2
BR,INFLAMMATION OF WOUND,2
BR,INGROWING NAIL,2
BR,INJECTION SITE INFECTION,2
BR,INJECTION SITE INJURY,2
BR,INJURY CORNEAL,2
BR,INTERMITTENT CLAUDICATION,2
BR,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
BR,INTERSTITIAL LUNG DISEASE,2
BR,INTERVERTEBRAL DISC DEGENERATION,2
BR,INTERVERTEBRAL DISC DISORDER,2
BR,INTESTINAL MASS,2
BR,INTESTINAL OPERATION,2
BR,INTRACRANIAL ANEURYSM,2
BR,INTRAOCULAR PRESSURE TEST ABNORMAL,2
BR,INVASIVE DUCTAL BREAST CARCINOMA,2
BR,JAW DISORDER,2
BR,KYPHOSIS,2
BR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
BR,LABORATORY TEST ABNORMAL,2
BR,LEFT VENTRICULAR DYSFUNCTION,2
BR,LEFT VENTRICULAR FAILURE,2
BR,LENS DISLOCATION,2
BG,ANGINA PECTORIS,3
BG,CARDIAC FAILURE,2
BG,SYNCOPE,2
BG,ANGINA UNSTABLE,1
BG,APHASIA,1
BG,BLOOD GLUCOSE ABNORMAL,1
BG,CEREBROVASCULAR ACCIDENT,1
BG,CHEMICAL POISONING,1
BG,DYSLIPIDAEMIA,1
BG,GOUT,1
BG,HEMIPARESIS,1
BG,HEPATIC FAILURE,1
BG,MYOCARDIAL ISCHAEMIA,1
BG,OSTEOPOROSIS,1
CA,FATIGUE,71
CA,DIARRHOEA,67
CA,DYSPNOEA,64
CA,DRUG INEFFECTIVE,63
CA,ARTHRALGIA,60
CA,FALL,58
CA,ASTHENIA,51
CA,NAUSEA,49
CA,PNEUMONIA,48
CA,DEATH,42
CA,PAIN,42
CA,MALAISE,41
CA,HEADACHE,39
CA,PAIN IN EXTREMITY,39
CA,BLOOD PRESSURE INCREASED,36
CA,WEIGHT DECREASED,36
CA,ARTERIOSCLEROSIS CORONARY ARTERY,34
CA,ASPHYXIA,34
CA,DIZZINESS,32
CA,HAEMOGLOBIN DECREASED,31
CA,NASOPHARYNGITIS,31
CA,HYPOTENSION,29
CA,CONTUSION,26
CA,COUGH,26
CA,PYREXIA,26
CA,CHEST PAIN,25
CA,VOMITING,25
CA,WEIGHT INCREASED,25
CA,MYOCARDIAL INFARCTION,24
CA,PERIPHERAL SWELLING,24
CA,CARDIAC FAILURE CONGESTIVE,23
CA,DECREASED APPETITE,23
CA,INSOMNIA,23
CA,HEART RATE DECREASED,21
CA,HYPERTENSION,20
CA,MUSCLE SPASMS,20
CA,MYALGIA,20
CA,CONSTIPATION,19
CA,GAIT DISTURBANCE,19
CA,JOINT SWELLING,19
CA,URINARY TRACT INFECTION,19
CA,ABDOMINAL DISCOMFORT,18
CA,ABDOMINAL PAIN,17
CA,RHEUMATOID ARTHRITIS,17
CA,ATRIAL FIBRILLATION,16
CA,BACK PAIN,16
CA,INFUSION RELATED REACTION,16
CA,OXYGEN SATURATION DECREASED,16
CA,CHILLS,15
CA,RASH,15
CA,SYNCOPE,15
CA,ABDOMINAL DISTENSION,14
CA,ANAEMIA,14
CA,BLOOD GLUCOSE INCREASED,14
CA,CONDITION AGGRAVATED,14
CA,CONFUSIONAL STATE,14
CA,HEART RATE INCREASED,14
CA,INFECTION,14
CA,INFLUENZA,14
CA,LOSS OF CONSCIOUSNESS,14
CA,OEDEMA PERIPHERAL,14
CA,BLOOD PRESSURE SYSTOLIC INCREASED,13
CA,CARDIAC DISORDER,13
CA,HYPOAESTHESIA,13
CA,SPEECH DISORDER,13
CA,ABDOMINAL PAIN UPPER,12
CA,ARTHROPATHY,12
CA,BLOOD PRESSURE FLUCTUATION,12
CA,BRONCHITIS,12
CA,GASTROINTESTINAL HAEMORRHAGE,12
CA,INJECTION SITE PAIN,12
CA,MUSCULAR WEAKNESS,12
CA,PROSTATE CANCER,12
CA,ARTHRITIS,11
CA,CEREBROVASCULAR ACCIDENT,11
CA,DEHYDRATION,11
CA,DYSPNOEA EXERTIONAL,11
CA,ERYTHEMA,11
CA,MUSCULOSKELETAL PAIN,11
CA,PULMONARY OEDEMA,11
CA,THROMBOSIS,11
CA,BLOOD CREATININE INCREASED,10
CA,BLOOD PRESSURE DECREASED,10
CA,CATARACT,10
CA,CHEST DISCOMFORT,10
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,10
CA,DIABETES MELLITUS INADEQUATE CONTROL,10
CA,DIVERTICULITIS,10
CA,FEBRILE NEUTROPENIA,10
CA,HEPATIC ENZYME INCREASED,10
CA,LUNG INFECTION,10
CA,OSTEOARTHRITIS,10
CA,PLATELET COUNT DECREASED,10
CA,PSORIASIS,10
CA,BLOOD PRESSURE DIASTOLIC DECREASED,9
CA,BODY TEMPERATURE DECREASED,9
CA,CELLULITIS,9
CA,CYSTITIS,9
CA,DRUG INTOLERANCE,9
CA,DYSPEPSIA,9
CA,FLUSHING,9
CA,GOUT,9
CA,LOWER RESPIRATORY TRACT INFECTION,9
CA,PALPITATIONS,9
CA,PRURITUS,9
CA,SWELLING,9
CA,AMNESIA,8
CA,BALANCE DISORDER,8
CA,BONE PAIN,8
CA,DISEASE PROGRESSION,8
CA,DYSPHONIA,8
CA,EPISTAXIS,8
CA,HEART RATE IRREGULAR,8
CA,HYPERHIDROSIS,8
CA,MUSCULOSKELETAL STIFFNESS,8
CA,PRODUCT SUBSTITUTION ISSUE,8
CA,RIB FRACTURE,8
CA,SKIN DISCOLOURATION,8
CA,URTICARIA,8
CA,ABASIA,7
CA,ANGINA PECTORIS,7
CA,BREAST CANCER,7
CA,DEPRESSION,7
CA,DIABETIC KETOACIDOSIS,7
CA,FEELING ABNORMAL,7
CA,FUNGAL INFECTION,7
CA,GENERAL PHYSICAL HEALTH DETERIORATION,7
CA,HAEMORRHAGE,7
CA,HYPOMAGNESAEMIA,7
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,7
CA,INTERNATIONAL NORMALISED RATIO INCREASED,7
CA,LYMPHOCYTE COUNT DECREASED,7
CA,MALIGNANT NEOPLASM PROGRESSION,7
CA,NEPHROLITHIASIS,7
CA,PRODUCTIVE COUGH,7
CA,RECTAL HAEMORRHAGE,7
CA,TREMOR,7
CA,VISION BLURRED,7
CA,AGITATION,6
CA,ANXIETY,6
CA,APHASIA,6
CA,BODY TEMPERATURE INCREASED,6
CA,BURNING SENSATION,6
CA,DEPRESSED MOOD,6
CA,DYSURIA,6
CA,FEELING HOT,6
CA,HOT FLUSH,6
CA,HYPERSENSITIVITY,6
CA,LIMB DISCOMFORT,6
CA,LUNG DISORDER,6
CA,NECK PAIN,6
CA,OROPHARYNGEAL PAIN,6
CA,PLEURAL EFFUSION,6
CA,POLLAKIURIA,6
CA,RASH GENERALISED,6
CA,RENAL FAILURE ACUTE,6
CA,SINUSITIS,6
CA,SOMNOLENCE,6
CA,SURGERY,6
CA,TACHYCARDIA,6
CA,TRANSIENT ISCHAEMIC ATTACK,6
CA,UROSEPSIS,6
CA,ACUTE MYOCARDIAL INFARCTION,5
CA,ANGIOEDEMA,5
CA,ASTHMA,5
CA,CARDIAC ARREST,5
CA,DELIRIUM,5
CA,DIABETES MELLITUS,5
CA,DISORIENTATION,5
CA,DRY MOUTH,5
CA,FLATULENCE,5
CA,HAEMATEMESIS,5
CA,HAEMATOMA,5
CA,HALLUCINATION_ VISUAL,5
CA,HERPES ZOSTER,5
CA,ILL-DEFINED DISORDER,5
CA,INTERVERTEBRAL DISC PROTRUSION,5
CA,LUNG NEOPLASM MALIGNANT,5
CA,MELAENA,5
CA,MOBILITY DECREASED,5
CA,NERVOUS SYSTEM DISORDER,5
CA,NEUROPATHY PERIPHERAL,5
CA,ORAL HERPES,5
CA,PANCYTOPENIA,5
CA,POOR QUALITY SLEEP,5
CA,RENAL DISORDER,5
CA,RESPIRATORY RATE INCREASED,5
CA,RHINORRHOEA,5
CA,STRESS,5
CA,SWELLING FACE,5
CA,UPPER LIMB FRACTURE,5
CA,VIRAL INFECTION,5
CA,WHITE BLOOD CELL COUNT DECREASED,5
CA,WRIST FRACTURE,5
CA,ACUTE KIDNEY INJURY,4
CA,ADRENAL INSUFFICIENCY,4
CA,ALOPECIA,4
CA,ANGINA UNSTABLE,4
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
CA,BREATH SOUNDS ABNORMAL,4
CA,C-REACTIVE PROTEIN INCREASED,4
CA,CHROMATURIA,4
CA,CHVOSTEK^S SIGN,4
CA,CLOSTRIDIUM DIFFICILE INFECTION,4
CA,COGNITIVE DISORDER,4
CA,COLITIS,4
CA,CONVULSION,4
CA,DEMENTIA,4
CA,DYSPHAGIA,4
CA,EYE INFECTION,4
CA,FAECES DISCOLOURED,4
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
CA,GASTROENTERITIS VIRAL,4
CA,GASTROINTESTINAL DISORDER,4
CA,GASTROINTESTINAL INFECTION,4
CA,GLAUCOMA,4
CA,HAEMATOCHEZIA,4
CA,HIP FRACTURE,4
CA,HOSPITALISATION,4
CA,HUMERUS FRACTURE,4
CA,HYPOCALCAEMIA,4
CA,HYPOKALAEMIA,4
CA,INFLAMMATION,4
CA,INJECTION SITE EXTRAVASATION,4
CA,INTESTINAL OBSTRUCTION,4
CA,LACERATION,4
CA,LOCAL SWELLING,4
CA,MANTLE CELL LYMPHOMA RECURRENT,4
CA,MEDICATION ERROR,4
CA,MOUTH ULCERATION,4
CA,MOVEMENT DISORDER,4
CA,NASAL CONGESTION,4
CA,NEEDLE ISSUE,4
CA,PANCREATITIS,4
CA,PARAESTHESIA,4
CA,PERICARDIAL EFFUSION,4
CA,PROCEDURAL PAIN,4
CA,PULMONARY FIBROSIS,4
CA,PULMONARY FUNCTION TEST DECREASED,4
CA,RASH PRURITIC,4
CA,RED BLOOD CELL COUNT DECREASED,4
CA,RENAL IMPAIRMENT,4
CA,RESPIRATORY FAILURE,4
CA,RESPIRATORY TRACT CONGESTION,4
CA,SCIATICA,4
CA,SEIZURE,4
CA,SEPSIS,4
CA,SQUAMOUS CELL CARCINOMA OF SKIN,4
CA,STEVENS-JOHNSON SYNDROME,4
CA,SUICIDAL IDEATION,4
CA,URINARY INCONTINENCE,4
CA,URINARY TRACT INFECTION BACTERIAL,4
CA,VERTIGO,4
CA,WHEEZING,4
CA,ABDOMINAL PAIN LOWER,3
CA,ABORTION,3
CA,ALANINE AMINOTRANSFERASE INCREASED,3
CA,AREFLEXIA,3
CA,ARRHYTHMIA,3
CA,ASPARTATE AMINOTRANSFERASE INCREASED,3
CA,ATAXIA,3
CA,ATRIAL FLUTTER,3
CA,ATYPICAL FEMUR FRACTURE,3
CA,BLOOD CHOLESTEROL INCREASED,3
CA,BLOOD IRON DECREASED,3
CA,BLOOD POTASSIUM DECREASED,3
CA,BLOOD URINE PRESENT,3
CA,BRONCHOSPASM,3
CA,BURSITIS,3
CA,CARDIAC FAILURE,3
CA,COLON CANCER,3
CA,CORONARY ARTERY DISEASE,3
CA,CUSHINGOID,3
CA,DEEP VEIN THROMBOSIS,3
CA,DERMATITIS EXFOLIATIVE,3
CA,DISCOMFORT,3
CA,DRUG ADMINISTRATION ERROR,3
CA,DRUG DOSE OMISSION,3
CA,DRUG EFFECT DECREASED,3
CA,DRUG HYPERSENSITIVITY,3
CA,DRUG-INDUCED LIVER INJURY,3
CA,DRY SKIN,3
CA,DYSGEUSIA,3
CA,EAR PAIN,3
CA,EXERCISE TOLERANCE DECREASED,3
CA,EYE SWELLING,3
CA,FIBROMYALGIA,3
CA,FLUID RETENTION,3
CA,FOOT DEFORMITY,3
CA,GASTRIC ULCER,3
CA,GASTROOESOPHAGEAL REFLUX DISEASE,3
CA,GENITAL SWELLING,3
CA,HALLUCINATION_ AUDITORY,3
CA,HEAD INJURY,3
CA,HIATUS HERNIA,3
CA,HYPERGLYCAEMIA,3
CA,HYPERKALAEMIA,3
CA,HYPERSENSITIVITY VASCULITIS,3
CA,HYPOGLYCAEMIA,3
CA,HYPONATRAEMIA,3
CA,HYPOPHAGIA,3
CA,IMPAIRED HEALING,3
CA,INCISION SITE INFECTION,3
CA,INCREASED APPETITE,3
CA,INFUSION SITE EXTRAVASATION,3
CA,INTERNATIONAL NORMALISED RATIO DECREASED,3
CA,KIDNEY INFECTION,3
CA,KNEE ARTHROPLASTY,3
CA,LACTIC ACIDOSIS,3
CA,LIMB OPERATION,3
CA,LIPASE INCREASED,3
CA,LUMBAR VERTEBRAL FRACTURE,3
CA,MACULAR DEGENERATION,3
CA,MASS,3
CA,MEAN CELL HAEMOGLOBIN INCREASED,3
CA,METASTASES TO LIVER,3
CA,MIGRAINE,3
CA,MOUTH SWELLING,3
CA,MUSCULOSKELETAL DISORDER,3
CA,NECK MASS,3
CA,OESOPHAGEAL CARCINOMA,3
CA,ORTHOSTATIC HYPOTENSION,3
CA,OVERDOSE,3
CA,PANCREATITIS CHRONIC,3
CA,PARALYSIS,3
CA,PNEUMONIA ASPIRATION,3
CA,PRODUCT USE ISSUE,3
CA,PULMONARY EMBOLISM,3
CA,PULMONARY FUNCTION TEST ABNORMAL,3
CA,PURPURA,3
CA,QUALITY OF LIFE DECREASED,3
CA,RESPIRATORY TRACT INFECTION,3
CA,RHABDOMYOLYSIS,3
CA,SEROTONIN SYNDROME,3
CA,SKIN ATROPHY,3
CA,SKIN CANCER,3
CA,SKIN EXFOLIATION,3
CA,SKIN HAEMORRHAGE,3
CA,SPINAL DISORDER,3
CA,SUPRAVENTRICULAR EXTRASYSTOLES,3
CA,SWOLLEN TONGUE,3
CA,TENDONITIS,3
CA,THROAT TIGHTNESS,3
CA,THROMBOCYTOPENIA,3
CA,THYROID DISORDER,3
CA,TOOTH ABSCESS,3
CA,TOOTH DISORDER,3
CA,TOXIC SHOCK SYNDROME,3
CA,TREATMENT NONCOMPLIANCE,3
CA,ULCER,3
CA,UNRESPONSIVE TO STIMULI,3
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,3
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,3
CA,VISUAL IMPAIRMENT,3
CA,WEIGHT LOSS POOR,3
CA,WHITE BLOOD CELL COUNT INCREASED,3
CA,WOUND,3
CA,ACOUSTIC STIMULATION TESTS ABNORMAL,2
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,2
CA,ACUTE CORONARY SYNDROME,2
CA,AGEUSIA,2
CA,AGGRESSION,2
CA,ANKLE FRACTURE,2
CA,AORTIC ANEURYSM,2
CA,APHONIA,2
CA,APLASTIC ANAEMIA,2
CA,ARTHRODESIS,2
CA,BACK DISORDER,2
CA,BACK INJURY,2
CA,BACTERIAL INFECTION,2
CA,BASAL CELL CARCINOMA,2
CA,BEDRIDDEN,2
CA,BLISTER,2
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,2
CA,BLOOD BILIRUBIN INCREASED,2
CA,BLOOD CALCIUM DECREASED,2
CA,BLOOD COUNT ABNORMAL,2
CA,BLOOD GLUCOSE FLUCTUATION,2
CA,BLOOD IMMUNOGLOBULIN E INCREASED,2
CA,BLOOD MAGNESIUM DECREASED,2
CA,BLOOD PRESSURE DIASTOLIC INCREASED,2
CA,BLOOD PRESSURE INADEQUATELY CONTROLLED,2
CA,BLOOD URINE,2
CA,BODY MASS INDEX INCREASED,2
CA,BONE DENSITY DECREASED,2
CA,BONE MARROW FAILURE,2
CA,BRADYCARDIA,2
CA,BUNION OPERATION,2
CA,BURNS THIRD DEGREE,2
CA,CARDIAC FAILURE CHRONIC,2
CA,CARDIAC PACEMAKER REPLACEMENT,2
CA,CATARACT OPERATION,2
CA,CATHETER SITE BRUISE,2
CA,CEREBRAL HAEMORRHAGE,2
CA,CHOLELITHIASIS,2
CA,COLD SWEAT,2
CA,COLITIS ISCHAEMIC,2
CA,COLITIS ULCERATIVE,2
CA,COMA,2
CA,CONGENITAL CYSTIC KIDNEY DISEASE,2
CA,CREATININE RENAL CLEARANCE DECREASED,2
CA,CROHN^S DISEASE,2
CA,CYST,2
CA,CYSTOCELE,2
CA,DEMENTIA ALZHEIMER^S TYPE,2
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,2
CA,DIARRHOEA HAEMORRHAGIC,2
CA,DIZZINESS POSTURAL,2
CA,DRY THROAT,2
CA,DUPUYTREN^S CONTRACTURE,2
CA,DYSARTHRIA,2
CA,DYSLIPIDAEMIA,2
CA,DYSSTASIA,2
CA,EAR CONGESTION,2
CA,EAR INFECTION,2
CA,EJECTION FRACTION DECREASED,2
CA,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,2
CA,ELECTROLYTE IMBALANCE,2
CA,ENDOCRINE OPHTHALMOPATHY,2
CA,EOSINOPHIL COUNT INCREASED,2
CA,EYE IRRITATION,2
CA,EYE PAIN,2
CA,EYELID DISORDER,2
CA,EYELID OEDEMA,2
CA,FACIAL PARALYSIS,2
CA,FAECES SOFT,2
CA,FAILURE TO THRIVE,2
CA,FEELING COLD,2
CA,FEMALE GENITAL TRACT FISTULA,2
CA,FISTULA,2
CA,FOOT FRACTURE,2
CA,FREQUENT BOWEL MOVEMENTS,2
CA,GASTRITIS EROSIVE,2
CA,GASTROINTESTINAL PAIN,2
CA,GASTROINTESTINAL ULCER,2
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
CA,GROWTH HORMONE DEFICIENCY,2
CA,HAEMATOCRIT DECREASED,2
CA,HAEMATURIA,2
CA,HAEMODIALYSIS,2
CA,HAEMORRHAGE INTRACRANIAL,2
CA,HAND FRACTURE,2
CA,HEAD DISCOMFORT,2
CA,HYPERCHOLESTEROLAEMIA,2
CA,HYPOACUSIS,2
CA,HYPOPITUITARISM,2
CA,HYPOXIA,2
CA,INCOHERENT,2
CA,INCORRECT DOSE ADMINISTERED,2
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
CA,INCREASED TENDENCY TO BRUISE,2
CA,INFLUENZA LIKE ILLNESS,2
CA,INJECTION SITE SWELLING,2
CA,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
CA,INTERSTITIAL LUNG DISEASE,2
CA,JOINT INJURY,2
CA,JOINT STIFFNESS,2
CA,LACRIMATION INCREASED,2
CA,LIGAMENT SPRAIN,2
CA,LIP SWELLING,2
CA,LOBAR PNEUMONIA,2
CA,LOCALISED INFECTION,2
CA,LYMPHOMA,2
CA,MEDICAL DEVICE COMPLICATION,2
CA,MEMORY IMPAIRMENT,2
CA,MULTIPLE DRUG THERAPY,2
CA,MULTIPLE SCLEROSIS RELAPSE,2
CA,MUSCLE TIGHTNESS,2
CA,MUSCULOSKELETAL CHEST PAIN,2
CA,MUSCULOSKELETAL DISCOMFORT,2
CA,NEOPLASM MALIGNANT,2
CA,NEOPLASM PROGRESSION,2
CA,NERVE INJURY,2
CA,NERVOUSNESS,2
CA,NEURALGIA,2
CA,NEUROMYOPATHY,2
CA,NEUTROPHIL COUNT DECREASED,2
CA,NODAL OSTEOARTHRITIS,2
CA,NON-HODGKIN^S LYMPHOMA,2
CA,OEDEMA,2
CA,OROPHARYNGEAL DISCOMFORT,2
CA,OSTEONECROSIS OF JAW,2
CA,OSTEOPOROSIS,2
CA,PAIN IN JAW,2
CA,PALLOR,2
CA,PANCREATIC CARCINOMA,2
CA,PANIC ATTACK,2
CA,PARAESTHESIA ORAL,2
CA,PARANASAL SINUS DISCOMFORT,2
CA,PERIPHERAL ISCHAEMIA,2
CA,PHARYNGITIS,2
CA,PHOTOPHOBIA,2
CA,PNEUMONITIS,2
CA,PNEUMOTHORAX,2
CA,POLYP,2
CA,PRESYNCOPE,2
CA,PRODUCT QUALITY ISSUE,2
CA,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
CA,PROTHROMBIN TIME PROLONGED,2
CA,PRURITUS GENERALISED,2
CA,PSORIATIC ARTHROPATHY,2
CA,RASH MACULAR,2
CA,RENAL CANCER,2
CA,RENAL FAILURE,2
CA,RENAL PAIN,2
CA,RESPIRATORY DISORDER,2
CA,RESPIRATORY DISTRESS,2
CA,RETCHING,2
CA,RETINAL TEAR,2
CA,ROAD TRAFFIC ACCIDENT,2
CA,SEPTIC SHOCK,2
CA,SHORT-BOWEL SYNDROME,2
CA,SINUS CONGESTION,2
CA,SKIN DISORDER,2
CA,SKIN INJURY,2
CA,SKIN LESION,2
CA,SKIN REACTION,2
CA,SLEEP DISORDER,2
CA,STOMATITIS,2
CA,SUBDURAL HAEMATOMA,2
CA,SUFFOCATION FEELING,2
CA,SYNOVIAL CYST,2
CA,SYNOVITIS,2
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,2
CA,TENDERNESS,2
CA,TENDON RUPTURE,2
CA,THERAPEUTIC RESPONSE DECREASED,2
CA,THROAT IRRITATION,2
CA,TINNITUS,2
CA,TONGUE BLISTERING,2
CA,TOOTHACHE,2
CA,TOXICITY TO VARIOUS AGENTS,2
CA,TRANSFUSION,2
CA,TROPONIN INCREASED,2
CA,UNEVALUABLE EVENT,2
CA,UPPER RESPIRATORY TRACT INFECTION,2
CA,URINARY BLADDER HAEMORRHAGE,2
CA,URINARY RETENTION,2
CA,VAGINAL LESION,2
CA,VISUAL ACUITY REDUCED,2
CA,WALKING DISABILITY,2
CA,5-HYDROXYINDOLACETIC ACID IN URINE DECREASED,1
CA,ABDOMINAL ADHESIONS,1
CA,ABDOMINAL HERNIA,1
CA,ABDOMINAL INFECTION,1
CA,ABDOMINAL MASS,1
CA,ABDOMINAL TENDERNESS,1
CA,ABNORMAL BEHAVIOUR,1
CA,ABSCESS NECK,1
CA,ABULIA,1
CA,ACIDOSIS,1
CA,ACNE,1
CA,ACTINIC KERATOSIS,1
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
CA,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
CA,ACUTE PULMONARY OEDEMA,1
CA,AFFECTIVE DISORDER,1
CA,AGRANULOCYTOSIS,1
CA,AKATHISIA,1
CA,ALTERED STATE OF CONSCIOUSNESS,1
CA,AMYLASE INCREASED,1
CA,AMYOTROPHIC LATERAL SCLEROSIS,1
CA,ANAL INCONTINENCE,1
CA,ANAPHYLACTIC REACTION,1
CA,ANAPHYLACTIC SHOCK,1
CA,ANGIOMYOLIPOMA,1
CA,ANKLE OPERATION,1
CA,ANKYLOSING SPONDYLITIS,1
CA,ANORECTAL DISORDER,1
CA,ANOSMIA,1
CA,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
CA,AORTIC DILATATION,1
CA,AORTIC STENOSIS,1
CA,APHTHOUS STOMATITIS,1
CA,APHTHOUS ULCER,1
CA,APPARENT DEATH,1
CA,APPENDICITIS PERFORATED,1
CA,APPLICATION SITE PURPURA,1
CA,APRAXIA,1
CA,ARTERIAL OCCLUSIVE DISEASE,1
CA,ARTERIAL THROMBOSIS,1
CA,ARTHRITIS BACTERIAL,1
CA,ARTHRITIS INFECTIVE,1
CA,ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME,1
CA,ATELECTASIS,1
CA,ATRIOVENTRICULAR BLOCK,1
CA,AUTOIMMUNE PANCREATITIS,1
CA,AXILLARY MASS,1
CA,BENIGN NEOPLASM,1
CA,BENIGN NEOPLASM OF SKIN,1
CA,BILIRUBIN CONJUGATED INCREASED,1
CA,BLADDER CANCER,1
CA,BLADDER MASS,1
CA,BLEEDING TIME PROLONGED,1
CA,BLINDNESS,1
CA,BLINDNESS UNILATERAL,1
CA,BLOOD ALBUMIN INCREASED,1
CA,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
CA,BLOOD CHLORIDE DECREASED,1
CA,BLOOD CULTURE POSITIVE,1
CA,BLOOD DISORDER,1
CA,BLOOD GLUCOSE ABNORMAL,1
CA,BLOOD GLUCOSE DECREASED,1
CA,BLOOD GROWTH HORMONE INCREASED,1
CA,BLOOD IRON INCREASED,1
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CA,BLOOD LACTIC ACID INCREASED,1
CA,BLOOD PRESSURE ABNORMAL,1
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,1
CA,BLOOD PRESSURE DIFFERENCE OF EXTREMITIES,1
CA,BLOOD SODIUM DECREASED,1
CA,BLOOD SODIUM INCREASED,1
CA,BLOOD TEST ABNORMAL,1
CA,BLOOD TRIGLYCERIDES INCREASED,1
CA,BLOOD UREA INCREASED,1
CA,BLOOD VISCOSITY INCREASED,1
CA,BONE DISORDER,1
CA,BONE LOSS,1
CA,BRAIN HERNIATION,1
CA,BRAIN INJURY,1
CA,BREAST CANCER METASTATIC,1
CA,BREAST MASS,1
CA,BREAST PAIN,1
CA,BRONCHOPULMONARY ASPERGILLOSIS,1
CA,BUTTOCK CRUSHING,1
CA,CALCULUS BLADDER,1
CA,CANCER PAIN,1
CA,CARBON MONOXIDE DIFFUSING CAPACITY DECREASED,1
CA,CARCINOEMBRYONIC ANTIGEN,1
CA,CARDIAC FLUTTER,1
CA,CARDIAC OPERATION,1
CA,CARDIAC PACEMAKER INSERTION,1
CA,CARDIAC VENTRICULAR THROMBOSIS,1
CA,CARDIO-RESPIRATORY ARREST,1
CA,CARDIOMEGALY,1
CA,CARDIOVASCULAR DISORDER,1
CA,CAROTID ARTERY CALCIFICATION,1
CA,CARTILAGE INJURY,1
CA,CATHETER PLACEMENT,1
CA,CEREBRAL PALSY,1
CA,CHEST INJURY,1
CA,CHEST X-RAY ABNORMAL,1
CA,CHOKING SENSATION,1
CA,CHOLECYSTITIS,1
CA,CHOLESTASIS,1
CA,CHRONIC KIDNEY DISEASE,1
CA,CHRONIC MYELOID LEUKAEMIA,1
CA,CIRCULATORY COLLAPSE,1
CA,CLAVICLE FRACTURE,1
CA,COLONIC ABSCESS,1
CA,COMPLICATION ASSOCIATED WITH DEVICE,1
CA,CONCOMITANT DISEASE AGGRAVATED,1
CA,CONTRAINDICATED PRODUCT ADMINISTERED,1
CA,CORONARY ARTERY OCCLUSION,1
CA,CORONARY ARTERY STENOSIS,1
CA,CRYING,1
CA,CYTOMEGALOVIRUS INFECTION,1
CA,DEAFNESS,1
CA,DEAFNESS UNILATERAL,1
CA,DEATH NEONATAL,1
CA,DEFAECATION URGENCY,1
CA,DERMATITIS ALLERGIC,1
CA,DEVICE DISLOCATION,1
CA,DEVICE MALFUNCTION,1
CA,DIABETIC COMA,1
CA,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,1
CA,DIFFUSE LARGE B-CELL LYMPHOMA STAGE I,1
CA,DIPLEGIA,1
CA,DIPLOPIA,1
CA,DISTURBANCE IN ATTENTION,1
CA,DRUG EFFECT DELAYED,1
CA,DRUG EFFECT INCOMPLETE,1
CA,DRUG SCREEN POSITIVE,1
CA,DYSPLASIA,1
CA,DYSPNOEA AT REST,1
CA,EAR HAEMORRHAGE,1
CA,EATING DISORDER,1
CA,ELECTROCARDIOGRAM CHANGE,1
CA,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
CA,ELECTROCARDIOGRAM QT PROLONGED,1
CA,EMBOLISM,1
CA,EMPHYSEMA,1
CA,EPIGASTRIC DISCOMFORT,1
CA,EPILEPSY,1
CA,EPSTEIN-BARR VIRUS INFECTION,1
CA,ERECTILE DYSFUNCTION,1
CA,ESCHERICHIA INFECTION,1
CA,EUPHORIC MOOD,1
CA,EXCESSIVE CERUMEN PRODUCTION,1
CA,EXPOSURE TO RADIATION,1
CA,EXTRASYSTOLES,1
CA,EXTRAVASCULAR HAEMOLYSIS,1
CA,EYE DISORDER,1
CA,EYE HAEMORRHAGE,1
CA,EYE OEDEMA,1
CA,EYE PARAESTHESIA,1
CA,EYE PRURITUS,1
CA,FACIAL BONES FRACTURE,1
CA,FAECALOMA,1
CA,FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION,1
CA,FEEDING DISORDER,1
CA,FEELING JITTERY,1
CA,FEELING OF BODY TEMPERATURE CHANGE,1
CA,FEELINGS OF WORTHLESSNESS,1
CA,FEMUR FRACTURE,1
CA,FIBRIN D DIMER INCREASED,1
CA,FINGER AMPUTATION,1
CA,FLANK PAIN,1
CA,FLUID OVERLOAD,1
CA,FOOD ALLERGY,1
CA,FOOD POISONING,1
CA,FOOT OPERATION,1
CA,FORCED VITAL CAPACITY DECREASED,1
CA,FRACTURE,1
CA,FULL BLOOD COUNT DECREASED,1
CA,FUNGAL SKIN INFECTION,1
CA,GASTRIC DISORDER,1
CA,GASTRIC INFECTION,1
CA,GASTRIC ULCER HAEMORRHAGE,1
CA,GENERALISED OEDEMA,1
CA,GINGIVAL DISORDER,1
CA,GLOMERULAR FILTRATION RATE DECREASED,1
CA,GLOSSODYNIA,1
CA,GLUCOSE TOLERANCE IMPAIRED,1
CA,GROIN ABSCESS,1
CA,GROIN PAIN,1
CA,HAEMARTHROSIS,1
CA,HAEMOGLOBIN ABNORMAL,1
CA,HAEMORRHAGE URINARY TRACT,1
CA,HAEMORRHOIDS,1
CA,HALLUCINATION,1
CA,HEMIPARESIS,1
CA,HEMIPLEGIA,1
CA,HEPATIC CIRRHOSIS,1
CA,HEPATIC STEATOSIS,1
CA,HEPATITIS,1
CA,HEPATOTOXICITY,1
CA,HIATUS HERNIA STRANGULATED,1
CA,HIP ARTHROPLASTY,1
CA,HIP SURGERY,1
CA,HUERTHLE CELL CARCINOMA,1
CA,HYPERCALCAEMIA,1
CA,HYPERLIPIDAEMIA,1
CA,HYPEROSMOLAR STATE,1
CA,HYPERTHYROIDISM,1
CA,HYPOAESTHESIA ORAL,1
CA,HYPOGEUSIA,1
CA,HYPOPNOEA,1
CA,HYPOVENTILATION,1
CA,HYPOVITAMINOSIS,1
CA,HYPOVOLAEMIC SHOCK,1
CA,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CA,ILLNESS ANXIETY DISORDER,1
CA,IMMUNE SYSTEM DISORDER,1
CA,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
CA,IMPULSIVE BEHAVIOUR,1
CA,INCISION SITE PRURITUS,1
CA,INCORRECT DRUG ADMINISTRATION DURATION,1
CA,INDURATION,1
CA,INFARCTION,1
CA,INFECTED SKIN ULCER,1
CA,INFECTIOUS PLEURAL EFFUSION,1
CA,INFREQUENT BOWEL MOVEMENTS,1
CA,INFUSION SITE BRUISING,1
CA,INFUSION SITE THROMBOSIS,1
CA,INHALATION THERAPY,1
CA,INJECTION SITE BRUISING,1
CA,INJECTION SITE HAEMATOMA,1
CA,INJECTION SITE HYPOAESTHESIA,1
CA,INJECTION SITE INJURY,1
CA,INJECTION SITE MASS,1
CA,INJECTION SITE REACTION,1
CA,INJURY,1
CA,INTENTIONAL PRODUCT MISUSE,1
CA,INTERNAL HAEMORRHAGE,1
CA,INTERVERTEBRAL DISC DEGENERATION,1
CA,INTESTINAL HAEMORRHAGE,1
CA,INTESTINAL ISCHAEMIA,1
CA,INTESTINAL PERFORATION,1
CA,INTESTINAL RESECTION,1
CA,INTRA-ABDOMINAL HAEMATOMA,1
CA,IRRITABILITY,1
CA,IRRITABLE BOWEL SYNDROME,1
CA,ISCHAEMIA,1
CA,ISCHAEMIC STROKE,1
CA,JAW DISORDER,1
CA,JOINT ABSCESS,1
CA,JOINT RANGE OF MOTION DECREASED,1
CA,LABYRINTHITIS,1
CA,LANGUAGE DISORDER,1
CA,LEFT ATRIAL DILATATION,1
CA,LEFT VENTRICULAR HYPERTROPHY,1
CA,LEG AMPUTATION,1
CA,LETHARGY,1
CA,LEUKOENCEPHALOPATHY,1
CA,LICHEN PLANUS,1
CA,LIGAMENT RUPTURE,1
CA,LIMB INJURY,1
CA,LIMB RECONSTRUCTIVE SURGERY,1
CA,LIP DISCOLOURATION,1
CA,LIPOMA,1
CA,LISTERIOSIS,1
CA,LISTLESS,1
CA,LIVER ABSCESS,1
CA,LIVER DISORDER,1
CA,LIVER INJURY,1
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
CA,LOWER EXTREMITY MASS,1
CA,LOWER LIMB FRACTURE,1
CA,LOWER RESPIRATORY TRACT CONGESTION,1
CA,LUNG NEOPLASM,1
CA,MALIGNANT MELANOMA,1
CA,MALIGNANT OVARIAN CYST,1
CA,MANIA,1
CA,MARROW HYPERPLASIA,1
CA,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
CA,MEAN CELL VOLUME INCREASED,1
CA,MENINGITIS,1
CA,MENINGITIS ASEPTIC,1
CA,MENISCUS INJURY,1
CA,METABOLIC ACIDOSIS,1
CA,METABOLIC SYNDROME,1
CA,METASTASES TO BONE,1
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CA,METASTASES TO PERITONEUM,1
CA,METASTASES TO SPINE,1
CA,MICROALBUMINURIA,1
CA,MICTURITION URGENCY,1
CA,MIDDLE EAR EFFUSION,1
CA,MITRAL VALVE INCOMPETENCE,1
CA,MOOD ALTERED,1
CA,MOOD SWINGS,1
CA,MUCOUS STOOLS,1
CA,MULTIPLE FRACTURES,1
CA,MULTIPLE INJURIES,1
CA,MULTIPLE SCLEROSIS,1
CA,MUSCLE RIGIDITY,1
CA,MUSCLE RUPTURE,1
CA,MYOCARDIAL ISCHAEMIA,1
CA,MYOGLOBINURIA,1
CA,MYOPATHY,1
CA,MYOTONIC DYSTROPHY,1
CA,NAIL DISCOLOURATION,1
CA,NASAL NEOPLASM,1
CA,NASAL SEPTUM PERFORATION,1
CA,NEOPLASM,1
CA,NEOPLASM RECURRENCE,1
CA,NEPHRITIS,1
CA,NEURITIS,1
CA,NEUROGENIC SHOCK,1
CA,NEUTROPENIA,1
CA,NEUTROPENIC COLITIS,1
CA,NEUTROPHIL COUNT INCREASED,1
CA,NEUTROPHILIA,1
CA,NIGHTMARE,1
CA,NITRITOID REACTION,1
CA,NO THERAPEUTIC RESPONSE,1
CA,NON-SMALL CELL LUNG CANCER,1
CA,OBSESSIVE-COMPULSIVE DISORDER,1
CA,OBSTRUCTIVE AIRWAYS DISORDER,1
CA,OCULAR HYPERAEMIA,1
CA,OEDEMA DUE TO RENAL DISEASE,1
CA,OEDEMATOUS PANCREATITIS,1
CA,OESOPHAGEAL ULCER,1
CA,OLIGURIA,1
CA,ORAL CANDIDIASIS,1
CA,ORAL MUCOSAL BLISTERING,1
CA,ORAL PAIN,1
CA,ORAL PRURITUS,1
CA,OSTEOMYELITIS,1
CA,OSTEONECROSIS,1
CA,OTITIS MEDIA ACUTE,1
CA,OXYGEN SATURATION ABNORMAL,1
CA,OXYGEN SUPPLEMENTATION,1
CA,PANCREATIC NEOPLASM,1
CA,PARATHYROIDECTOMY,1
CA,PARKINSON^S DISEASE,1
CA,PCO2 DECREASED,1
CA,PELVIC HAEMATOMA,1
CA,PEMPHIGUS,1
CA,PERIARTHRITIS,1
CA,PERICARDIAL HAEMORRHAGE,1
CA,PERIPHERAL ARTERY THROMBOSIS,1
CA,PERIPHERAL EMBOLISM,1
CA,PETECHIAE,1
CA,PETIT MAL EPILEPSY,1
CA,PHARYNGEAL MASS,1
CA,PHARYNGITIS STREPTOCOCCAL,1
CA,PHOTOSENSITIVITY REACTION,1
CA,PHRENIC NERVE PARALYSIS,1
CA,PLASMA CELL MYELOMA,1
CA,PLATELET COUNT ABNORMAL,1
CA,PLATELET COUNT INCREASED,1
CA,PLEUROPERICARDITIS,1
CA,POLYARTHRITIS,1
CA,POLYDIPSIA,1
CA,POLYMYOSITIS,1
CA,POOR PERIPHERAL CIRCULATION,1
CA,POOR VENOUS ACCESS,1
CA,POSTOPERATIVE WOUND COMPLICATION,1
CA,POSTOPERATIVE WOUND INFECTION,1
CA,POTENTIATING DRUG INTERACTION,1
CA,PRODUCT STORAGE ERROR,1
CA,PRODUCT USE IN UNAPPROVED INDICATION,1
CA,PROSTATE CANCER METASTATIC,1
CA,PROSTATE EXAMINATION ABNORMAL,1
CA,PROSTATIC SPECIFIC ANTIGEN ABNORMAL,1
CA,PROTEIN TOTAL DECREASED,1
CA,PROTEINURIA,1
CA,PSYCHOTIC DISORDER,1
CA,PUBIS FRACTURE,1
CA,PULMONARY ARTERIAL HYPERTENSION,1
CA,PULMONARY HYPERTENSION,1
CA,PULMONARY SEPSIS,1
CA,PULSELESS ELECTRICAL ACTIVITY,1
CA,PYODERMA,1
CA,QUADRIPARESIS,1
CA,RADICAL HYSTERECTOMY,1
CA,RALES,1
CA,RASH ERYTHEMATOUS,1
CA,RASH PAPULAR,1
CA,RAYNAUD^S PHENOMENON,1
CA,RECTAL CANCER,1
CA,RECURRENT CANCER,1
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
CA,RED CELL DISTRIBUTION WIDTH INCREASED,1
CA,RELAPSING-REMITTING MULTIPLE SCLEROSIS,1
CA,RENAL FAILURE CHRONIC,1
CA,RENAL HAEMORRHAGE,1
CA,RENAL TUBULAR NECROSIS,1
CA,RESTLESS LEGS SYNDROME,1
CA,RETINAL DETACHMENT,1
CA,RHINITIS,1
CA,ROTATOR CUFF SYNDROME,1
CA,SALIVA ALTERED,1
CA,SCAR,1
CA,SCHIZOAFFECTIVE DISORDER,1
CA,SCRATCH,1
CA,SCREAMING,1
CA,SEASONAL ALLERGY,1
CA,SEDATION,1
CA,SENSATION OF FOREIGN BODY,1
CA,SENSATION OF HEAVINESS,1
CA,SENSORY DISTURBANCE,1
CA,SERUM FERRITIN DECREASED,1
CA,SERUM FERRITIN INCREASED,1
CA,SHOCK,1
CA,SHOULDER OPERATION,1
CA,SINUS DISORDER,1
CA,SJOGREN^S SYNDROME,1
CA,SKIN ABRASION,1
CA,SKIN FISSURES,1
CA,SKIN INDURATION,1
CA,SKIN ULCER,1
CA,SKIN WARM,1
CA,SMALL INTESTINAL OBSTRUCTION,1
CA,SOFT TISSUE SWELLING,1
CA,SOMNAMBULISM,1
CA,SPINAL COLUMN STENOSIS,1
CA,SPINAL COMPRESSION FRACTURE,1
CA,SPINAL CORD HAEMORRHAGE,1
CA,SPINAL OSTEOARTHRITIS,1
CA,SPUTUM DISCOLOURED,1
CA,SQUAMOUS CELL CARCINOMA,1
CA,STENT PLACEMENT,1
CA,STERNAL FRACTURE,1
CA,SUBARACHNOID HAEMORRHAGE,1
CA,SUBCLAVIAN ARTERY THROMBOSIS,1
CA,SUBDURAL HYGROMA,1
CA,SUBILEUS,1
CA,SUDDEN ONSET OF SLEEP,1
CA,SUICIDE ATTEMPT,1
CA,SUPERINFECTION BACTERIAL,1
CA,SUPERINFECTION FUNGAL,1
CA,SUTURE INSERTION,1
CA,SYRINGE ISSUE,1
CA,TENSION HEADACHE,1
CA,THERAPEUTIC RESPONSE SHORTENED,1
CA,THERAPY CESSATION,1
CA,THERAPY NON-RESPONDER,1
CA,THERMAL BURN,1
CA,THROMBOPHLEBITIS,1
CA,THYROID FUNCTION TEST ABNORMAL,1
CA,TOOTH EXTRACTION,1
CA,TOOTH FRACTURE,1
CA,TOOTH INFECTION,1
CA,TOXICOLOGIC TEST ABNORMAL,1
CA,TRANSFUSION REACTION,1
CA,TRICUSPID VALVE INCOMPETENCE,1
CA,TRIGEMINAL NEURALGIA,1
CA,TROPONIN I INCREASED,1
CA,TUBERCULOSIS,1
CA,TUBULOINTERSTITIAL NEPHRITIS,1
CA,TYMPANIC MEMBRANE PERFORATION,1
CA,TYPE 2 DIABETES MELLITUS,1
CA,UMBILICAL HERNIA,1
CA,UNDERDOSE,1
CA,UPPER RESPIRATORY TRACT CONGESTION,1
CL,ADENOCARCINOMA,1
CL,COLON ADENOMA,1
CL,RECTAL NEOPLASM,1
CN,RHABDOMYOLYSIS,19
CN,DRUG-INDUCED LIVER INJURY,13
CN,CHEST DISCOMFORT,11
CN,HEPATIC FUNCTION ABNORMAL,11
CN,BLOOD CREATINE PHOSPHOKINASE INCREASED,8
CN,MYALGIA,8
CN,ASTHENIA,7
CN,NAUSEA,7
CN,VOMITING,7
CN,ALANINE AMINOTRANSFERASE INCREASED,6
CN,ASPARTATE AMINOTRANSFERASE INCREASED,6
CN,DIZZINESS,6
CN,DYSPNOEA,6
CN,BLOOD GLUCOSE INCREASED,5
CN,HEPATOCELLULAR INJURY,5
CN,LIVER DISORDER,5
CN,MYOPATHY,5
CN,OEDEMA PERIPHERAL,5
CN,RENAL IMPAIRMENT,5
CN,ABDOMINAL DISCOMFORT,4
CN,APLASIA PURE RED CELL,4
CN,DEATH,4
CN,LIVER INJURY,4
CN,MULTI-ORGAN FAILURE,4
CN,PRURITUS,4
CN,RENAL FAILURE,4
CN,BACK PAIN,3
CN,CEREBRAL HAEMORRHAGE,3
CN,DECREASED APPETITE,3
CN,DYSPEPSIA,3
CN,HEPATIC ENZYME INCREASED,3
CN,HYPOTENSION,3
CN,MYOCARDIAL NECROSIS MARKER INCREASED,3
CN,OLIGURIA,3
CN,PAIN,3
CN,PALPITATIONS,3
CN,RASH,3
CN,TRANSAMINASES INCREASED,3
CN,ABDOMINAL DISTENSION,2
CN,ANGINA PECTORIS,2
CN,ARRHYTHMIA,2
CN,ARTHRALGIA,2
CN,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,2
CN,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
CN,BLOOD POTASSIUM INCREASED,2
CN,CARDIAC FAILURE,2
CN,CORONARY ARTERY DISEASE,2
CN,DERMATITIS EXFOLIATIVE,2
CN,DIABETES MELLITUS,2
CN,DIABETIC NEPHROPATHY,2
CN,DRUG INEFFECTIVE,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,FATIGUE,2
CN,GASTRIC HAEMORRHAGE,2
CN,GASTRITIS,2
CN,HAEMOGLOBIN DECREASED,2
CN,HEADACHE,2
CN,INSOMNIA,2
CN,JAUNDICE,2
CN,JOINT SWELLING,2
CN,LUNG INFECTION,2
CN,MYOGLOBIN BLOOD INCREASED,2
CN,MYOSITIS,2
CN,NASOPHARYNGITIS,2
CN,NEUROPATHY PERIPHERAL,2
CN,OSTEOPOROSIS,2
CN,OVERDOSE,2
CN,PRODUCT COUNTERFEIT,2
CN,PYREXIA,2
CN,RENAL FAILURE ACUTE,2
CN,SHOCK,2
CN,TYPE 2 DIABETES MELLITUS,2
CN,ABDOMINAL PAIN,1
CN,ACUTE KIDNEY INJURY,1
CN,ADVERSE EVENT,1
CN,AFFECT LABILITY,1
CN,ALANINE AMINOTRANSFERASE ABNORMAL,1
CN,ALOPECIA,1
CN,ALTERED STATE OF CONSCIOUSNESS,1
CN,ANGINA UNSTABLE,1
CN,APHASIA,1
CN,ARTERIOSCLEROSIS CORONARY ARTERY,1
CN,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
CN,ATRIAL FIBRILLATION,1
CN,AUTOIMMUNE HEPATITIS,1
CN,AUTONOMIC NEUROPATHY,1
CN,BLADDER DILATATION,1
CN,BLOOD CREATINE PHOSPHOKINASE MB ABNORMAL,1
CN,BLOOD CREATININE ABNORMAL,1
CN,BLOOD CREATININE INCREASED,1
CN,BLOOD GLUCOSE ABNORMAL,1
CN,BLOOD GLUCOSE DECREASED,1
CN,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CN,BLOOD PRESSURE DECREASED,1
CN,BLOOD PRESSURE INCREASED,1
CN,BLOOD PRESSURE SYSTOLIC INCREASED,1
CN,BLOOD UREA INCREASED,1
CN,BLOOD URINE PRESENT,1
CN,C-REACTIVE PROTEIN INCREASED,1
CN,CARDIAC FAILURE CONGESTIVE,1
CN,CARDIOMYOPATHY,1
CN,CEREBRAL INFARCTION,1
CN,CEREBRAL ISCHAEMIA,1
CN,CERVICAL MYELOPATHY,1
CN,CHEST PAIN,1
CN,CHILLS,1
CN,CHOLESTASIS,1
CN,CHROMATURIA,1
CN,COLON CANCER STAGE 0,1
CN,CONDITION AGGRAVATED,1
CN,CONSTIPATION,1
CN,CONTRAINDICATED PRODUCT ADMINISTERED,1
CN,CORONARY ARTERY STENOSIS,1
CN,DEGENERATIVE AORTIC VALVE DISEASE,1
CN,DEGENERATIVE MITRAL VALVE DISEASE,1
CN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CN,DIABETIC FOOT,1
CN,DIABETIC KETOACIDOSIS,1
CN,DIARRHOEA,1
CN,DISCOMFORT,1
CN,DISORIENTATION,1
CN,DRUG ADMINISTRATION ERROR,1
CN,DRUG ERUPTION,1
CN,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
CN,DYSPHORIA,1
CN,DYSURIA,1
CN,EAR DISORDER,1
CN,ENZYME ABNORMALITY,1
CN,EPISTAXIS,1
CN,EXTRASYSTOLES,1
CN,FLATULENCE,1
CN,FLUSHING,1
CN,GASTROENTERITIS,1
CN,GASTROINTESTINAL HAEMORRHAGE,1
CN,HAEMATURIA,1
CN,HAEMOLYTIC ANAEMIA,1
CN,HAEMOPTYSIS,1
CN,HAEMORRHAGE SUBCUTANEOUS,1
CN,HAEMORRHAGIC DIATHESIS,1
CN,HALLUCINATION,1
CN,HEART RATE ABNORMAL,1
CN,HENOCH-SCHONLEIN PURPURA,1
CN,HEPATIC ENZYME ABNORMAL,1
CN,HEPATITIS,1
CN,HERNIA REPAIR,1
CN,HERPES ZOSTER,1
CN,HYPERCHLORHYDRIA,1
CN,HYPERLIPIDAEMIA,1
CN,HYPERTENSION,1
CN,HYPERTENSIVE HEART DISEASE,1
CN,HYPOGLYCAEMIC COMA,1
CN,INCISION SITE PAIN,1
CN,INTENTIONAL DRUG MISUSE,1
CN,INTENTIONAL PRODUCT MISUSE,1
CN,LACUNAR INFARCTION,1
CN,LEFT VENTRICULAR FAILURE,1
CN,LETHARGY,1
CN,LIPIDS INCREASED,1
CN,LOSS OF CONSCIOUSNESS,1
CN,LYMPHOCYTE COUNT DECREASED,1
CN,MENTAL DISORDER,1
CN,METHAEMOGLOBIN URINE PRESENT,1
CN,MOTION SICKNESS,1
CN,MOUTH ULCERATION,1
CN,MOVEMENT DISORDER,1
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CN,MUSCLE INJURY,1
CN,MUSCULAR WEAKNESS,1
CN,MUSCULOSKELETAL PAIN,1
CN,MUSCULOSKELETAL STIFFNESS,1
CN,NEUTROPHIL COUNT INCREASED,1
CN,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
CN,OEDEMA,1
CN,OESOPHAGEAL CARCINOMA,1
CN,PAIN IN EXTREMITY,1
CN,PANCREATIC INJURY,1
CN,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CN,PERIPHERAL SWELLING,1
CN,PHYSICAL EXAMINATION,1
CN,PLATELET COUNT DECREASED,1
CN,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
CN,PROTEIN URINE PRESENT,1
CN,PSORIASIS,1
CN,PULMONARY HAEMORRHAGE,1
CN,PULMONARY INFARCTION,1
CN,PULMONARY OEDEMA,1
CN,RALES,1
CN,RASH MACULAR,1
CN,RASH MACULO-PAPULAR,1
CN,RED BLOOD CELL COUNT DECREASED,1
CN,RENAL INJURY,1
CN,RENAL TUBULAR NECROSIS,1
CN,RESPIRATORY DISORDER,1
CN,RESPIRATORY FAILURE,1
CN,RETICULOCYTE COUNT DECREASED,1
CN,SCIATICA,1
CN,SENILE DEMENTIA,1
CN,SENSORY DISTURBANCE,1
CN,SKIN EXFOLIATION,1
CN,SUPRAVENTRICULAR TACHYCARDIA,1
CN,SURGERY,1
CN,SYNCOPE,1
CN,TACHYCARDIA,1
CN,TINNITUS,1
CN,TUBERCULOUS PLEURISY,1
CN,URTICARIA,1
CN,VASCULAR CALCIFICATION,1
CN,VISUAL ACUITY REDUCED,1
CN,WEIGHT DECREASED,1
CN,WEIGHT INCREASED,1
CN,WHEEZING,1
CN,WHITE BLOOD CELL COUNT INCREASED,1
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
CO,ANAPHYLACTIC REACTION,1
CO,BILE DUCT STONE,1
CO,CERVICAL DYSPLASIA,1
CO,CHEST PAIN,1
CO,CHOLECYSTITIS,1
CO,DIABETIC FOOT,1
CO,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
CO,INCORRECT DOSE ADMINISTERED,1
CO,INFARCTION,1
CO,MALAISE,1
CO,PAIN IN EXTREMITY,1
CO,PAIN IN JAW,1
CO,PANCREATITIS,1
CI,CHYLOTHORAX,2
CI,DIASTOLIC DYSFUNCTION,1
CI,LEFT ATRIAL DILATATION,1
CI,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
HR,PANCREATITIS ACUTE,13
HR,EXTRAPYRAMIDAL DISORDER,6
HR,ATRIAL FIBRILLATION,3
HR,ABDOMINAL PAIN UPPER,2
HR,DEHYDRATION,2
HR,DEPRESSED MOOD,2
HR,INTENTIONAL OVERDOSE,2
HR,PAIN IN EXTREMITY,2
HR,PERIPHERAL SWELLING,2
HR,SUICIDE ATTEMPT,2
HR,AMYLASE INCREASED,1
HR,ANGINA PECTORIS,1
HR,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS,1
HR,AORTIC STENOSIS,1
HR,APHASIA,1
HR,ARTERIOSCLEROSIS,1
HR,CARDIAC DISORDER,1
HR,CARDIAC FAILURE CONGESTIVE,1
HR,CARDIOMYOPATHY,1
HR,CEREBROVASCULAR ACCIDENT,1
HR,COUGH,1
HR,DEATH,1
HR,DECREASED APPETITE,1
HR,DEEP VEIN THROMBOSIS,1
HR,DIABETIC KETOACIDOSIS,1
HR,DISEASE PROGRESSION,1
HR,DYSPNOEA,1
HR,DYSPNOEA EXERTIONAL,1
HR,FACIAL PARALYSIS,1
HR,FATIGUE,1
HR,GANGRENE,1
HR,HEART RATE IRREGULAR,1
HR,HEMIPARESIS,1
HR,HYPERTENSION,1
HR,INTERSTITIAL LUNG DISEASE,1
HR,LIPASE INCREASED,1
HR,MUSCLE SPASMS,1
HR,OEDEMA PERIPHERAL,1
HR,ORTHOPNOEA,1
HR,RENAL FAILURE CHRONIC,1
HR,TYPE I HYPERSENSITIVITY,1
HR,VARICOSE VEIN,1
CY,ASTHENIA,1
CY,BREAST CANCER IN SITU,1
CY,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
CY,LUMBAR VERTEBRAL FRACTURE,1
CY,MACULAR DEGENERATION,1
CY,PANCREATIC CARCINOMA,1
CY,PYREXIA,1
CY,STATUS EPILEPTICUS,1
CZ,POLYMYOSITIS,12
CZ,IMMUNE-MEDIATED NECROTISING MYOPATHY,8
CZ,MUSCULAR WEAKNESS,3
CZ,ARTHRALGIA,2
CZ,BASAL CELL CARCINOMA,2
CZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
CZ,INTERSTITIAL LUNG DISEASE,2
CZ,MUSCLE CONTRACTIONS INVOLUNTARY,2
CZ,MUSCLE ENZYME INCREASED,2
CZ,MUSCLE NECROSIS,2
CZ,MYALGIA,2
CZ,MYOGLOBIN BLOOD INCREASED,2
CZ,PYREXIA,2
CZ,RASH,2
CZ,STEVENS-JOHNSON SYNDROME,2
CZ,ADENOCARCINOMA OF COLON,1
CZ,ASTHENIA,1
CZ,ATRIAL FIBRILLATION,1
CZ,BACK PAIN,1
CZ,BONE PAIN,1
CZ,CATARACT,1
CZ,CHOLECYSTITIS,1
CZ,CHRONIC KIDNEY DISEASE,1
CZ,CONSTIPATION,1
CZ,DEHYDRATION,1
CZ,DELIRIUM,1
CZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CZ,DERMATITIS BULLOUS,1
CZ,DIABETES MELLITUS INADEQUATE CONTROL,1
CZ,DIABETIC METABOLIC DECOMPENSATION,1
CZ,DIARRHOEA,1
CZ,DRUG INEFFECTIVE,1
CZ,DRUG PRESCRIBING ERROR,1
CZ,DRUG-INDUCED LIVER INJURY,1
CZ,DYSPEPSIA,1
CZ,DYSPNOEA EXERTIONAL,1
CZ,DYSURIA,1
CZ,FEMUR FRACTURE,1
CZ,FLUSHING,1
CZ,FOETAL EXPOSURE DURING PREGNANCY,1
CZ,FOOD INTOLERANCE,1
CZ,GASTROINTESTINAL PAIN,1
CZ,GENITAL DISORDER FEMALE,1
CZ,HEPATIC ENZYME INCREASED,1
CZ,HYPERALBUMINAEMIA,1
CZ,HYPERHIDROSIS,1
CZ,HYPERTENSION,1
CZ,HYPOPROTEINAEMIA,1
CZ,HYPOTENSION,1
CZ,INSOMNIA,1
CZ,JOINT STIFFNESS,1
CZ,LACERATION,1
CZ,LEUKOCYTURIA,1
CZ,LOW BIRTH WEIGHT BABY,1
CZ,MACULE,1
CZ,MALAISE,1
CZ,MATERNAL EXPOSURE DURING PREGNANCY,1
CZ,MIGRAINE,1
CZ,MUSCULOSKELETAL STIFFNESS,1
CZ,MYOPATHY,1
CZ,NAIL DISORDER,1
CZ,NAUSEA,1
CZ,NEPHROSCLEROSIS,1
CZ,NEPHROTIC SYNDROME,1
CZ,ONYCHOCLASIS,1
CZ,OSTEOARTHRITIS,1
CZ,PERITONITIS,1
CZ,PNEUMONIA,1
CZ,POLLAKIURIA,1
CZ,PREGNANCY,1
CZ,PREMATURE BABY,1
CZ,PREMATURE DELIVERY,1
CZ,PROTEINURIA,1
CZ,PYELONEPHRITIS,1
CZ,RASH PRURITIC,1
CZ,SOPOR,1
CZ,STATUS EPILEPTICUS,1
CZ,URINARY TRACT INFECTION,1
CZ,URINARY TRACT INFLAMMATION,1
CZ,URTICARIA,1
DK,DYSPNOEA,44
DK,NAUSEA,38
DK,DIZZINESS,32
DK,MYALGIA,32
DK,MUSCULAR WEAKNESS,28
DK,HYPOTENSION,27
DK,RHABDOMYOLYSIS,26
DK,VOMITING,25
DK,FATIGUE,24
DK,MALAISE,23
DK,TOXICITY TO VARIOUS AGENTS,22
DK,WEIGHT DECREASED,21
DK,DEHYDRATION,19
DK,ANAEMIA,18
DK,NEUROPATHY PERIPHERAL,18
DK,BEZOAR,17
DK,PNEUMONIA ASPIRATION,17
DK,GAIT DISTURBANCE,16
DK,LOSS OF CONSCIOUSNESS,16
DK,OESOPHAGEAL OBSTRUCTION,16
DK,OSTEONECROSIS OF JAW,15
DK,PAIN IN EXTREMITY,15
DK,PYREXIA,15
DK,ASTHENIA,14
DK,SEPSIS,14
DK,ARTHRALGIA,13
DK,MUSCLE SPASMS,13
DK,PAIN,13
DK,CARDIAC FAILURE,12
DK,RASH,12
DK,RESTLESSNESS,12
DK,SENSORY DISTURBANCE,12
DK,ABDOMINAL DISCOMFORT,11
DK,ATRIAL FIBRILLATION,11
DK,CARDIAC ARREST,11
DK,MEMORY IMPAIRMENT,11
DK,MUSCULOSKELETAL STIFFNESS,11
DK,MYOPATHY,11
DK,BACK PAIN,10
DK,CONFUSIONAL STATE,10
DK,DIARRHOEA,10
DK,HEADACHE,10
DK,INTENTIONAL OVERDOSE,10
DK,OESOPHAGEAL HAEMORRHAGE,10
DK,PNEUMONIA,10
DK,SYNCOPE,10
DK,ABDOMINAL PAIN,9
DK,BLOOD CREATINE PHOSPHOKINASE INCREASED,9
DK,BODY TEMPERATURE INCREASED,9
DK,CARDIOVASCULAR DISORDER,9
DK,DECREASED APPETITE,9
DK,HAEMOGLOBIN DECREASED,9
DK,MENTAL STATUS CHANGES,9
DK,PARAESTHESIA,9
DK,ABDOMINAL PAIN UPPER,8
DK,ANGINA PECTORIS,8
DK,ANXIETY,8
DK,COMPLETED SUICIDE,8
DK,FALL,8
DK,HYPOKALAEMIA,8
DK,INSOMNIA,8
DK,OEDEMA PERIPHERAL,8
DK,OVERDOSE,8
DK,RESPIRATORY DISORDER,8
DK,SLEEP DISORDER,8
DK,ACUTE KIDNEY INJURY,7
DK,ALANINE AMINOTRANSFERASE INCREASED,7
DK,BLOOD CREATININE INCREASED,7
DK,C-REACTIVE PROTEIN INCREASED,7
DK,CONSTIPATION,7
DK,ERYTHEMA,7
DK,GENERAL PHYSICAL HEALTH DETERIORATION,7
DK,HYPERHIDROSIS,7
DK,HYPERTENSION,7
DK,HYPOGLYCAEMIA,7
DK,HYPONATRAEMIA,7
DK,PRURITUS,7
DK,RENAL FAILURE,7
DK,ALTERED STATE OF CONSCIOUSNESS,6
DK,CHEST PAIN,6
DK,COUGH,6
DK,DEPRESSION,6
DK,DRUG CLEARANCE DECREASED,6
DK,DYSPHAGIA,6
DK,HYPERSENSITIVITY,6
DK,HYPOAESTHESIA,6
DK,MELAENA,6
DK,MYOCARDIAL INFARCTION,6
DK,NIGHTMARE,6
DK,PALPITATIONS,6
DK,PLEURAL EFFUSION,6
DK,PSEUDOMEMBRANOUS COLITIS,6
DK,RECTAL HAEMORRHAGE,6
DK,RENAL IMPAIRMENT,6
DK,TACHYCARDIA,6
DK,TENDON RUPTURE,6
DK,VISUAL IMPAIRMENT,6
DK,ABNORMAL FAECES,5
DK,ADENOCARCINOMA OF COLON,5
DK,AGGRESSION,5
DK,AUTOIMMUNE DISORDER,5
DK,BLOOD CHOLESTEROL INCREASED,5
DK,CEREBRAL HAEMORRHAGE,5
DK,DISEASE PROGRESSION,5
DK,FEELING OF BODY TEMPERATURE CHANGE,5
DK,GASTROINTESTINAL INFLAMMATION,5
DK,HAEMATEMESIS,5
DK,HAEMORRHAGE,5
DK,HALLUCINATION,5
DK,HEART RATE DECREASED,5
DK,HEART RATE INCREASED,5
DK,MOTOR DYSFUNCTION,5
DK,MYOGLOBIN BLOOD INCREASED,5
DK,OEDEMA,5
DK,POLYMYOSITIS,5
DK,PULMONARY EMBOLISM,5
DK,PULMONARY OEDEMA,5
DK,SKIN DISCOLOURATION,5
DK,SUICIDAL IDEATION,5
DK,SUICIDE ATTEMPT,5
DK,URINARY INCONTINENCE,5
DK,URINARY TRACT INFECTION,5
DK,VISUAL ACUITY REDUCED,5
DK,WEIGHT INCREASED,5
DK,ACUTE MYOCARDIAL INFARCTION,4
DK,AMNESIA,4
DK,ANAPHYLACTIC SHOCK,4
DK,ASCITES,4
DK,ASPARTATE AMINOTRANSFERASE INCREASED,4
DK,BLISTER,4
DK,CARDIOMEGALY,4
DK,CEREBRAL THROMBOSIS,4
DK,CEREBROVASCULAR ACCIDENT,4
DK,CRYING,4
DK,DEATH,4
DK,DIABETES MELLITUS,4
DK,DISCOMFORT,4
DK,DIVERTICULUM,4
DK,DRUG EFFECT INCOMPLETE,4
DK,ECZEMA,4
DK,EPISTAXIS,4
DK,ERECTILE DYSFUNCTION,4
DK,EYE PRURITUS,4
DK,HAEMATURIA,4
DK,HYPERTHYROIDISM,4
DK,IMMUNE-MEDIATED NECROTISING MYOPATHY,4
DK,INFECTION,4
DK,JOINT STIFFNESS,4
DK,MICTURITION URGENCY,4
DK,MOBILITY DECREASED,4
DK,MUSCLE INJURY,4
DK,NERVE INJURY,4
DK,ORAL CANDIDIASIS,4
DK,PAIN IN JAW,4
DK,PETIT MAL EPILEPSY,4
DK,PRESSURE OF SPEECH,4
DK,PSYCHOMOTOR HYPERACTIVITY,4
DK,RENAL CYST,4
DK,RENAL FAILURE ACUTE,4
DK,RESPIRATORY FAILURE,4
DK,SUDDEN ONSET OF SLEEP,4
DK,SWOLLEN TONGUE,4
DK,TENDERNESS,4
DK,TINNITUS,4
DK,ABORTION SPONTANEOUS,3
DK,ALOPECIA,3
DK,ANGIOEDEMA,3
DK,ARTHRITIS,3
DK,ATRIAL FLUTTER,3
DK,BLADDER CANCER,3
DK,BLOOD LACTATE DEHYDROGENASE INCREASED,3
DK,BLOOD THYROID STIMULATING HORMONE INCREASED,3
DK,BRAIN MIDLINE SHIFT,3
DK,BURNING SENSATION,3
DK,CATARACT,3
DK,CHILLS,3
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,3
DK,EPILEPSY,3
DK,EXTRASYSTOLES,3
DK,FEBRILE NEUTROPENIA,3
DK,FEELING COLD,3
DK,FEELING HOT,3
DK,GASTRIC ULCER,3
DK,GASTROINTESTINAL HAEMORRHAGE,3
DK,GOUTY ARTHRITIS,3
DK,HAEMATOMA,3
DK,HEART RATE IRREGULAR,3
DK,HEMIPLEGIA,3
DK,HIGH DENSITY LIPOPROTEIN DECREASED,3
DK,HYPOTONIA,3
DK,IMPAIRED HEALING,3
DK,INFLUENZA LIKE ILLNESS,3
DK,INTERNATIONAL NORMALISED RATIO DECREASED,3
DK,INTERSTITIAL LUNG DISEASE,3
DK,JAW OPERATION,3
DK,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,3
DK,LACTIC ACIDOSIS,3
DK,LIVER DISORDER,3
DK,MATERNAL EXPOSURE DURING PREGNANCY,3
DK,MENTAL DISORDER,3
DK,MULTI-ORGAN FAILURE,3
DK,MUSCLE ATROPHY,3
DK,MUSCLE FATIGUE,3
DK,MUSCLE RIGIDITY,3
DK,MUSCULOSKELETAL PAIN,3
DK,MYELODYSPLASTIC SYNDROME,3
DK,NEPHROGENIC SYSTEMIC FIBROSIS,3
DK,NEUROTOXICITY,3
DK,PANCREATITIS,3
DK,PANCREATITIS ACUTE,3
DK,PANCYTOPENIA,3
DK,PERIPHERAL SWELLING,3
DK,PSORIASIS,3
DK,PULMONARY FIBROSIS,3
DK,SEIZURE,3
DK,SEROTONIN SYNDROME,3
DK,SOMNOLENCE,3
DK,SWELLING,3
DK,THROMBOCYTOPENIA,3
DK,TREMOR,3
DK,VENTRICULAR FIBRILLATION,3
DK,VENTRICULAR TACHYCARDIA,3
DK,WHEELCHAIR USER,3
DK,WHITE BLOOD CELL COUNT INCREASED,3
DK,ABDOMINAL ABSCESS,2
DK,ABDOMINAL DISTENSION,2
DK,ADENOCARCINOMA,2
DK,ADENOCARCINOMA PANCREAS,2
DK,AMYLASE INCREASED,2
DK,ANGER,2
DK,ANURIA,2
DK,APHASIA,2
DK,ARRHYTHMIA,2
DK,ARTHROPATHY,2
DK,ATELECTASIS,2
DK,ATRIOVENTRICULAR BLOCK COMPLETE,2
DK,BLADDER PAIN,2
DK,BLOOD ALKALINE PHOSPHATASE INCREASED,2
DK,BLOOD GLUCOSE INCREASED,2
DK,BLOOD PRESSURE DECREASED,2
DK,BLOOD PRESSURE INCREASED,2
DK,BLOOD URINE PRESENT,2
DK,BONE LESION,2
DK,CARDIAC OPERATION,2
DK,CEREBRAL INFARCTION,2
DK,CHEST DISCOMFORT,2
DK,CHOLESTASIS,2
DK,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
DK,CLOSTRIDIUM DIFFICILE INFECTION,2
DK,CLOSTRIDIUM DIFFICILE SEPSIS,2
DK,COGNITIVE DISORDER,2
DK,CONCOMITANT DISEASE PROGRESSION,2
DK,CONJUNCTIVAL HAEMORRHAGE,2
DK,CONTRAINDICATED DRUG PRESCRIBED,2
DK,CONTRAINDICATED PRODUCT ADMINISTERED,2
DK,DECREASED IMMUNE RESPONSIVENESS,2
DK,DELIRIUM,2
DK,DEPRESSED MOOD,2
DK,DIPLOPIA,2
DK,DISORIENTATION,2
DK,DISTURBANCE IN ATTENTION,2
DK,DRUG INTOLERANCE,2
DK,DRY MOUTH,2
DK,DYSARTHRIA,2
DK,DYSSTASIA,2
DK,EAR DISCOMFORT,2
DK,EJACULATION DISORDER,2
DK,EJECTION FRACTION DECREASED,2
DK,ELECTROCARDIOGRAM QT PROLONGED,2
DK,EMPHYSEMA,2
DK,EXPOSED BONE IN JAW,2
DK,EXTRADURAL HAEMATOMA,2
DK,FAECES DISCOLOURED,2
DK,FEMORAL NECK FRACTURE,2
DK,FOOD AVERSION,2
DK,GAIT INABILITY,2
DK,GASTRIC HAEMORRHAGE,2
DK,GASTROINTESTINAL DISORDER,2
DK,GOUT,2
DK,GROIN PAIN,2
DK,HAEMATOCHEZIA,2
DK,HAEMODIALYSIS,2
DK,HEARING IMPAIRED,2
DK,HENOCH-SCHONLEIN PURPURA NEPHRITIS,2
DK,HEPATIC FAILURE,2
DK,HEPATITIS ACUTE,2
DK,HYPERKALAEMIA,2
DK,IMPAIRED WORK ABILITY,2
DK,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
DK,INFLAMMATION,2
DK,INTERNATIONAL NORMALISED RATIO INCREASED,2
DK,JOINT SWELLING,2
DK,LEUKOPENIA,2
DK,LUNG INFECTION,2
DK,LUNG INFILTRATION,2
DK,MEDICATION ERROR,2
DK,MENTAL IMPAIRMENT,2
DK,METASTASES TO BONE,2
DK,MOUTH SWELLING,2
DK,MOUTH ULCERATION,2
DK,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
DK,MUSCLE DISORDER,2
DK,MYDRIASIS,2
DK,NEURALGIA,2
DK,NEUROLEPTIC MALIGNANT SYNDROME,2
DK,ODYNOPHAGIA,2
DK,OSTEOMYELITIS,2
DK,OXYGEN SATURATION DECREASED,2
DK,PARALYSIS,2
DK,PLASMAPHERESIS,2
DK,PLATELET COUNT DECREASED,2
DK,PREGNANCY ON ORAL CONTRACEPTIVE,2
DK,PRESYNCOPE,2
DK,PRURITUS GENERALISED,2
DK,PSEUDOPORPHYRIA,2
DK,RASH ERYTHEMATOUS,2
DK,RASH GENERALISED,2
DK,RASH PAPULAR,2
DK,RESPIRATORY DEPRESSION,2
DK,SEDATION,2
DK,SEPTIC SHOCK,2
DK,SKIN ULCER,2
DK,SMALL FIBRE NEUROPATHY,2
DK,SQUAMOUS CELL CARCINOMA OF SKIN,2
DK,STEVENS-JOHNSON SYNDROME,2
DK,SUBDURAL HAEMATOMA,2
DK,SUBDURAL HAEMORRHAGE,2
DK,SURGERY,2
DK,SWELLING FACE,2
DK,THINKING ABNORMAL,2
DK,THROAT IRRITATION,2
DK,TOOTH DISORDER,2
DK,TUBULOINTERSTITIAL NEPHRITIS,2
DK,UNINTENDED PREGNANCY,2
DK,UPPER GASTROINTESTINAL HAEMORRHAGE,2
DK,URINARY RETENTION,2
DK,URTICARIA,2
DK,VASCULITIS,2
DK,VENTRICULAR ARRHYTHMIA,2
DK,VISION BLURRED,2
DK,ABASIA,1
DK,ABDOMINAL CAVITY DRAINAGE,1
DK,ABDOMINAL HERNIA,1
DK,ABNORMAL LOSS OF WEIGHT,1
DK,ABSCESS,1
DK,ABSCESS JAW,1
DK,ABSCESS LIMB,1
DK,ABSCESS ORAL,1
DK,ACCIDENTAL OVERDOSE,1
DK,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
DK,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DK,ACUTE ABDOMEN,1
DK,ACUTE HEPATIC FAILURE,1
DK,ACUTE LYMPHOCYTIC LEUKAEMIA,1
DK,ACUTE RESPIRATORY FAILURE,1
DK,AFFECT LABILITY,1
DK,AGEUSIA,1
DK,AGITATION,1
DK,ALCOHOL USE,1
DK,AMAUROSIS FUGAX,1
DK,ANAPHYLACTIC REACTION,1
DK,ANGINA UNSTABLE,1
DK,ANOSMIA,1
DK,ANTIMITOCHONDRIAL ANTIBODY POSITIVE,1
DK,APNOEA,1
DK,APPENDICITIS PERFORATED,1
DK,ASTHENOPIA,1
DK,AUTOIMMUNE HEPATITIS,1
DK,BACTERIAL TEST POSITIVE,1
DK,BALANCE DISORDER,1
DK,BARRETT^S OESOPHAGUS,1
DK,BASAL CELL CARCINOMA,1
DK,BENIGN LUNG NEOPLASM,1
DK,BIOPSY LIVER,1
DK,BIPOLAR DISORDER,1
DK,BLINDNESS,1
DK,BLINDNESS TRANSIENT,1
DK,BLOOD ALBUMIN DECREASED,1
DK,BLOOD BILIRUBIN INCREASED,1
DK,BLOOD GLUCOSE FLUCTUATION,1
DK,BLOOD IMMUNOGLOBULIN G INCREASED,1
DK,BLOOD LACTIC ACID INCREASED,1
DK,BLOOD OSMOLARITY DECREASED,1
DK,BLOOD PRESSURE FLUCTUATION,1
DK,BLOOD UREA INCREASED,1
DK,BONE MARROW TOXICITY,1
DK,BONE PAIN,1
DK,BRAIN INJURY,1
DK,BRAIN STEM THROMBOSIS,1
DK,BREAST CANCER,1
DK,BRONCHOPULMONARY DISEASE,1
DK,BUNDLE BRANCH BLOCK RIGHT,1
DK,CALCULUS URINARY,1
DK,CANCER SURGERY,1
DK,CARDIAC DISCOMFORT,1
DK,CARDIAC DISORDER,1
DK,CARDIAC MURMUR,1
DK,CARDIAC PACEMAKER INSERTION,1
DK,CARDIAC TAMPONADE,1
DK,CARDIOTOXICITY,1
DK,CEREBRAL DISORDER,1
DK,CEREBRAL HAEMATOMA,1
DK,CEREBRAL VENTRICLE DILATATION,1
DK,CHOLECYSTITIS,1
DK,CHOLECYSTITIS ACUTE,1
DK,CHOLELITHIASIS,1
DK,CHROMATURIA,1
DK,CIRCULATORY COLLAPSE,1
DK,CLOSTRIDIUM DIFFICILE COLITIS,1
DK,COAGULOPATHY,1
DK,COLD SWEAT,1
DK,COLITIS,1
DK,COLORECTAL CANCER,1
DK,COMA,1
DK,COMA HEPATIC,1
DK,COMMUNICATION DISORDER,1
DK,COMPARTMENT SYNDROME,1
DK,CONCUSSION,1
DK,CONDITION AGGRAVATED,1
DK,CONFABULATION,1
DK,CONTRAST MEDIA ALLERGY,1
DK,CONTUSION,1
DK,COORDINATION ABNORMAL,1
DK,CRANIAL NERVE DISORDER,1
DK,CSF SHUNT OPERATION,1
DK,CYANOSIS,1
DK,CYSTITIS,1
DK,DANDRUFF,1
DK,DENTAL CARIES,1
DK,DERMATITIS,1
DK,DERMATITIS EXFOLIATIVE,1
DK,DERMATITIS INFECTED,1
DK,DEVICE DISLOCATION,1
DK,DEVICE LEAD ISSUE,1
DK,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,1
DK,DIAPHRAGMALGIA,1
DK,DIAPHRAGMATIC PARALYSIS,1
DK,DIARRHOEA HAEMORRHAGIC,1
DK,DIFFUSE LARGE B-CELL LYMPHOMA,1
DK,DISABILITY,1
DK,DISSOCIATION,1
DK,DIZZINESS POSTURAL,1
DK,DRUG DISPENSING ERROR,1
DK,DRUG INEFFECTIVE,1
DK,DRUG LEVEL INCREASED,1
DK,DRUG-INDUCED LIVER INJURY,1
DK,DRY SKIN,1
DK,DUODENAL ULCER,1
DK,DYSKINESIA,1
DK,DYSPHEMIA,1
DK,DYSPNOEA EXERTIONAL,1
DK,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
DK,ELECTROLYTE IMBALANCE,1
DK,EMBOLISM VENOUS,1
DK,ENCEPHALITIS,1
DK,ENDOPHTHALMITIS,1
DK,ENTEROCOCCAL INFECTION,1
DK,EOSINOPHILIA,1
DK,ERYSIPELAS,1
DK,EXFOLIATIVE RASH,1
DK,EXTRA DOSE ADMINISTERED,1
DK,EYE DISORDER,1
DK,EYE HAEMORRHAGE,1
DK,EYE OEDEMA,1
DK,FACIAL PAIN,1
DK,FACIAL PARESIS,1
DK,FAECAL INCONTINENCE,1
DK,FEEDING DISORDER,1
DK,FEELING ABNORMAL,1
DK,FEELING DRUNK,1
DK,FEMORAL HERNIA INCARCERATED,1
DK,FEMUR FRACTURE,1
DK,FIBROADENOMA OF BREAST,1
DK,FINGER AMPUTATION,1
DK,FLUID INTAKE REDUCED,1
DK,FLUID OVERLOAD,1
DK,FLUID RETENTION,1
DK,FLUSHING,1
DK,FOLLICLE CENTRE LYMPHOMA_ FOLLICULAR GRADE I_ II_ III,1
DK,GASTRITIS,1
DK,GASTRITIS HAEMORRHAGIC,1
DK,GASTROINTESTINAL CANCER METASTATIC,1
DK,GASTROINTESTINAL MOTILITY DISORDER,1
DK,GASTROINTESTINAL PAIN,1
DK,GASTROINTESTINAL ULCER,1
DK,GENERALISED ERYTHEMA,1
DK,GENITAL SWELLING,1
DK,GINGIVAL INJURY,1
DK,GINGIVITIS,1
DK,HAEMOPTYSIS,1
DK,HAEMORRHAGIC CEREBRAL INFARCTION,1
DK,HAEMORRHAGIC STROKE,1
DK,HALLUCINATION_ AUDITORY,1
DK,HEAD DISCOMFORT,1
DK,HEMIANOPIA HOMONYMOUS,1
DK,HEMIPARESIS,1
DK,HEPATIC CANCER,1
DK,HEPATIC ENCEPHALOPATHY,1
DK,HEPATIC ENZYME INCREASED,1
DK,HEPATOTOXICITY,1
DK,HIATUS HERNIA,1
DK,HIP ARTHROPLASTY,1
DK,HOSPITALISATION,1
DK,HOT FLUSH,1
DK,HYDROCHOLECYSTIS,1
DK,HYDRONEPHROSIS,1
DK,HYPERSOMNIA,1
DK,HYPOCALCAEMIA,1
DK,HYPOGLYCAEMIC ENCEPHALOPATHY,1
DK,HYPOKINESIA,1
DK,HYPOPNOEA,1
DK,HYPOTHYROIDISM,1
DK,HYPOVOLAEMIA,1
DK,HYPOXIA,1
DK,ILEUS,1
DK,ILEUS PARALYTIC,1
DK,IMMUNE THROMBOCYTOPENIC PURPURA,1
DK,IMPAIRED SELF-CARE,1
DK,INCORRECT DOSE ADMINISTERED,1
DK,INCORRECT DRUG ADMINISTRATION RATE,1
DK,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
DK,INFUSION RELATED REACTION,1
DK,INJECTION SITE HAEMORRHAGE,1
DK,INJECTION SITE URTICARIA,1
DK,INTENTIONAL PRODUCT MISUSE,1
DK,INTERCEPTED MEDICATION ERROR,1
DK,INTERVERTEBRAL DISC PROTRUSION,1
DK,INTRA-ABDOMINAL HAEMORRHAGE,1
DK,INTRACRANIAL PRESSURE INCREASED,1
DK,INTRAVENTRICULAR HAEMORRHAGE,1
DK,INVASIVE DUCTAL BREAST CARCINOMA,1
DK,IRIDOCYCLITIS,1
DK,KNEE OPERATION,1
DK,LARGE INTESTINAL ULCER HAEMORRHAGE,1
DK,LARGE INTESTINE PERFORATION,1
DK,LARYNGEAL CANCER,1
DK,LARYNX IRRITATION,1
DK,LEARNING DISABILITY,1
DK,LEUKOCYTOSIS,1
DK,LIMB DISCOMFORT,1
DK,LIMB INJURY,1
DK,LIP OEDEMA,1
DK,LIP SWELLING,1
DK,LIVER FUNCTION TEST ABNORMAL,1
DK,LOCAL SWELLING,1
DK,LOCALISED OEDEMA,1
DK,LOSS OF CONTROL OF LEGS,1
DK,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
DK,LUMBAR VERTEBRAL FRACTURE,1
DK,LUNG ADENOCARCINOMA,1
DK,LUNG ADENOCARCINOMA METASTATIC,1
DK,LUNG DISORDER,1
DK,MALIGNANT PERITONEAL NEOPLASM,1
DK,MEDICATION RESIDUE PRESENT,1
DK,MENINGITIS TUBERCULOUS,1
DK,METASTASES TO LIVER,1
DK,METASTASES TO LYMPH NODES,1
DK,MIGRAINE,1
DK,MONOPARESIS,1
DK,MOOD SWINGS,1
DK,MULTIPLE INJURIES,1
DK,MYELITIS,1
DK,MYOCARDIAL ISCHAEMIA,1
DK,MYOSITIS,1
DK,NASAL CONGESTION,1
DK,NEOPLASM MALIGNANT,1
DK,NEPHRITIS,1
DK,NERVOUS SYSTEM DISORDER,1
DK,NEUROLOGIC NEGLECT SYNDROME,1
DK,NEUTROPHIL COUNT DECREASED,1
DK,NEUTROPHIL COUNT INCREASED,1
DK,NOCTURIA,1
DK,NODAL ARRHYTHMIA,1
DK,NON-SMALL CELL LUNG CANCER,1
DK,OBSESSIVE-COMPULSIVE PERSONALITY DISORDER,1
DK,OCULAR HYPERAEMIA,1
DK,OESOPHAGEAL CANCER METASTATIC,1
DK,OESOPHAGEAL ULCER,1
DK,OESOPHAGITIS ULCERATIVE,1
DK,ORAL HERPES,1
DK,ORAL MUCOSAL ERUPTION,1
DK,ORGAN FAILURE,1
DK,OROPHARYNGEAL PAIN,1
DK,ORTHOPNOEA,1
DK,ORTHOSTATIC HYPOTENSION,1
DK,OSTEONECROSIS,1
DK,OSTEOPOROSIS,1
DK,PAIN OF SKIN,1
DK,PALLIATIVE CARE,1
DK,PANCREATECTOMY,1
DK,PANCREATIC CARCINOMA,1
DK,PANCREATIC CARCINOMA METASTATIC,1
DK,PARAESTHESIA ORAL,1
DK,PARANOIA,1
DK,PARTIAL SEIZURES,1
DK,PATHOLOGICAL FRACTURE,1
DK,PCO2 INCREASED,1
DK,PEAU D^ORANGE,1
DK,PERIPHERAL COLDNESS,1
DK,PERITONITIS,1
DK,PHOBIA,1
DK,PHOTOSENSITIVITY REACTION,1
DK,PHRENIC NERVE PARALYSIS,1
DK,PLASMA CELL MYELOMA,1
DK,PLATELET COUNT INCREASED,1
DK,PLEURAL FIBROSIS,1
DK,PNEUMONIA HAEMOPHILUS,1
DK,PNEUMONITIS CHEMICAL,1
DK,POLLAKIURIA,1
DK,POLYNEUROPATHY,1
DK,POOR PERSONAL HYGIENE,1
DK,PORPHYRIA NON-ACUTE,1
DK,PORTAL FIBROSIS,1
DK,PORTAL TRACT INFLAMMATION,1
DK,POTENTIATING DRUG INTERACTION,1
DK,PRESCRIBED UNDERDOSE,1
DK,PRIMARY SEQUESTRUM,1
DK,PRODUCT USE IN UNAPPROVED INDICATION,1
DK,PRODUCT USE ISSUE,1
DK,PROGRESSIVE MUSCULAR ATROPHY,1
DK,PROSTATE CANCER,1
DK,PROTEINURIA,1
DK,PSYCHOMOTOR SKILLS IMPAIRED,1
DK,PSYCHOTIC DISORDER,1
DK,PULMONARY ARTERIAL HYPERTENSION,1
DK,PULMONARY FUNCTION TEST DECREASED,1
DK,PULMONARY HAEMORRHAGE,1
DK,PULMONARY HYPERTENSION,1
DK,PULMONARY TOXICITY,1
DK,PULSE ABNORMAL,1
DK,PULSE ABSENT,1
DK,PURULENT DISCHARGE,1
DK,PYONEPHROSIS,1
DK,QUALITY OF LIFE DECREASED,1
DK,RASH PRURITIC,1
DK,RECTAL ULCER HAEMORRHAGE,1
DK,RENAL DISORDER,1
DK,RENAL TUBULAR NECROSIS,1
DK,RESPIRATION ABNORMAL,1
DK,RESPIRATORY THERAPY,1
DK,SCAR,1
DK,SCRATCH,1
DK,SECOND PRIMARY MALIGNANCY,1
DK,SENSORY LOSS,1
DK,SEQUESTRECTOMY,1
DK,SERUM FERRITIN INCREASED,1
DK,SHUNT INFECTION,1
DK,SINUS TACHYCARDIA,1
DK,SKIN DISORDER,1
DK,SKIN EXFOLIATION,1
DK,SKIN FIBROSIS,1
DK,SKIN HAEMORRHAGE,1
DK,SKIN HYPERTROPHY,1
DK,SKIN INDURATION,1
DK,SKIN NECROSIS,1
DK,SKIN REACTION,1
DK,SKIN TEXTURE ABNORMAL,1
DK,SKIN WOUND,1
DK,SLEEP APNOEA SYNDROME,1
DK,SPEECH DISORDER,1
DK,SPINAL COLUMN STENOSIS,1
DK,SPLENECTOMY,1
DK,SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED,1
DK,SPONTANEOUS HAEMATOMA,1
DK,SQUAMOUS CELL CARCINOMA,1
DK,STOMATITIS,1
DK,STRAWBERRY TONGUE,1
DK,SUBARACHNOID HAEMORRHAGE,1
DK,SUBCUTANEOUS ABSCESS,1
DK,SUBILEUS,1
DK,SUDDEN CARDIAC DEATH,1
DK,TEETH BRITTLE,1
DK,TENDON PAIN,1
DK,TENDONITIS,1
DK,TERMINAL STATE,1
DK,THROMBOCYTOSIS,1
DK,TOE AMPUTATION,1
DK,TONGUE DISCOLOURATION,1
DK,TONGUE MOVEMENT DISTURBANCE,1
DK,TOOTH FRACTURE,1
DK,TOOTHACHE,1
DK,TORSADE DE POINTES,1
DK,TRANSAMINASES INCREASED,1
DK,TUMOUR LYSIS SYNDROME,1
DK,TUMOUR NECROSIS,1
DK,UNEVALUABLE EVENT,1
DK,URINARY BLADDER HAEMORRHAGE,1
DK,URINARY TRACT NEOPLASM,1
DK,URINE OSMOLARITY INCREASED,1
DK,URINE SODIUM INCREASED,1
DK,UTERINE PROLAPSE,1
DK,VAGINAL HAEMORRHAGE,1
DK,VENTRICULAR TACHYARRHYTHMIA,1
DK,VISUAL FIELD DEFECT,1
DK,VITH NERVE PARALYSIS,1
DK,WALKING DISABILITY,1
DK,WHEEZING,1
DK,WOUND,1
DK,WOUND DEHISCENCE,1
DK,YELLOW SKIN,1
DO,ANAEMIA,1
DO,DUODENAL ULCER,1
DO,GASTROINTESTINAL HAEMORRHAGE,1
EC,CEREBRAL INFARCTION,2
EC,DISORIENTATION,2
EC,DIZZINESS,2
EC,ABDOMINAL PAIN,1
EC,ACINETOBACTER TEST POSITIVE,1
EC,ACUTE MYOCARDIAL INFARCTION,1
EC,ASTHMATIC CRISIS,1
EC,BLOOD GLUCOSE INCREASED,1
EC,BLOOD PARATHYROID HORMONE ABNORMAL,1
EC,BLOOD PHOSPHORUS ABNORMAL,1
EC,BLOOD PRESSURE INCREASED,1
EC,BRADYCARDIA,1
EC,CARDIAC ARREST,1
EC,CARDIAC FAILURE,1
EC,CARDIO-RESPIRATORY ARREST,1
EC,CATARACT,1
EC,CEREBROVASCULAR ACCIDENT,1
EC,CONTRAINDICATED PRODUCT ADMINISTERED,1
EC,DEMENTIA,1
EC,DYSARTHRIA,1
EC,DYSPNOEA,1
EC,FATIGUE,1
EC,GAIT DISTURBANCE,1
EC,GUILLAIN-BARRE SYNDROME,1
EC,HEADACHE,1
EC,HYPONATRAEMIA,1
EC,ISCHAEMIC STROKE,1
EC,MEMORY IMPAIRMENT,1
EC,MITRAL VALVE CALCIFICATION,1
EC,MYOCARDIAL INFARCTION,1
EC,NAUSEA,1
EC,NERVOUS SYSTEM DISORDER,1
EC,PERITONITIS,1
EC,PNEUMONIA,1
EC,PNEUMONIA STAPHYLOCOCCAL,1
EC,PNEUMOTHORAX,1
EC,RENAL TRANSPLANT,1
EC,RESPIRATORY FAILURE,1
EC,SENSORY DISTURBANCE,1
EC,SEPTIC SHOCK,1
EC,TRICUSPID VALVE INCOMPETENCE,1
EC,URINE SODIUM ABNORMAL,1
EC,VOMITING,1
EG,POTENTIATING DRUG INTERACTION,3
EG,DELAYED RECOVERY FROM ANAESTHESIA,2
EG,MYOPATHY TOXIC,2
EG,UNRESPONSIVE TO STIMULI,2
EG,AREFLEXIA,1
EG,BLOOD CHOLESTEROL INCREASED,1
EG,CORONARY ARTERY BYPASS,1
EG,DIZZINESS,1
EG,DRUG DOSE OMISSION,1
EG,DRUG EFFECT PROLONGED,1
EG,HEADACHE,1
EG,LOSS OF CONSCIOUSNESS,1
EG,MUSCLE DISORDER,1
EG,MYALGIA,1
EG,MYOPATHY,1
EG,NEUROMUSCULAR BLOCK PROLONGED,1
EG,TOXICITY TO VARIOUS AGENTS,1
EG,VASCULAR GRAFT,1
EE,CEREBROVASCULAR ACCIDENT,1
EE,CHEST PAIN,1
FI,FALL,12
FI,FATIGUE,11
FI,PYREXIA,11
FI,DIARRHOEA,10
FI,ABDOMINAL PAIN,9
FI,LOSS OF CONSCIOUSNESS,9
FI,PNEUMONIA,9
FI,C-REACTIVE PROTEIN INCREASED,8
FI,DYSPNOEA,8
FI,HAEMOGLOBIN DECREASED,8
FI,NAUSEA,8
FI,PAIN IN EXTREMITY,8
FI,DIZZINESS,7
FI,HYPOGLYCAEMIA,7
FI,MYOCARDIAL INFARCTION,7
FI,DECREASED APPETITE,6
FI,DEPRESSED LEVEL OF CONSCIOUSNESS,6
FI,MALAISE,6
FI,OSTEONECROSIS OF JAW,6
FI,BACK PAIN,5
FI,BLOOD CREATININE INCREASED,5
FI,BLOOD PRESSURE INCREASED,5
FI,CARDIAC FAILURE,5
FI,CEREBRAL INFARCTION,5
FI,DRUG INEFFECTIVE,5
FI,HEADACHE,5
FI,HYPERTENSION,5
FI,HYPOTENSION,5
FI,PROCEDURAL COMPLICATION,5
FI,WOUND,5
FI,ANAEMIA,4
FI,ARRHYTHMIA,4
FI,ARTHRALGIA,4
FI,ASTHENIA,4
FI,CEREBRAL HAEMORRHAGE,4
FI,CONDITION AGGRAVATED,4
FI,CONTUSION,4
FI,EPILEPSY,4
FI,ERYTHEMA,4
FI,FEELING ABNORMAL,4
FI,MEMORY IMPAIRMENT,4
FI,MUSCULAR WEAKNESS,4
FI,MYALGIA,4
FI,NEUTROPENIA,4
FI,RHABDOMYOLYSIS,4
FI,SEIZURE,4
FI,TACHYCARDIA,4
FI,VOMITING,4
FI,WEIGHT DECREASED,4
FI,WHITE BLOOD CELL COUNT INCREASED,4
FI,ALANINE AMINOTRANSFERASE INCREASED,3
FI,ALOPECIA,3
FI,ATRIAL FIBRILLATION,3
FI,CHILLS,3
FI,CONFUSIONAL STATE,3
FI,COUGH,3
FI,DEATH,3
FI,DYSARTHRIA,3
FI,EPISTAXIS,3
FI,GENERAL PHYSICAL HEALTH DETERIORATION,3
FI,HEART RATE INCREASED,3
FI,HYPOCALCAEMIA,3
FI,INFECTION,3
FI,KETOACIDOSIS,3
FI,LOCAL SWELLING,3
FI,MUSCLE SPASMS,3
FI,PARAESTHESIA,3
FI,RENAL FAILURE,3
FI,SEPSIS,3
FI,URINARY TRACT INFECTION,3
FI,WEIGHT INCREASED,3
FI,WHITE BLOOD CELL COUNT DECREASED,3
FI,AMNESIA,2
FI,ANURIA,2
FI,BLINDNESS,2
FI,BLISTER,2
FI,BLOOD ALKALINE PHOSPHATASE INCREASED,2
FI,BLOOD BILIRUBIN INCREASED,2
FI,BLOOD BLISTER,2
FI,BLOOD PRESSURE DECREASED,2
FI,BONE MARROW FAILURE,2
FI,BRUXISM,2
FI,CARDIAC ARREST,2
FI,CARDIAC FIBRILLATION,2
FI,CHEST PAIN,2
FI,CHROMATURIA,2
FI,DEAFNESS UNILATERAL,2
FI,DEHYDRATION,2
FI,DELIRIUM,2
FI,DIABETES MELLITUS,2
FI,DIVERTICULITIS,2
FI,DRUG ADMINISTRATION ERROR,2
FI,ECZEMA,2
FI,ERYSIPELAS,2
FI,FAECES PALE,2
FI,FEELING DRUNK,2
FI,GAIT DISTURBANCE,2
FI,HALLUCINATION,2
FI,HEAD INJURY,2
FI,HEART RATE DECREASED,2
FI,HEMIPARESIS,2
FI,HERPES ZOSTER,2
FI,HIP FRACTURE,2
FI,HYPOTHERMIA,2
FI,HYPOTONIA,2
FI,INTESTINAL HAEMORRHAGE,2
FI,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
FI,LACTIC ACIDOSIS,2
FI,LEUKOPENIA,2
FI,LIVER FUNCTION TEST ABNORMAL,2
FI,LUNG DISORDER,2
FI,MENTAL DISORDER,2
FI,MUSCLE TWITCHING,2
FI,NEUTROPHIL COUNT DECREASED,2
FI,PANCREATIC CYST,2
FI,PANCREATIC NEOPLASM,2
FI,PLATELET COUNT DECREASED,2
FI,PRURITUS,2
FI,PULMONARY EMBOLISM,2
FI,ROAD TRAFFIC ACCIDENT,2
FI,SOMNOLENCE,2
FI,SPEECH DISORDER,2
FI,SUBARACHNOID HAEMORRHAGE,2
FI,SYNCOPE,2
FI,TREMOR,2
FI,UPPER RESPIRATORY TRACT INFECTION,2
FI,UROSEPSIS,2
FI,ABDOMINAL DISTENSION,1
FI,ABDOMINAL PAIN UPPER,1
FI,ABSCESS RUPTURE,1
FI,ACUTE KIDNEY INJURY,1
FI,AGGRESSION,1
FI,AGRANULOCYTOSIS,1
FI,ALCOHOL POISONING,1
FI,AMYLASE INCREASED,1
FI,ANAPHYLACTIC SHOCK,1
FI,ANGINA PECTORIS,1
FI,ANGIOPLASTY,1
FI,ANTICONVULSANT DRUG LEVEL DECREASED,1
FI,ANTICONVULSANT DRUG LEVEL INCREASED,1
FI,ANXIETY,1
FI,APPLICATION SITE EXFOLIATION,1
FI,APPLICATION SITE SCAB,1
FI,ASTHMA,1
FI,ATRIAL FLUTTER,1
FI,BALANCE DISORDER,1
FI,BALANOPOSTHITIS,1
FI,BENIGN NEOPLASM OF THYROID GLAND,1
FI,BEZOAR,1
FI,BLADDER CANCER,1
FI,BLADDER PROLAPSE,1
FI,BLOOD CHOLESTEROL INCREASED,1
FI,BLOOD CORTISOL DECREASED,1
FI,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
FI,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
FI,BLOOD GLUCOSE DECREASED,1
FI,BLOOD GLUCOSE INCREASED,1
FI,BLOOD PH ABNORMAL,1
FI,BLOOD PH INCREASED,1
FI,BLOOD PHOSPHORUS DECREASED,1
FI,BLOOD POTASSIUM DECREASED,1
FI,BLOOD PRESSURE ABNORMAL,1
FI,BLOOD SODIUM INCREASED,1
FI,BLOOD UREA INCREASED,1
FI,BODY TEMPERATURE DECREASED,1
FI,BODY TEMPERATURE INCREASED,1
FI,BRONCHOALVEOLAR LAVAGE,1
FI,BRONCHOSPASM,1
FI,CAPILLARY LEAK SYNDROME,1
FI,CARDIAC DISORDER,1
FI,CARDIOVASCULAR DISORDER,1
FI,CAROTID ARTERY OCCLUSION,1
FI,CELLULITIS,1
FI,CENTRAL NERVOUS SYSTEM LESION,1
FI,CEREBELLAR HAEMATOMA,1
FI,CEREBELLAR HAEMORRHAGE,1
FI,CEREBRAL ATROPHY,1
FI,CEREBROVASCULAR ACCIDENT,1
FI,CHEST DISCOMFORT,1
FI,CHOLANGITIS,1
FI,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
FI,COLECTOMY,1
FI,COLORECTAL ADENOCARCINOMA,1
FI,COMPLETED SUICIDE,1
FI,COMPUTERISED TOMOGRAM ABNORMAL,1
FI,CONJUNCTIVITIS,1
FI,CONSTIPATION,1
FI,CONTRAINDICATION TO MEDICAL TREATMENT,1
FI,CORONARY ARTERY THROMBOSIS,1
FI,CUTANEOUS SYMPTOM,1
FI,CYSTITIS,1
FI,CYTOMEGALOVIRUS CHORIORETINITIS,1
FI,DANDRUFF,1
FI,DECREASED IMMUNE RESPONSIVENESS,1
FI,DEEP VEIN THROMBOSIS,1
FI,DELUSION,1
FI,DENTAL CARIES,1
FI,DENTAL FISTULA,1
FI,DERMATITIS,1
FI,DEVICE OCCLUSION,1
FI,DIAPHRAGMATIC DISORDER,1
FI,DIAPHRAGMATIC HERNIA,1
FI,DIASTOLIC DYSFUNCTION,1
FI,DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY,1
FI,DISEASE PROGRESSION,1
FI,DISORIENTATION,1
FI,DISTURBANCE IN ATTENTION,1
FI,DIVERTICULAR PERFORATION,1
FI,DRUG DOSE OMISSION,1
FI,DRUG ERUPTION,1
FI,DRY SKIN,1
FI,DYSKINESIA,1
FI,DYSPEPSIA,1
FI,DYSPHONIA,1
FI,DYSSTASIA,1
FI,EJECTION FRACTION DECREASED,1
FI,ELECTROCARDIOGRAM QT INTERVAL ABNORMAL,1
FI,ELECTROCARDIOGRAM QT PROLONGED,1
FI,EMOTIONAL DISTRESS,1
FI,ENCEPHALOMYELITIS,1
FI,ENCEPHALOPATHY,1
FI,ENTERITIS INFECTIOUS,1
FI,ENTEROCOCCAL SEPSIS,1
FI,EOSINOPHILIA,1
FI,ESCHERICHIA URINARY TRACT INFECTION,1
FI,EXFOLIATIVE RASH,1
FI,EXTRAVASATION BLOOD,1
FI,EYE DISCHARGE,1
FI,EYE IRRITATION,1
FI,EYE OEDEMA,1
FI,EYE SWELLING,1
FI,FACE OEDEMA,1
FI,FAECES DISCOLOURED,1
FI,FEBRILE NEUTROPENIA,1
FI,FEELING COLD,1
FI,FEELING HOT,1
FI,FEMALE GENITAL TRACT FISTULA,1
FI,FEMORAL NECK FRACTURE,1
FI,FEMUR FRACTURE,1
FI,FLUSHING,1
FI,FOLATE DEFICIENCY,1
FI,FORMICATION,1
FI,FRACTURE,1
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,GASTRIC DISORDER,1
FI,GASTROINTESTINAL HYPOMOTILITY,1
FI,GASTROINTESTINAL NEOPLASM,1
FI,HAEMATEMESIS,1
FI,HAEMATOCHEZIA,1
FI,HAEMATOCRIT DECREASED,1
FI,HAEMATURIA,1
FI,HAEMODYNAMIC INSTABILITY,1
FI,HAEMOLYSIS,1
FI,HAEMOPTYSIS,1
FI,HAEMORRHAGE,1
FI,HAEMORRHAGE INTRACRANIAL,1
FI,HAEMORRHAGIC ANAEMIA,1
FI,HALLUCINATION_ AUDITORY,1
FI,HENOCH-SCHONLEIN PURPURA,1
FI,HEPATIC CIRRHOSIS,1
FI,HEPATIC ENZYME INCREASED,1
FI,HEPATIC STEATOSIS,1
FI,HEPATITIS,1
FI,HEPATITIS ACUTE,1
FI,HEPATOCELLULAR CARCINOMA,1
FI,HERPES SIMPLEX MENINGOENCEPHALITIS,1
FI,HIATUS HERNIA,1
FI,HOSPITALISATION,1
FI,HYPERKALAEMIA,1
FI,HYPERSENSITIVITY VASCULITIS,1
FI,HYPOAESTHESIA,1
FI,HYPOAESTHESIA ORAL,1
FI,HYPOKALAEMIA,1
FI,HYPOKINESIA,1
FI,HYPOMAGNESAEMIA,1
FI,HYPONATRAEMIA,1
FI,ILEUS PARALYTIC,1
FI,ILL-DEFINED DISORDER,1
FI,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
FI,IMPAIRED HEALING,1
FI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
FI,INCOHERENT,1
FI,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
FI,INFLAMMATION,1
FI,INFLUENZA,1
FI,INFLUENZA A VIRUS TEST POSITIVE,1
FI,INJECTION SITE INFECTION,1
FI,INJECTION SITE INFLAMMATION,1
FI,INSOMNIA,1
FI,INTENTIONAL OVERDOSE,1
FI,INTESTINAL ISCHAEMIA,1
FI,INTESTINAL OBSTRUCTION,1
FI,INVASIVE DUCTAL BREAST CARCINOMA,1
FI,JAUNDICE,1
FI,JEJUNAL PERFORATION,1
FI,JOINT EFFUSION,1
FI,KETONURIA,1
FI,LACUNAR INFARCTION,1
FI,LARGE INTESTINAL OBSTRUCTION,1
FI,LARGE INTESTINE PERFORATION,1
FI,LEUKOCYTOCLASTIC VASCULITIS,1
FI,LICHENOID KERATOSIS,1
FI,LIP SWELLING,1
FI,LIP ULCERATION,1
FI,LIVIDITY,1
FI,LIVING IN RESIDENTIAL INSTITUTION,1
FI,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
FI,LOW DENSITY LIPOPROTEIN ABNORMAL,1
FI,LUNG INFECTION,1
FI,LYMPH NODE PAIN,1
FI,LYMPHADENOPATHY,1
FI,MAJOR DEPRESSION,1
FI,MALIGNANT MELANOMA,1
FI,MALIGNANT NEOPLASM PROGRESSION,1
FI,MALNUTRITION,1
FI,MASTICATION DISORDER,1
FI,MEDICATION ERROR,1
FI,MENINGITIS VIRAL,1
FI,MENORRHAGIA,1
FI,MENTAL IMPAIRMENT,1
FI,MESENTERIC ARTERY THROMBOSIS,1
FI,METABOLIC ACIDOSIS,1
FI,METASTASES TO BREAST,1
FI,METASTASES TO LIVER,1
FI,METASTASES TO LYMPH NODES,1
FI,METASTASES TO SKIN,1
FI,METASTASIS,1
FI,MOBILITY DECREASED,1
FI,MUSCLE ATROPHY,1
FI,MUSCLE RUPTURE,1
FI,MUSCULOSKELETAL CHEST PAIN,1
FI,MUSCULOSKELETAL PAIN,1
FI,MUSCULOSKELETAL STIFFNESS,1
FI,MYCOPLASMA TEST POSITIVE,1
FI,MYOCARDITIS INFECTIOUS,1
FI,NASOPHARYNGITIS,1
FI,NECROTISING RETINITIS,1
FI,NERVE INJURY,1
FI,NEUROPATHY PERIPHERAL,1
FI,NEUTROPENIC INFECTION,1
FI,NON-SMALL CELL LUNG CANCER,1
FI,OBSTRUCTIVE AIRWAYS DISORDER,1
FI,OCULAR ICTERUS,1
FI,OESOPHAGITIS,1
FI,OLIGURIA,1
FI,ORAL DISORDER,1
FI,ORAL PAIN,1
FI,OROPHARYNGEAL PAIN,1
FI,OSTEOARTHRITIS,1
FI,OSTEOSCLEROSIS,1
FI,OVERDOSE,1
FI,OXYGEN SATURATION DECREASED,1
FI,PAIN,1
FI,PAIN IN JAW,1
FI,PALLOR,1
FI,PANCREATIC DISORDER,1
FI,PANCYTOPENIA,1
FI,PANIC DISORDER,1
FI,PAPULE,1
FI,PARESIS,1
FI,PARINAUD SYNDROME,1
FI,PEMPHIGOID,1
FI,PERFORMANCE STATUS DECREASED,1
FI,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
FI,PERIPHERAL ARTERY BYPASS,1
FI,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
FI,PERITONITIS,1
FI,PNEUMONIA ASPIRATION,1
FI,PNEUMONIA BACTERIAL,1
FI,PNEUMONIA VIRAL,1
FI,POISONING,1
FI,POLYDIPSIA,1
FI,POLYMYALGIA RHEUMATICA,1
FI,POLYNEUROPATHY,1
FI,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
FI,PROCEDURAL HAEMORRHAGE,1
FI,PRODUCT USE IN UNAPPROVED INDICATION,1
FI,PRODUCT USE ISSUE,1
FI,PROSTATE CANCER,1
FI,PSEUDOMONAS INFECTION,1
FI,PULMONARY FUNCTION TEST DECREASED,1
FI,PULMONARY HAEMORRHAGE,1
FI,PULMONARY VASCULITIS,1
FI,PULSE PRESSURE DECREASED,1
FI,PYELONEPHRITIS,1
FI,QUALITY OF LIFE DECREASED,1
FI,RASH VESICULAR,1
FI,RED BLOOD CELL COUNT DECREASED,1
FI,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
FI,RENAL CELL CARCINOMA,1
FI,RESPIRATORY DISORDER,1
FI,RESPIRATORY TRACT INFECTION,1
FI,RESPIRATORY TRACT INFECTION VIRAL,1
FI,RHEUMATOID ARTHRITIS,1
FI,RHINITIS ALLERGIC,1
FI,SCAB,1
FI,SCHIZOPHRENIA,1
FI,SCIATICA,1
FI,SEDATION,1
FI,SEPTIC SHOCK,1
FI,SINUSITIS,1
FI,SKIN DISORDER,1
FI,SKIN LESION,1
FI,SKIN NECROSIS,1
FI,SKIN SCAR CONTRACTURE,1
FI,SLEEP DISORDER,1
FI,SMALL INTESTINAL OBSTRUCTION,1
FI,SOMNAMBULISM,1
FI,SPINAL FRACTURE,1
FI,SPINAL OSTEOARTHRITIS,1
FI,SQUAMOUS CELL CARCINOMA OF SKIN,1
FI,STARING,1
FI,STEATOHEPATITIS,1
FI,SUBDURAL HAEMATOMA,1
FI,SUDDEN DEATH,1
FI,SURGERY,1
FI,SWELLING,1
FI,SYNOVIAL RUPTURE,1
FI,TEARFULNESS,1
FI,TENDERNESS,1
FI,THERAPEUTIC RESPONSE CHANGED,1
FI,THROMBOSIS,1
FI,THYMUS DISORDER,1
FI,THYROID DISORDER,1
FI,THYROXINE INCREASED,1
FI,TIME PERCEPTION ALTERED,1
FI,TOXICITY TO VARIOUS AGENTS,1
FI,TRANSAMINASES INCREASED,1
FI,TUBULOINTERSTITIAL NEPHRITIS,1
FI,UNRESPONSIVE TO STIMULI,1
FI,UPPER LIMB FRACTURE,1
FI,URINE OUTPUT DECREASED,1
FI,URINE OUTPUT INCREASED,1
FI,VAGINAL HAEMORRHAGE,1
FI,VENTRICULAR FIBRILLATION,1
FI,VENTRICULAR TACHYCARDIA,1
FI,VERTIGO,1
FI,VITAMIN B12 DECREASED,1
FI,VITAMIN B6 DECREASED,1
FI,VITAMIN D DECREASED,1
FI,WHITE MATTER LESION,1
FI,WOUND COMPLICATION,1
FI,WOUND INFECTION,1
FI,WOUND NECROSIS,1
FI,YELLOW SKIN,1
FR,ACUTE KIDNEY INJURY,83
FR,FALL,55
FR,HYPONATRAEMIA,44
FR,ANAEMIA,42
FR,DIARRHOEA,40
FR,RENAL FAILURE,39
FR,GENERAL PHYSICAL HEALTH DETERIORATION,37
FR,HYPERKALAEMIA,37
FR,CARDIAC FAILURE,36
FR,DYSPNOEA,33
FR,HEPATOCELLULAR INJURY,30
FR,LACTIC ACIDOSIS,30
FR,MALAISE,30
FR,HYPOTENSION,29
FR,PYREXIA,29
FR,ABDOMINAL PAIN,28
FR,CONFUSIONAL STATE,28
FR,PRURITUS,28
FR,FATIGUE,27
FR,INTERSTITIAL LUNG DISEASE,27
FR,ASTHENIA,23
FR,ATRIAL FIBRILLATION,23
FR,GAIT DISTURBANCE,23
FR,THROMBOCYTOPENIA,23
FR,WEIGHT DECREASED,22
FR,BRADYCARDIA,21
FR,EOSINOPHILIA,21
FR,MYALGIA,21
FR,PANCYTOPENIA,21
FR,ISCHAEMIC STROKE,20
FR,NAUSEA,20
FR,OVERDOSE,20
FR,RENAL FAILURE ACUTE,20
FR,VOMITING,20
FR,CHOLESTASIS,19
FR,RHABDOMYOLYSIS,19
FR,VERTIGO,19
FR,ANGIOEDEMA,18
FR,HYPOKALAEMIA,18
FR,MUSCLE SPASMS,18
FR,PAIN IN EXTREMITY,18
FR,PNEUMONIA,17
FR,RASH MACULO-PAPULAR,17
FR,RESPIRATORY DISTRESS,17
FR,SUBDURAL HAEMATOMA,17
FR,DEHYDRATION,16
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,16
FR,HEADACHE,16
FR,PARAESTHESIA,16
FR,RASH,16
FR,AMNESIA,15
FR,BLOOD CREATININE INCREASED,15
FR,COMA,15
FR,OEDEMA PERIPHERAL,15
FR,CHEST PAIN,14
FR,EPISTAXIS,14
FR,SKIN LESION,14
FR,SOMNOLENCE,14
FR,ARTHRALGIA,13
FR,BALANCE DISORDER,13
FR,HAEMATOMA,13
FR,HYPOGLYCAEMIA,13
FR,MYOCARDIAL INFARCTION,13
FR,NEUTROPENIA,13
FR,CEREBROVASCULAR ACCIDENT,12
FR,HYPERTHERMIA,12
FR,INTERNATIONAL NORMALISED RATIO INCREASED,12
FR,LUNG DISORDER,12
FR,MELAENA,12
FR,PANCREATITIS ACUTE,12
FR,PEMPHIGOID,12
FR,PULMONARY EMBOLISM,12
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,11
FR,ALTERED STATE OF CONSCIOUSNESS,11
FR,CARDIAC ARREST,11
FR,CARDIO-RESPIRATORY ARREST,11
FR,CONSTIPATION,11
FR,DEATH,11
FR,DISORIENTATION,11
FR,DRUG INEFFECTIVE,11
FR,ERYTHEMA,11
FR,HYPERTHYROIDISM,11
FR,INSOMNIA,11
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,11
FR,SEPSIS,11
FR,TRANSAMINASES INCREASED,11
FR,PALPITATIONS,10
FR,SEPTIC SHOCK,10
FR,URINARY RETENTION,10
FR,ACUTE CORONARY SYNDROME,9
FR,ANGINA PECTORIS,9
FR,APHASIA,9
FR,CEREBRAL HAEMATOMA,9
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,9
FR,HEPATITIS,9
FR,HYPERHIDROSIS,9
FR,IRRITABILITY,9
FR,TOXICITY TO VARIOUS AGENTS,9
FR,VISION BLURRED,9
FR,ACUTE PULMONARY OEDEMA,8
FR,DIZZINESS,8
FR,DRUG LEVEL INCREASED,8
FR,DRUG-INDUCED LIVER INJURY,8
FR,ECZEMA,8
FR,ELECTROCARDIOGRAM QT PROLONGED,8
FR,GASTROINTESTINAL HAEMORRHAGE,8
FR,MUCOSAL INFLAMMATION,8
FR,NEPHROLITHIASIS,8
FR,PLEURAL EFFUSION,8
FR,RECTAL HAEMORRHAGE,8
FR,RENAL COLIC,8
FR,RESPIRATORY FAILURE,8
FR,TRIGEMINAL NEURALGIA,8
FR,AGRANULOCYTOSIS,7
FR,DECREASED APPETITE,7
FR,DEPRESSION,7
FR,DRY SKIN,7
FR,ENCEPHALOPATHY,7
FR,EYE BURNS,7
FR,FEELING HOT,7
FR,FEELING JITTERY,7
FR,HAEMOGLOBIN DECREASED,7
FR,HYPERTENSION,7
FR,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
FR,MALIGNANT NEOPLASM PROGRESSION,7
FR,NASAL DRYNESS,7
FR,NEOPLASM MALIGNANT,7
FR,OXYGEN SATURATION DECREASED,7
FR,PHLEBITIS,7
FR,SYNCOPE,7
FR,TENDON RUPTURE,7
FR,URTICARIA,7
FR,ABDOMINAL PAIN UPPER,6
FR,BACK PAIN,6
FR,CHEST DISCOMFORT,6
FR,CHILLS,6
FR,COGNITIVE DISORDER,6
FR,COLITIS MICROSCOPIC,6
FR,CONDITION AGGRAVATED,6
FR,CONGESTIVE CARDIOMYOPATHY,6
FR,COUGH,6
FR,DEMENTIA,6
FR,DERMATITIS EXFOLIATIVE,6
FR,HEAD INJURY,6
FR,HEMIPLEGIA,6
FR,INFLAMMATION,6
FR,LOSS OF CONSCIOUSNESS,6
FR,LYMPHOPENIA,6
FR,METABOLIC ACIDOSIS,6
FR,OEDEMA,6
FR,PAIN,6
FR,RENAL IMPAIRMENT,6
FR,SKIN EXFOLIATION,6
FR,TOXIC SKIN ERUPTION,6
FR,TRANSIENT ISCHAEMIC ATTACK,6
FR,TREMOR,6
FR,BLOOD CULTURE POSITIVE,5
FR,BLOOD THYROID STIMULATING HORMONE,5
FR,BRONCHITIS,5
FR,COLITIS,5
FR,CONTRAINDICATED PRODUCT ADMINISTERED,5
FR,CREATININE RENAL CLEARANCE DECREASED,5
FR,DRY MOUTH,5
FR,EJECTION FRACTION DECREASED,5
FR,EPILEPSY,5
FR,FACE OEDEMA,5
FR,GASTROINTESTINAL DISORDER,5
FR,GASTROINTESTINAL STOMA COMPLICATION,5
FR,HAEMATURIA,5
FR,HAEMORRHAGIC ANAEMIA,5
FR,HAEMORRHAGIC STROKE,5
FR,HALLUCINATION,5
FR,HYPERGLYCAEMIA,5
FR,HYPOTHERMIA,5
FR,INTENTIONAL OVERDOSE,5
FR,LIPASE INCREASED,5
FR,MUCOSAL HAEMORRHAGE,5
FR,NEUROPATHY PERIPHERAL,5
FR,ODYNOPHAGIA,5
FR,PERIPHERAL SWELLING,5
FR,PRODUCT USE ISSUE,5
FR,PURPURA,5
FR,SEIZURE,5
FR,SHOCK HAEMORRHAGIC,5
FR,SUBARACHNOID HAEMORRHAGE,5
FR,TACHYCARDIA,5
FR,TRANSFUSION,5
FR,URINARY TRACT INFECTION,5
FR,VISUAL ACUITY REDUCED,5
FR,ACCIDENTAL OVERDOSE,4
FR,ACUTE PRERENAL FAILURE,4
FR,ALOPECIA,4
FR,ANURIA,4
FR,ANXIETY,4
FR,ARRHYTHMIA,4
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
FR,BLOOD PRESSURE DECREASED,4
FR,BLOOD PRESSURE INCREASED,4
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,4
FR,BONE MARROW FAILURE,4
FR,BUNDLE BRANCH BLOCK LEFT,4
FR,C-REACTIVE PROTEIN INCREASED,4
FR,CEREBRAL ARTERY THROMBOSIS,4
FR,CEREBRAL HAEMORRHAGE,4
FR,CUTANEOUS LUPUS ERYTHEMATOSUS,4
FR,DERMATITIS EXFOLIATIVE GENERALISED,4
FR,DUODENAL ULCER,4
FR,ERYSIPELAS,4
FR,ESCHERICHIA INFECTION,4
FR,HAEMOPTYSIS,4
FR,HEMIPARESIS,4
FR,HIATUS HERNIA,4
FR,HYPOALBUMINAEMIA,4
FR,HYPOCALCAEMIA,4
FR,HYPOGLYCAEMIC COMA,4
FR,HYPOTHYROIDISM,4
FR,ILEUS PARALYTIC,4
FR,INCORRECT DOSE ADMINISTERED,4
FR,JAUNDICE CHOLESTATIC,4
FR,LEUKOPENIA,4
FR,MUSCLE RUPTURE,4
FR,ORTHOSTATIC HYPOTENSION,4
FR,PACKED RED BLOOD CELL TRANSFUSION,4
FR,PANCREATIC CARCINOMA,4
FR,PROTEINURIA,4
FR,RASH ERYTHEMATOUS,4
FR,RENAL TUBULAR NECROSIS,4
FR,SHOCK,4
FR,SINUS BRADYCARDIA,4
FR,SLEEP DISORDER,4
FR,STENT PLACEMENT,4
FR,TUBULOINTERSTITIAL NEPHRITIS,4
FR,URINARY INCONTINENCE,4
FR,ABNORMAL BEHAVIOUR,3
FR,ACUTE HEPATIC FAILURE,3
FR,ACUTE RESPIRATORY FAILURE,3
FR,ADENOCARCINOMA OF COLON,3
FR,ADRENAL INSUFFICIENCY,3
FR,ADVERSE EVENT,3
FR,AGGRESSION,3
FR,AGITATION,3
FR,ARTHROPATHY,3
FR,ATRIOVENTRICULAR BLOCK,3
FR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,3
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,3
FR,BLOOD BILIRUBIN INCREASED,3
FR,BLOOD UREA INCREASED,3
FR,BREAST PAIN,3
FR,BURNING SENSATION,3
FR,CELL DEATH,3
FR,CLOSTRIDIUM DIFFICILE COLITIS,3
FR,CRANIOCEREBRAL INJURY,3
FR,DEPRESSED MOOD,3
FR,DIABETES MELLITUS,3
FR,DIABETES MELLITUS INADEQUATE CONTROL,3
FR,DIVERTICULITIS,3
FR,DRUG ADMINISTRATION ERROR,3
FR,DRUG ERUPTION,3
FR,DYSARTHRIA,3
FR,DYSPEPSIA,3
FR,DYSPHAGIA,3
FR,ELECTROCARDIOGRAM ABNORMAL,3
FR,EOSINOPHIL COUNT INCREASED,3
FR,EXTRAPYRAMIDAL DISORDER,3
FR,GASTRITIS,3
FR,GYNAECOMASTIA,3
FR,HAEMARTHROSIS,3
FR,HAEMATEMESIS,3
FR,HYPOVOLAEMIA,3
FR,HYPOXIA,3
FR,IMMUNE THROMBOCYTOPENIC PURPURA,3
FR,INTERMITTENT CLAUDICATION,3
FR,INTRACRANIAL HAEMATOMA,3
FR,IRON DEFICIENCY ANAEMIA,3
FR,LARGE INTESTINE PERFORATION,3
FR,LYMPHOEDEMA,3
FR,METABOLIC ENCEPHALOPATHY,3
FR,METASTASES TO LUNG,3
FR,MONOPLEGIA,3
FR,MOVEMENT DISORDER,3
FR,MULTI-ORGAN FAILURE,3
FR,MUSCULAR WEAKNESS,3
FR,MUSCULOSKELETAL PAIN,3
FR,NEOPLASM,3
FR,NERVOUS SYSTEM DISORDER,3
FR,NIGHTMARE,3
FR,ORTHOPNOEA,3
FR,PALLOR,3
FR,PNEUMONITIS,3
FR,PRESYNCOPE,3
FR,PRODUCT USE IN UNAPPROVED INDICATION,3
FR,PRODUCTIVE COUGH,3
FR,PULMONARY OEDEMA,3
FR,SKIN DISCOLOURATION,3
FR,SKIN DISORDER,3
FR,SLEEP APNOEA SYNDROME,3
FR,TENDONITIS,3
FR,THROMBOSIS,3
FR,TREATMENT NONCOMPLIANCE,3
FR,VESTIBULAR DISORDER,3
FR,WEIGHT INCREASED,3
FR,ABDOMINAL DISTENSION,2
FR,ACUTE MYOCARDIAL INFARCTION,2
FR,AGEUSIA,2
FR,ALANINE AMINOTRANSFERASE INCREASED,2
FR,ARTERIOSCLEROSIS,2
FR,ASTHMA,2
FR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,2
FR,BEDRIDDEN,2
FR,BLISTER,2
FR,BLOOD BLISTER,2
FR,BLOOD POTASSIUM INCREASED,2
FR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,2
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,2
FR,BONE CANCER,2
FR,BUNDLE BRANCH BLOCK,2
FR,BUNDLE BRANCH BLOCK RIGHT,2
FR,CARDIAC DISORDER,2
FR,CARDIAC FAILURE ACUTE,2
FR,CARDIAC TAMPONADE,2
FR,CARDIOGENIC SHOCK,2
FR,CEREBELLAR HAEMATOMA,2
FR,CEREBRAL ISCHAEMIA,2
FR,CHEILITIS,2
FR,CHOLANGITIS,2
FR,CHOLELITHIASIS,2
FR,CHOLESTATIC LIVER INJURY,2
FR,CHROMATURIA,2
FR,COMPLICATIONS OF BONE MARROW TRANSPLANT,2
FR,CONJUNCTIVAL HAEMORRHAGE,2
FR,CONVULSION,2
FR,CORONARY ARTERY STENOSIS,2
FR,CREATININE RENAL CLEARANCE ABNORMAL,2
FR,CUTANEOUS VASCULITIS,2
FR,DEAFNESS,2
FR,DECUBITUS ULCER,2
FR,DEEP VEIN THROMBOSIS,2
FR,DEMENTIA ALZHEIMER^S TYPE,2
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,2
FR,DERMATOMYOSITIS,2
FR,DIFFUSE ALOPECIA,2
FR,DISEASE PROGRESSION,2
FR,DIVERTICULUM INTESTINAL,2
FR,DRUG DOSE OMISSION,2
FR,DRUG INTOLERANCE,2
FR,DUODENITIS,2
FR,DYSAESTHESIA,2
FR,DYSKINESIA,2
FR,DYSMORPHISM,2
FR,DYSPNOEA EXERTIONAL,2
FR,DYSSTASIA,2
FR,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,2
FR,ENTEROCOCCAL INFECTION,2
FR,EOSINOPHILIC PNEUMONIA,2
FR,FAECALOMA,2
FR,FLANK PAIN,2
FR,FLUSHING,2
FR,FOETAL EXPOSURE DURING PREGNANCY,2
FR,GASTRIC ULCER,2
FR,GASTROINTESTINAL NECROSIS,2
FR,GASTROINTESTINAL ULCER,2
FR,GENERALISED ERYTHEMA,2
FR,GRANULOMATOUS LIVER DISEASE,2
FR,HAEMORRHAGE,2
FR,HALLUCINATION_ VISUAL,2
FR,HEART RATE DECREASED,2
FR,HEART VALVE OPERATION,2
FR,HEPATIC FUNCTION ABNORMAL,2
FR,HEPATIC STEATOSIS,2
FR,HEPATITIS ACUTE,2
FR,HEPATITIS CHOLESTATIC,2
FR,HEPATITIS FULMINANT,2
FR,HISTIOCYTOSIS HAEMATOPHAGIC,2
FR,HOT FLUSH,2
FR,HYPERCALCAEMIA,2
FR,HYPERLACTACIDAEMIA,2
FR,HYPERLIPASAEMIA,2
FR,HYPERNATRAEMIA,2
FR,HYPERSENSITIVITY,2
FR,HYPERTENSIVE CRISIS,2
FR,HYPOMAGNESAEMIA,2
FR,HYPOPHYSITIS,2
FR,HYPOPROTHROMBINAEMIA,2
FR,IMPAIRED QUALITY OF LIFE,2
FR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
FR,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
FR,INFLUENZA,2
FR,INTRA-ABDOMINAL HAEMATOMA,2
FR,INTRACRANIAL MASS,2
FR,KLEBSIELLA INFECTION,2
FR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
FR,LARGE INTESTINE POLYP,2
FR,LIP OEDEMA,2
FR,LYMPHADENOPATHY,2
FR,LYMPHOCYTIC LEUKAEMIA,2
FR,LYMPHOCYTOSIS,2
FR,MACULAR OEDEMA,2
FR,MALABSORPTION,2
FR,MALNUTRITION,2
FR,MEMORY IMPAIRMENT,2
FR,MENTAL IMPAIRMENT,2
FR,MICROCYTIC ANAEMIA,2
FR,MOTOR DYSFUNCTION,2
FR,MOUTH HAEMORRHAGE,2
FR,MUSCLE CONTRACTURE,2
FR,MUSCLE HAEMORRHAGE,2
FR,MUSCULOSKELETAL DISORDER,2
FR,MYDRIASIS,2
FR,MYELODYSPLASTIC SYNDROME,2
FR,MYOCLONUS,2
FR,MYOPATHY,2
FR,NEPHRITIS ALLERGIC,2
FR,NEPHROTIC SYNDROME,2
FR,NEUROLOGICAL DECOMPENSATION,2
FR,NIGHT SWEATS,2
FR,NOCTURIA,2
FR,OESOPHAGITIS,2
FR,OLIGOHYDRAMNIOS,2
FR,OLIGURIA,2
FR,OSTEOARTHRITIS,2
FR,OSTEONECROSIS,2
FR,PANCREATIC NECROSIS,2
FR,PANCREATITIS,2
FR,PAPULE,2
FR,PATHOLOGICAL FRACTURE,2
FR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
FR,PERIPHERAL ARTERY THROMBOSIS,2
FR,PERIPHERAL MOTOR NEUROPATHY,2
FR,PERIPHERAL SENSORY NEUROPATHY,2
FR,PHARYNGEAL OEDEMA,2
FR,PLASMA CELL MYELOMA,2
FR,PNEUMONIA HAEMOPHILUS,2
FR,PNEUMOTHORAX,2
FR,POLLAKIURIA,2
FR,POLYNEUROPATHY,2
FR,POOR QUALITY SLEEP,2
FR,PRESCRIBED OVERDOSE,2
FR,PRURITUS GENERALISED,2
FR,PULMONARY FIBROSIS,2
FR,PULMONARY SEPSIS,2
FR,PYELONEPHRITIS ACUTE,2
FR,RASH MORBILLIFORM,2
FR,RENAL HAEMORRHAGE,2
FR,RENAL INFARCT,2
FR,RETROPERITONEAL FIBROSIS,2
FR,RHINITIS,2
FR,RHINORRHOEA,2
FR,SINUSITIS,2
FR,SKIN REACTION,2
FR,SKIN TEST POSITIVE,2
FR,SKULL FRACTURE,2
FR,SPINAL COMPRESSION FRACTURE,2
FR,SPLENIC INFARCTION,2
FR,SQUAMOUS CELL CARCINOMA OF SKIN,2
FR,STATUS EPILEPTICUS,2
FR,SUDDEN DEATH,2
FR,SUICIDAL IDEATION,2
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,2
FR,TENDON DISORDER,2
FR,THROMBOTIC MICROANGIOPATHY,2
FR,TIBIA FRACTURE,2
FR,TINNITUS,2
FR,TONGUE OEDEMA,2
FR,TORSADE DE POINTES,2
FR,TRANSPLANT REJECTION,2
FR,TROPONIN INCREASED,2
FR,TUMOUR FLARE,2
FR,ULCERATIVE KERATITIS,2
FR,VASCULAR PURPURA,2
FR,VASCULITIS,2
FR,VENTRICULAR DYSFUNCTION,2
FR,VENTRICULAR TACHYCARDIA,2
FR,VIITH NERVE PARALYSIS,2
FR,VISUAL IMPAIRMENT,2
FR,ABASIA,1
FR,ABDOMINAL BRUIT,1
FR,ABORTION SPONTANEOUS,1
FR,ABSCESS INTESTINAL,1
FR,ACQUIRED HAEMOPHILIA,1
FR,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
FR,ADENOCARCINOMA PANCREAS,1
FR,ADRENAL HAEMATOMA,1
FR,AEROMONAS INFECTION,1
FR,ALKALOSIS,1
FR,ALVEOLAR LUNG DISEASE,1
FR,ALVEOLITIS,1
FR,AMYLOIDOSIS,1
FR,ANAL FISTULA,1
FR,ANAL INCONTINENCE,1
FR,ANAPHYLACTIC SHOCK,1
FR,ANGIOPATHY,1
FR,ANGIOSARCOMA,1
FR,ANORECTAL INFECTION,1
FR,ANOSMIA,1
FR,ANTEROGRADE AMNESIA,1
FR,ANTIDEPRESSANT DRUG LEVEL INCREASED,1
FR,ANTIDIURETIC HORMONE ABNORMALITY,1
FR,AORTIC DILATATION,1
FR,AORTITIS,1
FR,APATHY,1
FR,APLASIA,1
FR,APPENDICITIS,1
FR,AREFLEXIA,1
FR,ARTERIAL DISORDER,1
FR,ARTERIOGRAM CORONARY,1
FR,ARTERITIS,1
FR,ARTHRITIS,1
FR,ASCITES,1
FR,ASPARTATE AMINOTRANSFERASE INCREASED,1
FR,ATAXIA,1
FR,ATELECTASIS,1
FR,ATRIAL FLUTTER,1
FR,ATRIOVENTRICULAR BLOCK COMPLETE,1
FR,ATYPICAL FEMUR FRACTURE,1
FR,B-CELL LYMPHOMA,1
FR,BACILLUS INFECTION,1
FR,BACTERIAL INFECTION,1
FR,BACTERIAL SEPSIS,1
FR,BASAL CELL CARCINOMA,1
FR,BASAL GANGLIA HAEMATOMA,1
FR,BEHCET^S SYNDROME,1
FR,BENZODIAZEPINE DRUG LEVEL,1
FR,BETA 2 MICROGLOBULIN INCREASED,1
FR,BICYTOPENIA,1
FR,BILE DUCT STENOSIS,1
FR,BILIARY CYST,1
FR,BILIRUBIN CONJUGATED ABNORMAL,1
FR,BLADDER CATHETERISATION,1
FR,BLADDER DILATATION,1
FR,BLEEDING TIME PROLONGED,1
FR,BLOOD ALBUMIN DECREASED,1
FR,BLOOD BICARBONATE DECREASED,1
FR,BLOOD BICARBONATE INCREASED,1
FR,BLOOD BILIRUBIN UNCONJUGATED INCREASED,1
FR,BLOOD CHROMOGRANIN A INCREASED,1
FR,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,1
FR,BLOOD CREATININE ABNORMAL,1
FR,BLOOD GLUCOSE ABNORMAL,1
FR,BLOOD LACTATE DEHYDROGENASE INCREASED,1
FR,BLOOD LACTIC ACID INCREASED,1
FR,BLOOD PH DECREASED,1
FR,BLOOD POTASSIUM DECREASED,1
FR,BLOOD PRESSURE ABNORMAL,1
FR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
FR,BLOOD SODIUM DECREASED,1
FR,BLOOD THYROID STIMULATING HORMONE NORMAL,1
FR,BONE MARROW ISCHAEMIA,1
FR,BRAIN HERNIATION,1
FR,BRAIN INJURY,1
FR,BRAIN NEOPLASM,1
FR,BRAIN OEDEMA,1
FR,BRAIN SCAN ABNORMAL,1
FR,BREAST CANCER,1
FR,BRONCHITIS BACTERIAL,1
FR,BRONCHOSPASM,1
FR,CAMPYLOBACTER INFECTION,1
FR,CARDIAC FAILURE CONGESTIVE,1
FR,CARDIAC FLUTTER,1
FR,CARDIAC MURMUR,1
FR,CARDIOACTIVE DRUG LEVEL INCREASED,1
FR,CARDIOTOXICITY,1
FR,CARDIOVASCULAR INSUFFICIENCY,1
FR,CEPHALHAEMATOMA,1
FR,CEREBRAL HYPOPERFUSION,1
FR,CHILLBLAINS,1
FR,CHOKING SENSATION,1
FR,CHONDRITIS,1
FR,CHONDROCALCINOSIS,1
FR,CHONDROCALCINOSIS PYROPHOSPHATE,1
FR,CIRCULATORY COLLAPSE,1
FR,CLEFT PALATE,1
FR,COLECTOMY,1
FR,COLITIS ISCHAEMIC,1
FR,COMA SCALE ABNORMAL,1
FR,COMMUNICATION DISORDER,1
FR,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
FR,CONCOMITANT DISEASE AGGRAVATED,1
FR,CONCOMITANT DISEASE PROGRESSION,1
FR,CONJUNCTIVITIS ALLERGIC,1
FR,CONTRAINDICATED DRUG PRESCRIBED,1
FR,CONTUSION,1
FR,COORDINATION ABNORMAL,1
FR,CORONARY ARTERIAL STENT INSERTION,1
FR,CORONARY ARTERY DISEASE,1
FR,CYTOMEGALOVIRUS INFECTION,1
FR,CYTOMEGALOVIRUS TEST POSITIVE,1
FR,DEAFNESS BILATERAL,1
FR,DECREASED INTEREST,1
FR,DERMABRASION,1
FR,DERMATITIS,1
FR,DERMATITIS BULLOUS,1
FR,DERMATITIS PSORIASIFORM,1
FR,DERMO-HYPODERMITIS,1
FR,DEVICE RELATED INFECTION,1
FR,DIABETIC COMPLICATION,1
FR,DIABETIC HYPEROSMOLAR COMA,1
FR,DIABETIC KETOACIDOSIS,1
FR,DIALYSIS,1
FR,DIPLOPIA,1
FR,DISEASE COMPLICATION,1
FR,DISEASE RECURRENCE,1
FR,DISSEMINATED INTRAVASCULAR COAGULATION,1
FR,DISSOCIATIVE AMNESIA,1
FR,DISTURBANCE IN ATTENTION,1
FR,DROP ATTACKS,1
FR,DRUG EFFECT INCOMPLETE,1
FR,DRUG HYPERSENSITIVITY,1
FR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
FR,DRY EYE,1
FR,DYSGEUSIA,1
FR,DYSPHONIA,1
FR,EATING DISORDER,1
FR,ECCHYMOSIS,1
FR,EDENTULOUS,1
FR,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,1
FR,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
FR,ENCEPHALITIS,1
FR,ENDOCARDITIS STAPHYLOCOCCAL,1
FR,ENDOMETRIAL ADENOCARCINOMA,1
FR,ENTEROBACTER INFECTION,1
FR,ENTEROBACTER SEPSIS,1
FR,ENTEROCOCCAL SEPSIS,1
FR,ENTEROCOLITIS HAEMORRHAGIC,1
FR,EOSINOPHILIC PNEUMONIA ACUTE,1
FR,ERYSIPELOID,1
FR,ERYTHEMA MULTIFORME,1
FR,ERYTHROMELALGIA,1
FR,ESCHAR,1
FR,EXERCISE TEST,1
FR,EXFOLIATIVE RASH,1
FR,EXOSTOSIS,1
FR,EXPIRED DRUG ADMINISTERED,1
FR,EXTREMITY NECROSIS,1
FR,EYELID DISORDER,1
FR,FACE INJURY,1
FR,FACIAL BONES FRACTURE,1
FR,FACIAL PARALYSIS,1
FR,FAECES DISCOLOURED,1
FR,FEBRILE BONE MARROW APLASIA,1
FR,FEBRILE NEUTROPENIA,1
FR,FEELING ABNORMAL,1
FR,FEELING DRUNK,1
FR,FLUID RETENTION,1
FR,FOETAL GROWTH RESTRICTION,1
FR,FOOD INTOLERANCE,1
FR,FRACTURE,1
FR,FUNGAL INFECTION,1
FR,GASTRIC HAEMORRHAGE,1
FR,GASTRITIS EROSIVE,1
FR,GASTROENTERITIS,1
FR,GASTROENTERITIS VIRAL,1
FR,GASTROINTESTINAL EROSION,1
FR,GASTROINTESTINAL INFLAMMATION,1
FR,GASTROINTESTINAL MOTILITY DISORDER,1
FR,GASTROINTESTINAL STROMAL TUMOUR,1
FR,GASTROINTESTINAL TOXICITY,1
FR,GASTROINTESTINAL TUBE INSERTION,1
FR,GASTROINTESTINAL ULCER HAEMORRHAGE,1
FR,GASTROOESOPHAGEAL REFLUX DISEASE,1
FR,GENERAL PHYSICAL CONDITION,1
FR,GENERAL PHYSICAL CONDITION ABNORMAL,1
FR,GENITAL PAIN,1
FR,GLAUCOMA,1
FR,GLOMERULAR FILTRATION RATE DECREASED,1
FR,GLUCOCORTICOID DEFICIENCY,1
FR,GLUCOSE TOLERANCE IMPAIRED,1
FR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
FR,GOITRE,1
FR,GOUT,1
FR,GRIP STRENGTH DECREASED,1
FR,GROIN PAIN,1
FR,HAEMODIALYSIS,1
FR,HAEMODYNAMIC INSTABILITY,1
FR,HAEMOLYTIC ANAEMIA,1
FR,HAEMOTHORAX,1
FR,HALLUCINATION_ AUDITORY,1
FR,HEAD DISCOMFORT,1
FR,HEART RATE INCREASED,1
FR,HEART VALVE REPLACEMENT,1
FR,HEPATIC CONGESTION,1
FR,HEPATIC ENCEPHALOPATHY,1
FR,HEPATIC ENZYME INCREASED,1
FR,HEPATIC FAILURE,1
FR,HEPATIC LESION,1
FR,HEPATITIS A,1
FR,HEPATITIS B VIRUS TEST POSITIVE,1
FR,HEPATOJUGULAR REFLUX,1
FR,HEPATOMEGALY,1
FR,HIP FRACTURE,1
FR,HYPERAEMIA,1
FR,HYPERAESTHESIA,1
FR,HYPERCAPNIC COMA,1
FR,HYPERCREATINAEMIA,1
FR,HYPERKERATOSIS,1
FR,HYPERPROLACTINAEMIA,1
FR,HYPERTROPHIC CARDIOMYOPATHY,1
FR,HYPERVENTILATION,1
FR,HYPERVOLAEMIA,1
FR,HYPOACUSIS,1
FR,HYPOAESTHESIA,1
FR,HYPOCHLORAEMIA,1
FR,HYPOGAMMAGLOBULINAEMIA,1
FR,HYPOGLYCAEMIC SEIZURE,1
FR,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
FR,HYPOKINESIA,1
FR,HYPOMANIA,1
FR,HYPONATRAEMIC SEIZURE,1
FR,HYPOPERFUSION,1
FR,HYPOREFLEXIA,1
FR,HYPOTONIA,1
FR,HYPOVENTILATION,1
FR,HYPOVOLAEMIC SHOCK,1
FR,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
FR,ILEUS,1
FR,IMMOBILE,1
FR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,1
FR,IMPAIRED GASTRIC EMPTYING,1
FR,IMPULSE-CONTROL DISORDER,1
FR,INCISION SITE CELLULITIS,1
FR,INCISION SITE HAEMATOMA,1
FR,INCISION SITE HAEMORRHAGE,1
FR,INCOHERENT,1
FR,INCORRECT DRUG ADMINISTRATION DURATION,1
FR,INCORRECT DRUG ADMINISTRATION RATE,1
FR,INFECTIVE ANEURYSM,1
FR,INFUSION RELATED REACTION,1
FR,INFUSION SITE REACTION,1
FR,INJECTION SITE HAEMATOMA,1
FR,INJECTION SITE HAEMORRHAGE,1
FR,INJURY,1
FR,INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS,1
FR,INTERNATIONAL NORMALISED RATIO DECREASED,1
FR,INTERVERTEBRAL DISC DISORDER,1
FR,INTESTINAL OBSTRUCTION,1
FR,INTESTINAL POLYP,1
FR,INTRACRANIAL PRESSURE INCREASED,1
FR,INTRAVENTRICULAR HAEMORRHAGE,1
FR,IRIDOCYCLITIS,1
FR,JAUNDICE,1
FR,JOINT EFFUSION,1
FR,JOINT INJURY,1
FR,LABORATORY TEST ABNORMAL,1
FR,LANGUAGE DISORDER,1
FR,LARYNGEAL SQUAMOUS CELL CARCINOMA,1
FR,LEFT VENTRICULAR FAILURE,1
FR,LEGIONELLA INFECTION,1
FR,LEUKOCYTURIA,1
FR,LIP BLISTER,1
FR,LIPIDS ABNORMAL,1
FR,LIVEDO RETICULARIS,1
FR,LIVER DISORDER,1
FR,LIVER FUNCTION TEST ABNORMAL,1
FR,LIVER INJURY,1
FR,LOCAL SWELLING,1
FR,LOCALISED OEDEMA,1
FR,LOSS OF LIBIDO,1
FR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
FR,LUNG INFECTION,1
FR,LUNG NEOPLASM MALIGNANT,1
FR,LYMPHANGIOSIS CARCINOMATOSA,1
FR,LYMPHOCYTE COUNT DECREASED,1
FR,LYMPHOCYTIC HYPOPHYSITIS,1
FR,LYMPHOMA,1
FR,MACROGLOSSIA,1
FR,MACULAR DEGENERATION,1
FR,MAJOR DEPRESSION,1
FR,MEDIASTINITIS,1
FR,MEDICAL DEVICE COMPLICATION,1
FR,MEDICATION ERROR,1
FR,MENIERE^S DISEASE,1
FR,MENINGITIS BACTERIAL,1
FR,MENINGOCOCCAL INFECTION,1
FR,MENINGOENCEPHALITIS HERPETIC,1
FR,MENINGORADICULITIS,1
FR,MENINGORRHAGIA,1
FR,MENTAL DISORDER,1
FR,METASTASES TO BONE,1
FR,METASTASES TO LIVER,1
FR,METRORRHAGIA,1
FR,MICROCEPHALY,1
FR,MIDDLE INSOMNIA,1
FR,MIOSIS,1
FR,MITRAL VALVE INCOMPETENCE,1
FR,MIXED LIVER INJURY,1
FR,MONOPARESIS,1
FR,MUCOSAL ULCERATION,1
FR,MULTIMORBIDITY,1
FR,MULTIPLE ALLERGIES,1
FR,MUSCLE CONTRACTIONS INVOLUNTARY,1
FR,MUSCULOSKELETAL STIFFNESS,1
FR,MUTISM,1
FR,MYOCARDIAL ISCHAEMIA,1
FR,MYOCARDIAL NECROSIS,1
FR,MYOGLOBIN BLOOD INCREASED,1
FR,MYOSITIS,1
FR,NAIL DISCOLOURATION,1
FR,NAIL DISORDER,1
FR,NAIL DYSTROPHY,1
FR,NASAL SEPTUM DEVIATION,1
FR,NECROSIS OF ARTERY,1
FR,NECROTISING FASCIITIS,1
FR,NEPHROGENIC ANAEMIA,1
FR,NEUROENDOCRINE CARCINOMA METASTATIC,1
FR,NEUROLEPTIC MALIGNANT SYNDROME,1
FR,NOREPINEPHRINE INCREASED,1
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
FR,OCULAR HYPERAEMIA,1
FR,OCULOFACIAL PARALYSIS,1
FR,OEDEMA MOUTH,1
FR,OESOPHAGEAL PERFORATION,1
FR,OESOPHAGEAL ULCER,1
FR,OESOPHAGEAL VARICES HAEMORRHAGE,1
FR,OESOPHAGITIS ULCERATIVE,1
FR,ORTHOSTATIC HYPERTENSION,1
FR,OSTEONECROSIS OF JAW,1
FR,OSTEOPOROSIS,1
FR,PAIN IN JAW,1
FR,PALMAR ERYTHEMA,1
FR,PANCREATIC CYST,1
FR,PANCREATIC DUCT STENOSIS,1
FR,PANCREATIC NEOPLASM,1
FR,PANCREATITIS NECROTISING,1
FR,PARAGANGLION NEOPLASM,1
FR,PARKINSONISM,1
FR,PATHOLOGICAL GAMBLING,1
FR,PELVIC PAIN,1
FR,PERFORMANCE STATUS DECREASED,1
FR,PERICARDIAL EFFUSION,1
FR,PERICARDIAL HAEMORRHAGE,1
FR,PERIODIC LIMB MOVEMENT DISORDER,1
FR,PERIPHERAL VENOUS DISEASE,1
FR,PERITONEAL HAEMORRHAGE,1
FR,PETECHIAE,1
FR,PHOTOSENSITIVITY REACTION,1
FR,PHYSICAL DISABILITY,1
FR,PLASMA CELL LEUKAEMIA,1
FR,PLATELET TRANSFUSION,1
FR,PLEURAL MESOTHELIOMA,1
FR,PLEURISY,1
FR,PNEUMOCOCCAL INFECTION,1
FR,PNEUMONIA ASPIRATION,1
FR,PNEUMONIA PSEUDOMONAL,1
FR,PNEUMONIA STAPHYLOCOCCAL,1
FR,POLYCYTHAEMIA,1
FR,POOR SUCKING REFLEX,1
FR,POST PROCEDURAL HAEMATOMA,1
FR,POST PROCEDURAL HAEMORRHAGE,1
FR,POST PROCEDURAL SEPSIS,1
FR,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
FR,PREGNANCY OF PARTNER,1
FR,PRERENAL FAILURE,1
FR,PRESBYACUSIS,1
FR,PRESCRIBED UNDERDOSE,1
FR,PROCTITIS,1
FR,PRODUCT FORMULATION ISSUE,1
FR,PRODUCT PACKAGING ISSUE,1
FR,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
FR,PROSTATE CANCER,1
FR,PROSTATE CANCER METASTATIC,1
FR,PROSTATITIS,1
FR,PROSTHETIC CARDIAC VALVE THROMBOSIS,1
FR,PRURIGO,1
FR,PSEUDOMONAS INFECTION,1
FR,PSYCHOMOTOR HYPERACTIVITY,1
FR,PSYCHOMOTOR RETARDATION,1
FR,PULMONARY ARTERIAL HYPERTENSION,1
FR,PULMONARY EOSINOPHILIA,1
FR,PULMONARY FUNCTION TEST ABNORMAL,1
FR,PULMONARY HYPERTENSION,1
FR,PULMONARY TUBERCULOSIS,1
FR,PULMONARY VENO-OCCLUSIVE DISEASE,1
FR,PUPILS UNEQUAL,1
FR,PURPURA NON-THROMBOCYTOPENIC,1
FR,PUSTULAR PSORIASIS,1
FR,RADIUS FRACTURE,1
FR,RASH GENERALISED,1
FR,RASH PAPULAR,1
FR,RASH PRURITIC,1
FR,RECTAL ABSCESS,1
FR,RENAL FAILURE CHRONIC,1
FR,RENAL FUNCTION TEST ABNORMAL,1
FR,RENAL INJURY,1
FR,RENAL TUBULAR DISORDER,1
FR,RESPIRATORY DISORDER,1
FR,RESTRICTIVE PULMONARY DISEASE,1
FR,RETICULOCYTOPENIA,1
FR,RETROPERITONEAL HAEMATOMA,1
FR,ROMBERG TEST POSITIVE,1
FR,ROTATOR CUFF SYNDROME,1
FR,SCROTAL HAEMATOMA,1
FR,SECOND PRIMARY MALIGNANCY,1
FR,SEDATION,1
FR,SENSE OF OPPRESSION,1
FR,SENSORY DISTURBANCE,1
FR,SINUS TACHYCARDIA,1
FR,SKELETAL INJURY,1
FR,SKIN BURNING SENSATION,1
FR,SKIN HAEMORRHAGE,1
FR,SKIN NECROSIS,1
FR,SKIN PLAQUE,1
FR,SKIN TURGOR DECREASED,1
FR,SKIN ULCER,1
FR,SKULL FRACTURED BASE,1
FR,SPINAL CORD COMPRESSION,1
FR,SPINAL FRACTURE,1
FR,SPLENOMEGALY,1
FR,SQUAMOUS CELL CARCINOMA,1
FR,STAPHYLOCOCCAL SEPSIS,1
FR,STAPHYLOCOCCAL SKIN INFECTION,1
FR,STARING,1
FR,STASIS DERMATITIS,1
FR,STEVENS-JOHNSON SYNDROME,1
FR,STOMATITIS,1
FR,STRESS,1
FR,SUBCUTANEOUS EMPHYSEMA,1
FR,SUBDURAL HAEMORRHAGE,1
FR,SUDDEN ONSET OF SLEEP,1
FR,SUICIDE ATTEMPT,1
FR,SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA,1
FR,SYNOVITIS,1
FR,TELANGIECTASIA,1
FR,TEMPORAL ARTERITIS,1
FR,TENDON PAIN,1
FR,THALAMUS HAEMORRHAGE,1
FR,THERAPEUTIC EMBOLISATION,1
FR,THROMBOCYTOPENIC PURPURA,1
FR,THROMBOCYTOSIS,1
FR,THROMBOPHLEBITIS,1
FR,THROMBOPHLEBITIS SUPERFICIAL,1
FR,THROMBOSIS IN DEVICE,1
FR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
FR,THYROID FUNCTION TEST ABNORMAL,1
FR,THYROIDITIS,1
FR,THYROXINE INCREASED,1
FR,TONGUE ULCERATION,1
FR,TOOTH AVULSION,1
FR,TOOTH EXTRACTION,1
FR,TOXIC ENCEPHALOPATHY,1
FR,TOXIC EPIDERMAL NECROLYSIS,1
FR,TOXIC NODULAR GOITRE,1
FR,TRACHEOBRONCHITIS,1
FR,TRAUMATIC FRACTURE,1
FR,TRAUMATIC HAEMOTHORAX,1
FR,TRICUSPID VALVE INCOMPETENCE,1
FR,TROPONIN I INCREASED,1
FR,TROPONIN T INCREASED,1
FR,TYPE 2 DIABETES MELLITUS,1
FR,UNDERDOSE,1
FR,UPPER LIMB FRACTURE,1
FR,URGE INCONTINENCE,1
FR,URINARY BLADDER POLYP,1
FR,URINARY TRACT DISORDER,1
FR,UROSEPSIS,1
FR,UVEITIS,1
FR,VASCULAR INJURY,1
FR,VENOUS THROMBOSIS,1
FR,VENTRICULAR ARRHYTHMIA,1
FR,VENTRICULAR ASYSTOLE,1
FR,VERTEBROBASILAR INSUFFICIENCY,1
FR,VITREOUS FLOATERS,1
FR,VITREOUS HAEMORRHAGE,1
FR,WHEEZING,1
FR,WHITE BLOOD CELL COUNT INCREASED,1
FR,WHITE BLOOD CELL DISORDER,1
FR,WITHDRAWAL SYNDROME,1
FR,WOUND HAEMORRHAGE,1
FR,WRIST FRACTURE,1
FR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
GE,ANGINA PECTORIS,1
GE,CORONARY ARTERY RESTENOSIS,1
DE,MYALGIA,295
DE,GENERAL PHYSICAL HEALTH DETERIORATION,178
DE,NAUSEA,176
DE,PNEUMONIA,170
DE,DYSPNOEA,167
DE,RHABDOMYOLYSIS,153
DE,FALL,151
DE,DIARRHOEA,150
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,148
DE,FATIGUE,145
DE,ACUTE KIDNEY INJURY,131
DE,DIZZINESS,126
DE,RENAL FAILURE,124
DE,ANAEMIA,111
DE,CARDIAC FAILURE,111
DE,ATRIAL FIBRILLATION,103
DE,GAIT DISTURBANCE,102
DE,VOMITING,100
DE,CEREBROVASCULAR ACCIDENT,93
DE,ARTHRALGIA,92
DE,SYNCOPE,90
DE,THROMBOCYTOPENIA,84
DE,ASTHENIA,82
DE,PYREXIA,82
DE,MYOPATHY,80
DE,WEIGHT DECREASED,79
DE,RASH,77
DE,RENAL FAILURE ACUTE,77
DE,MUSCLE SPASMS,76
DE,MYOCARDIAL INFARCTION,76
DE,BLOOD CREATININE INCREASED,74
DE,PAIN IN EXTREMITY,73
DE,GASTROINTESTINAL HAEMORRHAGE,72
DE,DECREASED APPETITE,70
DE,PAIN,69
DE,HEADACHE,68
DE,HYPERTENSION,67
DE,MUSCULAR WEAKNESS,67
DE,SEPSIS,65
DE,DEATH,64
DE,HYPONATRAEMIA,64
DE,URINARY TRACT INFECTION,60
DE,ACTINIC KERATOSIS,59
DE,CONFUSIONAL STATE,59
DE,PRURITUS,59
DE,C-REACTIVE PROTEIN INCREASED,58
DE,CHEST PAIN,57
DE,ABDOMINAL PAIN,56
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,56
DE,PLEURAL EFFUSION,56
DE,CORONARY ARTERY DISEASE,55
DE,DEPRESSION,55
DE,HAEMOGLOBIN DECREASED,55
DE,LACTIC ACIDOSIS,55
DE,LEUKOPENIA,55
DE,BASAL CELL CARCINOMA,54
DE,CEREBRAL HAEMORRHAGE,54
DE,DEHYDRATION,53
DE,HYPOKALAEMIA,53
DE,CEREBRAL INFARCTION,52
DE,OEDEMA PERIPHERAL,51
DE,PULMONARY EMBOLISM,51
DE,CIRCULATORY COLLAPSE,49
DE,HEPATIC ENZYME INCREASED,49
DE,RESTLESSNESS,49
DE,BLOOD GLUCOSE INCREASED,48
DE,DRUG INEFFECTIVE,48
DE,HYPERHIDROSIS,48
DE,HYPERTENSIVE CRISIS,48
DE,BACK PAIN,47
DE,INFECTION,47
DE,RESPIRATORY FAILURE,46
DE,HAEMATOMA,45
DE,HYPOAESTHESIA,45
DE,ISCHAEMIC STROKE,45
DE,SLEEP DISORDER,45
DE,ACUTE MYOCARDIAL INFARCTION,43
DE,ANGINA PECTORIS,43
DE,BLOOD PRESSURE INCREASED,43
DE,COUGH,43
DE,EPISTAXIS,43
DE,PANCYTOPENIA,43
DE,TRANSAMINASES INCREASED,42
DE,HEMIPARESIS,41
DE,POLYNEUROPATHY,41
DE,VISUAL IMPAIRMENT,41
DE,RENAL IMPAIRMENT,40
DE,SOMNOLENCE,40
DE,DYSARTHRIA,39
DE,TENDON RUPTURE,39
DE,ANGIOEDEMA,37
DE,CONSTIPATION,37
DE,DELIRIUM,37
DE,ASPARTATE AMINOTRANSFERASE INCREASED,36
DE,HYPOTENSION,36
DE,LOSS OF CONSCIOUSNESS,36
DE,ALANINE AMINOTRANSFERASE INCREASED,35
DE,ARRHYTHMIA,35
DE,BOWEN^S DISEASE,35
DE,DYSPHAGIA,35
DE,HAEMORRHAGE,35
DE,MELAENA,35
DE,OVERDOSE,35
DE,SKIN CANCER,35
DE,VERTIGO,34
DE,HYPOGLYCAEMIA,33
DE,PARAESTHESIA,33
DE,ABDOMINAL PAIN UPPER,32
DE,HEPATIC FAILURE,32
DE,OSTEOARTHRITIS,32
DE,BLOOD GLUCOSE ABNORMAL,31
DE,DYSPEPSIA,31
DE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,31
DE,INSOMNIA,31
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,30
DE,CONTUSION,30
DE,GASTRITIS,30
DE,JAUNDICE,30
DE,MOBILITY DECREASED,30
DE,PRESCRIBED UNDERDOSE,30
DE,TRANSIENT ISCHAEMIC ATTACK,30
DE,CHILLS,29
DE,DRUG-INDUCED LIVER INJURY,29
DE,ERYTHEMA,29
DE,INTESTINAL HAEMORRHAGE,29
DE,DRUG INTOLERANCE,28
DE,IMPAIRED HEALING,28
DE,APHASIA,27
DE,DYSPNOEA EXERTIONAL,26
DE,GASTRIC ULCER,26
DE,ANXIETY,25
DE,CARDIOVASCULAR DISORDER,25
DE,CORONARY ARTERY STENOSIS,25
DE,HYPERKALAEMIA,25
DE,LIVER FUNCTION TEST ABNORMAL,25
DE,MALAISE,25
DE,MALIGNANT NEOPLASM PROGRESSION,25
DE,STOMATITIS,25
DE,UPPER GASTROINTESTINAL HAEMORRHAGE,25
DE,ABDOMINAL DISCOMFORT,24
DE,BRONCHITIS,24
DE,CEREBRAL ISCHAEMIA,24
DE,PANCREATITIS,24
DE,URINARY INCONTINENCE,24
DE,ALTERED STATE OF CONSCIOUSNESS,23
DE,BRADYCARDIA,23
DE,CARDIAC DISORDER,23
DE,CARDIOGENIC SHOCK,23
DE,CONDITION AGGRAVATED,23
DE,DISTURBANCE IN ATTENTION,23
DE,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,23
DE,PULMONARY OEDEMA,23
DE,ACIDOSIS,22
DE,ASCITES,22
DE,COGNITIVE DISORDER,22
DE,DISORIENTATION,22
DE,GASTRIC HAEMORRHAGE,22
DE,NEUTROPENIA,22
DE,PALPITATIONS,22
DE,RHEUMATOID ARTHRITIS,22
DE,SUBDURAL HAEMATOMA,22
DE,FEBRILE NEUTROPENIA,21
DE,HAEMATOCHEZIA,21
DE,MULTI-ORGAN FAILURE,21
DE,SKIN EXFOLIATION,21
DE,TACHYCARDIA,21
DE,TYPE 2 DIABETES MELLITUS,21
DE,DUODENAL ULCER,20
DE,HALLUCINATION,20
DE,LUNG INFECTION,20
DE,MUSCULOSKELETAL DISCOMFORT,20
DE,OEDEMA,20
DE,PHOTOSENSITIVITY REACTION,20
DE,THROMBOSIS,20
DE,CARDIAC ARREST,19
DE,CHOLELITHIASIS,19
DE,DIVERTICULITIS,19
DE,HAEMATURIA,19
DE,PNEUMONITIS,19
DE,SHOCK HAEMORRHAGIC,19
DE,URINARY RETENTION,19
DE,UROSEPSIS,19
DE,VENTRICULAR FIBRILLATION,19
DE,ACUTE CORONARY SYNDROME,18
DE,DRUG PRESCRIBING ERROR,18
DE,DRY MOUTH,18
DE,EPILEPSY,18
DE,ERYSIPELAS,18
DE,FLUSHING,18
DE,FOETAL EXPOSURE DURING PREGNANCY,18
DE,HAEMORRHAGE INTRACRANIAL,18
DE,HEPATIC STEATOSIS,18
DE,HEPATITIS,18
DE,MITRAL VALVE INCOMPETENCE,18
DE,NASOPHARYNGITIS,18
DE,PRECANCEROUS SKIN LESION,18
DE,PSYCHOTIC DISORDER,18
DE,PULMONARY HYPERTENSION,18
DE,SKIN BURNING SENSATION,18
DE,SPEECH DISORDER,18
DE,TOXICITY TO VARIOUS AGENTS,18
DE,WEIGHT INCREASED,18
DE,ABDOMINAL DISTENSION,17
DE,APATHY,17
DE,DIABETES MELLITUS,17
DE,GLYCOSYLATED HAEMOGLOBIN INCREASED,17
DE,MEMORY IMPAIRMENT,17
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,17
DE,MUSCLE RUPTURE,17
DE,PARKINSON^S DISEASE,17
DE,SEPTIC SHOCK,17
DE,SQUAMOUS CELL CARCINOMA,17
DE,VENTRICULAR TACHYCARDIA,17
DE,ADVERSE DRUG REACTION,16
DE,BLOOD PRESSURE DECREASED,16
DE,CHEST DISCOMFORT,16
DE,CONVULSION,16
DE,GASTRITIS EROSIVE,16
DE,INCORRECT DOSE ADMINISTERED,16
DE,MUCOSAL INFLAMMATION,16
DE,PNEUMONIA ASPIRATION,16
DE,STAPHYLOCOCCAL INFECTION,16
DE,URTICARIA,16
DE,VISION BLURRED,16
DE,ACUTE HEPATIC FAILURE,15
DE,ALOPECIA,15
DE,ANGINA UNSTABLE,15
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,15
DE,HAEMORRHAGIC ANAEMIA,15
DE,HYPERGLYCAEMIA,15
DE,ILEUS,15
DE,INFLAMMATION,15
DE,INTERSTITIAL LUNG DISEASE,15
DE,INTERVERTEBRAL DISC PROTRUSION,15
DE,LEUKOCYTOSIS,15
DE,LIPASE INCREASED,15
DE,LIVER DISORDER,15
DE,METABOLIC ACIDOSIS,15
DE,PROSTATE CANCER,15
DE,RED BLOOD CELL COUNT DECREASED,15
DE,RENAL CYST,15
DE,RESPIRATORY TRACT INFECTION,15
DE,SUBACUTE HEPATIC FAILURE,15
DE,TACHYARRHYTHMIA,15
DE,TREMOR,15
DE,ATRIAL FLUTTER,14
DE,ATYPICAL PNEUMONIA,14
DE,BALANCE DISORDER,14
DE,BLOOD UREA INCREASED,14
DE,BRAIN INJURY,14
DE,COAGULOPATHY,14
DE,COLITIS,14
DE,DEEP VEIN THROMBOSIS,14
DE,ELECTROENCEPHALOGRAM ABNORMAL,14
DE,GASTROENTERITIS,14
DE,GLOMERULAR FILTRATION RATE DECREASED,14
DE,GOUT,14
DE,HOT FLUSH,14
DE,HYPOKINESIA,14
DE,INTESTINAL ISCHAEMIA,14
DE,LACERATION,14
DE,LEFT VENTRICULAR HYPERTROPHY,14
DE,PERIPHERAL SWELLING,14
DE,PERSISTENT DEPRESSIVE DISORDER,14
DE,RESPIRATORY DISTRESS,14
DE,SEIZURE,14
DE,SKIN DISORDER,14
DE,WHITE BLOOD CELL COUNT INCREASED,14
DE,BLOOD URINE PRESENT,13
DE,DEPRESSED MOOD,13
DE,GASTROOESOPHAGEAL REFLUX DISEASE,13
DE,HAEMOPTYSIS,13
DE,HEPATOMEGALY,13
DE,HYPERSENSITIVITY,13
DE,INTRAVENTRICULAR HAEMORRHAGE,13
DE,PANCREATITIS ACUTE,13
DE,PARKINSONISM,13
DE,PETECHIAE,13
DE,PLATELET COUNT DECREASED,13
DE,PULMONARY FIBROSIS,13
DE,RAYNAUD^S PHENOMENON,13
DE,SUICIDE ATTEMPT,13
DE,ABASIA,12
DE,AGGRESSION,12
DE,ARTERIAL OCCLUSIVE DISEASE,12
DE,ARTERIOSCLEROSIS,12
DE,ATRIOVENTRICULAR BLOCK COMPLETE,12
DE,BLOOD ALKALINE PHOSPHATASE INCREASED,12
DE,BLOOD BILIRUBIN INCREASED,12
DE,CHROMATURIA,12
DE,DISEASE PROGRESSION,12
DE,DRUG ADMINISTRATION ERROR,12
DE,DRUG EFFECT DECREASED,12
DE,DRY SKIN,12
DE,ELECTROCARDIOGRAM QT PROLONGED,12
DE,EMBOLIC CEREBRAL INFARCTION,12
DE,FACIAL NERVE DISORDER,12
DE,FAECAL INCONTINENCE,12
DE,GASTROINTESTINAL PAIN,12
DE,HERPES ZOSTER,12
DE,ISCHAEMIA,12
DE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,12
DE,MALIGNANT MELANOMA,12
DE,MYELODYSPLASTIC SYNDROME,12
DE,MYOCLONUS,12
DE,PANCREATITIS NECROTISING,12
DE,PERICARDIAL EFFUSION,12
DE,POST PROCEDURAL HAEMORRHAGE,12
DE,SUICIDAL IDEATION,12
DE,VASCULITIS,12
DE,VENOUS THROMBOSIS,12
DE,ABORTION MISSED,11
DE,BLOOD CHOLESTEROL INCREASED,11
DE,CAROTID ARTERY STENOSIS,11
DE,CHOLESTASIS,11
DE,COMA,11
DE,CREATININE RENAL CLEARANCE DECREASED,11
DE,CYSTITIS,11
DE,EXPOSURE DURING PREGNANCY,11
DE,GASTROINTESTINAL DISORDER,11
DE,HAEMOTHORAX,11
DE,HEPATIC FUNCTION ABNORMAL,11
DE,HYPERKINESIA,11
DE,HYPERLIPIDAEMIA,11
DE,HYPERURICAEMIA,11
DE,INTERNATIONAL NORMALISED RATIO INCREASED,11
DE,JOINT STIFFNESS,11
DE,LIMB DISCOMFORT,11
DE,MUSCLE ATROPHY,11
DE,PALLOR,11
DE,PANCREATITIS CHRONIC,11
DE,PREMATURE BABY,11
DE,PRESYNCOPE,11
DE,PRODUCT USE ISSUE,11
DE,RESUSCITATION,11
DE,SKIN HAEMORRHAGE,11
DE,TENDONITIS,11
DE,VISUAL ACUITY REDUCED,11
DE,AGITATION,10
DE,ALVEOLITIS,10
DE,ARTHROPATHY,10
DE,BRAIN STEM INFARCTION,10
DE,CORONARY ARTERIAL STENT INSERTION,10
DE,CORONARY ARTERY OCCLUSION,10
DE,DEMENTIA,10
DE,DYSGEUSIA,10
DE,EMBOLIC STROKE,10
DE,FEBRILE INFECTION,10
DE,HEPATIC CYST,10
DE,HYPOTHYROIDISM,10
DE,HYPOXIA,10
DE,INFLAMMATORY MARKER INCREASED,10
DE,IRON DEFICIENCY ANAEMIA,10
DE,JOINT SWELLING,10
DE,LUNG INFILTRATION,10
DE,LYMPHADENOPATHY,10
DE,MOVEMENT DISORDER,10
DE,MYOGLOBIN BLOOD INCREASED,10
DE,NEOPLASM,10
DE,NIGHTMARE,10
DE,PRODUCT USE IN UNAPPROVED INDICATION,10
DE,PRURITUS GENERALISED,10
DE,PSORIASIS,10
DE,RECTAL HAEMORRHAGE,10
DE,RETINAL DETACHMENT,10
DE,SEDATION,10
DE,SKIN ULCER,10
DE,SPLENOMEGALY,10
DE,SWOLLEN TONGUE,10
DE,TESTICULAR PAIN,10
DE,TOXIC EPIDERMAL NECROLYSIS,10
DE,ABNORMAL PALMAR/PLANTAR CREASES,9
DE,ACUTE MYELOID LEUKAEMIA,9
DE,ANAEMIA OF MALIGNANT DISEASE,9
DE,ATRIAL SEPTAL DEFECT,9
DE,ATRIAL THROMBOSIS,9
DE,BLISTER,9
DE,BLOOD PRESSURE FLUCTUATION,9
DE,BONE PAIN,9
DE,BRONCHIAL CARCINOMA,9
DE,BURSITIS,9
DE,CANDIDA INFECTION,9
DE,CARCINOMA IN SITU OF SKIN,9
DE,CHOLANGITIS,9
DE,CHRONIC KIDNEY DISEASE,9
DE,COLD SWEAT,9
DE,DEVELOPMENTAL DELAY,9
DE,DRUG HYPERSENSITIVITY,9
DE,DYSMORPHISM,9
DE,DYSPNOEA AT REST,9
DE,ENDOCARDITIS,9
DE,ESCHERICHIA URINARY TRACT INFECTION,9
DE,FACIAL PARESIS,9
DE,FEELING ABNORMAL,9
DE,HAEMATEMESIS,9
DE,HAEMATOCRIT DECREASED,9
DE,HYPERBILIRUBINAEMIA,9
DE,HYPERBILIRUBINAEMIA NEONATAL,9
DE,HYPERTHYROIDISM,9
DE,HYPOTONIA NEONATAL,9
DE,KETOACIDOSIS,9
DE,LONG QT SYNDROME,9
DE,METASTASES TO LIVER,9
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,9
DE,NEUTROPHIL COUNT INCREASED,9
DE,OCULAR ICTERUS,9
DE,OSTEONECROSIS OF JAW,9
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,9
DE,PERONEAL NERVE PALSY,9
DE,PRERENAL FAILURE,9
DE,PULMONARY HAEMORRHAGE,9
DE,ROAD TRAFFIC ACCIDENT,9
DE,SELECTIVE EATING DISORDER,9
DE,SLEEP APNOEA SYNDROME,9
DE,SUDDEN DEATH,9
DE,SWELLING,9
DE,SWELLING FACE,9
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,9
DE,TESTICULAR ATROPHY,9
DE,URINE OUTPUT DECREASED,9
DE,VENTRICULAR EXTRASYSTOLES,9
DE,VESTIBULAR DISORDER,9
DE,WHITE BLOOD CELL COUNT DECREASED,9
DE,WOUND,9
DE,AGRANULOCYTOSIS,8
DE,ALVEOLITIS ALLERGIC,8
DE,ATRIOVENTRICULAR BLOCK,8
DE,AUTOIMMUNE HEPATITIS,8
DE,BLOOD TRIGLYCERIDES INCREASED,8
DE,BONE MARROW FAILURE,8
DE,CARDIAC FAILURE CONGESTIVE,8
DE,CHRONIC GASTRITIS,8
DE,CLOSTRIDIUM DIFFICILE COLITIS,8
DE,DRUG ERUPTION,8
DE,ECZEMA,8
DE,EXTREMITY NECROSIS,8
DE,GASTROINTESTINAL INFLAMMATION,8
DE,HEART RATE INCREASED,8
DE,HEPATITIS CHOLESTATIC,8
DE,HICCUPS,8
DE,INFARCTION,8
DE,IRRITABILITY,8
DE,LIVER INJURY,8
DE,MUSCULOSKELETAL PAIN,8
DE,MYOGLOBIN URINE,8
DE,NEUTROPENIC SEPSIS,8
DE,ORAL CANDIDIASIS,8
DE,OXYGEN SATURATION DECREASED,8
DE,PANIC ATTACK,8
DE,PANIC REACTION,8
DE,PARESIS,8
DE,PERIPHERAL EMBOLISM,8
DE,PNEUMOTHORAX,8
DE,PROTEINURIA,8
DE,PULMONARY ALVEOLAR HAEMORRHAGE,8
DE,RASH GENERALISED,8
DE,RENAL DISORDER,8
DE,SUDDEN CARDIAC DEATH,8
DE,THROMBOSIS IN DEVICE,8
DE,VENTRICULAR SEPTAL DEFECT,8
DE,ABDOMINAL PAIN LOWER,7
DE,ANAL HAEMORRHAGE,7
DE,AORTIC ARTERIOSCLEROSIS,7
DE,ASTHMA,7
DE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,7
DE,BASAL GANGLIA HAEMORRHAGE,7
DE,BLADDER CANCER,7
DE,BLOOD COUNT ABNORMAL,7
DE,BRAIN OEDEMA,7
DE,CARDIOMEGALY,7
DE,CATARACT,7
DE,CEREBELLAR INFARCTION,7
DE,COORDINATION ABNORMAL,7
DE,DIABETES MELLITUS INADEQUATE CONTROL,7
DE,DIALYSIS,7
DE,DIASTOLIC DYSFUNCTION,7
DE,DIPLOPIA,7
DE,DISSEMINATED INTRAVASCULAR COAGULATION,7
DE,DIVERTICULUM INTESTINAL,7
DE,DRUG LEVEL INCREASED,7
DE,EYE HAEMORRHAGE,7
DE,FAECES PALE,7
DE,FLUID RETENTION,7
DE,FOOT DEFORMITY,7
DE,FRACTURE,7
DE,GANGRENE,7
DE,GASTROINTESTINAL TUBE INSERTION,7
DE,HEMIPLEGIA,7
DE,HEPATIC NECROSIS,7
DE,HEPATOTOXICITY,7
DE,HIATUS HERNIA,7
DE,HOSPITALISATION,7
DE,HYPERNATRAEMIA,7
DE,HYPOPHAGIA,7
DE,HYPOVOLAEMIC SHOCK,7
DE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,7
DE,INFLUENZA,7
DE,INTRACRANIAL PRESSURE INCREASED,7
DE,LABORATORY TEST ABNORMAL,7
DE,LOW DENSITY LIPOPROTEIN INCREASED,7
DE,LYMPHOEDEMA,7
DE,MEDICATION ERROR,7
DE,METABOLIC MYOPATHY,7
DE,METASTASES TO BONE,7
DE,METASTASES TO CENTRAL NERVOUS SYSTEM,7
DE,MYOSITIS,7
DE,NECK PAIN,7
DE,NERVOUS SYSTEM DISORDER,7
DE,NEUTROPHIL COUNT DECREASED,7
DE,NIGHT SWEATS,7
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,7
DE,OSTEOPOROSIS,7
DE,PARTIAL SEIZURES,7
DE,PERIPHERAL ARTERY OCCLUSION,7
DE,PROCEDURAL HAEMORRHAGE,7
DE,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,7
DE,PULMONARY CONGESTION,7
DE,RESPIRATORY DISORDER,7
DE,RESTLESS LEGS SYNDROME,7
DE,SENSORY DISTURBANCE,7
DE,STATUS EPILEPTICUS,7
DE,STRESS,7
DE,SUBILEUS,7
DE,TINNITUS,7
DE,TRANSIENT GLOBAL AMNESIA,7
DE,TRICUSPID VALVE INCOMPETENCE,7
DE,TRUNCUS ARTERIOSUS PERSISTENT,7
DE,WALKING DISABILITY,7
DE,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,6
DE,AORTIC VALVE STENOSIS,6
DE,ASPHYXIA,6
DE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,6
DE,BENIGN PROSTATIC HYPERPLASIA,6
DE,BLOOD POTASSIUM DECREASED,6
DE,BLOOD URIC ACID INCREASED,6
DE,BRONCHITIS CHRONIC,6
DE,BUNDLE BRANCH BLOCK RIGHT,6
DE,CARDIOMYOPATHY,6
DE,CAROTID ARTERIOSCLEROSIS,6
DE,CELLULITIS,6
DE,CHOLECYSTITIS,6
DE,COLITIS ULCERATIVE,6
DE,CORONARY ARTERY THROMBOSIS,6
DE,CYANOSIS,6
DE,DERMATITIS ALLERGIC,6
DE,DERMATITIS EXFOLIATIVE,6
DE,DIVERTICULAR PERFORATION,6
DE,DYSURIA,6
DE,EJACULATION DISORDER,6
DE,EJECTION FRACTION DECREASED,6
DE,EXTRA DOSE ADMINISTERED,6
DE,FAECES DISCOLOURED,6
DE,FEELING HOT,6
DE,FEMORAL NECK FRACTURE,6
DE,HEPATITIS FULMINANT,6
DE,HEPATOCELLULAR INJURY,6
DE,HYPERCALCAEMIA,6
DE,HYPERFERRITINAEMIA,6
DE,HYPERSENSITIVITY VASCULITIS,6
DE,HYPOCALCAEMIA,6
DE,INTERMITTENT CLAUDICATION,6
DE,LEG AMPUTATION,6
DE,LOWER GASTROINTESTINAL HAEMORRHAGE,6
DE,MICTURITION DISORDER,6
DE,MOTOR DYSFUNCTION,6
DE,MOUTH HAEMORRHAGE,6
DE,MULTIPLE SCLEROSIS RELAPSE,6
DE,MUSCLE HAEMORRHAGE,6
DE,NEPHROLITHIASIS,6
DE,NEUROLOGIC NEGLECT SYNDROME,6
DE,NOCTURIA,6
DE,NON-ALCOHOLIC STEATOHEPATITIS,6
DE,OESOPHAGITIS,6
DE,ONYCHOMYCOSIS,6
DE,PACKED RED BLOOD CELL TRANSFUSION,6
DE,PAIN OF SKIN,6
DE,PANCREATIC CARCINOMA,6
DE,PANCREATIC DUCT STENOSIS,6
DE,PARAPARESIS,6
DE,PERSONALITY CHANGE,6
DE,PLATELET COUNT INCREASED,6
DE,PLEUROTHOTONUS,6
DE,POLYURIA,6
DE,PORTAL FIBROSIS,6
DE,POTENTIATING DRUG INTERACTION,6
DE,PRODUCTIVE COUGH,6
DE,REBOUND EFFECT,6
DE,SINUS TACHYCARDIA,6
DE,SINUSITIS,6
DE,SKIN REACTION,6
DE,SPINAL OSTEOARTHRITIS,6
DE,SPINAL PAIN,6
DE,STASIS DERMATITIS,6
DE,STENT PLACEMENT,6
DE,SUBCUTANEOUS HAEMATOMA,6
DE,SUFFOCATION FEELING,6
DE,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,6
DE,TENDON PAIN,6
DE,WHEEZING,6
DE,WRONG TECHNIQUE IN DRUG USAGE PROCESS,6
DE,ABSCESS,5
DE,ACCIDENTAL OVERDOSE,5
DE,AKINESIA,5
DE,AMYLASE INCREASED,5
DE,ANAPHYLACTIC REACTION,5
DE,ANAPHYLACTIC SHOCK,5
DE,ARTERIAL STENOSIS,5
DE,ATELECTASIS,5
DE,BLADDER TAMPONADE,5
DE,BLOOD CALCIUM DECREASED,5
DE,BLOOD GLUCOSE FLUCTUATION,5
DE,BLOOD PRESSURE SYSTOLIC INCREASED,5
DE,BRONCHOPNEUMONIA,5
DE,BUNDLE BRANCH BLOCK LEFT,5
DE,CACHEXIA,5
DE,CARDIAC FAILURE ACUTE,5
DE,CARDIAC TAMPONADE,5
DE,CARDIAC VENTRICULAR THROMBOSIS,5
DE,CEREBELLAR HAEMORRHAGE,5
DE,CHRONIC LYMPHOCYTIC LEUKAEMIA,5
DE,COLITIS ISCHAEMIC,5
DE,COMPARTMENT SYNDROME,5
DE,CONCOMITANT DISEASE PROGRESSION,5
DE,CYTOMEGALOVIRUS INFECTION,5
DE,DEAFNESS,5
DE,DEVICE DISLOCATION,5
DE,DEVICE OCCLUSION,5
DE,DEVICE RELATED INFECTION,5
DE,DIABETIC FOOT,5
DE,DIVERTICULUM,5
DE,DRUG DOSE OMISSION,5
DE,DRUG EFFECT INCOMPLETE,5
DE,DYSPHONIA,5
DE,DYSSTASIA,5
DE,EAR NEOPLASM MALIGNANT,5
DE,EMPHYSEMA,5
DE,EXTRASYSTOLES,5
DE,EYE IRRITATION,5
DE,FAECALOMA,5
DE,FLANK PAIN,5
DE,FLATULENCE,5
DE,GASTRIC MUCOSA ERYTHEMA,5
DE,GASTRITIS HAEMORRHAGIC,5
DE,GASTROINTESTINAL ANGIODYSPLASIA,5
DE,GASTROINTESTINAL INFECTION,5
DE,GLAUCOMA,5
DE,HAEMARTHROSIS,5
DE,HALLUCINATION_ VISUAL,5
DE,HEMIANOPIA,5
DE,HYPERTENSIVE HEART DISEASE,5
DE,HYPOACUSIS,5
DE,ILEUS PARALYTIC,5
DE,INCONTINENCE,5
DE,INJECTION SITE SWELLING,5
DE,INTENTIONAL OVERDOSE,5
DE,INTESTINAL PERFORATION,5
DE,IRON OVERLOAD,5
DE,LANGUAGE DISORDER,5
DE,LEFT VENTRICULAR DYSFUNCTION,5
DE,LIVER FUNCTION TEST INCREASED,5
DE,LOCAL SWELLING,5
DE,LUMBAR SPINAL STENOSIS,5
DE,LUNG DISORDER,5
DE,LYMPHOPENIA,5
DE,MENTAL DISORDER,5
DE,METASTASES TO LUNG,5
DE,MICROANGIOPATHY,5
DE,MONOPARESIS,5
DE,MULTIPLE SCLEROSIS,5
DE,MUSCULOSKELETAL STIFFNESS,5
DE,NEOPLASM MALIGNANT,5
DE,OBESITY,5
DE,ON AND OFF PHENOMENON,5
DE,OSTEOCHONDROSIS,5
DE,PANCREATIC CALCIFICATION,5
DE,PANCREATIC CARCINOMA METASTATIC,5
DE,PANCREATIC MASS,5
DE,PANCREATIC NEOPLASM,5
DE,PAPILLOEDEMA,5
DE,PATHOLOGICAL FRACTURE,5
DE,PERIPHERAL SENSORY NEUROPATHY,5
DE,PITUITARY TUMOUR BENIGN,5
DE,PNEUMONIA BACTERIAL,5
DE,POLYARTHRITIS,5
DE,PULMONARY MASS,5
DE,QUADRIPARESIS,5
DE,RENAL FAILURE CHRONIC,5
DE,RHINITIS,5
DE,RIB FRACTURE,5
DE,RIGHT VENTRICULAR FAILURE,5
DE,ROTATOR CUFF SYNDROME,5
DE,SCAR,5
DE,SCIATICA,5
DE,SEROMA,5
DE,SKIN DISCOLOURATION,5
DE,SKIN LESION,5
DE,STEVENS-JOHNSON SYNDROME,5
DE,SUBARACHNOID HAEMORRHAGE,5
DE,SUPRAVENTRICULAR EXTRASYSTOLES,5
DE,SURGERY,5
DE,TENDON OPERATION,5
DE,THALAMIC INFARCTION,5
DE,THROMBOPHLEBITIS,5
DE,TOOTH ABSCESS,5
DE,TORSADE DE POINTES,5
DE,TROPONIN INCREASED,5
DE,URINARY BLADDER HAEMORRHAGE,5
DE,VASODILATATION,5
DE,WOUND INFECTION,5
DE,ABDOMINAL RIGIDITY,4
DE,ABNORMAL BEHAVIOUR,4
DE,ACNE,4
DE,AMNESIA,4
DE,AORTIC VALVE SCLEROSIS,4
DE,ARTERIOSCLEROSIS CORONARY ARTERY,4
DE,ARTHRITIS,4
DE,ATAXIA,4
DE,ATRIAL TACHYCARDIA,4
DE,BLOOD POTASSIUM INCREASED,4
DE,BLOOD PRESSURE ABNORMAL,4
DE,BORDERLINE PERSONALITY DISORDER,4
DE,BRADYARRHYTHMIA,4
DE,BRAIN STEM STROKE,4
DE,BREAST CANCER,4
DE,BREAST CANCER METASTATIC,4
DE,BREATH SOUNDS ABNORMAL,4
DE,CARDIAC DISCOMFORT,4
DE,CARDIAC FAILURE CHRONIC,4
DE,CEREBRAL ARTERY EMBOLISM,4
DE,CEREBRAL ARTERY OCCLUSION,4
DE,CEREBRAL MICROANGIOPATHY,4
DE,CHOLECYSTITIS ACUTE,4
DE,COLITIS MICROSCOPIC,4
DE,COLON CANCER,4
DE,CONCUSSION,4
DE,CONGENITAL CARDIOVASCULAR ANOMALY,4
DE,CONGESTIVE CARDIOMYOPATHY,4
DE,CONJUNCTIVAL HAEMORRHAGE,4
DE,CONTRAINDICATED PRODUCT ADMINISTERED,4
DE,CROHN^S DISEASE,4
DE,DELUSION,4
DE,DEMYELINATING POLYNEUROPATHY,4
DE,DERMATITIS,4
DE,DISCOMFORT,4
DE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
DE,DUODENITIS,4
DE,DYSTONIA,4
DE,ELECTROCARDIOGRAM ABNORMAL,4
DE,EMBOLISM,4
DE,ENCEPHALOPATHY,4
DE,EOSINOPHILIA,4
DE,EROSIVE DUODENITIS,4
DE,ERYTHEMA MULTIFORME,4
DE,EYELID OEDEMA,4
DE,FEELING COLD,4
DE,FISTULA,4
DE,GASTRIC CYST,4
DE,GASTROENTERITIS CLOSTRIDIAL,4
DE,GASTROENTERITIS NOROVIRUS,4
DE,GENERALISED TONIC-CLONIC SEIZURE,4
DE,GOITRE,4
DE,GRUNTING,4
DE,GYNAECOMASTIA,4
DE,HAEMORRHAGIC DIATHESIS,4
DE,HAEMORRHAGIC INFARCTION,4
DE,HAEMORRHAGIC TRANSFORMATION STROKE,4
DE,HALLUCINATION_ AUDITORY,4
DE,HELICOBACTER GASTRITIS,4
DE,HEPARIN-INDUCED THROMBOCYTOPENIA,4
DE,HEPATIC ENZYME ABNORMAL,4
DE,HEREDITARY ANGIOEDEMA,4
DE,HIP FRACTURE,4
DE,HYPERCHOLESTEROLAEMIA,4
DE,HYPOTHERMIA,4
DE,IMMOBILE,4
DE,IMMUNE THROMBOCYTOPENIC PURPURA,4
DE,INCISIONAL HERNIA,4
DE,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,4
DE,INGUINAL HERNIA,4
DE,INJECTION SITE INDURATION,4
DE,INTENTIONAL PRODUCT USE ISSUE,4
DE,INTRAOCULAR PRESSURE INCREASED,4
DE,IRON DEFICIENCY,4
DE,ISCHAEMIC CEREBRAL INFARCTION,4
DE,JOINT DISLOCATION,4
DE,LACUNAR INFARCTION,4
DE,LIP SWELLING,4
DE,LOCALISED INFECTION,4
DE,LYMPHOCYTE COUNT DECREASED,4
DE,LYMPHOMA,4
DE,MALLORY-WEISS SYNDROME,4
DE,MATERNAL EXPOSURE DURING PREGNANCY,4
DE,MESENTERIC ARTERIAL OCCLUSION,4
DE,METASTASES TO LYMPH NODES,4
DE,MONOCYTE COUNT INCREASED,4
DE,MUCOSAL DRYNESS,4
DE,MUSCLE INJURY,4
DE,NEURODERMATITIS,4
DE,NEUTROPENIC INFECTION,4
DE,NYSTAGMUS,4
DE,OCULAR HYPERAEMIA,4
DE,OESOPHAGEAL CANDIDIASIS,4
DE,PERIPHERAL ARTERY STENOSIS,4
DE,PERIPHERAL VASCULAR DISORDER,4
DE,PERITONITIS,4
DE,POLLAKIURIA,4
DE,POLYMYALGIA RHEUMATICA,4
DE,POST PROCEDURAL HAEMATOMA,4
DE,PRODUCT QUALITY ISSUE,4
DE,PROSTATIC SPECIFIC ANTIGEN INCREASED,4
DE,PROSTATITIS,4
DE,PROTHROMBIN TIME PROLONGED,4
DE,PROTHROMBIN TIME SHORTENED,4
DE,PULMONARY ARTERY STENOSIS,4
DE,PULMONARY FUNCTION TEST DECREASED,4
DE,PURULENT DISCHARGE,4
DE,PYELOCALIECTASIS,4
DE,RAPID CORRECTION OF HYPONATRAEMIA,4
DE,RASH MACULO-PAPULAR,4
DE,RASH PAPULAR,4
DE,RASH PRURITIC,4
DE,RASH PUSTULAR,4
DE,RED BLOOD CELL SEDIMENTATION RATE INCREASED,4
DE,RENAL CELL CARCINOMA,4
DE,RENAL FUNCTION TEST ABNORMAL,4
DE,RENAL INFARCT,4
DE,RETINAL ARTERY OCCLUSION,4
DE,RHEUMATIC DISORDER,4
DE,RHEUMATOID NODULE,4
DE,SARCOIDOSIS,4
DE,SECOND PRIMARY MALIGNANCY,4
DE,SERUM FERRITIN INCREASED,4
DE,SHUNT OCCLUSION,4
DE,SQUAMOUS CELL CARCINOMA OF SKIN,4
DE,STAPHYLOCOCCAL SEPSIS,4
DE,STAPHYLOCOCCUS TEST POSITIVE,4
DE,STOMA SITE DISCHARGE,4
DE,SUBCUTANEOUS ABSCESS,4
DE,SUPRAVENTRICULAR TACHYCARDIA,4
DE,TACHYPNOEA,4
DE,TENDON INJURY,4
DE,TENOSYNOVITIS,4
DE,THROAT IRRITATION,4
DE,TOOTH DISORDER,4
DE,TRANSFUSION,4
DE,TREATMENT NONCOMPLIANCE,4
DE,TROPONIN T INCREASED,4
DE,VASCULAR ENCEPHALOPATHY,4
DE,VASCULAR PSEUDOANEURYSM,4
DE,VASCULAR STENT STENOSIS,4
DE,VENOUS THROMBOSIS LIMB,4
DE,VERTIGO POSITIONAL,4
DE,VIRAL INFECTION,4
DE,VISUAL FIELD DEFECT,4
DE,WOUND HAEMORRHAGE,4
DE,ABNORMAL FAECES,3
DE,ACCIDENT,3
DE,ACUTE PRERENAL FAILURE,3
DE,ADENOCARCINOMA,3
DE,ADVERSE EVENT,3
DE,AGEUSIA,3
DE,ALLERGIC OEDEMA,3
DE,ANAL FISSURE,3
DE,ANAL INCONTINENCE,3
DE,ANGIOPLASTY,3
DE,ANKLE FRACTURE,3
DE,ANURIA,3
DE,AORTIC STENOSIS,3
DE,ARTERIAL HAEMORRHAGE,3
DE,ARTHRITIS BACTERIAL,3
DE,ASPIRATION,3
DE,BALANOPOSTHITIS,3
DE,BLADDER HYPERTROPHY,3
DE,BLINDNESS,3
DE,BLOOD CALCIUM INCREASED,3
DE,BLOOD CREATINE INCREASED,3
DE,BLOOD GLUCOSE DECREASED,3
DE,BLOOD LACTIC ACID INCREASED,3
DE,BLOOD PRESSURE DIASTOLIC DECREASED,3
DE,BLOOD THYROID STIMULATING HORMONE DECREASED,3
DE,BRAIN MIDLINE SHIFT,3
DE,BRONCHITIS BACTERIAL,3
DE,BURNING SENSATION,3
DE,CARDIAC ABLATION,3
DE,CARDIOVASCULAR INSUFFICIENCY,3
DE,CAROTID ARTERY OCCLUSION,3
DE,CENTRAL NERVOUS SYSTEM LESION,3
DE,CEREBRAL DISORDER,3
DE,CHOLECYSTECTOMY,3
DE,COMPLETED SUICIDE,3
DE,CONJUNCTIVITIS,3
DE,CORONARY ARTERY BYPASS,3
DE,CYSTITIS NONINFECTIVE,3
DE,DECREASED ACTIVITY,3
DE,DERMAL CYST,3
DE,DERMATITIS ACNEIFORM,3
DE,DIABETIC NEPHROPATHY,3
DE,DIABETIC NEUROPATHY,3
DE,DISABILITY,3
DE,DISEASE RECURRENCE,3
DE,DIZZINESS POSTURAL,3
DE,DRUG LEVEL DECREASED,3
DE,DRY EYE,3
DE,DYSKINESIA,3
DE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,3
DE,EMPYEMA,3
DE,ENTERITIS,3
DE,ENTEROCOCCAL INFECTION,3
DE,ENURESIS,3
DE,EPIGASTRIC DISCOMFORT,3
DE,ERYTHEMA NODOSUM,3
DE,ESCHERICHIA INFECTION,3
DE,EXTRAVASATION,3
DE,EYE PAIN,3
DE,FACIAL BONES FRACTURE,3
DE,FASCIITIS,3
DE,FEAR,3
DE,FEAR OF DEATH,3
DE,FEMUR FRACTURE,3
DE,FIBRIN D DIMER INCREASED,3
DE,FUNGAL INFECTION,3
DE,GAIT INABILITY,3
DE,GASTRIC DISORDER,3
DE,GENERAL PHYSICAL CONDITION ABNORMAL,3
DE,GENERALISED OEDEMA,3
DE,GLOSSODYNIA,3
DE,GRANULOMATOSIS WITH POLYANGIITIS,3
DE,GROIN PAIN,3
DE,HAEMATOMA EVACUATION,3
DE,HAEMOGLOBIN INCREASED,3
DE,HAEMOLYTIC ANAEMIA,3
DE,HEPATIC CIRRHOSIS,3
DE,HEPATIC CONGESTION,3
DE,HEPATIC ENCEPHALOPATHY,3
DE,HEPATITIS TOXIC,3
DE,HIP ARTHROPLASTY,3
DE,HUMERUS FRACTURE,3
DE,HYDROCEPHALUS,3
DE,HYDRONEPHROSIS,3
DE,HYPERAESTHESIA,3
DE,HYPERTRIGLYCERIDAEMIA,3
DE,HYPOALBUMINAEMIA,3
DE,HYPOMAGNESAEMIA,3
DE,HYPOPHYSITIS,3
DE,ILL-DEFINED DISORDER,3
DE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,3
DE,IMMUNE-MEDIATED NECROTISING MYOPATHY,3
DE,INCORRECT DRUG ADMINISTRATION RATE,3
DE,INFECTIOUS PLEURAL EFFUSION,3
DE,INJECTION SITE ERYTHEMA,3
DE,INJURY,3
DE,INTENTIONAL PRODUCT MISUSE,3
DE,INTERNATIONAL NORMALISED RATIO DECREASED,3
DE,INTRACRANIAL VENOUS SINUS THROMBOSIS,3
DE,JOINT INJURY,3
DE,JOINT RANGE OF MOTION DECREASED,3
DE,KNEE ARTHROPLASTY,3
DE,KYPHOSIS,3
DE,LARGE INTESTINE PERFORATION,3
DE,LEFT ATRIAL DILATATION,3
DE,LEUKOENCEPHALOPATHY,3
DE,LOWER LIMB FRACTURE,3
DE,LUMBAR VERTEBRAL FRACTURE,3
DE,LUNG NEOPLASM MALIGNANT,3
DE,MACULAR DEGENERATION,3
DE,MALNUTRITION,3
DE,MEAN CELL HAEMOGLOBIN INCREASED,3
DE,METASTASES TO SPINE,3
DE,METASTATIC MALIGNANT MELANOMA,3
DE,METASTATIC RENAL CELL CARCINOMA,3
DE,MICTURITION URGENCY,3
DE,MIGRAINE,3
DE,MONOPLEGIA,3
DE,MUSCLE RIGIDITY,3
DE,MUSCLE TWITCHING,3
DE,MYELITIS,3
DE,MYOCARDIAL ISCHAEMIA,3
DE,NECROSIS,3
DE,NEPHROGENIC ANAEMIA,3
DE,NERVOUSNESS,3
DE,NO THERAPEUTIC RESPONSE,3
DE,OCCULT BLOOD POSITIVE,3
DE,OLIGOHYDRAMNIOS,3
DE,ORGANISING PNEUMONIA,3
DE,OROPHARYNGEAL PAIN,3
DE,OSTEONECROSIS,3
DE,OTITIS MEDIA,3
DE,OVERWEIGHT,3
DE,PAIN IN JAW,3
DE,PANCREATIC INJURY,3
DE,PANCREATIC STEATOSIS,3
DE,PELVIC FRACTURE,3
DE,PERFORMANCE STATUS DECREASED,3
DE,PERIPHERAL ARTERY THROMBOSIS,3
DE,PERIPHERAL ISCHAEMIA,3
DE,PERSECUTORY DELUSION,3
DE,PHARYNGEAL OEDEMA,3
DE,PHIMOSIS,3
GR,ASTHENIA,6
GR,RHABDOMYOLYSIS,5
GR,MYALGIA,4
GR,DISCOMFORT,3
GR,LOSS OF CONSCIOUSNESS,3
GR,MYOCARDIAL INFARCTION,3
GR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
GR,BURNING SENSATION,2
GR,CARDIAC ARREST,2
GR,COUGH,2
GR,DEATH,2
GR,DIZZINESS,2
GR,GRAND MAL CONVULSION,2
GR,HYPERHIDROSIS,2
GR,LUNG NEOPLASM MALIGNANT,2
GR,NEUTROPENIA,2
GR,OVERDOSE,2
GR,PALLOR,2
GR,PEMPHIGOID,2
GR,PNEUMONIA ASPIRATION,2
GR,PNEUMOTHORAX,2
GR,ABDOMINAL PAIN,1
GR,ABDOMINAL PAIN UPPER,1
GR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
GR,ANAPHYLACTIC REACTION,1
GR,APPENDICITIS,1
GR,BACK PAIN,1
GR,BILE DUCT OBSTRUCTION,1
GR,BLOOD GLUCOSE FLUCTUATION,1
GR,BLOOD PRESSURE DECREASED,1
GR,BONE MARROW OEDEMA,1
GR,CANDIDA TEST POSITIVE,1
GR,CARDIOGENIC SHOCK,1
GR,CEREBRAL HAEMORRHAGE,1
GR,CHEST PAIN,1
GR,CHILLS,1
GR,CIRCULATORY COLLAPSE,1
GR,COGNITIVE DISORDER,1
GR,CONDITION AGGRAVATED,1
GR,DEVICE RELATED INFECTION,1
GR,DRUG INEFFECTIVE,1
GR,ENCAPSULATING PERITONEAL SCLEROSIS,1
GR,ENZYME INHIBITION,1
GR,FACE OEDEMA,1
GR,GALLBLADDER DISORDER,1
GR,GASTRIC CANCER,1
GR,GASTRIC ULCER,1
GR,HAEMATOCRIT DECREASED,1
GR,HYPERLIPIDAEMIA,1
GR,HYPERSENSITIVITY,1
GR,HYPERTRIGLYCERIDAEMIA,1
GR,HYPOAESTHESIA,1
GR,INFECTION,1
GR,INSOMNIA,1
GR,JAUNDICE,1
GR,KLEBSIELLA TEST POSITIVE,1
GR,KOUNIS SYNDROME,1
GR,LETHARGY,1
GR,LUNG INFECTION,1
GR,MALIGNANT NEOPLASM PROGRESSION,1
GR,MELAENA,1
GR,MUSCULOSKELETAL STIFFNESS,1
GR,MYELODYSPLASTIC SYNDROME,1
GR,NO ADVERSE EVENT,1
GR,OEDEMA,1
GR,OEDEMA MOUTH,1
GR,PANCREATITIS ACUTE,1
GR,PNEUMONITIS,1
GR,PYREXIA,1
GR,RASH,1
GR,TENDONITIS,1
GR,THYROIDITIS SUBACUTE,1
GR,TRANSAMINASES INCREASED,1
GR,UPPER RESPIRATORY TRACT INFECTION,1
GR,VASCULAR STENT THROMBOSIS,1
GR,VOMITING,1
GR,WEIGHT DECREASED,1
GT,CARDIOGENIC SHOCK,1
GT,MYOCARDIAL INFARCTION,1
GT,SEPSIS,1
HK,DECREASED APPETITE,3
HK,PNEUMONIA,3
HK,CEREBROVASCULAR DISORDER,2
HK,CHEST PAIN,2
HK,CYTOMEGALOVIRUS CHORIORETINITIS,2
HK,DEPOSIT EYE,2
HK,HYPOGLYCAEMIA,2
HK,HYPOKALAEMIA,2
HK,HYPONATRAEMIA,2
HK,MALAISE,2
HK,RENAL IMPAIRMENT,2
HK,RESPIRATORY FAILURE,2
HK,SPINAL OSTEOARTHRITIS,2
HK,TRANSIENT ISCHAEMIC ATTACK,2
HK,ANAEMIA,1
HK,ANGIOEDEMA,1
HK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
HK,BLOOD GLUCOSE INCREASED,1
HK,CARDIAC ARREST,1
HK,CARDIOVASCULAR DISORDER,1
HK,CERVICAL MYELOPATHY,1
HK,CRANIOCEREBRAL INJURY,1
HK,DEATH,1
HK,DEPRESSION,1
HK,DIABETES MELLITUS INADEQUATE CONTROL,1
HK,DIARRHOEA,1
HK,DISEASE PROGRESSION,1
HK,DIZZINESS,1
HK,DYSPNOEA,1
HK,EMPYEMA,1
HK,GENERAL PHYSICAL HEALTH DETERIORATION,1
HK,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
HK,HEADACHE,1
HK,HEMIPARESIS,1
HK,HYPERHIDROSIS,1
HK,HYPERNATRAEMIA,1
HK,HYPOTENSION,1
HK,INFECTION,1
HK,INSOMNIA,1
HK,JOINT INJURY,1
HK,LOWER RESPIRATORY TRACT INFECTION,1
HK,LUNG INFECTION,1
HK,MENIERE^S DISEASE,1
HK,METASTASES TO LUNG,1
HK,MUSCLE DISORDER,1
HK,MUSCULAR WEAKNESS,1
HK,MYOCARDIAL ISCHAEMIA,1
HK,MYOPATHY,1
HK,NECK MASS,1
HK,OVARIAN NEOPLASM,1
HK,PALPITATIONS,1
HK,PANCREATITIS,1
HK,PANCREATITIS ACUTE,1
HK,PERFORMANCE STATUS DECREASED,1
HK,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
HK,POLYMYOSITIS,1
HK,POOR QUALITY SLEEP,1
HK,RASH PAPULAR,1
HK,RECTAL CANCER,1
HK,RENAL FAILURE ACUTE,1
HK,ROTATOR CUFF SYNDROME,1
HK,SEPSIS,1
HK,SHOCK,1
HK,SLEEP APNOEA SYNDROME,1
HK,SOMNOLENCE,1
HK,UNRESPONSIVE TO STIMULI,1
HK,URINARY RETENTION,1
HK,VOMITING,1
HK,WEIGHT DECREASED,1
HK,WEIGHT INCREASED,1
HU,DRUG INEFFECTIVE,3
HU,ANGINA PECTORIS,2
HU,BLOOD PRESSURE INCREASED,2
HU,CARDIAC ARREST,2
HU,HYPONATRAEMIA,2
HU,NAUSEA,2
HU,OEDEMA PERIPHERAL,2
HU,PNEUMONIA,2
HU,WEIGHT DECREASED,2
HU,ALANINE AMINOTRANSFERASE INCREASED,1
HU,ASPARTATE AMINOTRANSFERASE INCREASED,1
HU,ASTHENIA,1
HU,ATRIAL FIBRILLATION,1
HU,BLADDER CANCER,1
HU,BLISTER,1
HU,BLOOD OSMOLARITY DECREASED,1
HU,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
HU,BRAIN CONTUSION,1
HU,BRONCHITIS,1
HU,CARDIAC FAILURE,1
HU,CHILLS,1
HU,CONDITION AGGRAVATED,1
HU,DEATH,1
HU,DEHYDRATION,1
HU,DEPRESSION,1
HU,DIARRHOEA,1
HU,DISORIENTATION,1
HU,DIZZINESS,1
HU,DYSPNOEA,1
HU,ELECTROCARDIOGRAM QT PROLONGED,1
HU,ERYTHEMA,1
HU,FATIGUE,1
HU,GENERALISED OEDEMA,1
HU,GINGIVAL SWELLING,1
HU,HAEMORRHAGIC TRANSFORMATION STROKE,1
HU,HALLUCINATION,1
HU,HEADACHE,1
HU,HEARING IMPAIRED,1
HU,HEART RATE INCREASED,1
HU,HYPERHIDROSIS,1
HU,HYPOAESTHESIA,1
HU,HYPOGLYCAEMIA,1
HU,INFLAMMATION,1
HU,INSOMNIA,1
HU,IRRITABILITY,1
HU,LIP SWELLING,1
HU,LOSS OF CONSCIOUSNESS,1
HU,MALIGNANT NEOPLASM PROGRESSION,1
HU,METASTASES TO BONE,1
HU,METASTASES TO BONE MARROW,1
HU,METASTASES TO CENTRAL NERVOUS SYSTEM,1
HU,MUSCULOSKELETAL PAIN,1
HU,MYALGIA,1
HU,NERVOUSNESS,1
HU,NIGHTMARE,1
HU,OEDEMA,1
HU,ORAL FUNGAL INFECTION,1
HU,PAIN IN EXTREMITY,1
HU,PERIPHERAL SWELLING,1
HU,PRURITUS,1
HU,PSYCHOMOTOR SKILLS IMPAIRED,1
HU,PULMONARY FIBROSIS,1
HU,PYREXIA,1
HU,RENAL IMPAIRMENT,1
HU,RESTLESSNESS,1
HU,RHEUMATOID ARTHRITIS,1
HU,SENSATION OF HEAVINESS,1
HU,SHOULDER OPERATION,1
HU,SMALL INTESTINE CARCINOMA,1
HU,SPEECH DISORDER,1
HU,SUICIDAL IDEATION,1
HU,TINNITUS,1
HU,URTICARIA,1
HU,VASODILATATION,1
HU,VISUAL IMPAIRMENT,1
HU,VOMITING,1
IS,JAUNDICE,3
IS,CARDIAC FIBRILLATION,1
IS,CHILLS,1
IS,CHROMATURIA,1
IS,CONSTIPATION,1
IS,DRUG-INDUCED LIVER INJURY,1
IS,FAECES DISCOLOURED,1
IS,HEPATITIS ACUTE,1
IS,HEPATOTOXICITY,1
IS,HYPERHIDROSIS,1
IS,INTENTIONAL PRODUCT MISUSE,1
IS,IRON DEFICIENCY ANAEMIA,1
IS,LARGE INTESTINAL STENOSIS,1
IS,LARGE INTESTINAL ULCER,1
IS,LIVER INJURY,1
IS,MYALGIA,1
IS,RENAL FAILURE,1
IN,MYOPATHY,5
IN,OPHTHALMOPLEGIA,5
IN,EYELID PTOSIS,4
IN,CORONARY ARTERY DISEASE,2
IN,HISTOPLASMOSIS,2
IN,LARYNGEAL ULCERATION,2
IN,AGGRESSION,1
IN,AGITATION,1
IN,CONTRAINDICATED PRODUCT ADMINISTERED,1
IN,FALL,1
IN,FAT INTOLERANCE,1
IN,FATIGUE,1
IN,GASTROINTESTINAL WALL THICKENING,1
IN,HEPATIC ENZYME INCREASED,1
IN,HYDROCELE,1
IN,INADEQUATE DIET,1
IN,MALAISE,1
IN,MATERNAL EXPOSURE DURING PREGNANCY,1
IN,NAUSEA,1
IN,NEOPLASM MALIGNANT,1
IN,PAIN,1
IN,PREMATURE DELIVERY,1
IN,PROCEDURAL HAEMORRHAGE,1
IN,URINARY TRACT INFECTION,1
ID,CHEST PAIN,2
ID,NAUSEA,2
ID,ACUTE MYOCARDIAL INFARCTION,1
ID,ANGIOEDEMA,1
ID,CARDIAC ARREST,1
ID,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
ID,COLD SWEAT,1
ID,DISEASE PROGRESSION,1
ID,INTENTIONAL DRUG MISUSE,1
ID,LOSS OF CONSCIOUSNESS,1
ID,PRODUCT USE ISSUE,1
ID,THROMBOSIS,1
ID,URINARY TRACT INFECTION,1
ID,VENTRICULAR TACHYCARDIA,1
IR,CEREBRAL HAEMANGIOMA,1
IR,CHEST PAIN,1
IR,CONDITION AGGRAVATED,1
IR,MYOCARDIAL INFARCTION,1
IQ,ANAEMIA,1
IQ,BLOOD UREA INCREASED,1
IQ,CARDIOVASCULAR DISORDER,1
IQ,HYPERGLYCAEMIA,1
IQ,RENAL DISORDER,1
IQ,YELLOW SKIN,1
IE,TOXICITY TO VARIOUS AGENTS,10
IE,DEATH,9
IE,DECREASED APPETITE,9
IE,NEUROMYOPATHY,8
IE,DIARRHOEA,6
IE,FALL,6
IE,LOWER RESPIRATORY TRACT INFECTION,6
IE,COUGH,5
IE,ACUTE KIDNEY INJURY,4
IE,DYSPNOEA,4
IE,ASTHMA,3
IE,DEHYDRATION,3
IE,FATIGUE,3
IE,HYPOTENSION,3
IE,MUSCULAR WEAKNESS,3
IE,NAUSEA,3
IE,TYPE 2 DIABETES MELLITUS,3
IE,ALANINE AMINOTRANSFERASE INCREASED,2
IE,ASTHENIA,2
IE,ATRIAL FIBRILLATION,2
IE,BLOOD CREATININE INCREASED,2
IE,C-REACTIVE PROTEIN INCREASED,2
IE,CONSTIPATION,2
IE,CORONARY ARTERY DISEASE,2
IE,DIVERTICULITIS,2
IE,DIZZINESS,2
IE,EXPOSURE DURING PREGNANCY,2
IE,EYELID PTOSIS,2
IE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IE,HAEMATURIA,2
IE,INSOMNIA,2
IE,LUNG DISORDER,2
IE,NEUTROPENIA,2
IE,ORAL PAIN,2
IE,OROPHARYNGEAL PAIN,2
IE,PAIN IN EXTREMITY,2
IE,PNEUMONIA,2
IE,PRODUCT USE ISSUE,2
IE,RENAL FAILURE ACUTE,2
IE,RHABDOMYOLYSIS,2
IE,RHINORRHOEA,2
IE,SKIN DISCOLOURATION,2
IE,STOMATITIS,2
IE,TACHYCARDIA,2
IE,TRANSIENT ISCHAEMIC ATTACK,2
IE,WHITE BLOOD CELL COUNT INCREASED,2
IE,ABDOMINAL DISTENSION,1
IE,ABDOMINAL PAIN UPPER,1
IE,ABDOMINAL TENDERNESS,1
IE,ABNORMAL CLOTTING FACTOR,1
IE,ABORTION SPONTANEOUS,1
IE,ACCIDENTAL OVERDOSE,1
IE,ACUTE MYOCARDIAL INFARCTION,1
IE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
IE,AGITATION,1
IE,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
IE,ANURIA,1
IE,ANXIETY,1
IE,ARTHRALGIA,1
IE,ARTHROPOD STING,1
IE,ASCITES,1
IE,ASPARTATE AMINOTRANSFERASE INCREASED,1
IE,AXONAL NEUROPATHY,1
IE,BACTERIAL SEPSIS,1
IE,BARRETT^S OESOPHAGUS,1
IE,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IE,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IE,BLOOD POTASSIUM INCREASED,1
IE,BLOOD UREA INCREASED,1
IE,BLOOD URIC ACID INCREASED,1
IE,BLOOD URINE PRESENT,1
IE,BODY MASS INDEX DECREASED,1
IE,BODY TEMPERATURE INCREASED,1
IE,BRONCHIECTASIS,1
IE,CARDIAC FAILURE,1
IE,CARDIAC FAILURE CHRONIC,1
IE,CELLULITIS,1
IE,CEREBRAL INFARCTION,1
IE,CEREBROVASCULAR ACCIDENT,1
IE,CHEST X-RAY ABNORMAL,1
IE,COLITIS,1
IE,COLORECTAL CANCER METASTATIC,1
IE,COMPLETED SUICIDE,1
IE,CONCOMITANT DISEASE PROGRESSION,1
IE,CONFUSIONAL STATE,1
IE,CYANOSIS CENTRAL,1
IE,CYTOPENIA,1
IE,DEPRESSION,1
IE,DISABILITY,1
IE,DISEASE PROGRESSION,1
IE,DISORIENTATION,1
IE,DRUG EFFECT DECREASED,1
IE,DYSPEPSIA,1
IE,EPILEPSY,1
IE,ERYTHEMA,1
IE,EYE PAIN,1
IE,EYE SWELLING,1
IE,FAECAL INCONTINENCE,1
IE,FLUID OVERLOAD,1
IE,FREQUENT BOWEL MOVEMENTS,1
IE,GAIT DISTURBANCE,1
IE,GASTROINTESTINAL CANDIDIASIS,1
IE,GLOSSODYNIA,1
IE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IE,GOUT,1
IE,HAEMOGLOBIN DECREASED,1
IE,HAEMOPTYSIS,1
IE,HAEMORRHAGE,1
IE,HAEMORRHAGE INTRACRANIAL,1
IE,HIP ARTHROPLASTY,1
IE,HYPERHIDROSIS,1
IE,HYPERSENSITIVITY VASCULITIS,1
IE,HYPOAESTHESIA,1
IE,INFLUENZA LIKE ILLNESS,1
IE,JOINT DISLOCATION,1
IE,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IE,LEFT VENTRICULAR HYPERTROPHY,1
IE,LETHARGY,1
IE,LIMB DISCOMFORT,1
IE,LYMPHOCYTE COUNT INCREASED,1
IE,MATERNAL EXPOSURE DURING DELIVERY,1
IE,MATERNAL EXPOSURE DURING PREGNANCY,1
IE,MEAN CELL HAEMOGLOBIN INCREASED,1
IE,MEAN CELL VOLUME INCREASED,1
IE,MEMORY IMPAIRMENT,1
IE,MICROCYTOSIS,1
IE,MITRAL VALVE INCOMPETENCE,1
IE,MULTIPLE SCLEROSIS RELAPSE,1
IE,MUSCULOSKELETAL STIFFNESS,1
IE,MYELODYSPLASTIC SYNDROME,1
IE,MYOCARDITIS,1
IE,MYOPATHY,1
IE,NECK PAIN,1
IE,NEUROPATHY PERIPHERAL,1
IE,NEUROSIS,1
IE,NEUTROPHIL COUNT DECREASED,1
IE,NEUTROPHIL COUNT INCREASED,1
IE,OCCUPATIONAL EXPOSURE TO PRODUCT,1
IE,OEDEMA PERIPHERAL,1
IE,ORAL DISCOMFORT,1
IE,ORTHOSTATIC HYPOTENSION,1
IE,PAIN,1
IE,PANCREATITIS NECROTISING,1
IE,PANCYTOPENIA,1
IE,PARKINSON^S DISEASE,1
IE,PELVIC FRACTURE,1
IE,PERICARDITIS,1
IE,PERIPHERAL SWELLING,1
IE,PLASMA CELL MYELOMA,1
IE,PLATELET COUNT DECREASED,1
IE,PLEURAL EFFUSION,1
IE,POLLAKIURIA,1
IE,PREMATURE DELIVERY,1
IE,PULMONARY OEDEMA,1
IE,RALES,1
IE,RASH,1
IE,RECTAL HAEMORRHAGE,1
IE,RESPIRATORY DISTRESS,1
IE,RESPIRATORY TRACT INFECTION,1
IE,RETROPERITONEAL HAEMORRHAGE,1
IE,RHEUMATOID ARTHRITIS,1
IE,RHEUMATOID NODULE,1
IE,SEIZURE,1
IE,SEPTIC SHOCK,1
IE,SERUM FERRITIN INCREASED,1
IE,SINUSITIS,1
IE,SKIN BURNING SENSATION,1
IE,SMALL INTESTINAL RESECTION,1
IE,SPINAL PAIN,1
IE,STAPHYLOCOCCAL INFECTION,1
IE,SYNCOPE,1
IE,SYNOVIAL CYST,1
IE,TACHYARRHYTHMIA,1
IE,THROMBOCYTOPENIA,1
IE,TONGUE DISCOMFORT,1
IE,TREATMENT NONCOMPLIANCE,1
IE,TREMOR,1
IE,TROPONIN INCREASED,1
IE,URTICARIA,1
IE,VENOUS THROMBOSIS,1
IE,VITAMIN B12 DECREASED,1
IE,VOMITING,1
IE,WEIGHT DECREASED,1
IL,ABDOMINAL PAIN,8
IL,ANGLE CLOSURE GLAUCOMA,8
IL,DYSPNOEA,8
IL,FALL,8
IL,PYREXIA,8
IL,VOMITING,8
IL,ASTHENIA,7
IL,DIARRHOEA,7
IL,HYPERTENSION,7
IL,PNEUMONIA,7
IL,NAUSEA,6
IL,HAEMORRHAGE INTRACRANIAL,5
IL,PNEUMONITIS,5
IL,PULMONARY EMBOLISM,5
IL,SEPSIS,5
IL,ATRIAL FIBRILLATION,4
IL,DEATH,4
IL,DECREASED APPETITE,4
IL,FATIGUE,4
IL,GENERAL PHYSICAL HEALTH DETERIORATION,4
IL,INFUSION RELATED REACTION,4
IL,OSTEONECROSIS OF JAW,4
IL,PULMONARY OEDEMA,4
IL,URINARY RETENTION,4
IL,ANAEMIA,3
IL,ASPARTATE AMINOTRANSFERASE INCREASED,3
IL,BACTERAEMIA,3
IL,BLOOD ALBUMIN DECREASED,3
IL,BLOOD ALKALINE PHOSPHATASE INCREASED,3
IL,BLOOD CREATININE INCREASED,3
IL,CONGENITAL HYPOTHYROIDISM,3
IL,DIZZINESS,3
IL,DYSPHAGIA,3
IL,FOETAL EXPOSURE DURING PREGNANCY,3
IL,GAIT DISTURBANCE,3
IL,HAEMOGLOBIN DECREASED,3
IL,HYPOAESTHESIA,3
IL,HYPOGLYCAEMIA,3
IL,ISCHAEMIC CEREBRAL INFARCTION,3
IL,MYALGIA,3
IL,PANCREATITIS,3
IL,RHABDOMYOLYSIS,3
IL,THROMBOTIC THROMBOCYTOPENIC PURPURA,3
IL,TOXICITY TO VARIOUS AGENTS,3
IL,WEIGHT DECREASED,3
IL,ABDOMINAL DISTENSION,2
IL,ACTIVITIES OF DAILY LIVING IMPAIRED,2
IL,ACUTE CORONARY SYNDROME,2
IL,ACUTE KIDNEY INJURY,2
IL,ACUTE MYOCARDIAL INFARCTION,2
IL,ACUTE RESPIRATORY FAILURE,2
IL,ALANINE AMINOTRANSFERASE INCREASED,2
IL,ARTHRALGIA,2
IL,BACK PAIN,2
IL,BLOOD PRESSURE DECREASED,2
IL,BLOOD THYROID STIMULATING HORMONE INCREASED,2
IL,BLOOD UREA INCREASED,2
IL,BREAST CANCER,2
IL,BURNING SENSATION,2
IL,CHEST PAIN,2
IL,CONFUSIONAL STATE,2
IL,CONTUSION,2
IL,COUGH,2
IL,DISEASE PROGRESSION,2
IL,DRUG INEFFECTIVE,2
IL,DRUG-INDUCED LIVER INJURY,2
IL,DYSGEUSIA,2
IL,DYSPHONIA,2
IL,EPISTAXIS,2
IL,FEBRILE NEUTROPENIA,2
IL,FOOD INTERACTION,2
IL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
IL,GASTRITIS,2
IL,GINGIVAL BLEEDING,2
IL,GLOMERULONEPHRITIS MINIMAL LESION,2
IL,HEART RATE DECREASED,2
IL,HEPATOTOXICITY,2
IL,HYPOTENSION,2
IL,IIIRD NERVE PARALYSIS,2
IL,INFECTION,2
IL,INTERNATIONAL NORMALISED RATIO INCREASED,2
IL,JAUNDICE,2
IL,LEFT VENTRICULAR DYSFUNCTION,2
IL,LIPASE INCREASED,2
IL,MALAISE,2
IL,MALIGNANT NEOPLASM PROGRESSION,2
IL,MELAENA,2
IL,MENINGIOMA,2
IL,MOBILITY DECREASED,2
IL,NEUTROPENIA,2
IL,PAIN,2
IL,PANCYTOPENIA,2
IL,PROSTATE CANCER,2
IL,PROTHROMBIN TIME PROLONGED,2
IL,RALES,2
IL,RENAL FAILURE,2
IL,SKIN EXFOLIATION,2
IL,SYNCOPE,2
IL,TACHYPNOEA,2
IL,TRANSIENT ISCHAEMIC ATTACK,2
IL,URINARY TRACT INFECTION,2
IL,VIRAL INFECTION,2
IL,WHITE BLOOD CELL COUNT INCREASED,2
IL,ABASIA,1
IL,ABDOMINAL OPERATION,1
IL,ABDOMINAL PAIN UPPER,1
IL,ABDOMINAL TENDERNESS,1
IL,ADDISON^S DISEASE,1
IL,ADENOCARCINOMA GASTRIC,1
IL,ADENOCARCINOMA OF COLON,1
IL,AMYLASE INCREASED,1
IL,AMYLOIDOSIS,1
IL,ANGINA PECTORIS,1
IL,ANGINA UNSTABLE,1
IL,ANKYLOSING SPONDYLITIS,1
IL,ANTINUCLEAR ANTIBODY POSITIVE,1
IL,APHASIA,1
IL,APHTHOUS STOMATITIS,1
IL,ARTERIOSPASM CORONARY,1
IL,ATAXIA,1
IL,ATELECTASIS,1
IL,ATRIAL FLUTTER,1
IL,BASAL CELL CARCINOMA,1
IL,BLINDNESS,1
IL,BLOOD BILIRUBIN INCREASED,1
IL,BLOOD GLUCOSE INCREASED,1
IL,BLOOD IRON DECREASED,1
IL,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IL,BLOOD PRESSURE ABNORMAL,1
IL,BLOOD SODIUM DECREASED,1
IL,BLOOD URINE PRESENT,1
IL,BONE PAIN,1
IL,BUNDLE BRANCH BLOCK RIGHT,1
IL,C-REACTIVE PROTEIN INCREASED,1
IL,CARDIAC ARREST,1
IL,CARDIAC FAILURE,1
IL,CARDIAC FAILURE CONGESTIVE,1
IL,CARDIAC FIBRILLATION,1
IL,CARDIAC OPERATION,1
IL,CARDIOVASCULAR EVALUATION,1
IL,CATARACT,1
IL,CEREBRAL HAEMORRHAGE,1
IL,CEREBROVASCULAR ACCIDENT,1
IL,CEREBROVASCULAR DISORDER,1
IL,CHOLECYSTITIS,1
IL,CHRONIC KIDNEY DISEASE,1
IL,CHRONIC MYELOID LEUKAEMIA,1
IL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IL,CLOSTRIDIUM DIFFICILE COLITIS,1
IL,COLITIS,1
IL,CONDITION AGGRAVATED,1
IL,CYSTITIS KLEBSIELLA,1
IL,DECUBITUS ULCER,1
IL,DEHYDRATION,1
IL,DERMATITIS,1
IL,DRUG LEVEL INCREASED,1
IL,DRY MOUTH,1
IL,DRY SKIN,1
IL,DYSPEPSIA,1
IL,ENCEPHALOPATHY,1
IL,ENDOMETRIAL CANCER METASTATIC,1
IL,EOSINOPHILIC FASCIITIS,1
IL,EPIDIDYMITIS,1
IL,ERYTHEMA,1
IL,ESSENTIAL HYPERTENSION,1
IL,EXPOSURE DURING PREGNANCY,1
IL,EYE IRRITATION,1
IL,EYE PRURITUS,1
IL,FACE OEDEMA,1
IL,FLATULENCE,1
IL,FLUID INTAKE REDUCED,1
IL,FUNGAL INFECTION,1
IL,GASTRECTOMY,1
IL,GASTROENTERITIS,1
IL,GASTROINTESTINAL ANGIODYSPLASIA,1
IL,GASTROINTESTINAL HAEMORRHAGE,1
IL,GENERALISED OEDEMA,1
IL,GENERALISED TONIC-CLONIC SEIZURE,1
IL,GINGIVAL PAIN,1
IL,GLOMERULONEPHRITIS MEMBRANOUS,1
IL,GRANULOMATOSIS WITH POLYANGIITIS,1
IL,GRIP STRENGTH DECREASED,1
IL,GUILLAIN-BARRE SYNDROME,1
IL,HAEMATOMA,1
IL,HAEMATURIA,1
IL,HAEMOGLOBIN ABNORMAL,1
IL,HAEMOPTYSIS,1
IL,HAEMORRHAGIC STROKE,1
IL,HAIR COLOUR CHANGES,1
IL,HAND FRACTURE,1
IL,HEADACHE,1
IL,HEART INJURY,1
IL,HEPATIC CONGESTION,1
IL,HEPATITIS TOXIC,1
IL,HERNIA,1
IL,HYPERBILIRUBINAEMIA,1
IL,HYPERKALAEMIA,1
IL,HYPERNATRAEMIA,1
IL,HYPERSENSITIVITY,1
IL,HYPERSENSITIVITY VASCULITIS,1
IL,HYPERSOMNIA,1
IL,HYPOKALAEMIA,1
IL,HYPOKINESIA,1
IL,HYPONATRAEMIA,1
IL,HYPOPHYSITIS,1
IL,HYPOTHYROIDISM,1
IL,IMMEDIATE POST-INJECTION REACTION,1
IL,IMMUNE THROMBOCYTOPENIC PURPURA,1
IL,INTESTINAL OBSTRUCTION,1
IL,INVESTIGATION,1
IL,ISCHAEMIA,1
IL,KAPOSI^S SARCOMA,1
IL,LARGE INTESTINE POLYP,1
IL,LIVER ABSCESS,1
IL,LIVER FUNCTION TEST INCREASED,1
IL,LUNG INFECTION,1
IL,LUNG NEOPLASM MALIGNANT,1
IL,LYMPHADENECTOMY,1
IL,MASS,1
IL,METASTASES TO LIVER,1
IL,METASTATIC RENAL CELL CARCINOMA,1
IL,MUCOSAL INFLAMMATION,1
IL,MULTIPLE SCLEROSIS RELAPSE,1
IL,MUSCULOSKELETAL CHEST PAIN,1
IL,MUSCULOSKELETAL PAIN,1
IL,MYELOPATHY,1
IL,MYOCARDIAL INFARCTION,1
IL,MYOCARDIAL ISCHAEMIA,1
IL,NASOPHARYNGITIS,1
IL,NEUROLOGICAL SYMPTOM,1
IL,NEUTROPENIC SEPSIS,1
IL,NEUTROPHIL COUNT ABNORMAL,1
IL,NUMB CHIN SYNDROME,1
IL,OCULAR HYPERAEMIA,1
IL,OEDEMA,1
IL,OEDEMA PERIPHERAL,1
IL,OESOPHAGEAL PERFORATION,1
IL,ON AND OFF PHENOMENON,1
IL,ORAL DISCOMFORT,1
IL,ORAL PAIN,1
IL,OSTEOPOROSIS,1
IL,OXYGEN SATURATION DECREASED,1
IL,PAIN IN EXTREMITY,1
IL,PAIN OF SKIN,1
IL,PANCREATIC CARCINOMA,1
IL,PANCREATITIS ACUTE,1
IL,PARAESTHESIA,1
IL,PHLEBITIS,1
IL,PLASMA CELL MYELOMA,1
IL,PLATELET COUNT ABNORMAL,1
IL,PLATELET COUNT DECREASED,1
IL,PLEURAL EFFUSION,1
IL,PNEUMONIA ASPIRATION,1
IL,POLYMERASE CHAIN REACTION,1
IL,POLYNEUROPATHY,1
IL,PSEUDOMONAL SEPSIS,1
IL,PSORIATIC ARTHROPATHY,1
IL,PSYCHOTIC DISORDER,1
IL,PULMONARY CONGESTION,1
IL,PULMONARY HYPERTENSION,1
IL,PULMONARY MASS,1
IL,RASH,1
IL,RASH GENERALISED,1
IL,RASH MACULAR,1
IL,RENAL CELL CARCINOMA,1
IL,RENAL FAILURE ACUTE,1
IL,RENAL IMPAIRMENT,1
IL,RESPIRATORY DISORDER,1
IL,RESPIRATORY TRACT CONGESTION,1
IL,RETINAL DETACHMENT,1
IL,RIGHT VENTRICULAR FAILURE,1
IL,ROTATOR CUFF SYNDROME,1
IL,SEPTIC SHOCK,1
IL,SEXUAL DYSFUNCTION,1
IL,SINUS BRADYCARDIA,1
IL,SKELETAL INJURY,1
IL,SKIN ABRASION,1
IL,SKIN DISCOLOURATION,1
IL,SKIN HYPERTROPHY,1
IL,SKIN ULCER,1
IL,SMALL INTESTINAL OBSTRUCTION,1
IL,SMALL INTESTINAL PERFORATION,1
IL,SPEECH DISORDER,1
IL,SPINAL COMPRESSION FRACTURE,1
IL,SPINAL OPERATION,1
IL,SPINAL OSTEOARTHRITIS,1
IL,SQUAMOUS CELL CARCINOMA OF SKIN,1
IL,STENT PLACEMENT,1
IL,STOMATITIS,1
IL,SUBARACHNOID HAEMORRHAGE,1
IL,SUBDURAL HAEMATOMA,1
IL,SWELLING FACE,1
IL,TACHYCARDIA,1
IL,THORACIC VERTEBRAL FRACTURE,1
IL,THROMBOCYTOPENIA,1
IL,TOXIC ENCEPHALOPATHY,1
IL,TRANSIENT ACANTHOLYTIC DERMATOSIS,1
IL,TRIGEMINAL NERVE DISORDER,1
IL,TRIGEMINAL NEURALGIA,1
IL,TUBULOINTERSTITIAL NEPHRITIS,1
IL,TUMOUR EXCISION,1
IL,URINARY INCONTINENCE,1
IL,URTICARIA,1
IL,VENTRICULAR TACHYCARDIA,1
IL,VERTIGO,1
IL,VISION BLURRED,1
IL,VISUAL IMPAIRMENT,1
IL,VITAMIN D DEFICIENCY,1
IL,VITREOUS HAEMORRHAGE,1
IL,WHITE BLOOD CELL COUNT ABNORMAL,1
IL,WOUND,1
IL,WOUND COMPLICATION,1
IT,HYPOGLYCAEMIA,110
IT,SOPOR,84
IT,SYNCOPE,77
IT,ASTHENIA,75
IT,ANAEMIA,63
IT,CONFUSIONAL STATE,62
IT,VOMITING,56
IT,HYPOTENSION,55
IT,RHABDOMYOLYSIS,53
IT,METABOLIC ACIDOSIS,52
IT,VERTIGO,51
IT,DRUG ABUSE,46
IT,ACUTE KIDNEY INJURY,43
IT,HYPONATRAEMIA,42
IT,HEADACHE,35
IT,PRESYNCOPE,34
IT,MYOPATHY,33
IT,DIARRHOEA,32
IT,LOSS OF CONSCIOUSNESS,32
IT,MALAISE,32
IT,PYREXIA,32
IT,DYSPNOEA,30
IT,FALL,30
IT,HYPERKALAEMIA,30
IT,ABDOMINAL PAIN,29
IT,MYALGIA,28
IT,HEAD INJURY,26
IT,DISORIENTATION,25
IT,RASH,25
IT,PAIN,24
IT,BRADYCARDIA,23
IT,ERYTHEMA,23
IT,HYPERHIDROSIS,23
IT,HYPERTENSIVE CRISIS,23
IT,VISION BLURRED,23
IT,CEREBRAL HAEMORRHAGE,21
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,21
IT,RENAL FAILURE ACUTE,21
IT,INTENTIONAL SELF-INJURY,20
IT,INTERNATIONAL NORMALISED RATIO INCREASED,20
IT,MELAENA,20
IT,NAUSEA,20
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,19
IT,EPISTAXIS,19
IT,ABDOMINAL PAIN UPPER,18
IT,HYPERSENSITIVITY,18
IT,OVERDOSE,18
IT,AGITATION,17
IT,BLOOD CREATININE INCREASED,17
IT,COMA,17
IT,MUSCULAR WEAKNESS,17
IT,PRURITUS,17
IT,TREMOR,17
IT,HYPERTRANSAMINASAEMIA,16
IT,RECTAL HAEMORRHAGE,16
IT,TOXICITY TO VARIOUS AGENTS,16
IT,DIZZINESS,15
IT,POISONING,15
IT,SKIN EXFOLIATION,15
IT,DIABETIC METABOLIC DECOMPENSATION,14
IT,HAEMATEMESIS,14
IT,HAEMATURIA,14
IT,MUSCLE SPASMS,14
IT,THROMBOCYTOPENIA,14
IT,BRADYPHRENIA,13
IT,COLD SWEAT,13
IT,DEHYDRATION,13
IT,HERPES ZOSTER,13
IT,MYOCARDIAL INFARCTION,13
IT,ARTHRALGIA,12
IT,PURPURA,12
IT,RENAL FAILURE,12
IT,RESPIRATORY FAILURE,12
IT,LIVER INJURY,11
IT,MEDICATION ERROR,11
IT,SEDATION,11
IT,ALANINE AMINOTRANSFERASE INCREASED,10
IT,ANGIOEDEMA,10
IT,DRUG INEFFECTIVE,10
IT,ELECTROLYTE IMBALANCE,10
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
IT,GASTROINTESTINAL HAEMORRHAGE,10
IT,HYPERGLYCAEMIA,10
IT,HYPOGLYCAEMIC COMA,10
IT,ISCHAEMIC STROKE,10
IT,PAIN IN EXTREMITY,10
IT,PROTEINURIA,10
IT,SINUS BRADYCARDIA,10
IT,SOMNOLENCE,10
IT,TRANSAMINASES INCREASED,10
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,9
IT,CAROTID ARTERIOSCLEROSIS,9
IT,CHEST PAIN,9
IT,CHOLECYSTITIS ACUTE,9
IT,DISEASE PROGRESSION,9
IT,EYE SWELLING,9
IT,HALLUCINATION,9
IT,HEPATOCELLULAR INJURY,9
IT,HYPERCHOLESTEROLAEMIA,9
IT,RENAL IMPAIRMENT,9
IT,SEPSIS,9
IT,SEROTONIN SYNDROME,9
IT,THROAT TIGHTNESS,9
IT,TOXIC SKIN ERUPTION,9
IT,ACCIDENTAL EXPOSURE TO PRODUCT,8
IT,APHASIA,8
IT,ASPARTATE AMINOTRANSFERASE INCREASED,8
IT,BALANCE DISORDER,8
IT,BLOOD PRESSURE INCREASED,8
IT,BRONCHOSPASM,8
IT,CARDIAC FAILURE,8
IT,CONDUCTION DISORDER,8
IT,DRUG-INDUCED LIVER INJURY,8
IT,DYSARTHRIA,8
IT,DYSKINESIA,8
IT,FEMUR FRACTURE,8
IT,HYPOKALAEMIA,8
IT,LACTIC ACIDOSIS,8
IT,MUSCLE RIGIDITY,8
IT,NEUTROPENIA,8
IT,NORMOCHROMIC NORMOCYTIC ANAEMIA,8
IT,PARAESTHESIA,8
IT,PERITONEAL HAEMORRHAGE,8
IT,URTICARIA,8
IT,CHOLESTASIS,7
IT,DRUG EFFECT INCOMPLETE,7
IT,ELECTROCARDIOGRAM QT PROLONGED,7
IT,GASTRIC ULCER,7
IT,GENERAL PHYSICAL HEALTH DETERIORATION,7
IT,HEPATITIS ACUTE,7
IT,HYPERLACTACIDAEMIA,7
IT,HYPERPYREXIA,7
IT,OEDEMA,7
IT,OESOPHAGEAL ULCER,7
IT,PANCREATITIS ACUTE,7
IT,POSTPRANDIAL HYPOGLYCAEMIA,7
IT,PSYCHOMOTOR RETARDATION,7
IT,RESPIRATORY FATIGUE,7
IT,SPONTANEOUS HAEMATOMA,7
IT,SUBARACHNOID HAEMORRHAGE,7
IT,SUBDURAL HAEMATOMA,7
IT,SUICIDE ATTEMPT,7
IT,TENDON RUPTURE,7
IT,TONGUE OEDEMA,7
IT,TUBULOINTERSTITIAL NEPHRITIS,7
IT,AMNESIA,6
IT,BLOOD SODIUM DECREASED,6
IT,CEREBRAL SALT-WASTING SYNDROME,6
IT,CLOSTRIDIUM DIFFICILE COLITIS,6
IT,CONJUNCTIVAL HAEMORRHAGE,6
IT,DECREASED APPETITE,6
IT,EPILEPSY,6
IT,GASTRITIS,6
IT,HEPATIC FAILURE,6
IT,HYPERTENSION,6
IT,HYPOVOLAEMIC SHOCK,6
IT,METABOLIC DISORDER,6
IT,METASTATIC MALIGNANT MELANOMA,6
IT,OSTEONECROSIS OF JAW,6
IT,PLEURAL EFFUSION,6
IT,PNEUMONIA,6
IT,ACCIDENTAL OVERDOSE,5
IT,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,5
IT,ACUTE RESPIRATORY FAILURE,5
IT,ALTERED STATE OF CONSCIOUSNESS,5
IT,ANAL INCONTINENCE,5
IT,ATRIAL FIBRILLATION,5
IT,CARDIOGENIC SHOCK,5
IT,CEREBROVASCULAR ACCIDENT,5
IT,COLITIS ISCHAEMIC,5
IT,CRANIOCEREBRAL INJURY,5
IT,DEEP VEIN THROMBOSIS,5
IT,EOSINOPENIA,5
IT,GASTRIC HAEMORRHAGE,5
IT,HAEMORRHAGE,5
IT,HYPERNATRAEMIA,5
IT,INSOMNIA,5
IT,LEUKOPENIA,5
IT,LYMPHADENOPATHY MEDIASTINAL,5
IT,MUCOSAL NECROSIS,5
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,5
IT,NODAL ARRHYTHMIA,5
IT,OEDEMA PERIPHERAL,5
IT,PROSTATE CANCER,5
IT,PULMONARY EMBOLISM,5
IT,SALIVARY HYPERSECRETION,5
IT,TACHYCARDIA,5
IT,TRANSIENT ISCHAEMIC ATTACK,5
IT,WEIGHT DECREASED,5
IT,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,4
IT,ACUTE MYOCARDIAL INFARCTION,4
IT,ANXIETY,4
IT,BLOOD GLUCOSE INCREASED,4
IT,BLOOD POTASSIUM INCREASED,4
IT,CONSTIPATION,4
IT,CYSTITIS HAEMORRHAGIC,4
IT,DRUG INTOLERANCE,4
IT,DYSPEPSIA,4
IT,DYSSTASIA,4
IT,ECCHYMOSIS,4
IT,ESCHERICHIA URINARY TRACT INFECTION,4
IT,FACE OEDEMA,4
IT,FATIGUE,4
IT,GAIT DISTURBANCE,4
IT,HAEMATOCHEZIA,4
IT,HEMIPLEGIA,4
IT,HEPATIC FUNCTION ABNORMAL,4
IT,HEPATOTOXICITY,4
IT,HYPERTHYROIDISM,4
IT,HYPOMAGNESAEMIA,4
IT,INJURY,4
IT,INTENTIONAL OVERDOSE,4
IT,LETHARGY,4
IT,LIP OEDEMA,4
IT,MYASTHENIA GRAVIS,4
IT,ORTHOSTATIC HYPOTENSION,4
IT,PANCREATITIS NECROTISING,4
IT,PRODUCT USE ISSUE,4
IT,RASH ERYTHEMATOUS,4
IT,SPEECH DISORDER,4
IT,VASOPLEGIA SYNDROME,4
IT,ACTINIC KERATOSIS,3
IT,ADVERSE DRUG REACTION,3
IT,ARRHYTHMIA,3
IT,BACK PAIN,3
IT,BLOOD PRESSURE DECREASED,3
IT,BLOOD UREA INCREASED,3
IT,CARDIO-RESPIRATORY ARREST,3
IT,DERMATOMYOSITIS,3
IT,DRUG PRESCRIBING ERROR,3
IT,DRUG USE DISORDER,3
IT,DYSPHAGIA,3
IT,DYSPHONIA,3
IT,ENTERITIS,3
IT,ERYTHEMA MULTIFORME,3
IT,HAEMOGLOBIN DECREASED,3
IT,HAEMOPTYSIS,3
IT,HEMIPARESIS,3
IT,HOT FLUSH,3
IT,HYPERALDOSTERONISM,3
IT,HYPOCALCAEMIA,3
IT,HYPOCOAGULABLE STATE,3
IT,INCORRECT DOSE ADMINISTERED,3
IT,INTENTIONAL PRODUCT MISUSE,3
IT,LIPASE INCREASED,3
IT,MOVEMENT DISORDER,3
IT,MUCOSAL INFLAMMATION,3
IT,MULTI-ORGAN FAILURE,3
IT,MUSCULOSKELETAL PAIN,3
IT,MYOSITIS,3
IT,OSTEOPENIA,3
IT,PANCREATITIS,3
IT,PANCYTOPENIA,3
IT,PERIORBITAL HAEMATOMA,3
IT,PERIPHERAL ISCHAEMIA,3
IT,PLATELET COUNT DECREASED,3
IT,PROCEDURAL DIZZINESS,3
IT,PRURITUS GENERALISED,3
IT,PSYCHOMOTOR SKILLS IMPAIRED,3
IT,RENAL FAILURE CHRONIC,3
IT,SKIN REACTION,3
IT,STEVENS-JOHNSON SYNDROME,3
IT,STRANGURY,3
IT,SUBCUTANEOUS HAEMATOMA,3
IT,SUBDURAL HAEMORRHAGE,3
IT,TACHYARRHYTHMIA,3
IT,UNDERDOSE,3
IT,VISUAL IMPAIRMENT,3
IT,ADENOCARCINOMA,2
IT,AMYLASE INCREASED,2
IT,ANGINA PECTORIS,2
IT,APPENDICITIS,2
IT,APPENDIX DISORDER,2
IT,APRAXIA,2
IT,ATAXIA,2
IT,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
IT,BACTERIAL SEPSIS,2
IT,BASAL CELL CARCINOMA,2
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,2
IT,BLOOD CREATINE INCREASED,2
IT,BLOOD CREATINE PHOSPHOKINASE MB INCREASED,2
IT,BLOOD MAGNESIUM DECREASED,2
IT,BRADYARRHYTHMIA,2
IT,BRADYKINESIA,2
IT,BRONCHITIS,2
IT,BUNDLE BRANCH BLOCK RIGHT,2
IT,CARDIAC ARREST,2
IT,CARDIAC DISORDER,2
IT,COGNITIVE DISORDER,2
IT,CONTUSION,2
IT,COUGH,2
IT,DEATH,2
IT,DELIRIUM,2
IT,DEPRESSED MOOD,2
IT,DEPRESSION,2
IT,DERMATITIS EXFOLIATIVE,2
IT,DIABETES MELLITUS,2
IT,DIPLOPIA,2
IT,DIVERTICULITIS,2
IT,DRUG HYPERSENSITIVITY,2
IT,DUODENAL ULCER,2
IT,DUODENAL ULCER HAEMORRHAGE,2
IT,DUODENITIS HAEMORRHAGIC,2
IT,DYSENTERY,2
IT,DYSPNOEA EXERTIONAL,2
IT,ENTEROCOCCAL INFECTION,2
IT,EOSINOPHIL COUNT ABNORMAL,2
IT,EXPOSED BONE IN JAW,2
IT,EXTRAPYRAMIDAL DISORDER,2
IT,EYE OEDEMA,2
IT,FASTING,2
IT,FEBRILE NEUTROPENIA,2
IT,FEELING ABNORMAL,2
IT,FEELING HOT,2
IT,FOLLICULITIS,2
IT,GASTRITIS EROSIVE,2
IT,GASTROINTESTINAL DISORDER,2
IT,GASTROINTESTINAL POLYP HAEMORRHAGE,2
IT,GENERALISED ERYTHEMA,2
IT,GINGIVAL PAIN,2
IT,GLOSSODYNIA,2
IT,HAEMATOMA,2
IT,HAEMOLYTIC URAEMIC SYNDROME,2
IT,HEART RATE DECREASED,2
IT,HEPATIC LESION,2
IT,HYPERAMYLASAEMIA,2
IT,HYPERBILIRUBINAEMIA,2
IT,HYPERCALCAEMIA,2
IT,HYPERCAPNIA,2
IT,HYPERCHLORAEMIA,2
IT,HYPERLIPASAEMIA,2
IT,HYPOAESTHESIA,2
IT,HYPOCHROMIC ANAEMIA,2
IT,INFLAMMATION,2
IT,INFLUENZA,2
IT,INTERNATIONAL NORMALISED RATIO ABNORMAL,2
IT,INTERSTITIAL LUNG DISEASE,2
IT,JAUNDICE,2
IT,LANGUAGE DISORDER,2
IT,LIVER DISORDER,2
IT,LYMPHADENOPATHY,2
IT,LYMPHOCYTE COUNT DECREASED,2
IT,LYMPHOPENIA,2
IT,MACROGLOSSIA,2
IT,MALIGNANT NEOPLASM PROGRESSION,2
IT,MIGRAINE,2
IT,MITRAL VALVE INCOMPETENCE,2
IT,MIXED LIVER INJURY,2
IT,MOBILITY DECREASED,2
IT,MUSCLE HAEMORRHAGE,2
IT,MUSCLE INJURY,2
IT,MUSCULOSKELETAL STIFFNESS,2
IT,MYOCARDIAL ISCHAEMIA,2
IT,MYOGLOBIN BLOOD INCREASED,2
IT,NEOPLASM,2
IT,NEPHROGENIC DIABETES INSIPIDUS,2
IT,NEPHROTIC SYNDROME,2
IT,NODAL RHYTHM,2
IT,OCCULT BLOOD,2
IT,OCCULT BLOOD POSITIVE,2
IT,OEDEMA MOUTH,2
IT,ORAL CANDIDIASIS,2
IT,OROPHARYNGEAL PAIN,2
IT,OSTEOMYELITIS ACUTE,2
IT,PACKED RED BLOOD CELL TRANSFUSION,2
IT,PALPITATIONS,2
IT,PNEUMONITIS,2
IT,POISONING DELIBERATE,2
IT,POLYNEUROPATHY,2
IT,PRODUCT MEASURED POTENCY ISSUE,2
IT,PRODUCT SUBSTITUTION ISSUE,2
IT,PSEUDOMONAS BRONCHITIS,2
IT,PSYCHOMOTOR HYPERACTIVITY,2
IT,PULMONARY HYPERTENSION,2
IT,RASH GENERALISED,2
IT,REACTION TO DRUG EXCIPIENTS,2
IT,RENAL CANCER,2
IT,RESPIRATORY ARREST,2
IT,SHOCK HAEMORRHAGIC,2
IT,SKIN LESION,2
IT,SKIN TOXICITY,2
IT,SUDDEN DEATH,2
IT,THROMBOPHLEBITIS SUPERFICIAL,2
IT,TINNITUS,2
IT,TRANSFUSION,2
IT,UNRESPONSIVE TO STIMULI,2
IT,URINARY TRACT INFECTION,2
IT,WHITE BLOOD CELL COUNT DECREASED,2
IT,WHITE BLOOD CELL COUNT INCREASED,2
IT,WOUND,2
IT,WRONG DRUG ADMINISTERED,2
IT,ABDOMINAL DISCOMFORT,1
IT,ABDOMINAL DISTENSION,1
IT,ABDOMINAL TENDERNESS,1
IT,ABDOMINAL WALL HAEMATOMA,1
IT,ACCIDENT,1
IT,ACIDOSIS,1
IT,ACTIVITIES OF DAILY LIVING IMPAIRED,1
IT,ACUTE CORONARY SYNDROME,1
IT,ACUTE LYMPHOCYTIC LEUKAEMIA,1
IT,ADENOCARCINOMA OF COLON,1
IT,ADENOCARCINOMA PANCREAS,1
IT,ALOPECIA,1
IT,ALPHA GLOBULIN INCREASED,1
IT,ANAEMIA MACROCYTIC,1
IT,ANGINA UNSTABLE,1
IT,ANION GAP INCREASED,1
IT,ANOXIA,1
IT,ANTIPHOSPHOLIPID SYNDROME,1
IT,ANURIA,1
IT,AORTIC ANEURYSM,1
IT,AORTIC DILATATION,1
IT,ARTERIAL DISORDER,1
IT,ATRIAL FLUTTER,1
IT,ATRIOVENTRICULAR BLOCK COMPLETE,1
IT,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
IT,AZOTAEMIA,1
IT,BALANOPOSTHITIS,1
IT,BIPOLAR DISORDER,1
IT,BLADDER NEOPLASM,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLISTER,1
IT,BLOOD BILIRUBIN INCREASED,1
IT,BLOOD CHOLINESTERASE DECREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
IT,BLOOD LACTIC ACID INCREASED,1
IT,BLOOD PARATHYROID HORMONE INCREASED,1
IT,BLOOD PH DECREASED,1
IT,BLOOD POTASSIUM DECREASED,1
IT,BLOOD THYROID STIMULATING HORMONE INCREASED,1
IT,BONE FISTULA,1
IT,BRAIN OEDEMA,1
IT,BREAST PAIN,1
IT,BRONCHOPNEUMONIA,1
IT,BRONCHOSTENOSIS,1
IT,CALCULUS URETERIC,1
IT,CARDIAC FAILURE CONGESTIVE,1
IT,CARDIAC OUTPUT DECREASED,1
IT,CATARACT,1
IT,CEREBELLAR STROKE,1
IT,CEREBRAL HAEMATOMA,1
IT,CEREBRAL INFARCTION,1
IT,CEREBRAL ISCHAEMIA,1
IT,CEREBRAL THROMBOSIS,1
IT,CHEST DISCOMFORT,1
IT,CHILLS,1
IT,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
IT,CIRCADIAN RHYTHM SLEEP DISORDER,1
IT,CIRCULATORY COLLAPSE,1
IT,CLEAR CELL RENAL CELL CARCINOMA,1
IT,CLOSTRIDIUM TEST POSITIVE,1
IT,COAGULATION TIME PROLONGED,1
IT,COLOUR BLINDNESS ACQUIRED,1
IT,CONCOMITANT DISEASE PROGRESSION,1
IT,CONDITION AGGRAVATED,1
IT,COORDINATION ABNORMAL,1
IT,CORONARY ARTERY DISSECTION,1
IT,CORONARY REVASCULARISATION,1
IT,CORROSIVE OROPHARYNGEAL INJURY,1
IT,CYSTITIS,1
IT,DELUSION,1
IT,DEMENTIA,1
IT,DERMATITIS BULLOUS,1
IT,DIABETES MELLITUS INADEQUATE CONTROL,1
IT,DIABETIC HYPEROSMOLAR COMA,1
IT,DIABETIC NEUROPATHY,1
IT,DIFFUSE ALOPECIA,1
IT,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
IT,DROOLING,1
IT,DROP ATTACKS,1
IT,DRUG ERUPTION,1
IT,DRUG LEVEL ABOVE THERAPEUTIC,1
IT,DRUG LEVEL INCREASED,1
IT,DYSGEUSIA,1
IT,DYSLIPIDAEMIA,1
IT,DYSSOMNIA,1
IT,EFFUSION,1
IT,ELECTROCARDIOGRAM T WAVE ABNORMAL,1
IT,EMBOLIC STROKE,1
IT,EMBOLISM VENOUS,1
IT,ENTEROCOCCAL SEPSIS,1
IT,ENZYME LEVEL INCREASED,1
IT,EPICONDYLITIS,1
IT,ERECTILE DYSFUNCTION,1
IT,EROSIVE OESOPHAGITIS,1
IT,ERYTHEMA INFECTIOSUM,1
IT,EUGLYCAEMIC DIABETIC KETOACIDOSIS,1
IT,EXTRADURAL HAEMATOMA,1
IT,EYELID HAEMATOMA,1
IT,EYELID PTOSIS,1
IT,FACIAL BONES FRACTURE,1
IT,FAECES DISCOLOURED,1
IT,FEELING JITTERY,1
IT,FINE MOTOR DELAY,1
IT,FLATULENCE,1
IT,FLUSHING,1
IT,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
IT,FOOT FRACTURE,1
IT,FRACTURE,1
IT,FUNGAL INFECTION,1
IT,GALLBLADDER ABSCESS,1
IT,GASTRIC DISORDER,1
IT,GASTRIC POLYPS,1
IT,GASTRODUODENAL HAEMORRHAGE,1
IT,GASTROINTESTINAL TRACT ADENOMA,1
IT,GLOMERULAR FILTRATION RATE DECREASED,1
IT,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
IT,GRANULOMA,1
IT,GRAVITATIONAL OEDEMA,1
IT,GYNAECOMASTIA,1
IT,HAEMANGIOMA OF BONE,1
IT,HAEMARTHROSIS,1
IT,HAEMATOCRIT DECREASED,1
IT,HAEMATOTOXICITY,1
IT,HAEMODYNAMIC INSTABILITY,1
IT,HAEMORRHAGIC ANAEMIA,1
IT,HAEMORRHOIDS,1
IT,HEART DISEASE CONGENITAL,1
IT,HEART VALVE INCOMPETENCE,1
IT,HEPATIC ENZYME ABNORMAL,1
IT,HEPATIC ENZYME INCREASED,1
IT,HEPATIC STEATOSIS,1
IT,HEPATITIS B,1
IT,HEPATITIS C,1
IT,HEPATITIS TOXIC,1
IT,HEPATOCELLULAR CARCINOMA,1
IT,HIATUS HERNIA,1
IT,HYPERCREATINAEMIA,1
IT,HYPERGLYCAEMIC UNCONSCIOUSNESS,1
IT,HYPERPARATHYROIDISM,1
IT,HYPERREFLEXIA,1
IT,HYPERSENSITIVITY VASCULITIS,1
IT,HYPERTRIGLYCERIDAEMIA,1
IT,HYPERTROPHIC CARDIOMYOPATHY,1
IT,HYPERURICAEMIA,1
IT,HYPOCALCAEMIC SEIZURE,1
IT,HYPOCAPNIA,1
IT,HYPOGLYCAEMIC SEIZURE,1
IT,HYPOGLYCAEMIC UNCONSCIOUSNESS,1
IT,HYPOREFLEXIA,1
IT,HYPOSIDERAEMIA,1
IT,HYPOTHERMIA,1
IT,HYPOTHYROIDISM,1
IT,HYPOXIA,1
IT,IDIOPATHIC PULMONARY FIBROSIS,1
IT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IT,INCORRECT DOSE ADMINISTERED BY DEVICE,1
IT,INFUSION RELATED REACTION,1
IT,INGUINAL HERNIA,1
IT,INJECTION SITE REACTION,1
IT,INTERSTITIAL GRANULOMATOUS DERMATITIS,1
IT,INTRACARDIAC THROMBUS,1
IT,IRON DEFICIENCY ANAEMIA,1
IT,IRRITABILITY,1
IT,ISCHAEMIC CARDIOMYOPATHY,1
IT,JOINT CONTRACTURE,1
IT,KERATOPATHY,1
IT,KETOACIDOSIS,1
IT,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
IT,LARYNGEAL CANCER,1
IT,LARYNGEAL OEDEMA,1
IT,LEUKOCYTOSIS,1
IT,LIPODYSTROPHY ACQUIRED,1
IT,LIVER ABSCESS,1
IT,LIVER FUNCTION TEST ABNORMAL,1
IT,LONG QT SYNDROME,1
IT,LUNG DISORDER,1
IT,LUNG INFECTION,1
IT,LYMPHOCYTOSIS,1
IT,LYMPHOEDEMA,1
IT,MEMORY IMPAIRMENT,1
IT,MENINGIOMA BENIGN,1
IT,MENINGITIS,1
IT,MENTAL IMPAIRMENT,1
IT,MENTAL RETARDATION,1
IT,MICROCYTIC ANAEMIA,1
IT,MITOCHONDRIAL TOXICITY,1
IT,MONOCYTOSIS,1
IT,MOTOR DYSFUNCTION,1
IT,MUCOSAL HAEMORRHAGE,1
IT,MULTIPLE SCLEROSIS,1
IT,MUSCULOSKELETAL CHEST PAIN,1
IT,MYDRIASIS,1
IT,MYELODYSPLASTIC SYNDROME,1
IT,MYOCARDIAL NECROSIS MARKER INCREASED,1
IT,MYOGLOBINURIA,1
IT,NECK PAIN,1
IT,NEPHRITIS,1
IT,NEUROPATHY PERIPHERAL,1
IT,NEUROTOXICITY,1
IT,NEUTROPHIL COUNT INCREASED,1
IT,NO ADVERSE EVENT,1
IT,NYSTAGMUS,1
IT,OBSTRUCTIVE AIRWAYS DISORDER,1
IT,OBSTRUCTIVE UROPATHY,1
IT,OCULAR HYPERAEMIA,1
IT,OESOPHAGEAL CANDIDIASIS,1
IT,ORAL MUCOSA EROSION,1
IT,OSTEOARTHRITIS,1
IT,OXYGEN SATURATION ABNORMAL,1
IT,OXYGEN SATURATION DECREASED,1
IT,PANCREATIC CARCINOMA,1
IT,PANCREATIC INJURY,1
IT,PAPULE,1
IT,PELVIC FRACTURE,1
IT,PELVIC HAEMATOMA,1
IT,PELVIC VENOUS THROMBOSIS,1
IT,PEPTIC ULCER,1
IT,PERICARDIAL EFFUSION,1
IT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
IT,PERITONEAL HAEMATOMA,1
IT,PITUITARY TUMOUR BENIGN,1
IT,PLATELET COUNT ABNORMAL,1
IT,PROCALCITONIN INCREASED,1
IT,PROCTALGIA,1
IT,PRODUCT DROPPER ISSUE,1
IT,PROTEIN URINE PRESENT,1
IT,PROTHROMBIN LEVEL DECREASED,1
IT,PROTHROMBIN LEVEL INCREASED,1
IT,PROTHROMBIN TIME PROLONGED,1
IT,PSORIATIC ARTHROPATHY,1
IT,PULMONARY CONGESTION,1
IT,PULMONARY INFARCTION,1
IT,PULMONARY OEDEMA,1
IT,PULMONARY TOXICITY,1
IT,PUPILS UNEQUAL,1
IT,PYRAMIDAL TRACT SYNDROME,1
IT,RALES,1
IT,RASH MORBILLIFORM,1
IT,RASH PUSTULAR,1
IT,RASH SCARLATINIFORM,1
IT,RED BLOOD CELL ABNORMALITY,1
IT,RED BLOOD CELL ANALYSIS ABNORMAL,1
IT,RED BLOOD CELL COUNT DECREASED,1
IT,RENAL CYST,1
IT,RENAL PAIN,1
IT,RENIN DECREASED,1
IT,RESPIRATORY ACIDOSIS,1
IT,RESPIRATORY DISORDER,1
IT,RESPIRATORY DISTRESS,1
IT,RETCHING,1
IT,RETINAL VASCULAR THROMBOSIS,1
IT,RETINAL VEIN OCCLUSION,1
IT,RETROGRADE AMNESIA,1
IT,ROAD TRAFFIC ACCIDENT,1
IT,SCAB,1
IT,SCROTAL OEDEMA,1
IT,SELF INJURIOUS BEHAVIOUR,1
IT,SEPTIC SHOCK,1
IT,SINUS TACHYCARDIA,1
IT,SKIN BURNING SENSATION,1
IT,SKIN EROSION,1
IT,SKIN HYPERPIGMENTATION,1
IT,SLOW RESPONSE TO STIMULI,1
IT,SOMNAMBULISM,1
IT,SPINAL PAIN,1
IT,SQUAMOUS CELL CARCINOMA OF LUNG,1
IT,SQUAMOUS CELL CARCINOMA OF SKIN,1
IT,STOMATITIS,1
IT,SUBILEUS,1
IT,SUPRAVENTRICULAR TACHYCARDIA,1
IT,SWOLLEN TONGUE,1
IT,TACHYPNOEA,1
IT,TETANY,1
IT,THROAT IRRITATION,1
IT,THROMBOCYTOSIS,1
IT,THYROID MASS,1
IT,TOXIC EPIDERMAL NECROLYSIS,1
IT,TRANSIENT GLOBAL AMNESIA,1
IT,TREATMENT FAILURE,1
IT,TRICUSPID VALVE INCOMPETENCE,1
IT,TROPONIN I INCREASED,1
IT,TROPONIN INCREASED,1
IT,TROPONIN T INCREASED,1
IT,TROUSSEAU^S SIGN,1
IT,TUBERCULOSIS,1
IT,ULCER,1
IT,URETHRITIS,1
IT,URINARY RETENTION,1
IT,URINE ANALYSIS ABNORMAL,1
IT,URINE CALCIUM DECREASED,1
IT,URINE SODIUM INCREASED,1
IT,VASCULITIS,1
IT,VASODILATATION,1
IT,VENOUS INSUFFICIENCY,1
IT,VENTRICULAR EXTRASYSTOLES,1
IT,VENTRICULAR FIBRILLATION,1
IT,VENTRICULAR TACHYCARDIA,1
IT,VITAMIN D DECREASED,1
IT,WRIST FRACTURE,1
IT,XEROSIS,1
JM,DEATH,2
JP,ANAEMIA,7
JP,NAUSEA,7
JP,DIARRHOEA,6
JP,HEPATIC FUNCTION ABNORMAL,6
JP,INTERSTITIAL LUNG DISEASE,6
JP,LIVER DISORDER,6
JP,LOSS OF CONSCIOUSNESS,6
JP,ACUTE KIDNEY INJURY,5
JP,CEREBRAL INFARCTION,5
JP,DIZZINESS,5
JP,FALL,5
JP,HYPOTENSION,5
JP,RENAL IMPAIRMENT,5
JP,RHABDOMYOLYSIS,5
JP,SEPTIC SHOCK,5
JP,ASPARTATE AMINOTRANSFERASE INCREASED,4
JP,CARDIAC FAILURE,4
JP,CHOLELITHIASIS,4
JP,DIABETES MELLITUS,4
JP,MALAISE,4
JP,PANCYTOPENIA,4
JP,PNEUMONIA,4
JP,PYREXIA,4
JP,ALANINE AMINOTRANSFERASE INCREASED,3
JP,ALTERED STATE OF CONSCIOUSNESS,3
JP,DECREASED APPETITE,3
JP,ECZEMA,3
JP,GASTROINTESTINAL HAEMORRHAGE,3
JP,PLATELET COUNT DECREASED,3
JP,PULMONARY ALVEOLAR HAEMORRHAGE,3
JP,SUBDURAL HAEMATOMA,3
JP,ACUTE MYOCARDIAL INFARCTION,2
JP,ANGINA PECTORIS,2
JP,BILOMA,2
JP,BLOOD GLUCOSE INCREASED,2
JP,BLOOD PRESSURE INCREASED,2
JP,BONE MARROW FAILURE,2
JP,C-REACTIVE PROTEIN INCREASED,2
JP,CHROMATURIA,2
JP,COLITIS MICROSCOPIC,2
JP,CONTUSION,2
JP,CYTOMEGALOVIRUS INFECTION,2
JP,DRUG-INDUCED LIVER INJURY,2
JP,DUODENAL PERFORATION,2
JP,DYSPHAGIA,2
JP,DYSURIA,2
JP,EOSINOPHILIC PNEUMONIA,2
JP,HERPES ZOSTER,2
JP,HYPERKALAEMIA,2
JP,HYPOTHERMIA,2
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
JP,INSOMNIA,2
JP,JAUNDICE,2
JP,MELAENA,2
JP,OEDEMA PERIPHERAL,2
JP,PNEUMONIA ASPIRATION,2
JP,PRINZMETAL ANGINA,2
JP,PRODUCT USE ISSUE,2
JP,RASH,2
JP,STOMATITIS,2
JP,SUDDEN DEATH,2
JP,TRANSIENT ISCHAEMIC ATTACK,2
JP,VOMITING,2
JP,WHITE BLOOD CELL COUNT DECREASED,2
JP,ABDOMINAL DISCOMFORT,1
JP,ABDOMINAL PAIN,1
JP,ALANINE AMINOTRANSFERASE DECREASED,1
JP,ANAPHYLACTIC REACTION,1
JP,ANGINA UNSTABLE,1
JP,ANTINUCLEAR ANTIBODY INCREASED,1
JP,AORTIC ANEURYSM,1
JP,AORTIC DISSECTION,1
JP,APPLICATION SITE ERYTHEMA,1
JP,APPLICATION SITE PRURITUS,1
JP,ARRHYTHMIA,1
JP,ARTHRALGIA,1
JP,ASPARTATE AMINOTRANSFERASE DECREASED,1
JP,ASTHENIA,1
JP,ATONIC SEIZURES,1
JP,ATRIAL FIBRILLATION,1
JP,BASILAR ARTERY OCCLUSION,1
JP,BILE DUCT STONE,1
JP,BLOOD BILIRUBIN INCREASED,1
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
JP,BLOOD CREATININE INCREASED,1
JP,BLOOD PARATHYROID HORMONE INCREASED,1
JP,BLOOD POTASSIUM INCREASED,1
JP,BLOOD PRESSURE DECREASED,1
JP,BREAST CANCER,1
JP,CARDIAC DISORDER,1
JP,CARDIAC FAILURE ACUTE,1
JP,CARDIO-RESPIRATORY ARREST,1
JP,CATARACT,1
JP,CEREBRAL THROMBOSIS,1
JP,CEREBRAL TOXOPLASMOSIS,1
JP,CHEST DISCOMFORT,1
JP,CHILLS,1
JP,CHOLANGITIS,1
JP,CHOLECYSTITIS,1
JP,CHOLECYSTITIS ACUTE,1
JP,CHOLESTASIS,1
JP,CHRONIC HEPATITIS,1
JP,COLITIS,1
JP,COLITIS ISCHAEMIC,1
JP,COMPUTERISED TOMOGRAM THORAX ABNORMAL,1
JP,CONSTIPATION,1
JP,CYSTITIS,1
JP,DEATH,1
JP,DEEP VEIN THROMBOSIS,1
JP,DEHYDRATION,1
JP,DELIRIUM,1
JP,DEPRESSED MOOD,1
JP,DEPRESSION,1
JP,DISEASE PROGRESSION,1
JP,DISSEMINATED INTRAVASCULAR COAGULATION,1
JP,DRUG EFFECT INCOMPLETE,1
JP,DRUG ERUPTION,1
JP,DRUG HYPERSENSITIVITY,1
JP,DRUG INEFFECTIVE,1
JP,DUODENAL ULCER PERFORATION,1
JP,DYSLALIA,1
JP,DYSPNOEA,1
JP,EAR PAIN,1
JP,ELECTROLYTE IMBALANCE,1
JP,ERYTHEMA,1
JP,EYE PAIN,1
JP,FACE OEDEMA,1
JP,FAECES DISCOLOURED,1
JP,FATIGUE,1
JP,FEBRILE NEUTROPENIA,1
JP,FLOPPY IRIS SYNDROME,1
JP,FOOD POISONING,1
JP,FREEZING PHENOMENON,1
JP,FUNGAL INFECTION,1
JP,GAIT DISTURBANCE,1
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
JP,GASTRIC CANCER,1
JP,GASTRITIS,1
JP,GASTROENTERITIS,1
JP,GAZE PALSY,1
JP,GENERALISED ERYTHEMA,1
JP,GLUCOSE URINE PRESENT,1
JP,GLYCOSURIA,1
JP,GRANULOCYTE COUNT DECREASED,1
JP,HAEMATEMESIS,1
JP,HAEMATOCHEZIA,1
JP,HAEMORRHAGIC ANAEMIA,1
JP,HAEMORRHAGIC CEREBRAL INFARCTION,1
JP,HALLUCINATION_ VISUAL,1
JP,HEADACHE,1
JP,HEAT ILLNESS,1
JP,HEPATITIS FULMINANT,1
JP,HERPES OESOPHAGITIS,1
JP,HYPERCALCAEMIA,1
JP,HYPERHIDROSIS,1
JP,HYPERPHOSPHATAEMIA,1
JP,HYPERTENSION,1
JP,HYPERURICAEMIA,1
JP,HYPOGAMMAGLOBULINAEMIA,1
JP,HYPOGLYCAEMIA,1
JP,IDIOPATHIC PULMONARY FIBROSIS,1
JP,IMPAIRED HEALING,1
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
JP,INCORRECT DRUG ADMINISTRATION DURATION,1
JP,INFECTIOUS PLEURAL EFFUSION,1
JP,INFLUENZA,1
JP,IRON DEFICIENCY ANAEMIA,1
JP,ISCHAEMIC STROKE,1
JP,LACTIC ACIDOSIS,1
JP,LARGE INTESTINE POLYP,1
JP,LIVER FUNCTION TEST ABNORMAL,1
JP,LUNG DISORDER,1
JP,LUNG NEOPLASM MALIGNANT,1
JP,LUPUS ENTERITIS,1
JP,LUPUS-LIKE SYNDROME,1
JP,LYMPHOMA,1
JP,LYMPHOPENIA,1
JP,MALIGNANT NEOPLASM PROGRESSION,1
JP,MALLORY-WEISS SYNDROME,1
JP,MICROSCOPIC POLYANGIITIS,1
JP,MIOSIS,1
JP,MULTI-ORGAN FAILURE,1
JP,MUSCLE SPASMS,1
JP,MUSCULAR WEAKNESS,1
JP,MYALGIA,1
JP,MYOCARDIAL INFARCTION,1
JP,NEOPLASM MALIGNANT,1
JP,NIGHTMARE,1
JP,NO ADVERSE EVENT,1
JP,OESOPHAGEAL STENOSIS,1
JP,ORAL CANDIDIASIS,1
JP,ORAL HERPES,1
JP,OROPHARYNGEAL PAIN,1
JP,PAIN IN EXTREMITY,1
JP,PARONYCHIA,1
JP,PEMPHIGOID,1
JP,PERICARDIAL EFFUSION,1
JP,PERIPHERAL EMBOLISM,1
JP,PLASMA CELL MYELOMA,1
JP,PLEURAL EFFUSION,1
JP,PLEURISY,1
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
JP,PNEUMOMEDIASTINUM,1
JP,PNEUMONIA BACTERIAL,1
JP,PNEUMOTHORAX,1
JP,POST PROCEDURAL HAEMORRHAGE,1
JP,PULMONARY OEDEMA,1
JP,PYELONEPHRITIS,1
JP,RENAL DISORDER,1
JP,RESPIRATORY TRACT INFECTION,1
JP,RHINITIS,1
JP,SEIZURE,1
JP,SEPSIS,1
JP,SERUM FERRITIN INCREASED,1
JP,SHOCK,1
JP,SHOCK HAEMORRHAGIC,1
JP,SIALOADENITIS,1
JP,SKIN FISSURES,1
JP,SUDDEN HEARING LOSS,1
JP,TAKAYASU^S ARTERITIS,1
JP,THIRST,1
JP,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
JP,TOXICITY TO VARIOUS AGENTS,1
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,1
JP,UPPER RESPIRATORY TRACT INFECTION,1
JP,UPPER RESPIRATORY TRACT INFLAMMATION,1
JP,URINARY TRACT INFECTION,1
JP,URINE KETONE BODY PRESENT,1
JP,URTICARIA,1
JP,VASOMOTOR RHINITIS,1
JP,VENTRICULAR EXTRASYSTOLES,1
JP,VERTIGO,1
JP,WEIGHT DECREASED,1
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
JP,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
JO,CIRCULATORY COLLAPSE,1
KZ,HAEMORRHAGE,1
KZ,HYPOAESTHESIA,1
KZ,PNEUMONIA,1
KZ,PULMONARY EMBOLISM,1
KR,RHABDOMYOLYSIS,8
KR,RENAL FAILURE ACUTE,7
KR,GASTROINTESTINAL HAEMORRHAGE,5
KR,DISSEMINATED INTRAVASCULAR COAGULATION,4
KR,COLONIC HAEMATOMA,3
KR,URINARY TRACT INFECTION,3
KR,DEATH,2
KR,DIARRHOEA,2
KR,EPISTAXIS,2
KR,HAEMOPTYSIS,2
KR,HYPOPHAGIA,2
KR,SEPTIC SHOCK,2
KR,ABDOMINAL PAIN,1
KR,ABDOMINAL PAIN UPPER,1
KR,ANGINA UNSTABLE,1
KR,ASTHENIA,1
KR,AZOTAEMIA,1
KR,BLOOD BICARBONATE DECREASED,1
KR,BLOOD PH DECREASED,1
KR,CANCER PAIN,1
KR,CHEST DISCOMFORT,1
KR,COMA,1
KR,CORONARY ARTERIAL STENT INSERTION,1
KR,COUGH,1
KR,DIZZINESS,1
KR,DYSPNOEA EXERTIONAL,1
KR,ESCHERICHIA INFECTION,1
KR,FALL,1
KR,FEBRILE NEUTROPENIA,1
KR,FOOT FRACTURE,1
KR,HAEMATOCHEZIA,1
KR,HAEMORRHAGE INTRACRANIAL,1
KR,HEADACHE,1
KR,HEPATIC ENZYME INCREASED,1
KR,HEPATOCELLULAR CARCINOMA,1
KR,HYPERSENSITIVITY,1
KR,HYPOACUSIS,1
KR,HYPONATRAEMIA,1
KR,HYPOXIA,1
KR,INTESTINAL PERFORATION,1
KR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
KR,LARGE INTESTINAL OBSTRUCTION,1
KR,LOWER GASTROINTESTINAL HAEMORRHAGE,1
KR,LUNG ADENOCARCINOMA,1
KR,LUNG ADENOCARCINOMA STAGE IV,1
KR,LUNG INFILTRATION,1
KR,METASTASES TO BONE,1
KR,METASTASES TO CENTRAL NERVOUS SYSTEM,1
KR,MUSCLE HAEMORRHAGE,1
KR,MYALGIA,1
KR,MYELODYSPLASTIC SYNDROME,1
KR,OESOPHAGEAL STENOSIS,1
KR,OESOPHAGEAL ULCER,1
KR,OVERDOSE,1
KR,OXYGEN SATURATION DECREASED,1
KR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
KR,PO2 DECREASED,1
KR,PRURITUS,1
KR,PULMONARY ALVEOLAR HAEMORRHAGE,1
KR,PULMONARY OEDEMA,1
KR,RESPIRATORY FAILURE,1
KR,RESPIRATORY RATE INCREASED,1
KR,RHONCHI,1
KR,SEPSIS,1
KR,SKIN LESION,1
KR,TINNITUS,1
KR,UPPER GASTROINTESTINAL HAEMORRHAGE,1
KR,URINE OUTPUT DECREASED,1
KR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
LB,DYSPNOEA,4
LB,CHEST PAIN,3
LB,DEATH,3
LB,DIARRHOEA,3
LB,HYPERGLYCAEMIA,3
LB,HYPERTENSION,3
LB,ANAEMIA,2
LB,FATIGUE,2
LB,HYPOAESTHESIA,2
LB,HYPOTENSION,2
LB,MYOCARDIAL INFARCTION,2
LB,OEDEMA,2
LB,PAIN IN EXTREMITY,2
LB,PYREXIA,2
LB,SYNCOPE,2
LB,TERMINAL STATE,2
LB,VOMITING,2
LB,ABDOMINAL PAIN,1
LB,ABDOMINAL PAIN UPPER,1
LB,ANAL ABSCESS,1
LB,BLINDNESS UNILATERAL,1
LB,BLOOD CORTICOTROPHIN ABNORMAL,1
LB,BLOOD CREATININE INCREASED,1
LB,CARDIAC FAILURE,1
LB,DEHYDRATION,1
LB,DELUSION,1
LB,DIZZINESS,1
LB,FALL,1
LB,FOOD INTERACTION,1
LB,FRACTURE,1
LB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
LB,GASTRIC DISORDER,1
LB,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
LB,HEADACHE,1
LB,HYPERHIDROSIS,1
LB,HYPOGLYCAEMIA,1
LB,INJECTION SITE PAIN,1
LB,INTERCEPTED DRUG PRESCRIBING ERROR,1
LB,INTERVERTEBRAL DISC DISORDER,1
LB,ISCHAEMIC STROKE,1
LB,LEUKOCYTOSIS,1
LB,LOSS OF CONSCIOUSNESS,1
LB,LUNG INFECTION,1
LB,LYMPHOMA,1
LB,MUSCULAR WEAKNESS,1
LB,MUSCULOSKELETAL PAIN,1
LB,MYALGIA,1
LB,NECROSIS,1
LB,NEUROPATHY PERIPHERAL,1
LB,OSTEOPOROSIS,1
LB,PAIN,1
LB,PANCREATITIS ACUTE,1
LB,PLEURAL EFFUSION,1
LB,PNEUMONIA,1
LB,PULMONARY OEDEMA,1
LB,RENAL FAILURE,1
LB,RENAL IMPAIRMENT,1
LB,RETINAL IMPLANT,1
LB,RHABDOMYOLYSIS,1
LB,SKIN INJURY,1
LB,SKIN IRRITATION,1
LB,SPEECH DISORDER,1
LB,SPINAL LAMINECTOMY,1
LB,THROMBOPHLEBITIS,1
LB,TROPONIN I INCREASED,1
LB,TYPE 2 DIABETES MELLITUS,1
LB,URINARY TRACT INFECTION,1
LB,URTICARIA,1
LB,VERTIGO,1
LB,VISION BLURRED,1
LU,CARDIAC PERFORATION,1
LU,ISCHAEMIC STROKE,1
LU,PRODUCT USE ISSUE,1
LU,SINUS ARREST,1
MY,ACUTE KIDNEY INJURY,9
MY,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,9
MY,TOXICITY TO VARIOUS AGENTS,6
MY,METABOLIC ACIDOSIS,5
MY,PNEUMONIA,5
MY,DEAFNESS NEUROSENSORY,4
MY,DELIRIUM,4
MY,DIARRHOEA,4
MY,DRUG INEFFECTIVE,4
MY,DYSPNOEA,4
MY,HYPOGLYCAEMIA,4
MY,IMMUNE-MEDIATED NECROTISING MYOPATHY,4
MY,NEUROTOXICITY,4
MY,PYREXIA,4
MY,ANGIOEDEMA,3
MY,ATRIAL FIBRILLATION,3
MY,CHOKING,3
MY,FOETAL EXPOSURE DURING PREGNANCY,3
MY,GASTROINTESTINAL STROMAL TUMOUR,3
MY,HYPONATRAEMIA,3
MY,LOW BIRTH WEIGHT BABY,3
MY,OEDEMA PERIPHERAL,3
MY,PREMATURE BABY,3
MY,SEPSIS,3
MY,TINNITUS,3
MY,TREMOR,3
MY,ANAPHYLACTIC SHOCK,2
MY,CARDIAC FAILURE,2
MY,CEREBRAL INFARCTION,2
MY,CEREBROVASCULAR ACCIDENT,2
MY,COUGH,2
MY,DEHYDRATION,2
MY,DIABETES MELLITUS INADEQUATE CONTROL,2
MY,DIZZINESS,2
MY,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
MY,DYSPHAGIA,2
MY,FACE OEDEMA,2
MY,FALL,2
MY,HERPES ZOSTER,2
MY,HYPOTENSION,2
MY,INTENTIONAL OVERDOSE,2
MY,LOSS OF CONSCIOUSNESS,2
MY,MALIGNANT NEOPLASM PROGRESSION,2
MY,MOUTH ULCERATION,2
MY,NOSOCOMIAL INFECTION,2
MY,PRURITUS,2
MY,RASH ERYTHEMATOUS,2
MY,RENAL FAILURE ACUTE,2
MY,STEVENS-JOHNSON SYNDROME,2
MY,THROMBOCYTOPENIA,2
MY,TOXIC EPIDERMAL NECROLYSIS,2
MY,URINARY TRACT INFECTION,2
MY,WEIGHT DECREASED,2
MY,ABASIA,1
MY,ABDOMINAL PAIN UPPER,1
MY,ABSCESS,1
MY,ABSCESS LIMB,1
MY,ACTINIC KERATOSIS,1
MY,ACUTE ABDOMEN,1
MY,ALANINE AMINOTRANSFERASE INCREASED,1
MY,ALPHA 1 FOETOPROTEIN INCREASED,1
MY,ALTERED STATE OF CONSCIOUSNESS,1
MY,ANAEMIA,1
MY,ANAPHYLACTIC REACTION,1
MY,ANEURYSM,1
MY,ANXIETY,1
MY,AORTIC ANEURYSM,1
MY,AORTIC ARTERIOSCLEROSIS,1
MY,ARTHRALGIA,1
MY,ASPARTATE AMINOTRANSFERASE INCREASED,1
MY,ASTHENIA,1
MY,BACK PAIN,1
MY,BASAL CELL CARCINOMA,1
MY,BASAL GANGLIA HAEMATOMA,1
MY,BLISTER,1
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MY,BLOOD GLUCOSE DECREASED,1
MY,BLOOD GLUCOSE INCREASED,1
MY,BRAIN OEDEMA,1
MY,BULBAR PALSY,1
MY,CARDIAC FAILURE CONGESTIVE,1
MY,CARDIAC FLUTTER,1
MY,CARDIAC TAMPONADE,1
MY,CARDIO-RESPIRATORY ARREST,1
MY,CATHETER SITE ABSCESS,1
MY,CEREBRAL HAEMATOMA,1
MY,CHEST DISCOMFORT,1
MY,CHRONIC KIDNEY DISEASE,1
MY,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
MY,CORONARY ARTERY DISEASE,1
MY,CREPITATIONS,1
MY,DEATH,1
MY,DECREASED APPETITE,1
MY,DERMATITIS BULLOUS,1
MY,DEVICE RELATED SEPSIS,1
MY,DIABETES MELLITUS,1
MY,DIABETIC FOOT,1
MY,DISCOMFORT,1
MY,DISORIENTATION,1
MY,EAR DISCOMFORT,1
MY,END STAGE RENAL DISEASE,1
MY,EXPOSURE DURING PREGNANCY,1
MY,EYE IRRITATION,1
MY,FLUID RETENTION,1
MY,FOETAL DEATH,1
MY,GAIT DISTURBANCE,1
MY,GASTROINTESTINAL HAEMORRHAGE,1
MY,GASTROOESOPHAGEAL REFLUX DISEASE,1
MY,GENERALISED OEDEMA,1
MY,GENERALISED TONIC-CLONIC SEIZURE,1
MY,GINGIVAL BLEEDING,1
MY,GLAUCOMA,1
MY,GLOMERULAR FILTRATION RATE,1
MY,HAEMOGLOBIN DECREASED,1
MY,HEPATOCELLULAR CARCINOMA,1
MY,HERPES VIRUS INFECTION,1
MY,HUNGER,1
MY,HYDROCEPHALUS,1
MY,HYDRONEPHROSIS,1
MY,HYPERKALAEMIA,1
MY,HYPERTENSION,1
MY,HYPOKALAEMIA,1
MY,INFECTION,1
MY,INTERNATIONAL NORMALISED RATIO INCREASED,1
MY,INTERVERTEBRAL DISC PROTRUSION,1
MY,INTESTINAL ISCHAEMIA,1
MY,INTRACRANIAL MASS,1
MY,INTRAVENTRICULAR HAEMORRHAGE,1
MY,INVASIVE DUCTAL BREAST CARCINOMA,1
MY,IRIDOCYCLITIS,1
MY,ISCHAEMIC HEPATITIS,1
MY,JAUNDICE CHOLESTATIC,1
MY,LACRIMATION INCREASED,1
MY,LEUKOPENIA,1
MY,LIP SWELLING,1
MY,LYMPHADENITIS,1
MY,LYMPHOPENIA,1
MY,NAUSEA,1
MY,NECROTISING FASCIITIS,1
MY,NEUTROPENIA,1
MY,NORMAL PRESSURE HYDROCEPHALUS,1
MY,OBSTRUCTION GASTRIC,1
MY,ORBITAL OEDEMA,1
MY,PAIN IN EXTREMITY,1
MY,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
MY,PALPITATIONS,1
MY,PERITONITIS BACTERIAL,1
MY,PHOTOSENSITIVITY REACTION,1
MY,PLANTAR FASCIITIS,1
MY,PNEUMONIA ASPIRATION,1
MY,POSTPARTUM HAEMORRHAGE,1
MY,POTENTIATING DRUG INTERACTION,1
MY,PRODUCT USE ISSUE,1
MY,PROTHROMBIN TIME PROLONGED,1
MY,PRURITUS GENERALISED,1
MY,PURPURA,1
MY,RASH MACULO-PAPULAR,1
MY,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
MY,RENAL CYST,1
MY,RENAL HAEMATOMA,1
MY,RESPIRATORY DISTRESS,1
MY,RHEUMATOID ARTHRITIS,1
MY,SEPTIC SHOCK,1
MY,SOMNOLENCE,1
MY,SPEECH DISORDER,1
MY,SPINAL CORD HAEMORRHAGE,1
MY,SPINAL OSTEOARTHRITIS,1
MY,SQUAMOUS CELL CARCINOMA,1
MY,STILLBIRTH,1
MY,SUICIDAL BEHAVIOUR,1
MY,THERAPEUTIC RESPONSE DECREASED,1
MY,TREATMENT FAILURE,1
MY,TUBERCULOSIS OF EYE,1
MY,UPPER GASTROINTESTINAL HAEMORRHAGE,1
MY,URINARY TRACT DISORDER,1
MY,UROSEPSIS,1
MY,URTICARIA,1
MY,UTERINE ATONY,1
MY,VISION BLURRED,1
MY,VITAMIN B12 DEFICIENCY,1
MY,WOUND,1
MT,COUGH,4
MT,SYNCOPE,3
MT,ATRIAL FIBRILLATION,2
MT,CONFUSIONAL STATE,2
MT,DIZZINESS,2
MT,LOSS OF CONSCIOUSNESS,2
MT,AGGRESSION,1
MT,ARRHYTHMIA,1
MT,ASTHENIA,1
MT,BLISTER,1
MT,BLOOD PRESSURE DECREASED,1
MT,BLOOD PRESSURE ORTHOSTATIC DECREASED,1
MT,DEMENTIA,1
MT,DERMATITIS BULLOUS,1
MT,DISEASE PROGRESSION,1
MT,DRUG DOSE OMISSION,1
MT,EYE MOVEMENT DISORDER,1
MT,HEPATITIS CHOLESTATIC,1
MT,HYPERGLYCAEMIA,1
MT,HYPERHIDROSIS,1
MT,HYPOTENSION,1
MT,LUNG ADENOCARCINOMA METASTATIC,1
MT,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
MT,PULMONARY EMBOLISM,1
MT,RHABDOMYOLYSIS,1
MT,SPINAL OSTEOARTHRITIS,1
MT,SUDDEN DEATH,1
MX,PEMPHIGUS,4
MX,ASTHENIA,2
MX,FATIGUE,2
MX,HYPERGLYCAEMIA,2
MX,INTESTINAL OBSTRUCTION,2
MX,PANCREATITIS NECROTISING,2
MX,PNEUMONIA,2
MX,RENAL FAILURE,2
MX,ABDOMINAL DISTENSION,1
MX,ABDOMINAL PAIN,1
MX,ACUTE MYOCARDIAL INFARCTION,1
MX,ACUTE PULMONARY OEDEMA,1
MX,ADVERSE REACTION,1
MX,ANAEMIA,1
MX,ANGINA PECTORIS,1
MX,ANURIA,1
MX,ARRHYTHMIA,1
MX,ARTHRALGIA,1
MX,AZOTAEMIA,1
MX,BENIGN PROSTATIC HYPERPLASIA,1
MX,BLOOD GLUCOSE DECREASED,1
MX,BLOOD PRESSURE INCREASED,1
MX,BONE PAIN,1
MX,BURNING SENSATION,1
MX,CARDIAC ARREST,1
MX,CHEST DISCOMFORT,1
MX,COORDINATION ABNORMAL,1
MX,CORONARY ARTERY DISEASE,1
MX,CORONARY ARTERY OCCLUSION,1
MX,DEAFNESS,1
MX,DEATH,1
MX,DIARRHOEA,1
MX,DISORIENTATION,1
MX,DISSEMINATED INTRAVASCULAR COAGULATION,1
MX,DIZZINESS,1
MX,DRUG ADMINISTRATION ERROR,1
MX,DRUG INEFFECTIVE,1
MX,EFFUSION,1
MX,ESCHERICHIA TEST POSITIVE,1
MX,EYE SWELLING,1
MX,EYELID OEDEMA,1
MX,FALL,1
MX,FLUSHING,1
MX,GAIT INABILITY,1
MX,GASTRITIS,1
MX,GASTROINTESTINAL ULCER HAEMORRHAGE,1
MX,GENERAL PHYSICAL HEALTH DETERIORATION,1
MX,GINGIVAL PAIN,1
MX,HAEMATURIA,1
MX,HEADACHE,1
MX,HEART RATE INCREASED,1
MX,HEPATIC FAILURE,1
MX,HYPERTENSION,1
MX,HYPERTRIGLYCERIDAEMIA,1
MX,HYPOAESTHESIA,1
MX,INCORRECT DOSE ADMINISTERED,1
MX,INFARCTION,1
MX,ISCHAEMIC STROKE,1
MX,LIMB DISCOMFORT,1
MX,LIVER FUNCTION TEST ABNORMAL,1
MX,LOSS OF CONSCIOUSNESS,1
MX,MEMORY IMPAIRMENT,1
MX,MITRAL VALVE INCOMPETENCE,1
MX,MULTI-ORGAN FAILURE,1
MX,MUSCLE INJURY,1
MX,MUSCLE TIGHTNESS,1
MX,MYALGIA,1
MX,MYOCARDIAL INFARCTION,1
MX,MYOPATHY,1
MX,NAUSEA,1
MX,OLIGURIA,1
MX,PERIPHERAL SWELLING,1
MX,PETECHIAE,1
MX,POLLAKIURIA,1
MX,POLYURIA,1
MX,PROTEINURIA,1
MX,RHABDOMYOLYSIS,1
MX,RIB FRACTURE,1
MX,SEIZURE,1
MX,SEPTIC SHOCK,1
MX,SKIN FISSURES,1
MX,SKIN HYPERTROPHY,1
MX,STOMATITIS,1
MX,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
MX,TACHYCARDIA,1
MX,TENDON RUPTURE,1
MX,THERAPEUTIC RESPONSE DECREASED,1
MX,THIRST,1
MX,TOOTH EXTRACTION,1
MX,TOOTH INJURY,1
MX,TREATMENT NONCOMPLIANCE,1
MX,TRICUSPID VALVE INCOMPETENCE,1
MX,URINARY INCONTINENCE,1
MX,URINE ANALYSIS ABNORMAL,1
MD,CEREBROVASCULAR ACCIDENT,1
MD,DYSARTHRIA,1
MD,HEMIPARESIS,1
ME,HEPATOTOXICITY,3
ME,JAUNDICE,2
ME,LIVER INJURY,2
ME,PRURITUS GENERALISED,2
ME,RASH,2
ME,ACUTE HEPATIC FAILURE,1
ME,ACUTE HEPATITIS B,1
ME,ALANINE AMINOTRANSFERASE INCREASED,1
ME,ASPARTATE AMINOTRANSFERASE INCREASED,1
ME,BILIRUBIN CONJUGATED INCREASED,1
ME,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ME,BLOOD BILIRUBIN INCREASED,1
ME,DRUG-INDUCED LIVER INJURY,1
ME,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
MA,DERMATITIS BULLOUS,2
NP,ACCIDENTAL OVERDOSE,1
NP,DIZZINESS,1
NP,HYPOTENSION,1
NP,MYASTHENIA GRAVIS,1
NP,PRESYNCOPE,1
NL,DEATH,44
NL,MUSCLE RUPTURE,32
NL,PNEUMONIA,24
NL,MYALGIA,22
NL,DYSPNOEA,20
NL,CARDIAC FAILURE,19
NL,FATIGUE,18
NL,MYOCARDIAL INFARCTION,17
NL,RHABDOMYOLYSIS,17
NL,FALL,16
NL,DIARRHOEA,15
NL,NAUSEA,15
NL,PYREXIA,15
NL,MALAISE,14
NL,GAIT DISTURBANCE,13
NL,DIZZINESS,12
NL,BACK PAIN,10
NL,CONSTIPATION,10
NL,GENERAL PHYSICAL HEALTH DETERIORATION,10
NL,PAIN,10
NL,RENAL IMPAIRMENT,10
NL,CHEST PAIN,9
NL,LOSS OF CONSCIOUSNESS,9
NL,MUSCULAR WEAKNESS,9
NL,PROSTATE CANCER METASTATIC,9
NL,RESPIRATORY FAILURE,9
NL,TRANSIENT ISCHAEMIC ATTACK,9
NL,URINARY TRACT INFECTION,9
NL,VOMITING,9
NL,ARTHRALGIA,8
NL,CEREBRAL INFARCTION,8
NL,CEREBROVASCULAR ACCIDENT,8
NL,DEHYDRATION,8
NL,HYPERTENSION,8
NL,PAIN IN EXTREMITY,8
NL,PROSTATIC SPECIFIC ANTIGEN INCREASED,8
NL,RENAL FAILURE,8
NL,SWOLLEN TONGUE,8
NL,TENDON RUPTURE,8
NL,TENDONITIS,8
NL,TERMINAL STATE,8
NL,WEIGHT DECREASED,8
NL,ACUTE KIDNEY INJURY,7
NL,ANAEMIA,7
NL,CARDIAC DISORDER,7
NL,HEADACHE,7
NL,OEDEMA PERIPHERAL,7
NL,SYNCOPE,7
NL,ABDOMINAL DISCOMFORT,6
NL,ASTHENIA,6
NL,DECREASED APPETITE,6
NL,EPILEPSY,6
NL,INJECTION SITE ERYTHEMA,6
NL,PARAESTHESIA,6
NL,UROSEPSIS,6
NL,VISION BLURRED,6
NL,WEIGHT INCREASED,6
NL,APHASIA,5
NL,BACTERIAL INFECTION,5
NL,CHEST DISCOMFORT,5
NL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
NL,COUGH,5
NL,DRUG INEFFECTIVE,5
NL,HIP FRACTURE,5
NL,HOT FLUSH,5
NL,HYPERKALAEMIA,5
NL,HYPERSENSITIVITY,5
NL,HYPOAESTHESIA,5
NL,HYPOKALAEMIA,5
NL,MALIGNANT NEOPLASM PROGRESSION,5
NL,MUSCLE SPASMS,5
NL,MUSCULOSKELETAL PAIN,5
NL,OEDEMA,5
NL,PALPITATIONS,5
NL,PRODUCT USE ISSUE,5
NL,PRURITUS,5
NL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,5
NL,TACHYCARDIA,5
NL,THROMBOCYTOPENIA,5
NL,TOXICITY TO VARIOUS AGENTS,5
NL,ABASIA,4
NL,ABNORMAL FAECES,4
NL,ACUTE MYOCARDIAL INFARCTION,4
NL,ANGIOPATHY,4
NL,ARRHYTHMIA,4
NL,ATRIAL FIBRILLATION,4
NL,BLOOD GLUCOSE INCREASED,4
NL,BLOOD PRESSURE INCREASED,4
NL,CARDIAC ARREST,4
NL,CIRCULATORY COLLAPSE,4
NL,DEPRESSED MOOD,4
NL,DRUG LEVEL INCREASED,4
NL,HAEMORRHAGE,4
NL,HYPERCHOLESTEROLAEMIA,4
NL,HYPERHIDROSIS,4
NL,HYPOTENSION,4
NL,INFLUENZA LIKE ILLNESS,4
NL,INTERNATIONAL NORMALISED RATIO INCREASED,4
NL,LIVER FUNCTION TEST ABNORMAL,4
NL,NEURALGIA,4
NL,PARKINSON^S DISEASE,4
NL,PHARYNGEAL OEDEMA,4
NL,SECOND PRIMARY MALIGNANCY,4
NL,SKIN DISCOLOURATION,4
NL,SPEECH DISORDER,4
NL,TREMOR,4
NL,ABDOMINAL PAIN,3
NL,ALOPECIA,3
NL,ANGIOEDEMA,3
NL,ARTHROPATHY,3
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
NL,BLOOD GLUCOSE FLUCTUATION,3
NL,BONE PAIN,3
NL,BREAST CANCER METASTATIC,3
NL,CHILLS,3
NL,CHOLECYSTITIS,3
NL,COGNITIVE DISORDER,3
NL,COMA,3
NL,CONFUSIONAL STATE,3
NL,DEPRESSION,3
NL,DIABETES MELLITUS,3
NL,DIARRHOEA HAEMORRHAGIC,3
NL,DISEASE PROGRESSION,3
NL,DRUG HYPERSENSITIVITY,3
NL,DYSGEUSIA,3
NL,DYSKINESIA,3
NL,EYE DISORDER,3
NL,GASTRIC HAEMORRHAGE,3
NL,GASTROENTERITIS VIRAL,3
NL,GASTROINTESTINAL HAEMORRHAGE,3
NL,HAEMATOCHEZIA,3
NL,HAEMORRHAGIC STROKE,3
NL,HEMIPARESIS,3
NL,HEPATIC FUNCTION ABNORMAL,3
NL,HYPOCALCAEMIA,3
NL,HYPOMAGNESAEMIA,3
NL,IMPAIRED HEALING,3
NL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
NL,INJECTION SITE MASS,3
NL,INJECTION SITE PAIN,3
NL,INJECTION SITE WARMTH,3
NL,INSOMNIA,3
NL,LIMB DISCOMFORT,3
NL,LIP SWELLING,3
NL,MOVEMENT DISORDER,3
NL,MULTI-ORGAN FAILURE,3
NL,MUSCULOSKELETAL DISCOMFORT,3
NL,MUSCULOSKELETAL STIFFNESS,3
NL,ORAL LICHEN PLANUS,3
NL,OSTEOARTHRITIS,3
NL,PARAKERATOSIS,3
NL,PERIPHERAL ARTERY THROMBOSIS,3
NL,PHIMOSIS,3
NL,PRODUCT USE IN UNAPPROVED INDICATION,3
NL,PULMONARY EMBOLISM,3
NL,PULMONARY HYPERTENSION,3
NL,RETINAL VASCULAR THROMBOSIS,3
NL,SKIN CANCER,3
NL,SLEEP DISORDER,3
NL,TREATMENT FAILURE,3
NL,URINARY RETENTION,3
NL,URINARY TRACT DISORDER,3
NL,VASCULITIS,3
NL,VISUAL ACUITY REDUCED,3
NL,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
NL,ABDOMINAL DISTENSION,2
NL,ABDOMINAL PAIN UPPER,2
NL,ACUTE CORONARY SYNDROME,2
NL,ADENOCARCINOMA OF COLON,2
NL,AGEUSIA,2
NL,AMNESIA,2
NL,ANAPHYLACTIC SHOCK,2
NL,ANGINA PECTORIS,2
NL,ANGINA UNSTABLE,2
NL,ANGIOPLASTY,2
NL,ARTERIAL OCCLUSIVE DISEASE,2
NL,ARTHRITIS,2
NL,ATRIOVENTRICULAR BLOCK SECOND DEGREE,2
NL,BACK DISORDER,2
NL,BALANCE DISORDER,2
NL,BEDRIDDEN,2
NL,BLOOD CREATININE INCREASED,2
NL,BRADYCARDIA,2
NL,BREAST CANCER,2
NL,BURNING SENSATION,2
NL,C-REACTIVE PROTEIN INCREASED,2
NL,CALCULUS BLADDER,2
NL,CARDIAC ASTHMA,2
NL,CARDIAC PACEMAKER INSERTION,2
NL,CAROTID ARTERY STENOSIS,2
NL,CATARACT,2
NL,CEREBRAL HAEMORRHAGE,2
NL,CEREBROSPINAL FLUID LEAKAGE,2
NL,COLITIS,2
NL,CORONARY ARTERY STENOSIS,2
NL,DEVICE RELATED SEPSIS,2
NL,DISTURBANCE IN ATTENTION,2
NL,DRUG-DISEASE INTERACTION,2
NL,DYSARTHRIA,2
NL,DYSPHAGIA,2
NL,DYSSTASIA,2
NL,DYSURIA,2
NL,ELECTROCARDIOGRAM QT PROLONGED,2
NL,ELECTROLYTE IMBALANCE,2
NL,EUTHANASIA,2
NL,EXTREMITY NECROSIS,2
NL,EYELID OEDEMA,2
NL,FEBRILE NEUTROPENIA,2
NL,FIBROMYALGIA,2
NL,FINE MOTOR DELAY,2
NL,FLUID RETENTION,2
NL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
NL,GASTROINTESTINAL DISORDER,2
NL,GYNAECOMASTIA,2
NL,HAEMATEMESIS,2
NL,HAEMOGLOBIN DECREASED,2
NL,HAEMOPTYSIS,2
NL,HAEMORRHAGIC TRANSFORMATION STROKE,2
NL,HEPATITIS TOXIC,2
NL,HERNIA,2
NL,HYPERVENTILATION,2
NL,HYPOGLYCAEMIA,2
NL,ILEUS,2
NL,INCORRECT DRUG ADMINISTRATION DURATION,2
NL,INFLUENZA,2
NL,INFUSION RELATED REACTION,2
NL,INJECTION SITE HYPOAESTHESIA,2
NL,INJECTION SITE INFECTION,2
NL,INJECTION SITE PRURITUS,2
NL,INJECTION SITE REACTION,2
NL,INJECTION SITE SWELLING,2
NL,INTERSTITIAL LUNG DISEASE,2
NL,JAUNDICE,2
NL,KIDNEY TRANSPLANT REJECTION,2
NL,LACTIC ACIDOSIS,2
NL,LEFT VENTRICULAR HYPERTROPHY,2
NL,LIVER DISORDER,2
NL,LOCALISED INFECTION,2
NL,MALIGNANT MELANOMA,2
NL,METASTASES TO BONE,2
NL,MOBILITY DECREASED,2
NL,MOOD SWINGS,2
NL,MULTIPLE SCLEROSIS,2
NL,MUSCLE ATROPHY,2
NL,MUSCULOSKELETAL DISORDER,2
NL,NASOPHARYNGITIS,2
NL,NEUTROPENIA,2
NL,ON AND OFF PHENOMENON,2
NL,ORTHOPNOEA,2
NL,OSTEOMYELITIS,2
NL,OSTEONECROSIS OF JAW,2
NL,OSTEOPOROSIS,2
NL,OVERDOSE,2
NL,OXYGEN SATURATION DECREASED,2
NL,PALLIATIVE CARE,2
NL,PANCREATIC CARCINOMA METASTATIC,2
NL,PANCYTOPENIA,2
NL,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,2
NL,PLEURAL EFFUSION,2
NL,PNEUMONIA ASPIRATION,2
NL,POLLAKIURIA,2
NL,POLYNEUROPATHY,2
NL,POLYURIA,2
NL,POST PROCEDURAL COMPLICATION,2
NL,PRODUCT AVAILABILITY ISSUE,2
NL,PULMONARY FIBROSIS,2
NL,PULMONARY HAEMORRHAGE,2
NL,PULMONARY OEDEMA,2
NL,PYELONEPHRITIS,2
NL,RECTAL HAEMORRHAGE,2
NL,RENAL FAILURE ACUTE,2
NL,RESPIRATORY DISTRESS,2
NL,RESPIRATORY TRACT INFECTION,2
NL,RESTLESS LEGS SYNDROME,2
NL,RHEUMATOID ARTHRITIS,2
NL,SEDATION,2
NL,SEPSIS,2
NL,SINUS ARREST,2
NL,SINUS BRADYCARDIA,2
NL,SUDDEN DEATH,2
NL,SUICIDAL IDEATION,2
NL,THERAPEUTIC RESPONSE UNEXPECTED,2
NL,TRISMUS,2
NL,UPPER RESPIRATORY TRACT INFECTION,2
NL,VASCULAR PSEUDOANEURYSM,2
NL,VISUAL IMPAIRMENT,2
NL,VOCAL CORD DISORDER,2
NL,ABORTION SPONTANEOUS,1
NL,ACANTHOSIS,1
NL,ACUTE PRERENAL FAILURE,1
NL,ADENOCARCINOMA,1
NL,ADJUSTMENT DISORDER WITH DEPRESSED MOOD,1
NL,ADVERSE DRUG REACTION,1
NL,ADVERSE EVENT,1
NL,ALANINE AMINOTRANSFERASE INCREASED,1
NL,ALCOHOL ABUSE,1
NL,ALCOHOLIC PANCREATITIS,1
NL,AMAUROSIS FUGAX,1
NL,ANEURYSM,1
NL,ANGER,1
NL,ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT,1
NL,ANXIETY,1
NL,AORTIC ANEURYSM RUPTURE,1
NL,AORTIC CALCIFICATION,1
NL,AORTOENTERIC FISTULA,1
NL,APHAGIA,1
NL,APNOEIC ATTACK,1
NL,ARTERECTOMY,1
NL,ARTERIOSCLEROSIS,1
NL,ARTERIOVENOUS FISTULA,1
NL,ASCITES,1
NL,ASPARTATE AMINOTRANSFERASE INCREASED,1
NL,ASPIRATION,1
NL,BACTERAEMIA,1
NL,BAND SENSATION,1
NL,BASAL CELL CARCINOMA,1
NL,BILIARY COLIC,1
NL,BLADDER SPHINCTER ATONY,1
NL,BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT,1
NL,BLINDNESS UNILATERAL,1
NL,BLOOD ALBUMIN DECREASED,1
NL,BLOOD ALKALINE PHOSPHATASE INCREASED,1
NL,BLOOD BICARBONATE INCREASED,1
NL,BLOOD CALCIUM INCREASED,1
NL,BLOOD CHOLESTEROL INCREASED,1
NL,BLOOD GLUCOSE DECREASED,1
NL,BLOOD INSULIN INCREASED,1
NL,BLOOD IRON INCREASED,1
NL,BLOOD LACTIC ACID INCREASED,1
NL,BLOOD MAGNESIUM DECREASED,1
NL,BLOOD PH DECREASED,1
NL,BLOOD PHOSPHORUS DECREASED,1
NL,BLOOD PRESSURE DECREASED,1
NL,BLOOD PRESSURE DIASTOLIC INCREASED,1
NL,BLOOD PRESSURE SYSTOLIC INCREASED,1
NL,BLOOD SODIUM DECREASED,1
NL,BONE MARROW FAILURE,1
NL,BRAIN NEOPLASM,1
NL,BREAST ENLARGEMENT,1
NL,BREAST PAIN,1
NL,BURNING SENSATION MUCOSAL,1
NL,BURNS SECOND DEGREE,1
NL,CANDIDA SEPSIS,1
NL,CARDIAC FLUTTER,1
NL,CARDIOGENIC SHOCK,1
NL,CARDIOMEGALY,1
NL,CARDIOVASCULAR DISORDER,1
NL,CAROTID INTIMA-MEDIA THICKNESS INCREASED,1
NL,CARPAL TUNNEL SYNDROME,1
NL,CELLULITIS,1
NL,CEREBRAL ARTERY OCCLUSION,1
NL,CHEMICAL PERITONITIS,1
NL,CHEMOTHERAPY,1
NL,CHEST INJURY,1
NL,CHOLANGITIS,1
NL,CHOLECYSTECTOMY,1
NL,CHOLELITHIASIS,1
NL,CHROMATURIA,1
NL,COAGULATION TEST ABNORMAL,1
NL,COCCYDYNIA,1
NL,COLLATERAL CIRCULATION,1
NL,COLON CANCER,1
NL,CONDITION AGGRAVATED,1
NL,CONJUNCTIVAL HAEMORRHAGE,1
NL,CONTRAINDICATED DRUG ADMINISTERED,1
NL,CONTRAST ENCEPHALOPATHY,1
NL,CONTUSION,1
NL,CONVULSION,1
NL,CORNEAL TRANSPLANT,1
NL,CORONARY ARTERY OCCLUSION,1
NL,CREATININE RENAL CLEARANCE DECREASED,1
NL,CYST,1
NL,DEEP VEIN THROMBOSIS,1
NL,DELIRIUM,1
NL,DEMENTIA,1
NL,DEPRESSION SUICIDAL,1
NL,DERMATITIS,1
NL,DERMATITIS ACNEIFORM,1
NL,DERMATITIS EXFOLIATIVE,1
NL,DEVICE FAILURE,1
NL,DEVICE INTOLERANCE,1
NL,DIABETIC KETOACIDOSIS,1
NL,DIABETIC NEUROPATHY,1
NL,DISABILITY,1
NL,DISCOMFORT,1
NL,DISORIENTATION,1
NL,DIVERTICULITIS,1
NL,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG EFFECT INCOMPLETE,1
NL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NL,DRY THROAT,1
NL,DUODENAL ULCER HAEMORRHAGE,1
NL,DUPUYTREN^S CONTRACTURE,1
NL,DYSPNOEA EXERTIONAL,1
NL,DYSPRAXIA,1
NL,EAR DISORDER,1
NL,EAR INFECTION,1
NL,EATING DISORDER,1
NL,EMOTIONAL DISORDER,1
NL,EMOTIONAL DISTRESS,1
NL,ENDOPHTHALMITIS,1
NL,ENTEROCUTANEOUS FISTULA,1
NL,EPISTAXIS,1
NL,ERYSIPELAS,1
NL,ERYTHEMA,1
NL,ESSENTIAL THROMBOCYTHAEMIA,1
NL,EXPOSURE DURING PREGNANCY,1
NL,EYE PAIN,1
NL,EYELID PTOSIS,1
NL,FACIAL BONES FRACTURE,1
NL,FACIAL PAIN,1
NL,FACIAL PARALYSIS,1
NL,FAECES DISCOLOURED,1
NL,FEELING ABNORMAL,1
NL,FEELING COLD,1
NL,FEELING HOT,1
NL,FEMORAL ARTERY OCCLUSION,1
NL,FIBROMA,1
NL,FLATULENCE,1
NL,FOOT DEFORMITY,1
NL,FOREIGN BODY IN UROGENITAL TRACT,1
NL,FREEZING PHENOMENON,1
NL,FUNCTIONAL GASTROINTESTINAL DISORDER,1
NL,GASTRIC FISTULA,1
NL,GASTRIC ULCER,1
NL,GASTROENTERITIS,1
NL,GLOMERULAR FILTRATION RATE DECREASED,1
NL,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
NL,GROIN PAIN,1
NL,HAEMATOCRIT INCREASED,1
NL,HAEMATOMA INFECTION,1
NL,HAEMODYNAMIC INSTABILITY,1
NL,HAEMOTHORAX,1
NL,HALLUCINATION,1
NL,HEART RATE IRREGULAR,1
NL,HEMIPLEGIA,1
NL,HEPATIC CANCER,1
NL,HEPATIC ENZYME ABNORMAL,1
NL,HEPATIC ENZYME INCREASED,1
NL,HEPATIC LESION,1
NL,HEPATIC NEOPLASM,1
NL,HERPES SIMPLEX,1
NL,HIP SURGERY,1
NL,HUMERUS FRACTURE,1
NL,HYDRONEPHROSIS,1
NL,HYPERCALCAEMIA,1
NL,HYPERKINESIA,1
NL,HYPERNATRAEMIA,1
NL,HYPERTENSIVE CRISIS,1
NL,HYPNAGOGIC HALLUCINATION,1
NL,HYPOACUSIS,1
NL,HYPONATRAEMIA,1
NL,HYPOPARATHYROIDISM,1
NL,HYPOPNOEA,1
NL,HYPOVOLAEMIC SHOCK,1
NL,HYPOXIA,1
NL,IMPAIRED DRIVING ABILITY,1
NL,IMPAIRED SELF-CARE,1
NL,INCONTINENCE,1
NL,INFARCTION,1
NL,INFECTION,1
NL,INFLAMMATORY MARKER INCREASED,1
NL,INGUINAL HERNIA,1
NL,INHIBITORY DRUG INTERACTION,1
NL,INJECTED LIMB MOBILITY DECREASED,1
NL,INJECTION SITE DISCOLOURATION,1
NL,INJECTION SITE HAEMORRHAGE,1
NL,INJECTION SITE INDURATION,1
NL,INNER EAR DISORDER,1
NL,INTENTIONAL OVERDOSE,1
NL,INTENTIONAL PRODUCT MISUSE,1
NL,INTERMITTENT CLAUDICATION,1
NL,INTERNATIONAL NORMALISED RATIO DECREASED,1
NL,INTERVERTEBRAL DISC OPERATION,1
NL,INTESTINAL ISCHAEMIA,1
NL,INTESTINAL POLYP,1
NL,INTRAOCULAR PRESSURE INCREASED,1
NL,INVASIVE LOBULAR BREAST CARCINOMA,1
NL,IRON DEFICIENCY ANAEMIA,1
NL,IRRITABLE BOWEL SYNDROME,1
NL,ISCHAEMIC CEREBRAL INFARCTION,1
NL,JOINT DISLOCATION,1
NL,JOINT SWELLING,1
NL,KIDNEY CONGESTION,1
NL,LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR,1
NL,LABORATORY TEST ABNORMAL,1
NL,LACERATION,1
NL,LACUNAR INFARCTION,1
NL,LARGE INTESTINE PERFORATION,1
NL,LARYNGEAL CANCER,1
NL,LEG AMPUTATION,1
NL,LIBIDO DECREASED,1
NL,LUNG DISORDER,1
NL,LUNG INFECTION,1
NL,LUNG INFILTRATION,1
NL,LUNG NEOPLASM MALIGNANT,1
NL,LUPUS-LIKE SYNDROME,1
NL,LYMPHOEDEMA,1
NL,MACULAR DEGENERATION,1
NL,MAJOR DEPRESSION,1
NL,MALIGNANT HYPERTENSION,1
NL,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
NL,MALLET FINGER,1
NL,MEMORY IMPAIRMENT,1
NL,MENINGIOMA,1
NL,MENINGITIS,1
NL,MENTAL DISORDER,1
NL,METASTASES TO LIVER,1
NL,METASTASES TO LUNG,1
NL,METASTASES TO PELVIS,1
NL,METASTASIS,1
NL,METASTATIC BRONCHIAL CARCINOMA,1
NL,METASTATIC NEOPLASM,1
NL,METHAEMOGLOBINAEMIA,1
NL,MICROCYTIC ANAEMIA,1
NL,MIOSIS,1
NL,MITRAL VALVE INCOMPETENCE,1
NL,MOTOR DYSFUNCTION,1
NL,MOUTH SWELLING,1
NL,MUCINOUS BREAST CARCINOMA,1
NL,MUCOSAL DRYNESS,1
NL,MUCOSAL INFLAMMATION,1
NL,MUSCLE CONTRACTIONS INVOLUNTARY,1
NL,MUSCLE DISORDER,1
NL,MUSCLE INJURY,1
NL,MUSCLE NECROSIS,1
NL,MUSCLE RIGIDITY,1
NL,MUSCLE TIGHTNESS,1
NL,MUSCULOSKELETAL CHEST PAIN,1
NL,MYASTHENIA GRAVIS,1
NL,MYDRIASIS,1
NL,MYELOFIBROSIS,1
NL,MYELOPROLIFERATIVE DISORDER,1
NL,MYOGLOBINURIA,1
NL,MYOPATHY,1
NL,NASAL OEDEMA,1
NL,NEOPLASM MALIGNANT,1
NL,NEOPLASM PROGRESSION,1
NL,NEPHROSTOMY,1
NL,NEUROMYOPATHY,1
NL,NIGHT SWEATS,1
NL,NOCTURIA,1
NL,NON-HODGKIN^S LYMPHOMA,1
NL,NON-SMALL CELL LUNG CANCER,1
NL,NONINFECTIVE ENCEPHALITIS,1
NL,OBESITY,1
NL,OBSESSIVE THOUGHTS,1
NL,OBSESSIVE-COMPULSIVE DISORDER,1
NL,OCULAR MYASTHENIA,1
NL,OCULAR RETROBULBAR HAEMORRHAGE,1
NL,ORAL MUCOSAL BLISTERING,1
NL,OROPHARYNGEAL PAIN,1
NL,OSTEOPENIA,1
NL,PAINFUL RESPIRATION,1
NL,PANCREATIC CARCINOMA,1
NL,PANCREATITIS,1
NL,PANCREATITIS NECROTISING,1
NL,PANIC ATTACK,1
NL,PAPULE,1
NL,PARTIAL SEIZURES,1
NL,PERICARDIAL EFFUSION,1
NL,PERIORBITAL OEDEMA,1
NL,PERIPHERAL ARTERY STENOSIS,1
NL,PERIPHERAL ARTERY STENT INSERTION,1
NL,PERIPHERAL SWELLING,1
NL,PERIPHERAL VASCULAR DISORDER,1
NL,PERITONITIS,1
NL,PETIT MAL EPILEPSY,1
NL,PHARYNGEAL ERYTHEMA,1
NL,PHOTOSENSITIVITY REACTION,1
NL,PINEAL GLAND CYST,1
NL,PLASMA CELL MYELOMA,1
NL,PNEUMONIA PNEUMOCOCCAL,1
NL,POLYMYALGIA RHEUMATICA,1
NL,POOR QUALITY SLEEP,1
NL,POST-INJECTION DELIRIUM SEDATION SYNDROME,1
NL,POSTMENOPAUSAL HAEMORRHAGE,1
NL,PRESCRIBED UNDERDOSE,1
NL,PRINZMETAL ANGINA,1
NL,PROCTITIS ULCERATIVE,1
NL,PRODUCT SUBSTITUTION ISSUE,1
NL,PROSTATE CANCER,1
NL,PROSTATIC SPECIFIC ANTIGEN DECREASED,1
NL,PROSTATOMEGALY,1
NL,PROTEIN DEFICIENCY,1
NL,PSEUDOMONAS INFECTION,1
NL,PSORIASIS,1
NL,PSYCHIATRIC SYMPTOM,1
NL,PSYCHOTIC DISORDER,1
NL,PULMONARY ARTERIAL HYPERTENSION,1
NL,PULMONARY SEPSIS,1
NL,PULMONARY VASCULITIS,1
NL,QUALITY OF LIFE DECREASED,1
NL,RASH,1
NL,RASH ERYTHEMATOUS,1
NL,RASH MACULO-PAPULAR,1
NL,RASH PRURITIC,1
NL,RAYNAUD^S PHENOMENON,1
NL,RECTAL ADENOCARCINOMA,1
NL,RECTAL CANCER,1
NL,RENAL CYST,1
NL,RENAL FAILURE CHRONIC,1
NL,RENAL INFARCT,1
NL,RENAL NEOPLASM,1
NL,RENAL TUBULAR NECROSIS,1
NL,RESPIRATORY RATE INCREASED,1
NL,RESTLESSNESS,1
NL,RHEUMATIC DISORDER,1
NL,RHEUMATOID NODULE,1
NL,RIB FRACTURE,1
NL,ROAD TRAFFIC ACCIDENT,1
NL,ROTATOR CUFF SYNDROME,1
NL,SCAN ABNORMAL,1
NL,SENSE OF OPPRESSION,1
NL,SENSORY DISTURBANCE,1
NL,SENSORY LOSS,1
NL,SEPTIC SHOCK,1
NL,SERUM FERRITIN INCREASED,1
NL,SHORT-BOWEL SYNDROME,1
NL,SKIN FISSURES,1
NL,SKIN INFECTION,1
NL,SKIN LESION,1
NL,SKIN PLAQUE,1
NL,SLEEP APNOEA SYNDROME,1
NL,SLUGGISHNESS,1
NL,SPINAL COLUMN INJURY,1
NL,SPINAL CORD INJURY,1
NL,SPINAL FRACTURE,1
NL,SPLENECTOMY,1
NL,SPLENOMEGALY,1
NL,SQUAMOUS CELL CARCINOMA,1
NL,STRESS,1
NL,SUBARACHNOID HAEMORRHAGE,1
NL,SUBDIAPHRAGMATIC ABSCESS,1
NL,SUBDURAL HAEMATOMA,1
NL,SUPPORTIVE CARE,1
NL,SURGERY,1
NL,SUSPECTED COUNTERFEIT PRODUCT,1
NL,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,1
NL,TACHYPNOEA,1
NL,TEMPORAL ARTERITIS,1
NL,THERAPEUTIC RESPONSE DECREASED,1
NL,THROAT CANCER,1
NL,THROMBOTIC MICROANGIOPATHY,1
NL,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
NL,TOBACCO INTERACTION,1
NL,TRANSFUSION,1
NL,TRICUSPID VALVE INCOMPETENCE,1
NL,TYPE 2 DIABETES MELLITUS,1
NL,UNDERDOSE,1
NL,UPPER LIMB FRACTURE,1
NL,URETHRAL STENOSIS,1
NL,URINARY INCONTINENCE,1
NL,URINARY TRACT INFECTION BACTERIAL,1
NL,UTERINE POLYP,1
NL,VAGINAL HAEMORRHAGE,1
NL,VARICOSE VEIN,1
NL,VASCULAR DEMENTIA,1
NL,VASCULAR OCCLUSION,1
NL,VENTILATION PERFUSION MISMATCH,1
NL,VENTRICULAR EXTRASYSTOLES,1
NL,VITH NERVE PARALYSIS,1
NL,WEIGHT ABNORMAL,1
NL,WHITE BLOOD CELL COUNT DECREASED,1
NL,WOUND INFECTION,1
NL,WRIST FRACTURE,1
NL,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
NZ,NECROTISING MYOSITIS,18
NZ,RHABDOMYOLYSIS,15
NZ,ACUTE KIDNEY INJURY,12
NZ,DIZZINESS,11
NZ,BALANCE DISORDER,8
NZ,GAIT DISTURBANCE,8
NZ,DYSPNOEA,7
NZ,CONFUSIONAL STATE,6
NZ,HYPOTENSION,6
NZ,LOWER RESPIRATORY TRACT INFECTION,6
NZ,MALAISE,6
NZ,PNEUMONIA,6
NZ,WHITE BLOOD CELL COUNT INCREASED,6
NZ,ANAEMIA,5
NZ,ARTHRALGIA,5
NZ,CEREBROVASCULAR ACCIDENT,5
NZ,DEATH,5
NZ,FATIGUE,5
NZ,PAIN,5
NZ,RENAL IMPAIRMENT,5
NZ,BACK PAIN,4
NZ,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
NZ,CARDIAC FAILURE,4
NZ,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
NZ,HAEMOGLOBIN DECREASED,4
NZ,HEPATIC FAILURE,4
NZ,MYOCARDIAL INFARCTION,4
NZ,PYREXIA,4
NZ,TACHYCARDIA,4
NZ,ABDOMINAL PAIN,3
NZ,ACUTE MYOCARDIAL INFARCTION,3
NZ,ATRIAL FIBRILLATION,3
NZ,C-REACTIVE PROTEIN INCREASED,3
NZ,COUGH,3
NZ,DEPRESSION,3
NZ,DIARRHOEA,3
NZ,DRUG-INDUCED LIVER INJURY,3
NZ,FALL,3
NZ,HAEMOPTYSIS,3
NZ,HEADACHE,3
NZ,HEPATIC ENZYME INCREASED,3
NZ,INSOMNIA,3
NZ,MELAENA,3
NZ,MYALGIA,3
NZ,MYOCARDITIS,3
NZ,NEUTROPENIA,3
NZ,NEUTROPHIL COUNT INCREASED,3
NZ,PNEUMONITIS,3
NZ,PULMONARY EMBOLISM,3
NZ,SEPSIS,3
NZ,SOMNOLENCE,3
NZ,SPINAL SUBDURAL HAEMATOMA,3
NZ,TYPE 2 DIABETES MELLITUS,3
NZ,VOMITING,3
NZ,ABASIA,2
NZ,ACTIVITIES OF DAILY LIVING IMPAIRED,2
NZ,ALANINE AMINOTRANSFERASE INCREASED,2
NZ,AMNESIA,2
NZ,ANGINA UNSTABLE,2
NZ,ANOSOGNOSIA,2
NZ,ANXIETY,2
NZ,ARTHRITIS,2
NZ,ASTHENIA,2
NZ,ATAXIA,2
NZ,ATELECTASIS,2
NZ,ATRIAL FLUTTER,2
NZ,BLOOD ALKALINE PHOSPHATASE INCREASED,2
NZ,BLOOD CREATININE INCREASED,2
NZ,BLOOD SODIUM DECREASED,2
NZ,BODY TEMPERATURE INCREASED,2
NZ,BRADYCARDIA,2
NZ,CARDIAC ARREST,2
NZ,CARDIAC FAILURE CONGESTIVE,2
NZ,CELLULITIS,2
NZ,CHEST PAIN,2
NZ,CIRCULATORY COLLAPSE,2
NZ,COLON CANCER,2
NZ,COMPLETED SUICIDE,2
NZ,CONSTIPATION,2
NZ,DEHYDRATION,2
NZ,DYSPHAGIA,2
NZ,EPISTAXIS,2
NZ,FACE OEDEMA,2
NZ,FEELING ABNORMAL,2
NZ,GASTROINTESTINAL HAEMORRHAGE,2
NZ,GASTROOESOPHAGEAL REFLUX DISEASE,2
NZ,GLOMERULAR FILTRATION RATE DECREASED,2
NZ,HAEMOGLOBIN ABNORMAL,2
NZ,HYPONATRAEMIA,2
NZ,HYPORESPONSIVE TO STIMULI,2
NZ,HYPOXIA,2
NZ,IMPAIRED WORK ABILITY,2
NZ,INFECTION,2
NZ,INTERSTITIAL LUNG DISEASE,2
NZ,LACTIC ACIDOSIS,2
NZ,MALIGNANT MELANOMA,2
NZ,MEDICATION ERROR,2
NZ,MENTAL IMPAIRMENT,2
NZ,METASTATIC MALIGNANT MELANOMA,2
NZ,MUSCULAR WEAKNESS,2
NZ,MYOCARDIAL ISCHAEMIA,2
NZ,MYOPATHY,2
NZ,MYOSITIS,2
NZ,NAUSEA,2
NZ,OBESITY,2
NZ,ORTHOSTATIC HYPOTENSION,2
NZ,PSYCHOTIC DISORDER,2
NZ,RASH,2
NZ,RECTAL HAEMORRHAGE,2
NZ,RENAL FAILURE,2
NZ,RESPIRATORY FAILURE,2
NZ,RHINITIS,2
NZ,SLEEP APNOEA SYNDROME,2
NZ,SPINAL COLUMN STENOSIS,2
NZ,STAPHYLOCOCCAL ABSCESS,2
NZ,SUBARACHNOID HAEMORRHAGE,2
NZ,VISUAL IMPAIRMENT,2
NZ,WEIGHT DECREASED,2
NZ,ABDOMINAL DISCOMFORT,1
NZ,ABDOMINAL PAIN UPPER,1
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NZ,AGGRESSION,1
NZ,AGITATION,1
NZ,AGRANULOCYTOSIS,1
NZ,ALVEOLITIS ALLERGIC,1
NZ,ANAL SPHINCTER ATONY,1
NZ,ANAPHYLACTIC SHOCK,1
NZ,ANGIOEDEMA,1
NZ,ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC,1
NZ,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
NZ,ANTIPSYCHOTIC DRUG LEVEL DECREASED,1
NZ,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
NZ,APHASIA,1
NZ,AREFLEXIA,1
NZ,ARTERIAL HAEMORRHAGE,1
NZ,ASTHMA,1
NZ,ATYPICAL FEMUR FRACTURE,1
NZ,B-CELL LYMPHOMA,1
NZ,BASAL CELL CARCINOMA,1
NZ,BILIARY SEPSIS,1
NZ,BLOOD ALBUMIN DECREASED,1
NZ,BLOOD CALCIUM DECREASED,1
NZ,BLOOD CREATININE ABNORMAL,1
NZ,BLOOD GLUCOSE INCREASED,1
NZ,BLOOD IMMUNOGLOBULIN E INCREASED,1
NZ,BLOOD POTASSIUM INCREASED,1
NZ,BLOOD UREA DECREASED,1
NZ,BONE PAIN,1
NZ,BRAIN NATRIURETIC PEPTIDE INCREASED,1
NZ,C-REACTIVE PROTEIN ABNORMAL,1
NZ,CARBOXYHAEMOGLOBIN INCREASED,1
NZ,CARDIAC VALVE REPLACEMENT COMPLICATION,1
NZ,CARDIOMEGALY,1
NZ,CATARACT,1
NZ,CENTRAL NERVOUS SYSTEM LESION,1
NZ,CEREBRAL HAEMORRHAGE,1
NZ,CHILLS,1
NZ,CHOLELITHIASIS,1
NZ,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NZ,CLOSTRIDIUM DIFFICILE INFECTION,1
NZ,COLITIS,1
NZ,COLITIS ISCHAEMIC,1
NZ,COLONOSCOPY,1
NZ,CONDITION AGGRAVATED,1
NZ,CONTRAINDICATED DRUG PRESCRIBED,1
NZ,CONTUSION,1
NZ,CORONARY ARTERY DISEASE,1
NZ,CORONARY ARTERY OCCLUSION,1
NZ,CREPITATIONS,1
NZ,DEEP VEIN THROMBOSIS,1
NZ,DELUSION,1
NZ,DIABETES MELLITUS,1
NZ,DIABETES MELLITUS INADEQUATE CONTROL,1
NZ,DIABETIC FOOT INFECTION,1
NZ,DIABETIC NEPHROPATHY,1
NZ,DIABETIC RETINOPATHY,1
NZ,DIPLEGIA,1
NZ,DIVERTICULUM,1
NZ,DRUG INEFFECTIVE,1
NZ,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NZ,DYSGEUSIA,1
NZ,DYSLIPIDAEMIA,1
NZ,DYSPNOEA AT REST,1
NZ,DYSPNOEA EXERTIONAL,1
NZ,ENURESIS,1
NZ,EOSINOPHIL COUNT INCREASED,1
NZ,FAECES DISCOLOURED,1
NZ,FUNGAL INFECTION,1
NZ,FURUNCLE,1
NZ,GASTRIC ULCER,1
NZ,GASTROENTERITIS,1
NZ,GENERAL PHYSICAL CONDITION ABNORMAL,1
NZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
NZ,GLOSSITIS,1
NZ,GLUCOSE TOLERANCE IMPAIRED,1
NZ,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
NZ,GOUT,1
NZ,HAEMATOCHEZIA,1
NZ,HAEMATOCRIT DECREASED,1
NZ,HAEMATOCRIT INCREASED,1
NZ,HAEMATURIA,1
NZ,HAEMOGLOBIN INCREASED,1
NZ,HAEMORRHAGE,1
NZ,HAEMORRHAGE INTRACRANIAL,1
NZ,HALLUCINATION_ AUDITORY,1
NZ,HEMIPARESIS,1
NZ,HEMIPLEGIA,1
NZ,HEMISENSORY NEGLECT,1
NZ,HEPATIC FUNCTION ABNORMAL,1
NZ,HEPATIC STEATOSIS,1
NZ,HYPERGLYCAEMIA,1
NZ,HYPERHIDROSIS,1
NZ,HYPERKALAEMIA,1
NZ,HYPERLIPIDAEMIA,1
NZ,HYPERSENSITIVITY VASCULITIS,1
NZ,HYPERSEXUALITY,1
NZ,HYPERTENSION,1
NZ,HYPOTHERMIA,1
NZ,IMPAIRED HEALING,1
NZ,IMPULSE-CONTROL DISORDER,1
NZ,INCONTINENCE,1
NZ,INGUINAL HERNIA,1
NZ,INTERNAL FIXATION OF FRACTURE,1
NZ,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
NZ,INTERNATIONAL NORMALISED RATIO INCREASED,1
NZ,IRRITABILITY,1
NZ,LARGE INTESTINAL HAEMORRHAGE,1
NZ,LARGE INTESTINE POLYP,1
NZ,LEFT VENTRICULAR DYSFUNCTION,1
NZ,LETHARGY,1
NZ,LIMB DISCOMFORT,1
NZ,LIVER FUNCTION TEST ABNORMAL,1
NZ,LOCAL SWELLING,1
NZ,LOCALISED INFECTION,1
NZ,LOSS OF CONSCIOUSNESS,1
NZ,LUNG DISORDER,1
NZ,LUNG INFILTRATION,1
NZ,LYMPH NODE PAIN,1
NZ,LYMPHOCYTE COUNT DECREASED,1
NZ,LYMPHOCYTE COUNT INCREASED,1
NZ,MEAN CELL HAEMOGLOBIN DECREASED,1
NZ,MEAN CELL VOLUME DECREASED,1
NZ,MENORRHAGIA,1
NZ,MENTAL DISORDER,1
NZ,METASTASES TO CENTRAL NERVOUS SYSTEM,1
NZ,METASTASES TO LUNG,1
NZ,METASTATIC NEOPLASM,1
NZ,MOBILITY DECREASED,1
NZ,MONOCYTE COUNT DECREASED,1
NZ,MONOCYTE COUNT INCREASED,1
NZ,MOUTH ULCERATION,1
NZ,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
NZ,MUSCULOSKELETAL STIFFNESS,1
NZ,NECK MASS,1
NZ,NECROBIOSIS LIPOIDICA DIABETICORUM,1
NZ,NEUROPATHY PERIPHERAL,1
NZ,OEDEMA PERIPHERAL,1
NZ,ORGANISING PNEUMONIA,1
NZ,OSTEONECROSIS,1
NZ,OVERDOSE,1
NZ,OXYGEN SATURATION DECREASED,1
NZ,PAIN IN EXTREMITY,1
NZ,PAIN IN JAW,1
NZ,PANCREATITIS,1
NZ,PANIC DISORDER,1
NZ,PARAESTHESIA,1
NZ,PERIORBITAL OEDEMA,1
NZ,PERIPHERAL CIRCULATORY FAILURE,1
NZ,PLASMA CELL MYELOMA,1
NZ,PLATELET COUNT INCREASED,1
NZ,PLATELET TOXICITY,1
NZ,PLEURAL EFFUSION,1
NZ,PNEUMONIA ASPIRATION,1
NZ,POLYPECTOMY,1
NZ,POST-TRAUMATIC PAIN,1
NZ,PRODUCT BLISTER PACKAGING ISSUE,1
NZ,PRODUCT USE ISSUE,1
NZ,PRODUCTIVE COUGH,1
NZ,PSORIASIS,1
NZ,PSYCHIATRIC DECOMPENSATION,1
NZ,PSYCHIATRIC SYMPTOM,1
NZ,PULMONARY HAEMORRHAGE,1
NZ,PULMONARY OEDEMA,1
NZ,PURPURA,1
NZ,RASH ERYTHEMATOUS,1
NZ,RASH MACULO-PAPULAR,1
NZ,RASH PRURITIC,1
NZ,RECTAL ADENOCARCINOMA,1
NZ,RECTAL CANCER,1
NZ,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
NZ,RENAL FAILURE ACUTE,1
NZ,RHEUMATOID ARTHRITIS,1
NZ,SCHIZOPHRENIA,1
NZ,SEDATION,1
NZ,SINUS TACHYCARDIA,1
NZ,SINUSITIS,1
NZ,SKIN INFECTION,1
NZ,SPINAL CORD HAEMATOMA,1
NZ,SQUAMOUS CELL CARCINOMA OF SKIN,1
NZ,SUDDEN DEATH,1
NZ,SUICIDAL IDEATION,1
NZ,SUPRAVENTRICULAR TACHYCARDIA,1
NZ,SUTURE RUPTURE,1
NZ,SYNCOPE,1
NZ,TENDON RUPTURE,1
NZ,THERAPEUTIC RESPONSE DECREASED,1
NZ,THROMBOSIS,1
NZ,TORSADE DE POINTES,1
NZ,TOXICITY TO VARIOUS AGENTS,1
NZ,TROPONIN INCREASED,1
NZ,TROPONIN T INCREASED,1
NZ,TYPE IV HYPERSENSITIVITY REACTION,1
NZ,UNEVALUABLE EVENT,1
NZ,URINARY RETENTION,1
NZ,UROSEPSIS,1
NZ,URTICARIA,1
NZ,UVEITIS,1
NZ,VASCULITIS,1
NZ,VENTRICULAR FIBRILLATION,1
NZ,VERTIGO,1
NZ,VISION BLURRED,1
NZ,VITREOUS DETACHMENT,1
NZ,WEIGHT INCREASED,1
NZ,WEIGHT LOSS POOR,1
NZ,WHITE BLOOD CELL COUNT DECREASED,1
NG,AMNESIA,1
NG,INCOHERENT,1
NG,MEMORY IMPAIRMENT,1
NG,MUSCLE SPASMS,1
NG,MYALGIA,1
NG,READING DISORDER,1
NG,RENAL FAILURE ACUTE,1
NG,TOXIC EPIDERMAL NECROLYSIS,1
NO,MYALGIA,17
NO,DEATH,16
NO,GENERAL PHYSICAL HEALTH DETERIORATION,16
NO,ATRIAL FIBRILLATION,14
NO,CEREBRAL HAEMORRHAGE,14
NO,DYSPNOEA,14
NO,ASTHENIA,13
NO,LACTIC ACIDOSIS,12
NO,HYPOTENSION,11
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,10
NO,OSTEONECROSIS OF JAW,10
NO,FATIGUE,9
NO,RENAL FAILURE,9
NO,ACUTE KIDNEY INJURY,8
NO,PNEUMONIA,8
NO,PYREXIA,8
NO,WEIGHT INCREASED,8
NO,CEREBRAL INFARCTION,7
NO,MALAISE,7
NO,MYOPATHY,7
NO,OSTEITIS,7
NO,ADENOCARCINOMA OF COLON,6
NO,ALANINE AMINOTRANSFERASE INCREASED,6
NO,BLOOD CREATININE INCREASED,6
NO,HYPERKALAEMIA,6
NO,HYPOGLYCAEMIA,6
NO,IMMUNE-MEDIATED NECROTISING MYOPATHY,6
NO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,6
NO,INFLUENZA LIKE ILLNESS,6
NO,LARGE INTESTINE POLYP,6
NO,RENAL FAILURE ACUTE,6
NO,VOMITING,6
NO,CARDIAC FAILURE,5
NO,DIARRHOEA,5
NO,DIZZINESS,5
NO,DRUG EFFECT DECREASED,5
NO,DRUG LEVEL BELOW THERAPEUTIC,5
NO,DUODENAL ULCER HAEMORRHAGE,5
NO,GAIT DISTURBANCE,5
NO,HEADACHE,5
NO,HEPATIC FAILURE,5
NO,HERPES ZOSTER,5
NO,HYPOTHERMIA,5
NO,OPHTHALMIC HERPES ZOSTER,5
NO,PHOTOSENSITIVITY REACTION,5
NO,PLATELET COUNT DECREASED,5
NO,PULMONARY FIBROSIS,5
NO,ROSACEA,5
NO,SINUS BRADYCARDIA,5
NO,ULCERATIVE KERATITIS,5
NO,ARTHRALGIA,4
NO,BLOOD PRESSURE DECREASED,4
NO,CONSTIPATION,4
NO,DEHYDRATION,4
NO,DRUG INEFFECTIVE,4
NO,DRUG LEVEL INCREASED,4
NO,FEMUR FRACTURE,4
NO,HAEMORRHAGE,4
NO,HYPOAESTHESIA,4
NO,MUSCLE NECROSIS,4
NO,MUSCULAR WEAKNESS,4
NO,MYELODYSPLASTIC SYNDROME,4
NO,MYOGLOBIN BLOOD INCREASED,4
NO,NEUTROPENIA,4
NO,PERICARDITIS,4
NO,PLEURISY,4
NO,POLYNEUROPATHY,4
NO,PULMONARY EMBOLISM,4
NO,RHABDOMYOLYSIS,4
NO,SEPSIS,4
NO,SOMNOLENCE,4
NO,SPLENIC HAEMORRHAGE,4
NO,SYNCOPE,4
NO,TOXICITY TO VARIOUS AGENTS,4
NO,WHITE BLOOD CELL COUNT DECREASED,4
NO,ACUTE HEPATIC FAILURE,3
NO,AMNESIA,3
NO,ANAEMIA,3
NO,ANAPHYLACTIC REACTION,3
NO,ARRHYTHMIA,3
NO,BALANCE DISORDER,3
NO,BLOOD URINE PRESENT,3
NO,CHEST PAIN,3
NO,CHROMATURIA,3
NO,COLLAGEN DISORDER,3
NO,CONDITION AGGRAVATED,3
NO,EPISTAXIS,3
NO,HAEMOGLOBIN DECREASED,3
NO,HAEMORRHAGIC ANAEMIA,3
NO,HYPOKALAEMIA,3
NO,IMPAIRED WORK ABILITY,3
NO,INTERNATIONAL NORMALISED RATIO INCREASED,3
NO,INTERSTITIAL LUNG DISEASE,3
NO,LEUKOPENIA,3
NO,LOSS OF CONSCIOUSNESS,3
NO,MYOSITIS,3
NO,NAUSEA,3
NO,OSTEOMYELITIS,3
NO,PALPITATIONS,3
NO,PARAESTHESIA,3
NO,RESPIRATION ABNORMAL,3
NO,SPEECH DISORDER,3
NO,STOMATITIS,3
NO,THROMBOCYTOPENIA,3
NO,TRANSAMINASES INCREASED,3
NO,URINARY BLADDER HAEMORRHAGE,3
NO,URINARY TRACT INFECTION,3
NO,URTICARIA,3
NO,ABDOMINAL PAIN,2
NO,ABDOMINAL PAIN UPPER,2
NO,ACUTE MYOCARDIAL INFARCTION,2
NO,ANGINA UNSTABLE,2
NO,AORTIC VALVE INCOMPETENCE,2
NO,ARTERIOSCLEROSIS,2
NO,AUTOIMMUNE DISORDER,2
NO,BONE LESION,2
NO,C-REACTIVE PROTEIN INCREASED,2
NO,CEREBROVASCULAR ACCIDENT,2
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
NO,CIRCULATORY COLLAPSE,2
NO,COGNITIVE DISORDER,2
NO,COMA,2
NO,CORONARY ARTERY STENOSIS,2
NO,COUGH,2
NO,DECREASED APPETITE,2
NO,DELIRIUM,2
NO,DEPRESSION,2
NO,DILATATION VENTRICULAR,2
NO,DISABILITY,2
NO,DISSEMINATED INTRAVASCULAR COAGULATION,2
NO,DRUG EFFECT INCOMPLETE,2
NO,DUODENITIS,2
NO,DYSCHEZIA,2
NO,EMBOLISM ARTERIAL,2
NO,ERECTILE DYSFUNCTION,2
NO,ERYTHEMA,2
NO,EXPOSED BONE IN JAW,2
NO,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
NO,GASTRITIS,2
NO,GASTRODUODENITIS,2
NO,GASTROENTERITIS,2
NO,HAEMORRHAGE SUBCUTANEOUS,2
NO,HEPATITIS,2
NO,HEPATOCELLULAR CARCINOMA,2
NO,HYPOTHYROIDISM,2
NO,INFECTION,2
NO,INTESTINAL STENOSIS,2
NO,LUNG DISORDER,2
NO,MEDICATION ERROR,2
NO,MEMORY IMPAIRMENT,2
NO,METASTASES TO LIVER,2
NO,MONOPLEGIA,2
NO,MULTI-ORGAN FAILURE,2
NO,MUSCLE CONTRACTIONS INVOLUNTARY,2
NO,MUSCULOSKELETAL PAIN,2
NO,MUSCULOSKELETAL STIFFNESS,2
NO,NECROTISING MYOSITIS,2
NO,OEDEMA PERIPHERAL,2
NO,OROPHARYNGEAL PAIN,2
NO,PAIN,2
NO,PAIN IN EXTREMITY,2
NO,PANCREATIC CARCINOMA,2
NO,PERICARDIAL EFFUSION,2
NO,PERIPHERAL ARTERY THROMBOSIS,2
NO,PERIPHERAL ISCHAEMIA,2
NO,PLATELET COUNT INCREASED,2
NO,PLEURAL EFFUSION,2
NO,PLEUROPERICARDITIS,2
NO,PNEUMONITIS,2
NO,PRODUCT USE IN UNAPPROVED INDICATION,2
NO,PRURITUS,2
NO,PULMONARY CONGESTION,2
NO,RASH,2
NO,STEVENS-JOHNSON SYNDROME,2
NO,SUBILEUS,2
NO,SUDDEN DEATH,2
NO,SWELLING FACE,2
NO,TESTICULAR MASS,2
NO,THROMBOTIC CEREBRAL INFARCTION,2
NO,URINE OUTPUT INCREASED,2
NO,UROSEPSIS,2
NO,VISUAL FIELD DEFECT,2
NO,VISUAL IMPAIRMENT,2
NO,WEIGHT DECREASED,2
NO,ABDOMINAL DISTENSION,1
NO,ABDOMINAL INFECTION,1
NO,ABNORMAL BEHAVIOUR,1
NO,ACCIDENTAL OVERDOSE,1
NO,ACCIDENTAL POISONING,1
NO,ACUTE RESPIRATORY DISTRESS SYNDROME,1
NO,ANAL HAEMORRHAGE,1
NO,ANASTOMOTIC STENOSIS,1
NO,ANGIOEDEMA,1
NO,ANKLE FRACTURE,1
NO,ANTEROGRADE AMNESIA,1
NO,ANXIETY,1
NO,AORTIC ANEURYSM,1
NO,AORTIC ANEURYSM RUPTURE,1
NO,APHASIA,1
NO,APLASTIC ANAEMIA,1
NO,ASPARTATE AMINOTRANSFERASE INCREASED,1
NO,ATRIAL THROMBOSIS,1
NO,ATRIOVENTRICULAR BLOCK,1
NO,ATYPICAL FEMUR FRACTURE,1
NO,BACTERIAL TEST POSITIVE,1
NO,BILIARY TRACT DISORDER,1
NO,BIOPSY KIDNEY ABNORMAL,1
NO,BLOOD BILIRUBIN INCREASED,1
NO,BLOOD GLUCOSE INCREASED,1
NO,BLOOD UREA INCREASED,1
NO,BONE MARROW FAILURE,1
NO,BONE NEOPLASM,1
NO,BREAST CANCER RECURRENT,1
NO,BURSITIS,1
NO,CARDIAC ARREST,1
NO,CARDIAC DEATH,1
NO,CHEST DISCOMFORT,1
NO,CHEST X-RAY ABNORMAL,1
NO,CHEYNE-STOKES RESPIRATION,1
NO,CHILLS,1
NO,CHOLELITHIASIS,1
NO,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
NO,CLOSTRIDIUM TEST POSITIVE,1
NO,COLITIS ISCHAEMIC,1
NO,CONGESTIVE CARDIOMYOPATHY,1
NO,CONJUNCTIVAL IRRITATION,1
NO,CONTRAINDICATION TO MEDICAL TREATMENT,1
NO,CONVULSION,1
NO,COORDINATION ABNORMAL,1
NO,CORONARY ARTERY DISEASE,1
NO,CRYSTAL URINE,1
NO,CYANOSIS,1
NO,DERMATITIS,1
NO,DIABETES MELLITUS INADEQUATE CONTROL,1
NO,DIABETIC KETOACIDOSIS,1
NO,DIALYSIS,1
NO,DIFFUSE LARGE B-CELL LYMPHOMA,1
NO,DIPLOPIA,1
NO,DISEASE COMPLICATION,1
NO,DISEASE RECURRENCE,1
NO,DRUG ERUPTION,1
NO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NO,DRUG-INDUCED LIVER INJURY,1
NO,DRY MOUTH,1
NO,DUODENAL ULCER,1
NO,DYSPHAGIA,1
NO,DYSPHONIA,1
NO,DYSPNOEA EXERTIONAL,1
NO,ELECTROCARDIOGRAM PQ INTERVAL PROLONGED,1
NO,ELECTROCARDIOGRAM QRS COMPLEX,1
NO,EMPYEMA,1
NO,ENCEPHALOPATHY,1
NO,EOSINOPHIL COUNT INCREASED,1
NO,EPILEPSY,1
NO,EPSTEIN-BARR VIRUS INFECTION,1
NO,ERYSIPELAS,1
NO,ESCHERICHIA BACTERAEMIA,1
NO,EXTRA DOSE ADMINISTERED,1
NO,EXTRADURAL ABSCESS,1
NO,EYE PRURITUS,1
NO,FALL,1
NO,FEELING HOT,1
NO,FIBRIN D DIMER INCREASED,1
NO,FRACTURE,1
NO,GASTROENTERITIS ROTAVIRUS,1
NO,GENERALISED ANXIETY DISORDER,1
NO,HAEMATOCRIT INCREASED,1
NO,HAEMATOMA,1
NO,HAEMATURIA TRAUMATIC,1
NO,HAEMOGLOBIN INCREASED,1
NO,HAEMOLYTIC URAEMIC SYNDROME,1
NO,HAEMORRHAGE INTRACRANIAL,1
NO,HAEMORRHAGIC CEREBRAL INFARCTION,1
NO,HAEMOTHORAX,1
NO,HEMIPARESIS,1
NO,HEPATIC CIRRHOSIS,1
NO,HEPATIC CONGESTION,1
NO,HEPATIC ENZYME INCREASED,1
NO,HERBAL TOXICITY,1
NO,HYPERCALCAEMIA,1
NO,HYPERSENSITIVITY,1
NO,HYPERSOMNIA,1
NO,HYPERTENSION,1
NO,HYPERTHYROIDISM,1
NO,HYPERVENTILATION,1
NO,HYPOGLYCAEMIA UNAWARENESS,1
NO,HYPONATRAEMIA,1
NO,HYPOOSMOLAR STATE,1
NO,HYPOTONIA,1
NO,HYPOVENTILATION,1
NO,HYPOXIA,1
NO,IRON DEFICIENCY ANAEMIA,1
NO,ISCHAEMIC CARDIOMYOPATHY,1
NO,ISCHAEMIC STROKE,1
NO,JAUNDICE,1
NO,JAW FRACTURE,1
NO,JOINT STIFFNESS,1
NO,KETOACIDOSIS,1
NO,KIDNEY INFECTION,1
NO,LARGE INTESTINE PERFORATION,1
NO,LIPOMA,1
NO,LIPOPROTEIN (A) INCREASED,1
NO,LUNG NEOPLASM MALIGNANT,1
NO,MALIGNANT NEOPLASM PROGRESSION,1
NO,MELAENA,1
NO,METABOLIC ACIDOSIS,1
NO,METASTASES TO LYMPH NODES,1
NO,MOBILITY DECREASED,1
NO,MUSCLE SPASMS,1
NO,MYDRIASIS,1
NO,MYOCARDIAL INFARCTION,1
NO,MYOCARDIAL ISCHAEMIA,1
NO,NASOPHARYNGITIS,1
NO,NECROSIS,1
NO,NERVOUS SYSTEM DISORDER,1
NO,NEURALGIC AMYOTROPHY,1
NO,NIGHTMARE,1
NO,OEDEMA,1
NO,OESOPHAGITIS,1
NO,OLIGURIA,1
NO,OPHTHALMIC VEIN THROMBOSIS,1
NO,ORAL DISCOMFORT,1
NO,ORTHOSTATIC HYPOTENSION,1
NO,OSTEOARTHRITIS,1
NO,OVARIAN CYST,1
NO,OVERDOSE,1
NO,OXYGEN SATURATION DECREASED,1
NO,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
NO,PANCREATITIS,1
NO,PANIC DISORDER WITH AGORAPHOBIA,1
NO,PARESIS,1
NO,PHARYNGEAL OEDEMA,1
NO,PHOTOPSIA,1
NO,POLLAKIURIA,1
NO,POLYURIA,1
NO,POOR QUALITY SLEEP,1
NO,PRERENAL FAILURE,1
NO,PRESCRIBED OVERDOSE,1
NO,PRINZMETAL ANGINA,1
NO,PROGRESSIVE SUPRANUCLEAR PALSY,1
NO,PROSTATE CANCER,1
NO,PSEUDOMONAS TEST POSITIVE,1
NO,PSORIATIC ARTHROPATHY,1
NO,PULMONARY ARTERIAL HYPERTENSION,1
NO,PULMONARY EOSINOPHILIA,1
NO,PULMONARY OEDEMA,1
NO,PULSE ABSENT,1
NO,PURPURA,1
NO,RASH ERYTHEMATOUS,1
NO,RASH GENERALISED,1
NO,RASH MACULO-PAPULAR,1
NO,RECTAL POLYP,1
NO,RENAL IMPAIRMENT,1
NO,RESPIRATORY TRACT INFECTION,1
NO,RETINAL ARTERY OCCLUSION,1
NO,RETROPERITONEAL MASS,1
NO,RHEUMATOID ARTHRITIS,1
NO,ROAD TRAFFIC ACCIDENT,1
NO,SARCOPENIA,1
NO,SENSORY DISTURBANCE,1
NO,SHOCK,1
NO,SKIN DISCOLOURATION,1
NO,SKIN HAEMORRHAGE,1
NO,SKIN REACTION,1
NO,SOMNAMBULISM,1
NO,SPINAL CORD INFARCTION,1
NO,STAPHYLOCOCCAL INFECTION,1
NO,STRESS FRACTURE,1
NO,SUBDURAL HAEMATOMA,1
NO,SUDDEN CARDIAC DEATH,1
NO,SUDDEN VISUAL LOSS,1
NO,SWOLLEN TONGUE,1
NO,TENDON RUPTURE,1
NO,THORACOSTOMY,1
NO,THROMBOSIS,1
NO,TOXIC EPIDERMAL NECROLYSIS,1
NO,TRANSIENT ISCHAEMIC ATTACK,1
NO,TREATMENT FAILURE,1
NO,TREMOR,1
NO,TUBULOINTERSTITIAL NEPHRITIS,1
NO,ULCER HAEMORRHAGE,1
NO,UPPER RESPIRATORY TRACT INFECTION,1
NO,URINARY RETENTION,1
NO,VIITH NERVE PARALYSIS,1
NO,VISION BLURRED,1
NO,WAIST CIRCUMFERENCE INCREASED,1
NO,WRONG PATIENT RECEIVED MEDICATION,1
PA,MYOCARDIAL INFARCTION,2
PA,AMNESIA,1
PA,ASTHMATIC CRISIS,1
PA,BLOOD PRESSURE DECREASED,1
PA,BRADYARRHYTHMIA,1
PA,DECREASED APPETITE,1
PA,DIABETES MELLITUS,1
PA,DYSKINESIA,1
PA,DYSSTASIA,1
PA,FATIGUE,1
PA,GLOMERULAR FILTRATION RATE DECREASED,1
PA,HAEMOGLOBIN DECREASED,1
PA,HUNGER,1
PA,MEMORY IMPAIRMENT,1
PA,METASTASES TO LUNG,1
PA,MUSCLE CONTRACTIONS INVOLUNTARY,1
PA,MUSCLE RIGIDITY,1
PA,MYALGIA,1
PA,NAUSEA,1
PA,NEOPLASM MALIGNANT,1
PA,NEURALGIA,1
PA,NUCHAL RIGIDITY,1
PA,PAIN,1
PA,PALATAL DISORDER,1
PA,PERIPHERAL SWELLING,1
PA,PLATELET COUNT DECREASED,1
PA,PRURITUS,1
PA,RENAL PAIN,1
PA,RESPIRATORY FAILURE,1
PA,SEIZURE,1
PA,SINGLE FUNCTIONAL KIDNEY,1
PA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
PE,ACUTE MYOCARDIAL INFARCTION,1
PE,ATRIAL FIBRILLATION,1
PE,CARCINOMA IN SITU,1
PE,DEATH,1
PE,EROSIVE DUODENITIS,1
PE,GASTROINTESTINAL HAEMORRHAGE,1
PE,IRON DEFICIENCY ANAEMIA,1
PE,MYOCARDIAL INFARCTION,1
PH,BLOOD GLUCOSE INCREASED,7
PH,PNEUMONIA,6
PH,CEREBROVASCULAR ACCIDENT,5
PH,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
PH,MYOCARDIAL INFARCTION,4
PH,BLOOD GLUCOSE ABNORMAL,3
PH,BLOOD PRESSURE INCREASED,3
PH,CHOLELITHIASIS,3
PH,DIABETIC COMPLICATION,3
PH,PERITONITIS,3
PH,ABDOMINAL PAIN UPPER,2
PH,ASTHENIA,2
PH,BLOOD CREATININE INCREASED,2
PH,CARDIAC ARREST,2
PH,CARDIAC FAILURE CONGESTIVE,2
PH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
PH,CONCOMITANT DISEASE PROGRESSION,2
PH,DIZZINESS,2
PH,DYSPNOEA,2
PH,EPISTAXIS,2
PH,GASTRITIS,2
PH,HAEMOGLOBIN DECREASED,2
PH,HYPERSENSITIVITY,2
PH,PLEURAL EFFUSION,2
PH,PULMONARY OEDEMA,2
PH,STRESS,2
PH,URINARY TRACT INFECTION,2
PH,VOMITING,2
PH,WHITE BLOOD CELL COUNT INCREASED,2
PH,WOUND,2
PH,ABDOMINAL ADHESIONS,1
PH,AKINESIA,1
PH,ALANINE AMINOTRANSFERASE INCREASED,1
PH,AMOEBIASIS,1
PH,ANGINA UNSTABLE,1
PH,ARRHYTHMIA,1
PH,ARTERIAL OCCLUSIVE DISEASE,1
PH,ASTHMA,1
PH,ATELECTASIS,1
PH,BLOOD CHOLESTEROL INCREASED,1
PH,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PH,BLOOD GLUCOSE DECREASED,1
PH,BRAIN OEDEMA,1
PH,BRAIN STEM INFARCTION,1
PH,BREAST CANCER FEMALE,1
PH,CARDIAC DISORDER,1
PH,CARDIAC PACEMAKER INSERTION,1
PH,CARDIO-RESPIRATORY ARREST,1
PH,CARDIOMEGALY,1
PH,CENTRAL NERVOUS SYSTEM HAEMORRHAGE,1
PH,CHOLECYSTECTOMY,1
PH,CHOLECYSTITIS,1
PH,CHRONIC MYELOID LEUKAEMIA,1
PH,COSTOVERTEBRAL ANGLE TENDERNESS,1
PH,DEATH,1
PH,DEBRIDEMENT,1
PH,DEEP VEIN THROMBOSIS,1
PH,DEFECT CONDUCTION INTRAVENTRICULAR,1
PH,DEHYDRATION,1
PH,DEMENTIA,1
PH,DENGUE FEVER,1
PH,DERMATITIS EXFOLIATIVE,1
PH,DIABETES MELLITUS,1
PH,DRUG INEFFECTIVE,1
PH,DRUG RESISTANCE,1
PH,DRUG-INDUCED LIVER INJURY,1
PH,DRY MOUTH,1
PH,DYSPNOEA PAROXYSMAL NOCTURNAL,1
PH,EATING DISORDER,1
PH,EXFOLIATIVE RASH,1
PH,EYE HAEMORRHAGE,1
PH,FATIGUE,1
PH,FIBROSIS,1
PH,FLUID OVERLOAD,1
PH,FURUNCLE,1
PH,GAIT DISTURBANCE,1
PH,GASTRITIS EROSIVE,1
PH,GASTROENTERITIS,1
PH,GUILLAIN-BARRE SYNDROME,1
PH,HAEMATEMESIS,1
PH,HAEMATOCHEZIA,1
PH,HAEMATOCRIT DECREASED,1
PH,HAEMATURIA,1
PH,HAEMORRHAGE INTRACRANIAL,1
PH,HAEMORRHAGIC STROKE,1
PH,HEMIPLEGIA,1
PH,HEPATIC STEATOSIS,1
PH,HEPATOTOXICITY,1
PH,HYPERPHAGIA,1
PH,HYPERTENSION,1
PH,IMPAIRED HEALING,1
PH,INJURY,1
PH,INTERMITTENT CLAUDICATION,1
PH,IRON DEFICIENCY ANAEMIA,1
PH,JAUNDICE,1
PH,LABORATORY TEST ABNORMAL,1
PH,LEFT ATRIAL DILATATION,1
PH,LEFT VENTRICULAR HYPERTROPHY,1
PH,LIVER INJURY,1
PH,LOCALISED INFECTION,1
PH,LUNG NEOPLASM MALIGNANT,1
PH,LYMPHOCYTE COUNT DECREASED,1
PH,MELAENA,1
PH,MOUTH SWELLING,1
PH,MULTI-ORGAN FAILURE,1
PH,MULTIPLE FRACTURES,1
PH,MYOCARDIAL ISCHAEMIA,1
PH,NEPHROLITHIASIS,1
PH,NERVE COMPRESSION,1
PH,NEUTROPHIL COUNT DECREASED,1
PH,NONINFECTIVE ENCEPHALITIS,1
PH,OESOPHAGEAL ULCER,1
PH,ONCOLOGIC COMPLICATION,1
PH,ORAL MUCOSAL ERYTHEMA,1
PH,ORTHOPNOEA,1
PH,PAIN IN EXTREMITY,1
PH,PEPTIC ULCER,1
PH,PERITONEAL DIALYSIS COMPLICATION,1
PH,PERITONEAL DISORDER,1
PH,PLATELET COUNT DECREASED,1
PH,PNEUMONIA ASPIRATION,1
PH,POLYURIA,1
PH,PRODUCT USE ISSUE,1
PH,PROSTATOMEGALY,1
PH,PULMONARY TUBERCULOSIS,1
PH,PYREXIA,1
PH,RASH,1
PH,RED BLOOD CELL COUNT DECREASED,1
PH,RED CELL DISTRIBUTION WIDTH INCREASED,1
PH,RENAL COLIC,1
PH,RENAL DISORDER,1
PH,RENAL FAILURE,1
PH,RHABDOMYOLYSIS,1
PH,SEPSIS,1
PH,SEPTIC SHOCK,1
PH,SINUS HEADACHE,1
PH,SPINAL DISORDER,1
PH,SUPRAVENTRICULAR TACHYCARDIA,1
PH,THROMBOTIC STROKE,1
PH,TRANSIENT ISCHAEMIC ATTACK,1
PH,ULCER,1
PH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
PH,UTERINE ATROPHY,1
PH,VAGINAL PROLAPSE,1
PH,VASCULAR GRAFT,1
PH,VENOUS OCCLUSION,1
PH,VENTRICULAR ARRHYTHMIA,1
PL,MYALGIA,14
PL,ASTHENIA,11
PL,DIZZINESS,11
PL,CONFUSIONAL STATE,10
PL,BLOOD PRESSURE DECREASED,8
PL,CHEST PAIN,8
PL,COUGH,8
PL,DYSPNOEA,8
PL,OEDEMA PERIPHERAL,7
PL,OVERDOSE,7
PL,THROMBOCYTOPENIA,7
PL,ANAEMIA,6
PL,BRADYCARDIA,6
PL,DRUG INTOLERANCE,6
PL,HYPERTENSION,6
PL,MUSCLE SPASMS,6
PL,MUSCULAR WEAKNESS,6
PL,TINNITUS,6
PL,ATRIAL FIBRILLATION,5
PL,DEPRESSION,5
PL,MALAISE,5
PL,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
PL,FEELING ABNORMAL,4
PL,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,4
PL,LABILE HYPERTENSION,4
PL,MYOCARDIAL INFARCTION,4
PL,PUSTULAR PSORIASIS,4
PL,PYREXIA,4
PL,TOXICITY TO VARIOUS AGENTS,4
PL,AGGRESSION,3
PL,CARDIAC FAILURE CONGESTIVE,3
PL,CEREBROVASCULAR ACCIDENT,3
PL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
PL,COGNITIVE DISORDER,3
PL,CORONARY ARTERY DISEASE,3
PL,DIABETES MELLITUS,3
PL,INSOMNIA,3
PL,ISCHAEMIC STROKE,3
PL,LABILE BLOOD PRESSURE,3
PL,MATERNAL EXPOSURE DURING PREGNANCY,3
PL,PNEUMONIA,3
PL,ACUTE MYOCARDIAL INFARCTION,2
PL,ANGINA PECTORIS,2
PL,ANXIETY,2
PL,ARTHRALGIA,2
PL,ASPARTATE AMINOTRANSFERASE INCREASED,2
PL,BLADDER CANCER,2
PL,BLOOD CHOLESTEROL INCREASED,2
PL,BLOOD GLUCOSE DECREASED,2
PL,BLOOD GLUCOSE INCREASED,2
PL,BONE MARROW FAILURE,2
PL,C-REACTIVE PROTEIN INCREASED,2
PL,CARDIAC FAILURE,2
PL,CHILLS,2
PL,CHOLECYSTITIS,2
PL,CHOLELITHIASIS,2
PL,CIRCULATORY COLLAPSE,2
PL,CONDITION AGGRAVATED,2
PL,DECREASED APPETITE,2
PL,DIARRHOEA,2
PL,DISTURBANCE IN ATTENTION,2
PL,DRUG INEFFECTIVE,2
PL,DYSLIPIDAEMIA,2
PL,EPISTAXIS,2
PL,FATIGUE,2
PL,GENERAL PHYSICAL HEALTH DETERIORATION,2
PL,HEPATIC STEATOSIS,2
PL,HYPOAESTHESIA,2
PL,LEUKOPENIA,2
PL,LIVE BIRTH,2
PL,LOSS OF CONSCIOUSNESS,2
PL,LOWER GASTROINTESTINAL HAEMORRHAGE,2
PL,LOWER RESPIRATORY TRACT INFECTION,2
PL,MITRAL VALVE INCOMPETENCE,2
PL,MUSCULOSKELETAL PAIN,2
PL,NERVOUSNESS,2
PL,NEUTROPENIA,2
PL,OBESITY,2
PL,PAIN IN EXTREMITY,2
PL,PANCYTOPENIA,2
PL,PELVIC ABSCESS,2
PL,PERIPHERAL SWELLING,2
PL,PLASMA CELL MYELOMA,2
PL,PREMATURE DELIVERY,2
PL,PSORIASIS,2
PL,RECTAL ADENOCARCINOMA,2
PL,URINARY TRACT INFECTION,2
PL,ABDOMINAL PAIN UPPER,1
PL,ABNORMAL LOSS OF WEIGHT,1
PL,ACANTHOSIS,1
PL,ACIDOSIS,1
PL,ACQUIRED HAEMOPHILIA,1
PL,ACUTE KIDNEY INJURY,1
PL,ADENOCARCINOMA OF COLON,1
PL,ALANINE AMINOTRANSFERASE INCREASED,1
PL,ALOPECIA,1
PL,AMNESIA,1
PL,AORTIC VALVE STENOSIS,1
PL,APPENDICITIS,1
PL,ARTERIOSCLEROSIS,1
PL,ARTERIOSCLEROSIS CORONARY ARTERY,1
PL,ARTERIOVENOUS FISTULA THROMBOSIS,1
PL,ATRIAL FLUTTER,1
PL,B-LYMPHOCYTE COUNT DECREASED,1
PL,BACK PAIN,1
PL,BLADDER NEOPLASM,1
PL,BLINDNESS,1
PL,BLOOD ALBUMIN ABNORMAL,1
PL,BLOOD ALBUMIN DECREASED,1
PL,BLOOD CREATININE ABNORMAL,1
PL,BLOOD POTASSIUM DECREASED,1
PL,BLOOD PRESSURE ABNORMAL,1
PL,BLOOD PRESSURE INCREASED,1
PL,BLOOD THYROID STIMULATING HORMONE INCREASED,1
PL,BLOOD TRIGLYCERIDES INCREASED,1
PL,BLOOD UREA INCREASED,1
PL,BODY TEMPERATURE INCREASED,1
PL,BONE MARROW TOXICITY,1
PL,BONE PAIN,1
PL,BRADYARRHYTHMIA,1
PL,BREAST CANCER FEMALE,1
PL,BRONCHITIS,1
PL,BRONCHOPNEUMONIA,1
PL,BUNDLE BRANCH BLOCK RIGHT,1
PL,CARDIAC ARREST,1
PL,CARDIAC FAILURE CHRONIC,1
PL,CARDIAC HYPERTROPHY,1
PL,CARDIAC MURMUR,1
PL,CARDIOMEGALY,1
PL,CARDIOMYOPATHY,1
PL,CARDIOPULMONARY FAILURE,1
PL,CARDIOVASCULAR DISORDER,1
PL,CHRONIC MYELOID LEUKAEMIA,1
PL,COAGULATION TIME PROLONGED,1
PL,COLON CANCER,1
PL,COLON CANCER METASTATIC,1
PL,CONCOMITANT DISEASE PROGRESSION,1
PL,CONTUSION,1
PL,COORDINATION ABNORMAL,1
PL,CORONARY ARTERY EMBOLISM,1
PL,CORONARY ARTERY STENOSIS,1
PL,CROHN^S DISEASE,1
PL,CYSTITIS,1
PL,CYTOMEGALOVIRUS INFECTION,1
PL,DEATH,1
PL,DEHYDRATION,1
PL,DERMATITIS ALLERGIC,1
PL,DIABETES MELLITUS INADEQUATE CONTROL,1
PL,DISSEMINATED INTRAVASCULAR COAGULATION,1
PL,DISSOCIATION,1
PL,DRUG-INDUCED LIVER INJURY,1
PL,DRY GANGRENE,1
PL,DYSARTHRIA,1
PL,DYSPHONIA,1
PL,DYSPNOEA EXERTIONAL,1
PL,DYSSTASIA,1
PL,ELECTROCARDIOGRAM QT PROLONGED,1
PL,ELECTROCARDIOGRAM T WAVE INVERSION,1
PL,ELECTROLYTE IMBALANCE,1
PL,EMBOLISM VENOUS,1
PL,ENTEROCUTANEOUS FISTULA,1
PL,ENZYME LEVEL INCREASED,1
PL,EOSINOPHIL COUNT INCREASED,1
PL,ERUCTATION,1
PL,ERYTHEMA,1
PL,EXERCISE TOLERANCE DECREASED,1
PL,EXTRAPYRAMIDAL DISORDER,1
PL,EYE HAEMORRHAGE,1
PL,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PL,GASTROENTERITIS,1
PL,GASTROOESOPHAGEAL REFLUX DISEASE,1
PL,GENERAL PHYSICAL CONDITION ABNORMAL,1
PL,GLOTTIS CARCINOMA,1
PL,HAEMATOCRIT DECREASED,1
PL,HAEMOGLOBIN DECREASED,1
PL,HAEMOPTYSIS,1
PL,HAEMORRHAGE,1
PL,HAEMORRHAGE INTRACRANIAL,1
PL,HAEMORRHAGIC DIATHESIS,1
PL,HAEMORRHAGIC TRANSFORMATION STROKE,1
PL,HEART RATE INCREASED,1
PL,HEART VALVE INCOMPETENCE,1
PL,HEMIPARESIS,1
PL,HISTIOCYTOSIS HAEMATOPHAGIC,1
PL,HYPERCHOLESTEROLAEMIA,1
PL,HYPERKALAEMIA,1
PL,HYPERTHYROIDISM,1
PL,HYPOGLYCAEMIA,1
PL,HYPOTENSION,1
PL,HYPOTHYROIDISM,1
PL,HYPOTONIA,1
PL,IDIOPATHIC PULMONARY FIBROSIS,1
PL,ILEUS,1
PL,ILL-DEFINED DISORDER,1
PL,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
PL,INFLUENZA LIKE ILLNESS,1
PL,INTERSTITIAL LUNG DISEASE,1
PL,INTESTINAL OBSTRUCTION,1
PL,INTESTINAL PERFORATION,1
PL,IRRITABILITY,1
PL,IRRITABLE BOWEL SYNDROME,1
PL,KUSSMAUL RESPIRATION,1
PL,LACTIC ACIDOSIS,1
PL,LEFT ATRIAL DILATATION,1
PL,LEFT VENTRICULAR DYSFUNCTION,1
PL,LEFT VENTRICULAR HYPERTROPHY,1
PL,LIPIDS INCREASED,1
PL,LIVER DISORDER,1
PL,LIVER INJURY,1
PL,LOW DENSITY LIPOPROTEIN INCREASED,1
PL,LUNG ADENOCARCINOMA,1
PL,LUNG NEOPLASM,1
PL,LUNG NEOPLASM MALIGNANT,1
PL,MALIGNANT NEOPLASM PROGRESSION,1
PL,MEMORY IMPAIRMENT,1
PL,MENTAL DISORDER,1
PL,METASTASES TO CENTRAL NERVOUS SYSTEM,1
PL,MITRAL VALVE CALCIFICATION,1
PL,MITRAL VALVE SCLEROSIS,1
PL,MITRAL VALVE STENOSIS,1
PL,MONOCYTE COUNT INCREASED,1
PL,MOTOR DYSFUNCTION,1
PL,MULTI-ORGAN FAILURE,1
PL,MUSCLE TIGHTNESS,1
PL,MYOCARDIAL ISCHAEMIA,1
PL,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
PL,NERVOUS SYSTEM DISORDER,1
PL,NEUROLEPTIC MALIGNANT SYNDROME,1
PL,OSTEOARTHRITIS,1
PL,OSTEONECROSIS OF JAW,1
PL,PAIN,1
PL,PALPITATIONS,1
PL,PANCREATIC CARCINOMA,1
PL,PARAESTHESIA ORAL,1
PL,PERFORMANCE STATUS DECREASED,1
PL,PERIPHERAL VASCULAR DISORDER,1
PL,PLATELET AGGREGATION INCREASED,1
PL,PREMATURE RUPTURE OF MEMBRANES,1
PL,PRINZMETAL ANGINA,1
PL,PROSTATE CANCER,1
PL,PSYCHOMOTOR RETARDATION,1
PL,PULMONARY CONGESTION,1
PL,PULMONARY EMBOLISM,1
PL,PULMONARY MASS,1
PL,RASH,1
PL,RASH PUSTULAR,1
PL,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PL,RENAL ARTERY STENOSIS,1
PL,RENAL FAILURE,1
PL,RESPIRATORY ARREST,1
PL,RESPIRATORY DISORDER,1
PL,RESTLESSNESS,1
PL,RETINAL DRUSEN,1
PL,RETINOPATHY,1
PL,RETINOPATHY HYPERTENSIVE,1
PL,RHEUMATOID ARTHRITIS,1
PL,RHINORRHOEA,1
PL,RIGHT ATRIAL DILATATION,1
PL,SEIZURE,1
PL,SINUS TACHYCARDIA,1
PL,SKIN PLAQUE,1
PL,SPINAL PAIN,1
PL,SPUTUM DISCOLOURED,1
PL,STAPHYLOCOCCAL SEPSIS,1
PL,SUDDEN DEATH,1
PL,SUICIDE ATTEMPT,1
PL,SYNCOPE,1
PL,SYSTEMIC SCLERODERMA,1
PL,T-LYMPHOCYTE COUNT INCREASED,1
PL,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
PL,TOXOPLASMOSIS,1
PL,TRANSIENT ISCHAEMIC ATTACK,1
PL,TREATMENT NONCOMPLIANCE,1
PL,TRICUSPID VALVE INCOMPETENCE,1
PL,TYPE 2 DIABETES MELLITUS,1
PL,VARICES OESOPHAGEAL,1
PL,VASCULAR PSEUDOANEURYSM,1
PL,VENTRICULAR TACHYCARDIA,1
PL,VOLVULUS,1
PL,WEIGHT DECREASED,1
PL,WEIGHT INCREASED,1
PT,DRUG INEFFECTIVE,30
PT,DYSPNOEA,16
PT,LACTIC ACIDOSIS,15
PT,ACUTE KIDNEY INJURY,14
PT,DIZZINESS,12
PT,FACE OEDEMA,12
PT,OEDEMA PERIPHERAL,12
PT,MYALGIA,11
PT,ARTHRALGIA,9
PT,ASTHENIA,9
PT,CHRONIC PIGMENTED PURPURA,9
PT,FATIGUE,9
PT,HEADACHE,9
PT,PYREXIA,9
PT,RASH,9
PT,RHABDOMYOLYSIS,9
PT,HYPOTENSION,8
PT,MALAISE,8
PT,VOMITING,8
PT,APRAXIA,7
PT,COGNITIVE DISORDER,7
PT,DIARRHOEA,7
PT,MYOCLONUS,7
PT,NAUSEA,7
PT,NECROSIS,7
PT,SEPSIS,7
PT,CONDITION AGGRAVATED,6
PT,CONFUSIONAL STATE,6
PT,DISORIENTATION,6
PT,DRUG HYPERSENSITIVITY,6
PT,METABOLIC DISORDER,6
PT,PHARYNGEAL OEDEMA,6
PT,PRURITUS GENERALISED,6
PT,RENAL IMPAIRMENT,6
PT,ABDOMINAL PAIN,5
PT,CARDIAC FAILURE CONGESTIVE,5
PT,COMA,5
PT,DEHYDRATION,5
PT,DISEASE PROGRESSION,5
PT,DISTURBANCE IN ATTENTION,5
PT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,5
PT,DYSPEPSIA,5
PT,HAEMORRHAGIC STROKE,5
PT,HYPERHIDROSIS,5
PT,HYPONATRAEMIA,5
PT,ISCHAEMIC STROKE,5
PT,PERIPHERAL ISCHAEMIA,5
PT,PULMONARY EMBOLISM,5
PT,TACHYCARDIA,5
PT,URINARY TRACT INFECTION,5
PT,ACTIVITIES OF DAILY LIVING IMPAIRED,4
PT,CONJUNCTIVAL HYPERAEMIA,4
PT,DERMATITIS,4
PT,DYSPHONIA,4
PT,EOSINOPHILIA,4
PT,FALL,4
PT,GAIT DISTURBANCE,4
PT,GENERALISED ERYTHEMA,4
PT,HAEMATOMA,4
PT,HYPERAMMONAEMIC ENCEPHALOPATHY,4
PT,HYPERNATRAEMIA,4
PT,HYPERREFLEXIA,4
PT,HYPOTHYROIDISM,4
PT,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,4
PT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,4
PT,LYMPHADENOPATHY,4
PT,MUSCLE SPASMS,4
PT,OVERDOSE,4
PT,PRODUCT USE ISSUE,4
PT,RENAL INJURY,4
PT,RESPIRATORY FAILURE,4
PT,SKIN LESION,4
PT,SOMNOLENCE,4
PT,STRIDOR,4
PT,THYROIDITIS,4
PT,TYPE IV HYPERSENSITIVITY REACTION,4
PT,WEIGHT DECREASED,4
PT,WEIGHT INCREASED,4
PT,ABNORMAL BEHAVIOUR,3
PT,ANGIOEDEMA,3
PT,APHASIA,3
PT,ATAXIA,3
PT,BLOOD CREATININE INCREASED,3
PT,BLOOD PRESSURE INCREASED,3
PT,BREAST MASS,3
PT,CARDIO-RESPIRATORY ARREST,3
PT,CARDIOTOXICITY,3
PT,CEREBROVASCULAR ACCIDENT,3
PT,CHEST PAIN,3
PT,DRUG RESISTANCE,3
PT,DRY MOUTH,3
PT,EMBOLIC STROKE,3
PT,GENERAL PHYSICAL HEALTH DETERIORATION,3
PT,HAEMOGLOBIN DECREASED,3
PT,HEMIPARESIS,3
PT,HEPATOTOXICITY,3
PT,HYPERCHLORAEMIA,3
PT,HYPOKALAEMIA,3
PT,HYPOVOLAEMIC SHOCK,3
PT,INCREASED APPETITE,3
PT,INFECTION,3
PT,INJECTION SITE PAIN,3
PT,INSOMNIA,3
PT,LIVER FUNCTION TEST ABNORMAL,3
PT,METASTASIS,3
PT,METASTATIC MALIGNANT MELANOMA,3
PT,MUSCULOSKELETAL PAIN,3
PT,NEPHROPATHY,3
PT,PAIN IN EXTREMITY,3
PT,PALLOR,3
PT,PERIPHERAL SWELLING,3
PT,PERSEVERATION,3
PT,PLATELET COUNT DECREASED,3
PT,PNEUMONIA,3
PT,PRODUCT QUALITY ISSUE,3
PT,PRODUCT SUBSTITUTION ISSUE,3
PT,RASH ERYTHEMATOUS,3
PT,RASH PRURITIC,3
PT,RESPIRATORY DEPRESSION,3
PT,SNORING,3
PT,STRESS CARDIOMYOPATHY,3
PT,THROMBOCYTOPENIA,3
PT,TOXIC SKIN ERUPTION,3
PT,TRAUMATIC LUNG INJURY,3
PT,VISUAL IMPAIRMENT,3
PT,ABASIA,2
PT,ABDOMINAL PAIN UPPER,2
PT,ACUTE PULMONARY OEDEMA,2
PT,ANAEMIA,2
PT,APATHY,2
PT,ARRHYTHMIA,2
PT,ATRIAL FIBRILLATION,2
PT,B-CELL LYMPHOMA,2
PT,BALANCE DISORDER,2
PT,BLOOD PRESSURE DECREASED,2
PT,BRADYPHRENIA,2
PT,BREAST NEOPLASM,2
PT,C-REACTIVE PROTEIN INCREASED,2
PT,CHILLS,2
PT,CHONDROSARCOMA,2
PT,CHRONIC KIDNEY DISEASE,2
PT,COLITIS MICROSCOPIC,2
PT,CONCOMITANT DISEASE AGGRAVATED,2
PT,CRYSTALLURIA,2
PT,DEATH,2
PT,DECREASED APPETITE,2
PT,DEEP VEIN THROMBOSIS,2
PT,DRUG SCREEN FALSE POSITIVE,2
PT,DRY GANGRENE,2
PT,DYSARTHRIA,2
PT,DYSPHAGIA,2
PT,EPISTAXIS,2
PT,ERYTHEMA,2
PT,EYE HAEMORRHAGE,2
PT,EYE PAIN,2
PT,FACIAL PARALYSIS,2
PT,FEELING ABNORMAL,2
PT,FRACTURE,2
PT,GASTROINTESTINAL DISORDER,2
PT,GINGIVAL BLEEDING,2
PT,GRANULOMATOUS LIVER DISEASE,2
PT,HAEMATOCHEZIA,2
PT,HAEMATURIA,2
PT,HEART RATE INCREASED,2
PT,HEMIANOPIA,2
PT,HEPATITIS,2
PT,HYPERAMMONAEMIA,2
PT,HYPERKALAEMIA,2
PT,HYPERTHYROIDISM,2
PT,HYPOMAGNESAEMIA,2
PT,HYPOXIA,2
PT,INTENTIONAL PRODUCT USE ISSUE,2
PT,LEG AMPUTATION,2
PT,LIP SWELLING,2
PT,LOSS OF CONSCIOUSNESS,2
PT,LUMBAR VERTEBRAL FRACTURE,2
PT,MOTOR DYSFUNCTION,2
PT,MUSCULAR WEAKNESS,2
PT,OSMOTIC DEMYELINATION SYNDROME,2
PT,OXYGEN SATURATION DECREASED,2
PT,PAIN,2
PT,PARAESTHESIA ORAL,2
PT,PERFORMANCE STATUS DECREASED,2
PT,PETECHIAE,2
PT,PLASMA CELL MYELOMA,2
PT,PRURITUS,2
PT,SKIN EXFOLIATION,2
PT,STAPHYLOCOCCAL INFECTION,2
PT,STRESS,2
PT,SWELLING,2
PT,SYNCOPE,2
PT,TACHYPNOEA,2
PT,TONGUE OEDEMA,2
PT,TOOTHACHE,2
PT,URINE OUTPUT DECREASED,2
PT,ABDOMINAL DISCOMFORT,1
PT,ABDOMINAL DISTENSION,1
PT,ACETONAEMIA,1
PT,ACUTE MYOCARDIAL INFARCTION,1
PT,ADENOCARCINOMA GASTRIC,1
PT,ADRENAL INSUFFICIENCY,1
PT,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
PT,ADVERSE REACTION,1
PT,AGGRESSION,1
PT,AGITATION,1
PT,AKINESIA,1
PT,AMNESIA,1
PT,ANAPHYLACTIC SHOCK,1
PT,ANKYLOSING SPONDYLITIS,1
PT,ANXIETY,1
PT,ASTHMA,1
PT,ATELECTASIS,1
PT,ATRIOVENTRICULAR BLOCK COMPLETE,1
PT,ATROPHY,1
PT,BASAL CELL CARCINOMA,1
PT,BASILAR ARTERY STENOSIS,1
PT,BASILAR ARTERY THROMBOSIS,1
PT,BETA GLOBULIN INCREASED,1
PT,BLINDNESS,1
PT,BLISTER,1
PT,BLOOD ALBUMIN DECREASED,1
PT,BLOOD CREATINE INCREASED,1
PT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PT,BLOOD CREATININE,1
PT,BLOOD GLUCOSE ABNORMAL,1
PT,BLOOD PRESSURE FLUCTUATION,1
PT,BLOOD PRESSURE SYSTOLIC INCREASED,1
PT,BODY TEMPERATURE INCREASED,1
PT,BRADYCARDIA,1
PT,BREAST CANCER,1
PT,BREAST HAEMATOMA,1
PT,BREAST PAIN,1
PT,BRONCHOSPASM,1
PT,BRUXISM,1
PT,CARDIAC ARREST,1
PT,CARDIAC FAILURE,1
PT,CARDIAC FAILURE ACUTE,1
PT,CARDIOMEGALY,1
PT,CATATONIA,1
PT,CATHETER SITE INFECTION,1
PT,CEREBRAL ISCHAEMIA,1
PT,CHEST DISCOMFORT,1
PT,CHEST WALL HAEMATOMA,1
PT,CHONDROSARCOMA METASTATIC,1
PT,CHRONIC MYELOMONOCYTIC LEUKAEMIA,1
PT,CIRCULATORY COLLAPSE,1
PT,COLITIS ISCHAEMIC,1
PT,COMA HEPATIC,1
PT,COMA SCALE,1
PT,CONSTIPATION,1
PT,CONVULSION,1
PT,CORONARY ARTERY DISEASE,1
PT,COUGH,1
PT,CRANIOCEREBRAL INJURY,1
PT,CUSHING^S SYNDROME,1
PT,CUTANEOUS LUPUS ERYTHEMATOSUS,1
PT,CYSTITIS,1
PT,DELIRIUM,1
PT,DELUSION,1
PT,DEMENTIA,1
PT,DENTAL CARIES,1
PT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
PT,DERMAL CYST,1
PT,DIABETES MELLITUS INADEQUATE CONTROL,1
PT,DIABETIC KETOACIDOSIS,1
PT,DIALYSIS,1
PT,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
PT,DRUG-INDUCED LIVER INJURY,1
PT,DRY EYE,1
PT,DYSAESTHESIA,1
PT,DYSGEUSIA,1
PT,DYSURIA,1
PT,EAR PAIN,1
PT,ECCHYMOSIS,1
PT,ECZEMA,1
PT,ERECTILE DYSFUNCTION,1
PT,ERYTHEMA OF EYELID,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EYE DISORDER,1
PT,EYELASH CHANGES,1
PT,EYELID OEDEMA,1
PT,EYELID PTOSIS,1
PT,FACIAL PAIN,1
PT,FAECAL VOLUME INCREASED,1
PT,FEELING HOT,1
PT,FEMUR FRACTURE,1
PT,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
PT,FOREIGN BODY SENSATION IN EYES,1
PT,GASTRITIS,1
PT,GASTROOESOPHAGEAL REFLUX DISEASE,1
PT,GAZE PALSY,1
PT,GENERALISED OEDEMA,1
PT,GINGIVAL HYPERTROPHY,1
PT,GINGIVAL OEDEMA,1
PT,GINGIVAL PAIN,1
PT,GLAUCOMA,1
PT,GLOMERULAR FILTRATION RATE DECREASED,1
PT,H1N1 INFLUENZA,1
PT,HAEMORRHAGE,1
PT,HEAD TITUBATION,1
PT,HEPATIC FUNCTION ABNORMAL,1
PT,HEPATIC STEATOSIS,1
PT,HEPATITIS TOXIC,1
PT,HERPES ZOSTER DISSEMINATED,1
PT,HIP FRACTURE,1
PT,HOT FLUSH,1
PT,HYPERGLYCAEMIA,1
PT,HYPERSENSITIVITY,1
PT,HYPERTENSION,1
PT,HYPERTENSIVE CRISIS,1
PT,HYPERTRIGLYCERIDAEMIA,1
PT,HYPERVOLAEMIA,1
PT,HYPOAESTHESIA,1
PT,HYPOAESTHESIA ORAL,1
PT,HYPOALBUMINAEMIA,1
PT,HYPOCALCAEMIA,1
PT,HYPOCAPNIA,1
PT,HYPOGLYCAEMIA,1
PT,HYPOPERFUSION,1
PT,IMMUNOGLOBULINS INCREASED,1
PT,IMPULSIVE BEHAVIOUR,1
PT,INFLAMMATORY MARKER INCREASED,1
PT,INFLUENZA,1
PT,INGROWING NAIL,1
PT,INJECTION SITE ERYTHEMA,1
PT,INJECTION SITE INDURATION,1
PT,INJECTION SITE OEDEMA,1
PT,INJECTION SITE PAPULE,1
PT,INJECTION SITE PRURITUS,1
PT,INJECTION SITE SWELLING,1
PT,INJECTION SITE WARMTH,1
PT,INTERNATIONAL NORMALISED RATIO,1
PT,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
PT,INTERNATIONAL NORMALISED RATIO INCREASED,1
PT,INTERSTITIAL LUNG DISEASE,1
PT,ISCHAEMIA,1
PT,JAUNDICE,1
PT,JOINT STIFFNESS,1
PT,KERATITIS,1
PT,KLEBSIELLA TEST POSITIVE,1
PT,LACRIMAL SAC CELLULITIS,1
PT,LARYNGEAL OEDEMA,1
PT,LEUKOCYTOSIS,1
PT,LEUKOENCEPHALOPATHY,1
PT,LICHENOID KERATOSIS,1
PT,LIMB DISCOMFORT,1
PT,LIMB INJURY,1
PT,LIVER DISORDER,1
PT,LUNG INFECTION,1
PT,LYMPHOCYTOSIS,1
PT,MALIGNANT NEOPLASM PROGRESSION,1
PT,MASTICATION DISORDER,1
PT,MEAN CELL HAEMOGLOBIN INCREASED,1
PT,MELAENA,1
PT,MEMORY IMPAIRMENT,1
PT,METABOLIC ACIDOSIS,1
PT,METASTASES TO LUNG,1
PT,METASTASES TO PERITONEUM,1
PT,MOVEMENT DISORDER,1
PT,MUCOSAL HYPERAEMIA,1
PT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
PT,MUSCLE HAEMORRHAGE,1
PT,MUSCLE RIGIDITY,1
PT,MUSCLE RUPTURE,1
PT,MUSCLE TWITCHING,1
PT,MYDRIASIS,1
PT,NECK PAIN,1
PT,NEPHROLITHIASIS,1
PT,NEURALGIA,1
PT,NEUROLEPTIC MALIGNANT SYNDROME,1
PT,NEUROLOGIC NEGLECT SYNDROME,1
PT,NEUROLOGICAL DECOMPENSATION,1
PT,NEUTROPHILIA,1
PT,NIGHTMARE,1
PT,NODULE,1
PT,OEDEMA,1
PT,OESOPHAGEAL PAIN,1
PT,OESOPHAGITIS,1
PT,OLIGURIA,1
PT,ORAL MUCOSAL BLISTERING,1
PT,ORAL MUCOSAL ERUPTION,1
PT,OSTEITIS,1
PT,PALPITATIONS,1
PT,PANCREATITIS,1
PT,PANCYTOPENIA,1
PT,PAPULE,1
PT,PARAESTHESIA,1
PT,PARESIS,1
PT,PAROTID GLAND ENLARGEMENT,1
PT,PAROTID GLAND HAEMORRHAGE,1
PT,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
PT,PATHOLOGICAL FRACTURE,1
PT,PERICARDIAL EFFUSION,1
PT,PERIPHERAL COLDNESS,1
PT,PERIPHERAL VASCULAR DISORDER,1
PT,PERITONITIS BACTERIAL,1
PT,PHLEBITIS,1
PT,PLEURAL EFFUSION,1
PT,PNEUMONIA LEGIONELLA,1
PT,POLLAKIURIA,1
PT,PORTAL FIBROSIS,1
PT,POSTICTAL PARALYSIS,1
PT,POSTOPERATIVE WOUND INFECTION,1
PT,PREMATURE DELIVERY,1
PT,PRESCRIBED OVERDOSE,1
PT,PRESYNCOPE,1
PT,PRODUCT TASTE ABNORMAL,1
PT,PRODUCT USE IN UNAPPROVED INDICATION,1
PT,PRODUCTIVE COUGH,1
PT,PROTEINURIA,1
PT,PROTHROMBIN TIME,1
PT,PROTHROMBIN TIME PROLONGED,1
PT,PULMONARY CONGESTION,1
PT,PULMONARY FIBROSIS,1
PT,PULMONARY TOXICITY,1
PT,PUPILS UNEQUAL,1
PT,RASH MACULO-PAPULAR,1
PT,RASH PAPULAR,1
PT,REBOUND PSYCHOSIS,1
PT,RENAL ARTERY THROMBOSIS,1
PT,RENAL COLIC,1
PT,RENAL FAILURE,1
PT,RENAL FAILURE ACUTE,1
PT,RENAL FUNCTION TEST ABNORMAL,1
PT,RENAL PAIN,1
PT,ROSACEA,1
PT,SALIVARY GLAND PAIN,1
PT,SELF-INDUCED VOMITING,1
PT,SEPTIC SHOCK,1
PT,SINUS TACHYCARDIA,1
PT,SKIN INFECTION,1
PT,SLEEP-RELATED EATING DISORDER,1
PT,SPEECH DISORDER,1
PT,SPINAL OPERATION,1
PT,SQUAMOUS CELL CARCINOMA,1
PT,STOMATITIS,1
PT,STUPOR,1
PT,SUDDEN DEATH,1
PT,SYSTEMIC LUPUS ERYTHEMATOSUS,1
PT,TELANGIECTASIA,1
PT,TENDERNESS,1
PT,THERAPEUTIC RESPONSE DECREASED,1
PT,THROAT IRRITATION,1
PT,THROMBOSIS,1
PT,THYROID DISORDER,1
PT,TONGUE DISCOMFORT,1
PT,TOOTH FRACTURE,1
PT,TOOTH LOSS,1
PT,TOXIC ENCEPHALOPATHY,1
PT,TRANSITIONAL CELL CARCINOMA,1
PT,TREATMENT NONCOMPLIANCE,1
PT,TREMOR,1
PT,TUMOUR HAEMORRHAGE,1
PT,UMBILICAL HAEMORRHAGE,1
PT,URINARY RETENTION,1
PT,URINE FLOW DECREASED,1
PT,URINE ODOUR ABNORMAL,1
PT,UROSEPSIS,1
PT,URTICARIA,1
PT,UTERINE HAEMORRHAGE,1
PT,VARICES OESOPHAGEAL,1
PT,VASCULAR DEMENTIA,1
PT,VASCULAR OCCLUSION,1
PT,VENTRICULAR FIBRILLATION,1
PT,VISION BLURRED,1
PT,VULVOVAGINAL PRURITUS,1
PT,WHITE BLOOD CELL COUNT INCREASED,1
PT,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PR,INJECTION SITE PAIN,36
PR,NASOPHARYNGITIS,34
PR,ARTHRALGIA,26
PR,PAIN,19
PR,DRUG INEFFECTIVE,18
PR,HEADACHE,17
PR,HYPERTENSION,15
PR,PAIN IN EXTREMITY,14
PR,FATIGUE,13
PR,ASTHMA,12
PR,PSORIASIS,11
PR,FALL,10
PR,BLOOD CHOLESTEROL INCREASED,9
PR,GAIT DISTURBANCE,9
PR,MALAISE,9
PR,PRURITUS,9
PR,BURNING SENSATION,8
PR,NAUSEA,8
PR,PERIPHERAL SWELLING,8
PR,ABDOMINAL PAIN,7
PR,ASTHENIA,7
PR,DIZZINESS,7
PR,HAEMOGLOBIN DECREASED,7
PR,INJECTION SITE HAEMATOMA,7
PR,MUSCLE SPASMS,7
PR,PYREXIA,7
PR,URINARY TRACT INFECTION,7
PR,DIARRHOEA,6
PR,ERYTHEMA,6
PR,INJECTION SITE ERYTHEMA,6
PR,ARTHROPATHY,5
PR,CHEST PAIN,5
PR,HYPERSENSITIVITY,5
PR,HYPOAESTHESIA,5
PR,INFLAMMATION,5
PR,INJECTION SITE PRURITUS,5
PR,JOINT SWELLING,5
PR,OSTEOARTHRITIS,5
PR,RASH,5
PR,SINUSITIS,5
PR,ANAEMIA,4
PR,ARTHRITIS,4
PR,BACK PAIN,4
PR,BLOOD GLUCOSE INCREASED,4
PR,CHOLELITHIASIS,4
PR,COUGH,4
PR,DISCOMFORT,4
PR,DYSPNOEA,4
PR,EXOSTOSIS,4
PR,KNEE ARTHROPLASTY,4
PR,LOCAL SWELLING,4
PR,NEUROPATHY PERIPHERAL,4
PR,PLATELET COUNT DECREASED,4
PR,PRODUCTIVE COUGH,4
PR,RHEUMATOID ARTHRITIS,4
PR,SOMNOLENCE,4
PR,ABDOMINAL DISCOMFORT,3
PR,ABDOMINAL PAIN UPPER,3
PR,BEDRIDDEN,3
PR,BRONCHITIS,3
PR,CATARACT,3
PR,CHIKUNGUNYA VIRUS INFECTION,3
PR,DECREASED APPETITE,3
PR,DEPRESSION,3
PR,DIABETES MELLITUS,3
PR,DRUG EFFECT INCOMPLETE,3
PR,DRUG PRESCRIBING ERROR,3
PR,DYSPHONIA,3
PR,FEELING ABNORMAL,3
PR,GASTRITIS,3
PR,INCORRECT DOSE ADMINISTERED,3
PR,INJECTION SITE REACTION,3
PR,INJECTION SITE WARMTH,3
PR,INSOMNIA,3
PR,INTERVERTEBRAL DISC PROTRUSION,3
PR,JOINT RANGE OF MOTION DECREASED,3
PR,LUNG DISORDER,3
PR,MYOCARDIAL INFARCTION,3
PR,NECK PAIN,3
PR,NERVOUSNESS,3
PR,OROPHARYNGEAL PAIN,3
PR,OSTEOPENIA,3
PR,RASH MACULAR,3
PR,SWELLING,3
PR,SWELLING FACE,3
PR,TENDON RUPTURE,3
PR,URTICARIA,3
PR,VOMITING,3
PR,WHITE BLOOD CELL COUNT INCREASED,3
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,3
PR,ANXIETY,2
PR,BLOOD TRIGLYCERIDES INCREASED,2
PR,CARDIAC ARREST,2
PR,CARDIAC MURMUR,2
PR,CARPAL TUNNEL SYNDROME,2
PR,CHEST DISCOMFORT,2
PR,CHOLECYSTITIS,2
PR,CONFUSIONAL STATE,2
PR,CROHN^S DISEASE,2
PR,DEHYDRATION,2
PR,DYSARTHRIA,2
PR,EYE INFLAMMATION,2
PR,EYE PAIN,2
PR,FIBROMYALGIA,2
PR,FOOT FRACTURE,2
PR,FUNGAL INFECTION,2
PR,GALLBLADDER OPERATION,2
PR,GASTROINTESTINAL INFLAMMATION,2
PR,HAEMATOCHEZIA,2
PR,HAEMATOMA,2
PR,HEPATIC ENZYME INCREASED,2
PR,HOT FLUSH,2
PR,HYPERCHOLESTEROLAEMIA,2
PR,HYPERHIDROSIS,2
PR,INFECTION,2
PR,INFLUENZA,2
PR,INJECTION SITE INDURATION,2
PR,INJURY ASSOCIATED WITH DEVICE,2
PR,INTRACRANIAL ANEURYSM,2
PR,INTRADUCTAL PAPILLOMA OF BREAST,2
PR,LIMB INJURY,2
PR,LOSS OF CONSCIOUSNESS,2
PR,MOVEMENT DISORDER,2
PR,MUSCULOSKELETAL PAIN,2
PR,MYALGIA,2
PR,NASAL CONGESTION,2
PR,PANCREATITIS,2
PR,PHARYNGITIS,2
PR,PLATELET COUNT INCREASED,2
PR,PNEUMONIA,2
PR,PRURITUS GENERALISED,2
PR,RECTAL HAEMORRHAGE,2
PR,RESPIRATORY TRACT CONGESTION,2
PR,RHEUMATOID FACTOR INCREASED,2
PR,SKIN DISCOLOURATION,2
PR,SYNCOPE,2
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
PR,THROMBOPHLEBITIS,2
PR,VENOUS OCCLUSION,2
PR,VIRAL INFECTION,2
PR,VISION BLURRED,2
PR,ABASIA,1
PR,ABDOMINAL ADHESIONS,1
PR,ABDOMINAL DISTENSION,1
PR,ABDOMINAL HERNIA,1
PR,ABSCESS,1
PR,ABSCESS NECK,1
PR,ADVERSE EVENT,1
PR,AFFECTIVE DISORDER,1
PR,AGGRESSION,1
PR,ALOPECIA,1
PR,ANAPHYLACTIC REACTION,1
PR,ANGINA PECTORIS,1
PR,ANGIOEDEMA,1
PR,ANKLE FRACTURE,1
PR,ANURIA,1
PR,APHASIA,1
PR,ARTHROPOD BITE,1
PR,ASPIRATION PLEURAL CAVITY,1
PR,ATRIAL FIBRILLATION,1
PR,ATYPICAL PNEUMONIA,1
PR,BACK INJURY,1
PR,BALANCE DISORDER,1
PR,BLINDNESS,1
PR,BLISTER,1
PR,BLOOD CHOLESTEROL ABNORMAL,1
PR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
PR,BLOOD GLUCOSE ABNORMAL,1
PR,BLOOD GLUCOSE DECREASED,1
PR,BLOOD POTASSIUM DECREASED,1
PR,BLOOD PRESSURE ABNORMAL,1
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PR,BLOOD TEST ABNORMAL,1
PR,BLOOD THYROID STIMULATING HORMONE DECREASED,1
PR,BLOOD TRIGLYCERIDES ABNORMAL,1
PR,BLOOD URINE PRESENT,1
PR,BONE DISORDER,1
PR,BONE MARROW FAILURE,1
PR,BONE OPERATION,1
PR,BONE PAIN,1
PR,BREAST DISORDER,1
PR,BREAST MASS,1
PR,BURNS SECOND DEGREE,1
PR,CANDIDA INFECTION,1
PR,CAPILLARY DISORDER,1
PR,CARDIAC DISORDER,1
PR,CARDIAC FAILURE CONGESTIVE,1
PR,CARDIOMEGALY,1
PR,CARDIOVASCULAR DISORDER,1
PR,CAROTID ARTERY OCCLUSION,1
PR,CELLULITIS,1
PR,CEREBROVASCULAR ACCIDENT,1
PR,CERVICAL VERTEBRAL FRACTURE,1
PR,CHOLECYSTITIS ACUTE,1
PR,COLD SWEAT,1
PR,COLITIS,1
PR,COLON OPERATION,1
PR,CONDITION AGGRAVATED,1
PR,CONSTIPATION,1
PR,CONVULSION,1
PR,CORONARY VEIN STENOSIS,1
PR,COSTOCHONDRITIS,1
PR,CYST,1
PR,DEAFNESS,1
PR,DEATH,1
PR,DELUSION OF GRANDEUR,1
PR,DEPRESSED MOOD,1
PR,DERMATITIS ALLERGIC,1
PR,DEVICE ALLERGY,1
PR,DIABETES MELLITUS INADEQUATE CONTROL,1
PR,DIVERTICULUM,1
PR,DRUG ADMINISTRATION ERROR,1
PR,DRUG DOSE OMISSION,1
PR,DRUG HYPERSENSITIVITY,1
PR,DRY SKIN,1
PR,DYSGEUSIA,1
PR,DYSPEPSIA,1
PR,DYSSTASIA,1
PR,DYSURIA,1
PR,EAR DISCOMFORT,1
PR,EAR INFECTION,1
PR,EMBOLISM,1
PR,ENDOMETRIAL THICKENING,1
PR,EYE DISCHARGE,1
PR,EYE DISORDER,1
PR,EYE HAEMORRHAGE,1
PR,EYE INFECTION,1
PR,EYE PRURITUS,1
PR,EYE SWELLING,1
PR,FEEDING DISORDER,1
PR,FEELING OF DESPAIR,1
PR,FIBROMA,1
PR,FINGER DEFORMITY,1
PR,FLANK PAIN,1
PR,FLATULENCE,1
PR,FRACTURE,1
PR,FREQUENT BOWEL MOVEMENTS,1
PR,FUNGAL SKIN INFECTION,1
PR,GASTRIC CANCER,1
PR,GASTRIC INFECTION,1
PR,GASTROINTESTINAL DISORDER,1
PR,GASTROOESOPHAGEAL REFLUX DISEASE,1
PR,GLAUCOMA,1
PR,GLUCOSE TOLERANCE IMPAIRED,1
PR,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
PR,GROIN ABSCESS,1
PR,HAEMATOCRIT DECREASED,1
PR,HAEMODIALYSIS,1
PR,HAEMORRHAGE,1
PR,HALLUCINATION_ AUDITORY,1
PR,HAND FRACTURE,1
PR,HEAD DISCOMFORT,1
PR,HEAD INJURY,1
PR,HEART RATE DECREASED,1
PR,HEPATIC MASS,1
PR,HEPATITIS,1
PR,HERPES ZOSTER,1
PR,HIP ARTHROPLASTY,1
PR,HYPOTHYROIDISM,1
PR,IMMUNODEFICIENCY,1
PR,INJECTION SITE DISCOLOURATION,1
PR,INJECTION SITE HAEMORRHAGE,1
PR,INJECTION SITE MASS,1
PR,INJECTION SITE PARAESTHESIA,1
PR,INJECTION SITE SWELLING,1
PR,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
PR,JAW FRACTURE,1
PR,JOINT DESTRUCTION,1
PR,KIDNEY INFECTION,1
PR,LABORATORY TEST ABNORMAL,1
PR,LACRIMATION INCREASED,1
PR,LARGE INTESTINE POLYP,1
PR,LIGAMENT RUPTURE,1
PR,LIGAMENT SPRAIN,1
PR,LIMB DEFORMITY,1
PR,LIP SWELLING,1
PR,LIPOMA,1
PR,LOCALISED INFECTION,1
PR,LOWER RESPIRATORY TRACT INFECTION,1
PR,LYMPHOCYTE COUNT DECREASED,1
PR,LYMPHOMA,1
PR,MACULAR DEGENERATION,1
PR,MALIGNANT NEOPLASM OF THORAX,1
PR,MASS,1
PR,MEDICAL DEVICE SITE PAIN,1
PR,MELANOCYTIC NAEVUS,1
PR,MENSTRUATION IRREGULAR,1
PR,MENTAL DISORDER,1
PR,MENTAL STATUS CHANGES,1
PR,METABOLIC ACIDOSIS,1
PR,MIGRAINE,1
PR,MOBILITY DECREASED,1
PR,MUSCLE STRAIN,1
PR,MUSCULOSKELETAL DISCOMFORT,1
PR,MUSCULOSKELETAL DISORDER,1
PR,MYOSITIS,1
PR,NAIL DISORDER,1
PR,NEOPLASM MALIGNANT,1
PR,NEPHROLITHIASIS,1
PR,NERVE BLOCK,1
PR,NIGHTMARE,1
PR,NODULE,1
PR,NOSOCOMIAL INFECTION,1
PR,OCULAR HYPERAEMIA,1
PR,ORAL INFECTION,1
PR,OVERDOSE,1
PR,PALPITATIONS,1
PR,PARAESTHESIA ORAL,1
PR,PERIPHERAL VASCULAR DISORDER,1
PR,PERIPHERAL VENOUS DISEASE,1
PR,PHARYNGEAL NEOPLASM,1
PR,PHLEBITIS,1
PR,PLEURAL EFFUSION,1
PR,PNEUMONIA LEGIONELLA,1
PR,POLYP,1
PR,POSTOPERATIVE WOUND INFECTION,1
PR,PRODUCT USE IN UNAPPROVED INDICATION,1
PR,PROTEIN URINE PRESENT,1
PR,PULMONARY MASS,1
PR,RASH GENERALISED,1
PR,RASH PUSTULAR,1
PR,RENAL CYST,1
PR,RESPIRATORY ACIDOSIS,1
PR,RESPIRATORY TRACT INFECTION,1
PR,RHINITIS,1
PR,SALIVARY HYPERSECRETION,1
PR,SEPTIC SHOCK,1
PR,SKIN DISORDER,1
PR,SKIN EXFOLIATION,1
PR,SKIN IRRITATION,1
PR,SLEEP APNOEA SYNDROME,1
PR,SLOW SPEECH,1
PR,SPINAL FRACTURE,1
PR,SPONDYLITIS,1
PR,STOMATITIS,1
PR,STRESS CARDIOMYOPATHY,1
PR,SUICIDE THREAT,1
PR,SURGERY,1
PR,TACHYCARDIA,1
PR,TERMINAL DRIBBLING,1
PR,THROMBOCYTOPENIA,1
PR,THROMBOSIS,1
PR,THYROID CANCER METASTATIC,1
PR,THYROID MASS,1
PR,THYROID PAIN,1
PR,TOOTHACHE,1
PR,TRACHEAL OBSTRUCTION,1
PR,TRANSFUSION,1
PR,TRANSIENT ISCHAEMIC ATTACK,1
PR,TREMOR,1
PR,TUBERCULIN TEST POSITIVE,1
PR,TYPE 1 DIABETES MELLITUS,1
PR,TYPE 2 DIABETES MELLITUS,1
PR,UMBILICAL HERNIA,1
PR,UNEVALUABLE EVENT,1
PR,URINARY TRACT INFECTION BACTERIAL,1
PR,VAGINAL CANCER,1
PR,VAGINAL HAEMORRHAGE,1
PR,VAGINAL INFECTION,1
PR,VARICOSE VEIN,1
PR,VISUAL IMPAIRMENT,1
PR,VULVOVAGINAL MYCOTIC INFECTION,1
PR,VULVOVAGINAL PAIN,1
PR,WEIGHT DECREASED,1
PR,WEIGHT INCREASED,1
PR,WHITE BLOOD CELL COUNT DECREASED,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
QA,GASTRIC POLYPS,2
QA,IRON DEFICIENCY ANAEMIA,2
QA,MYALGIA,2
QA,RASH,2
QA,TOXICITY TO VARIOUS AGENTS,2
QA,FACE OEDEMA,1
QA,SWELLING FACE,1
RO,MYALGIA,6
RO,ABDOMINAL PAIN,4
RO,ASTHENIA,4
RO,SPINAL PAIN,4
RO,CHOLESTASIS,3
RO,CHEST PAIN,2
RO,HEPATITIS CHOLESTATIC,2
RO,HYPERURICAEMIA,2
RO,MYOPATHY,2
RO,ORAL CANDIDIASIS,2
RO,PSYCHOTIC DISORDER,2
RO,TACHYCARDIA,2
RO,TREATMENT NONCOMPLIANCE,2
RO,ABDOMINAL DISTENSION,1
RO,AKINESIA,1
RO,ANGLE CLOSURE GLAUCOMA,1
RO,ANXIETY,1
RO,ATRIAL FLUTTER,1
RO,ATRIOVENTRICULAR BLOCK,1
RO,BALLISMUS,1
RO,BLOOD GLUCOSE INCREASED,1
RO,COGNITIVE DISORDER,1
RO,CONSTIPATION,1
RO,CRANIOCEREBRAL INJURY,1
RO,DELUSION,1
RO,DEPRESSION,1
RO,DEVICE OCCLUSION,1
RO,DIARRHOEA,1
RO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
RO,FALL,1
RO,GAIT DISTURBANCE,1
RO,GYNAECOMASTIA,1
RO,HAEMORRHAGIC STROKE,1
RO,HAEMORRHOIDS,1
RO,HEPATIC STEATOSIS,1
RO,HYPERTENSION,1
RO,HYPOGLYCAEMIA,1
RO,HYPOKALAEMIA,1
RO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
RO,MAJOR DEPRESSION,1
RO,MENINGIOMA,1
RO,MUSCLE RIGIDITY,1
RO,MUSCLE SPASMS,1
RO,MYOCARDIAL INFARCTION,1
RO,NEURALGIA,1
RO,OEDEMA PERIPHERAL,1
RO,ON AND OFF PHENOMENON,1
RO,PERIPHERAL SWELLING,1
RO,POOR PERSONAL HYGIENE,1
RO,PROSTATE CANCER,1
RO,PSYCHOMOTOR HYPERACTIVITY,1
RO,STOMA SITE DISCHARGE,1
RO,STOMA SITE ERYTHEMA,1
RO,STOMA SITE HAEMORRHAGE,1
RO,SUBDURAL HAEMATOMA,1
RO,TRANSAMINASES INCREASED,1
RO,TREMOR,1
RO,VERTIGO,1
RO,WEIGHT INCREASED,1
RU,BLOOD PRESSURE INCREASED,7
RU,CONTUSION,4
RU,EPISTAXIS,4
RU,BRADYCARDIA,3
RU,CHEST PAIN,3
RU,DYSPNOEA,3
RU,ANGINA PECTORIS,2
RU,BLOOD PRESSURE DECREASED,2
RU,CONDITION AGGRAVATED,2
RU,DEATH,2
RU,DISEASE PROGRESSION,2
RU,DIZZINESS,2
RU,DRUG-INDUCED LIVER INJURY,2
RU,GINGIVAL BLEEDING,2
RU,ACUTE MYOCARDIAL INFARCTION,1
RU,ANGINA UNSTABLE,1
RU,AORTIC DISSECTION,1
RU,ARRHYTHMIA,1
RU,ATRIAL FIBRILLATION,1
RU,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
RU,BILE DUCT STONE,1
RU,BLOOD GLUCOSE INCREASED,1
RU,CARDIAC FAILURE,1
RU,CARDIAC FAILURE ACUTE,1
RU,CARDIAC FAILURE CHRONIC,1
RU,CAROTID ARTERY STENOSIS,1
RU,CEREBRAL INFARCTION,1
RU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
RU,COLD SWEAT,1
RU,CORONARY ARTERY DISEASE,1
RU,CORONARY ARTERY REOCCLUSION,1
RU,DIABETIC METABOLIC DECOMPENSATION,1
RU,DRUG DOSE OMISSION,1
RU,DRUG INEFFECTIVE,1
RU,EAR HAEMORRHAGE,1
RU,FEELING ABNORMAL,1
RU,FEMORAL NECK FRACTURE,1
RU,FUNGAL SKIN INFECTION,1
RU,GOUT,1
RU,HAEMOGLOBIN DECREASED,1
RU,HAEMORRHAGE,1
RU,HEART RATE DECREASED,1
RU,HEART RATE INCREASED,1
RU,HEART RATE IRREGULAR,1
RU,HEPATIC CANCER,1
RU,HYDROTHORAX,1
RU,HYPERGLYCAEMIA,1
RU,HYPERTENSION,1
RU,HYPOAESTHESIA,1
RU,HYPOTENSION,1
RU,INSOMNIA,1
RU,ISCHAEMIC CEREBRAL INFARCTION,1
RU,ISCHAEMIC STROKE,1
RU,LIP AND/OR ORAL CAVITY CANCER,1
RU,LIQUID PRODUCT PHYSICAL ISSUE,1
RU,LOSS OF CONSCIOUSNESS,1
RU,MALLORY-WEISS SYNDROME,1
RU,MYOCARDIAL ISCHAEMIA,1
RU,NAUSEA,1
RU,OEDEMA,1
RU,PANCREATITIS,1
RU,PARAESTHESIA,1
RU,PULMONARY CONGESTION,1
RU,PULMONARY EMBOLISM,1
RU,PULMONARY OEDEMA,1
RU,RENAL ISCHAEMIA,1
RU,RETINAL ARTERY OCCLUSION,1
RU,RIGHT VENTRICULAR FAILURE,1
RU,SPINAL COMPRESSION FRACTURE,1
RU,THERAPEUTIC RESPONSE DECREASED,1
RU,THROMBOSIS IN DEVICE,1
RU,TRANSIENT ISCHAEMIC ATTACK,1
RU,VENTRICULAR EXTRASYSTOLES,1
RU,VENTRICULAR TACHYCARDIA,1
RU,VERTIGO,1
RU,WEIGHT DECREASED,1
RU,WEIGHT INCREASED,1
PM,LICHEN SCLEROSUS,1
PM,VAGINAL INFECTION,1
SA,TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME,6
SA,CHILLS,3
SA,CYSTOID MACULAR OEDEMA,2
SA,ERYTHEMA,2
SA,EYE PAIN,2
SA,FLANK PAIN,2
SA,HYPERGLYCAEMIA,2
SA,PUPILLARY DISORDER,2
SA,PYREXIA,2
SA,RETINAL EXUDATES,2
SA,URINE OUTPUT DECREASED,2
SA,VISION BLURRED,2
SA,VITREOUS FLOATERS,2
SA,ALANINE AMINOTRANSFERASE INCREASED,1
SA,ASPARTATE AMINOTRANSFERASE INCREASED,1
SA,BLOOD CREATININE INCREASED,1
SA,BRAIN ABSCESS,1
SA,HEADACHE,1
SA,HYPERTENSION,1
SA,IRIDOCYCLITIS,1
SA,LISTERIOSIS,1
SA,MYALGIA,1
SA,MYOPATHY,1
SA,RENAL FUNCTION TEST ABNORMAL,1
SA,TUBULOINTERSTITIAL NEPHRITIS,1
SA,UVEITIS,1
SN,ALANINE AMINOTRANSFERASE INCREASED,1
SN,ASPARTATE AMINOTRANSFERASE INCREASED,1
SN,DISCOMFORT,1
SN,FATIGUE,1
SN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SN,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
SN,LIVER DISORDER,1
RS,THROMBOCYTOPENIA,2
RS,URTICARIA,2
RS,ANGINA PECTORIS,1
RS,ARRHYTHMIA,1
RS,ARTHROPATHY,1
RS,CORONARY ARTERY THROMBOSIS,1
RS,DRUG ADMINISTRATION ERROR,1
RS,DRUG INEFFECTIVE,1
RS,DRUG-INDUCED LIVER INJURY,1
RS,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
RS,ELECTROCARDIOGRAM T WAVE INVERSION,1
SG,DELIRIUM,4
SG,PAIN,4
SG,PAIN IN EXTREMITY,4
SG,CHEST PAIN,3
SG,FALL,3
SG,PNEUMONIA,3
SG,RASH,3
SG,THROMBOCYTOPENIA,3
SG,BONE MARROW FAILURE,2
SG,HAEMATEMESIS,2
SG,ABDOMINAL PAIN,1
SG,ACETONAEMIA,1
SG,ACUTE CORONARY SYNDROME,1
SG,ACUTE KIDNEY INJURY,1
SG,ADENOCARCINOMA OF COLON,1
SG,ADENOCARCINOMA PANCREAS,1
SG,AGITATION,1
SG,ANAEMIA,1
SG,ANGIOEDEMA,1
SG,ARTHRALGIA,1
SG,ARTHROPATHY,1
SG,BACK PAIN,1
SG,BLOOD CREATINE INCREASED,1
SG,BLOOD CREATININE INCREASED,1
SG,CARDIAC FAILURE CONGESTIVE,1
SG,CELLULITIS,1
SG,CHEST DISCOMFORT,1
SG,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SG,COLD SWEAT,1
SG,COLITIS,1
SG,COLON CANCER,1
SG,CONSTIPATION,1
SG,CONTUSION,1
SG,DEAFNESS BILATERAL,1
SG,DEPRESSION,1
SG,DERMATITIS BULLOUS,1
SG,DIABETIC KETOACIDOSIS,1
SG,DISORIENTATION,1
SG,DIZZINESS,1
SG,DYSPNOEA,1
SG,EPILEPSY,1
SG,EXPOSED BONE IN JAW,1
SG,FATIGUE,1
SG,FEBRILE NEUTROPENIA,1
SG,FEELING ABNORMAL,1
SG,FLUID OVERLOAD,1
SG,FULL BLOOD COUNT DECREASED,1
SG,GASTROOESOPHAGEAL REFLUX DISEASE,1
SG,GENERAL PHYSICAL HEALTH DETERIORATION,1
SG,GENERALISED OEDEMA,1
SG,GLUCOCORTICOID DEFICIENCY,1
SG,HAEMOPTYSIS,1
SG,HEADACHE,1
SG,HEAT ILLNESS,1
SG,HYPERBILIRUBINAEMIA,1
SG,HYPERCALCAEMIA,1
SG,HYPERGLYCAEMIA,1
SG,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
SG,JOINT RANGE OF MOTION DECREASED,1
SG,KETOACIDOSIS,1
SG,LETHARGY,1
SG,LEUKOPENIA,1
SG,LIMB INJURY,1
SG,LIVER DISORDER,1
SG,LOWER RESPIRATORY TRACT INFECTION,1
SG,MALIGNANT NEOPLASM PROGRESSION,1
SG,MANIA,1
SG,MASS,1
SG,MENTAL STATUS CHANGES,1
SG,MUSCLE SPASMS,1
SG,MUSCULOSKELETAL CHEST PAIN,1
SG,MYOCARDIAL INFARCTION,1
SG,NEUTROPENIA,1
SG,NEUTROPHIL COUNT DECREASED,1
SG,NO THERAPEUTIC RESPONSE,1
SG,OEDEMA PERIPHERAL,1
SG,OROPHARYNGEAL PAIN,1
SG,PAIN IN JAW,1
SG,PALPITATIONS,1
SG,PANCREATIC CARCINOMA,1
SG,PANCREATITIS ACUTE,1
SG,PERIPHERAL SWELLING,1
SG,PERITONITIS,1
SG,PLASMA CELL MYELOMA,1
SG,PLEURAL EFFUSION,1
SG,PNEUMONITIS,1
SG,POLYP,1
SG,PRODUCT PRESCRIBING ISSUE,1
SG,PRURITUS,1
SG,PSEUDOMONAS INFECTION,1
SG,PULMONARY EMBOLISM,1
SG,RASH ERYTHEMATOUS,1
SG,RASH PRURITIC,1
SG,RENAL IMPAIRMENT,1
SG,RESPIRATORY SYMPTOM,1
SG,RETINAL DETACHMENT,1
SG,RHABDOMYOLYSIS,1
SG,ROTATOR CUFF SYNDROME,1
SG,SPINAL OSTEOARTHRITIS,1
SG,STATUS EPILEPTICUS,1
SG,SYNCOPE,1
SG,TOOTHACHE,1
SG,TOXICITY TO VARIOUS AGENTS,1
SG,TRANSAMINASES INCREASED,1
SG,TRANSITIONAL CELL CARCINOMA,1
SG,UPPER GASTROINTESTINAL HAEMORRHAGE,1
SG,URINARY TRACT INFECTION,1
SG,WITHDRAWAL SYNDROME,1
SK,METASTATIC NEOPLASM,1
SK,PARKINSON^S DISEASE,1
SI,ABNORMAL BEHAVIOUR,1
SI,ANXIETY,1
SI,ASCITES,1
SI,CHOKING,1
SI,COLD SWEAT,1
SI,CYANOSIS CENTRAL,1
SI,DISORIENTATION,1
SI,DRUG EFFECT DECREASED,1
SI,DYSPNOEA,1
SI,HALLUCINATION_ AUDITORY,1
SI,HEPATOMEGALY,1
SI,HYPERKALAEMIA,1
SI,INSOMNIA,1
SI,OEDEMA PERIPHERAL,1
SI,OVARIAN ADENOMA,1
SI,RALES,1
SI,RENAL FAILURE,1
SI,TACHYCARDIA,1
SI,VEIN DISORDER,1
ZA,DEATH,10
ZA,CEREBROVASCULAR ACCIDENT,7
ZA,HYPOTENSION,7
ZA,MYOCARDIAL INFARCTION,6
ZA,PNEUMONIA,6
ZA,ANAEMIA,5
ZA,CARDIAC FAILURE,5
ZA,CONFUSIONAL STATE,5
ZA,DYSPNOEA,5
ZA,FALL,5
ZA,HYPOGLYCAEMIA,5
ZA,HYPOKALAEMIA,5
ZA,MALAISE,5
ZA,RENAL FAILURE,5
ZA,BLOOD GLUCOSE INCREASED,4
ZA,DEHYDRATION,4
ZA,DIABETES MELLITUS,4
ZA,NAUSEA,4
ZA,PULMONARY EMBOLISM,4
ZA,RASH,4
ZA,RENAL IMPAIRMENT,4
ZA,UPPER GASTROINTESTINAL HAEMORRHAGE,4
ZA,BLOOD PRESSURE INCREASED,3
ZA,DIARRHOEA,3
ZA,DIZZINESS,3
ZA,FATIGUE,3
ZA,FEELING ABNORMAL,3
ZA,GAIT DISTURBANCE,3
ZA,HEADACHE,3
ZA,HOSPITALISATION,3
ZA,HYPERTENSION,3
ZA,MYOCARDIAL ISCHAEMIA,3
ZA,ABDOMINAL PAIN UPPER,2
ZA,ANGINA PECTORIS,2
ZA,ASTHENIA,2
ZA,BRONCHITIS,2
ZA,CHEST PAIN,2
ZA,CHRONIC KIDNEY DISEASE,2
ZA,CONTUSION,2
ZA,DECUBITUS ULCER,2
ZA,DEEP VEIN THROMBOSIS,2
ZA,DRUG INEFFECTIVE,2
ZA,DRUG-INDUCED LIVER INJURY,2
ZA,FEMUR FRACTURE,2
ZA,FISTULA,2
ZA,HAEMOGLOBIN DECREASED,2
ZA,HYPOTHYROIDISM,2
ZA,INGUINAL HERNIA,2
ZA,PAIN,2
ZA,PRURITUS,2
ZA,RENAL TUBULAR NECROSIS,2
ZA,RHABDOMYOLYSIS,2
ZA,ROAD TRAFFIC ACCIDENT,2
ZA,THROMBOCYTOPENIA,2
ZA,URINARY TRACT INFECTION,2
ZA,VASCULAR GRAFT,2
ZA,VOMITING,2
ZA,ABDOMINAL LYMPHADENOPATHY,1
ZA,ABDOMINAL STRANGULATED HERNIA,1
ZA,ABORTION INDUCED,1
ZA,ABSCESS,1
ZA,ACUTE KIDNEY INJURY,1
ZA,ACUTE MYOCARDIAL INFARCTION,1
ZA,ACUTE RESPIRATORY DISTRESS SYNDROME,1
ZA,ANAEMIA MEGALOBLASTIC,1
ZA,ANGIOEDEMA,1
ZA,ANXIETY,1
ZA,AORTIC ANEURYSM,1
ZA,AORTIC STENOSIS,1
ZA,APHASIA,1
ZA,ARTERIAL OCCLUSIVE DISEASE,1
ZA,ARTHROPATHY,1
ZA,ATRIAL FIBRILLATION,1
ZA,ATRIAL FLUTTER,1
ZA,ATRIOVENTRICULAR BLOCK COMPLETE,1
ZA,BACK PAIN,1
ZA,BLOOD COUNT ABNORMAL,1
ZA,BLOOD CREATINE INCREASED,1
ZA,BLOOD CREATININE INCREASED,1
ZA,BLOOD GLUCOSE DECREASED,1
ZA,BLOOD OSMOLARITY ABNORMAL,1
ZA,BLOOD PRESSURE ABNORMAL,1
ZA,BLOOD PRESSURE DECREASED,1
ZA,BONE MARROW FAILURE,1
ZA,BRADYCARDIA,1
ZA,BRAIN OEDEMA,1
ZA,BURNING SENSATION,1
ZA,CARDIAC DISORDER,1
ZA,CARDIAC OPERATION,1
ZA,CARDIOMYOPATHY,1
ZA,CATAPLEXY,1
ZA,CATARACT,1
ZA,CHEST DISCOMFORT,1
ZA,CHOLELITHIASIS,1
ZA,COLECTOMY,1
ZA,CONDITION AGGRAVATED,1
ZA,CONVULSION,1
ZA,COUGH,1
ZA,CROHN^S DISEASE,1
ZA,CYSTITIS,1
ZA,DEPRESSED MOOD,1
ZA,DEPRESSION,1
ZA,DERMATITIS,1
ZA,DERMATITIS EXFOLIATIVE,1
ZA,DIABETIC KETOACIDOSIS,1
ZA,DIALYSIS DISEQUILIBRIUM SYNDROME,1
ZA,DIVERTICULUM,1
ZA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
ZA,DRY MOUTH,1
ZA,DRY THROAT,1
ZA,DUODENITIS,1
ZA,DYSURIA,1
ZA,EATING DISORDER,1
ZA,ELECTROCARDIOGRAM QT PROLONGED,1
ZA,EPISTAXIS,1
ZA,EXERCISE TOLERANCE DECREASED,1
ZA,FACIAL PARESIS,1
ZA,FEMORAL NECK FRACTURE,1
ZA,FIBULA FRACTURE,1
ZA,FLUID OVERLOAD,1
ZA,FUNCTIONAL GASTROINTESTINAL DISORDER,1
ZA,GAIT INABILITY,1
ZA,GASTRIC HAEMORRHAGE,1
ZA,GASTRIC ULCER PERFORATION,1
ZA,GASTRITIS HAEMORRHAGIC,1
ZA,GASTROENTERITIS,1
ZA,GASTROINTESTINAL ANASTOMOTIC COMPLICATION,1
ZA,GASTROINTESTINAL NECROSIS,1
ZA,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
ZA,HAEMATEMESIS,1
ZA,HAEMOLYSIS,1
ZA,HAEMORRHAGE,1
ZA,HAEMORRHAGIC ANAEMIA,1
ZA,HAEMORRHOIDS,1
ZA,HEART RATE DECREASED,1
ZA,HEART VALVE REPLACEMENT,1
ZA,HEPATIC FAILURE,1
ZA,HEPATITIS,1
ZA,HEPATOCELLULAR CARCINOMA,1
ZA,HERNIA,1
ZA,HERPES ZOSTER,1
ZA,HYPERCHOLESTEROLAEMIA,1
ZA,HYPERGLYCAEMIA,1
ZA,HYPERVITAMINOSIS,1
ZA,HYPOACUSIS,1
ZA,HYPOALBUMINAEMIA,1
ZA,HYPOCALCAEMIA,1
ZA,HYPOMAGNESAEMIA,1
ZA,HYPONATRAEMIA,1
ZA,HYPOPNOEA,1
ZA,INFECTION,1
ZA,INSOMNIA,1
ZA,INTENTIONAL PRODUCT USE ISSUE,1
ZA,INTERNAL HAEMORRHAGE,1
ZA,INTESTINAL OBSTRUCTION,1
ZA,INTESTINAL SEPSIS,1
ZA,INTRACARDIAC THROMBUS,1
ZA,ISCHAEMIC HEPATITIS,1
ZA,ISCHAEMIC STROKE,1
ZA,JAUNDICE,1
ZA,JAUNDICE HEPATOCELLULAR,1
ZA,JOINT SWELLING,1
ZA,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
ZA,LARGE INTESTINE POLYP,1
ZA,LEG AMPUTATION,1
ZA,LETHARGY,1
ZA,LIVER DISORDER,1
ZA,LOWER LIMB FRACTURE,1
ZA,LUNG DISORDER,1
ZA,LUNG INFECTION,1
ZA,LUNG NEOPLASM MALIGNANT,1
ZA,MALIGNANT NEOPLASM PROGRESSION,1
ZA,MARROW HYPERPLASIA,1
ZA,MASS,1
ZA,MATERNAL EXPOSURE DURING PREGNANCY,1
ZA,MELAENA,1
ZA,MEMORY IMPAIRMENT,1
ZA,METASTASES TO LUNG,1
ZA,MIGRAINE,1
ZA,MULTI-ORGAN FAILURE,1
ZA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ZA,MUSCLE ATROPHY,1
ZA,MUSCLE SPASMS,1
ZA,MUSCULAR WEAKNESS,1
ZA,MUSCULOSKELETAL STIFFNESS,1
ZA,MYALGIA,1
ZA,MYOSITIS,1
ZA,NARCOLEPSY,1
ZA,NASAL DRYNESS,1
ZA,NEOPLASM PROGRESSION,1
ZA,NERVE INJURY,1
ZA,NEUROPATHY PERIPHERAL,1
ZA,NO THERAPEUTIC RESPONSE,1
ZA,NODULE,1
ZA,OESOPHAGITIS,1
ZA,OVERDOSE,1
ZA,PALLOR,1
ZA,PALPITATIONS,1
ZA,PANCREATIC CARCINOMA,1
ZA,PANCYTOPENIA,1
ZA,PARAESTHESIA,1
ZA,PARKINSON^S DISEASE,1
ZA,PEPTIC ULCER PERFORATION,1
ZA,PERIPHERAL EMBOLISM,1
ZA,PERIPHERAL VASCULAR DISORDER,1
ZA,PERITONITIS,1
ZA,PILOERECTION,1
ZA,PLATELET COUNT DECREASED,1
ZA,PLEURAL EFFUSION,1
ZA,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
ZA,PNEUMONIA CYTOMEGALOVIRAL,1
ZA,PNEUMONIA HAEMOPHILUS,1
ZA,PNEUMONITIS,1
ZA,POSTOPERATIVE WOUND COMPLICATION,1
ZA,PSEUDOMONAL SEPSIS,1
ZA,PSYCHOTIC DISORDER,1
ZA,PULMONARY OEDEMA,1
ZA,RECTAL CANCER,1
ZA,RED BLOOD CELL COUNT DECREASED,1
ZA,RENAL CANCER METASTATIC,1
ZA,RESPIRATORY DISORDER,1
ZA,RESPIRATORY FAILURE,1
ZA,RICKETS,1
ZA,SCAB,1
ZA,SEIZURE,1
ZA,SEPSIS,1
ZA,SEPTIC SHOCK,1
ZA,SJOGREN^S SYNDROME,1
ZA,SKIN LESION,1
ZA,SPINAL FUSION SURGERY,1
ZA,STRESS,1
ZA,SUBDURAL HAEMORRHAGE,1
ZA,SURGERY,1
ZA,TACHYCARDIA,1
ZA,TACHYCARDIA PAROXYSMAL,1
ZA,TAKAYASU^S ARTERITIS,1
ZA,THROAT CANCER,1
ZA,TIBIA FRACTURE,1
ZA,TRANSIENT ISCHAEMIC ATTACK,1
ZA,TUBERCULOSIS,1
ZA,URETHRAL OBSTRUCTION,1
ZA,URINARY INCONTINENCE,1
ZA,URTICARIA,1
ZA,VISUAL ACUITY REDUCED,1
ZA,WEIGHT DECREASED,1
ZA,WOUND DEHISCENCE,1
ZA,WOUND SEPSIS,1
ES,TORSADE DE POINTES,53
ES,ELECTROCARDIOGRAM QT PROLONGED,50
ES,HYPOMAGNESAEMIA,41
ES,CARDIO-RESPIRATORY ARREST,40
ES,HYPOKALAEMIA,37
ES,RHABDOMYOLYSIS,36
ES,DIZZINESS,31
ES,SOMNOLENCE,31
ES,FALL,29
ES,ACUTE KIDNEY INJURY,28
ES,HEADACHE,26
ES,ASTHENIA,25
ES,DIARRHOEA,25
ES,HYPONATRAEMIA,24
ES,PYREXIA,23
ES,ANAEMIA,22
ES,TOXICITY TO VARIOUS AGENTS,22
ES,DEPRESSION,21
ES,NEUTROPENIA,21
ES,RENAL FAILURE,21
ES,VENTRICULAR FIBRILLATION,20
ES,ATRIAL FIBRILLATION,19
ES,DRUG INEFFECTIVE,19
ES,PAIN IN EXTREMITY,19
ES,HEPATOTOXICITY,18
ES,INSOMNIA,18
ES,SEROTONIN SYNDROME,18
ES,VOMITING,17
ES,URINARY TRACT INFECTION,16
ES,CARDIAC FAILURE,15
ES,MALAISE,15
ES,PNEUMONIA,15
ES,DYSPNOEA,14
ES,FATIGUE,14
ES,HYPOCALCAEMIA,14
ES,MYOCLONUS,14
ES,NEUROTOXICITY,14
ES,RENAL FAILURE ACUTE,14
ES,RENAL IMPAIRMENT,14
ES,BUNDLE BRANCH BLOCK LEFT,13
ES,HYPOTENSION,13
ES,NAUSEA,13
ES,FIXED ERUPTION,12
ES,HISTIOCYTOSIS HAEMATOPHAGIC,12
ES,OVERDOSE,12
ES,SEIZURE,12
ES,TREATMENT NONCOMPLIANCE,12
ES,CONSTIPATION,11
ES,LACTIC ACIDOSIS,11
ES,PAIN,11
ES,CONFUSIONAL STATE,10
ES,METABOLIC ACIDOSIS,10
ES,SEPTIC SHOCK,10
ES,VENTRICULAR EXTRASYSTOLES,10
ES,VENTRICULAR TACHYCARDIA,10
ES,ARTHRALGIA,9
ES,CARDIAC ARREST,9
ES,CONDITION AGGRAVATED,9
ES,DEHYDRATION,9
ES,FEBRILE NEUTROPENIA,9
ES,HYPERKALAEMIA,9
ES,LUNG INFILTRATION,9
ES,BLOOD CREATININE INCREASED,8
ES,DECREASED APPETITE,8
ES,DISORIENTATION,8
ES,HEPATITIS,8
ES,HYPOGLYCAEMIA,8
ES,LOSS OF CONSCIOUSNESS,8
ES,RESPIRATORY TRACT INFECTION,8
ES,SYNCOPE,8
ES,THROMBOCYTOPENIA,8
ES,ABDOMINAL DISCOMFORT,7
ES,ABDOMINAL PAIN,7
ES,CELLULITIS,7
ES,DRUG-INDUCED LIVER INJURY,7
ES,DYSPHAGIA,7
ES,HYPERGLYCAEMIA,7
ES,INTERSTITIAL LUNG DISEASE,7
ES,ORAL CANDIDIASIS,7
ES,PRURITUS,7
ES,RASH,7
ES,SUBDURAL HAEMATOMA,7
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,7
ES,CEREBRAL HAEMORRHAGE,6
ES,CEREBROVASCULAR ACCIDENT,6
ES,CHEST PAIN,6
ES,GENERAL PHYSICAL HEALTH DETERIORATION,6
ES,HYPERBILIRUBINAEMIA,6
ES,HYPERTRANSAMINASAEMIA,6
ES,INFLAMMATION,6
ES,MYALGIA,6
ES,MYOCARDIAL INFARCTION,6
ES,PANCYTOPENIA,6
ES,PSYCHOTIC DISORDER,6
ES,SEPSIS,6
ES,TACHYCARDIA,6
ES,TOXIC EPIDERMAL NECROLYSIS,6
ES,TRANSAMINASES INCREASED,6
ES,TRANSIENT ISCHAEMIC ATTACK,6
ES,URINARY RETENTION,6
ES,ACUTE RESPIRATORY FAILURE,5
ES,AGITATION,5
ES,ASPARTATE AMINOTRANSFERASE INCREASED,5
ES,BACK PAIN,5
ES,CARDIAC DISORDER,5
ES,CHRONIC KIDNEY DISEASE,5
ES,EPISTAXIS,5
ES,ERYTHEMA,5
ES,GAIT DISTURBANCE,5
ES,GASTROINTESTINAL HAEMORRHAGE,5
ES,HAEMATOCHEZIA,5
ES,HAEMATOMA,5
ES,HAEMOGLOBIN DECREASED,5
ES,HAEMORRHAGE INTRACRANIAL,5
ES,HYPERHIDROSIS,5
ES,HYPOCOAGULABLE STATE,5
ES,INJECTION SITE ERYTHEMA,5
ES,INTENTIONAL OVERDOSE,5
ES,MUSCULAR WEAKNESS,5
ES,PLEURAL EFFUSION,5
ES,PRODUCT USE ISSUE,5
ES,PRURITUS GENERALISED,5
ES,URTICARIA,5
ES,WRONG PATIENT RECEIVED MEDICATION,5
ES,ACUTE MYOCARDIAL INFARCTION,4
ES,ANGIOEDEMA,4
ES,ANXIETY,4
ES,BLOOD PRESSURE INCREASED,4
ES,COGNITIVE DISORDER,4
ES,COUGH,4
ES,CRANIOCEREBRAL INJURY,4
ES,CYANOSIS,4
ES,DELIRIUM,4
ES,DIABETIC KETOACIDOSIS,4
ES,FIXED DRUG ERUPTION,4
ES,GAMMA-GLUTAMYLTRANSFERASE INCREASED,4
ES,HAEMODYNAMIC INSTABILITY,4
ES,INJECTION SITE HAEMATOMA,4
ES,INJECTION SITE PAIN,4
ES,INTERNATIONAL NORMALISED RATIO INCREASED,4
ES,ISCHAEMIC STROKE,4
ES,LOWER GASTROINTESTINAL HAEMORRHAGE,4
ES,LYMPHADENOPATHY,4
ES,MALIGNANT NEOPLASM PROGRESSION,4
ES,METABOLIC ENCEPHALOPATHY,4
ES,MUSCLE SPASMS,4
ES,ODYNOPHAGIA,4
ES,OEDEMA PERIPHERAL,4
ES,PSORIASIS,4
ES,PULMONARY EMBOLISM,4
ES,RESPIRATORY FAILURE,4
ES,TOXIC SKIN ERUPTION,4
ES,WEIGHT INCREASED,4
ES,ACUTE CORONARY SYNDROME,3
ES,AGRANULOCYTOSIS,3
ES,ALANINE AMINOTRANSFERASE INCREASED,3
ES,ANGINA PECTORIS,3
ES,ARTHRITIS,3
ES,ASPIRATION BRONCHIAL,3
ES,ATRIOVENTRICULAR BLOCK COMPLETE,3
ES,BILIARY COLIC,3
ES,BRADYCARDIA,3
ES,BRADYPHRENIA,3
ES,BUNDLE BRANCH BLOCK RIGHT,3
ES,BURNING SENSATION,3
ES,CARDIOVASCULAR DISORDER,3
ES,CATARACT,3
ES,CEREBRAL ATROPHY,3
ES,CEREBRAL HAEMATOMA,3
ES,CHOLELITHIASIS,3
ES,DEATH,3
ES,DEPRESSED MOOD,3
ES,DISCOMFORT,3
ES,DRUG EFFECT INCOMPLETE,3
ES,DRUG INTOLERANCE,3
ES,DYSPHONIA,3
ES,DYSURIA,3
ES,FEELING ABNORMAL,3
ES,FEMUR FRACTURE,3
ES,FLUID RETENTION,3
ES,GASTRIC ULCER,3
ES,GENERALISED ERYTHEMA,3
ES,HAEMORRHAGIC ANAEMIA,3
ES,HEPATIC FUNCTION ABNORMAL,3
ES,HEPATITIS TOXIC,3
ES,HYPERTENSION,3
ES,HYPERTENSIVE CRISIS,3
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,3
ES,INFLUENZA,3
ES,INJECTION SITE WARMTH,3
ES,KLEBSIELLA INFECTION,3
ES,KOUNIS SYNDROME,3
ES,MOUTH ULCERATION,3
ES,MUSCULOSKELETAL PAIN,3
ES,MYOPATHY,3
ES,NORMETANEPHRINE URINE INCREASED,3
ES,OSTEONECROSIS,3
ES,PANCREATITIS ACUTE,3
ES,PERICARDIAL EFFUSION,3
ES,PERICARDIAL HAEMORRHAGE,3
ES,PERIPHERAL ISCHAEMIA,3
ES,PHOTOSENSITIVITY REACTION,3
ES,PLATELET COUNT DECREASED,3
ES,PROSTATE CANCER,3
ES,PULMONARY HYPERTENSION,3
ES,RECTAL HAEMORRHAGE,3
ES,RENAL TUBULAR NECROSIS,3
ES,SKIN EXFOLIATION,3
ES,SPINAL FRACTURE,3
ES,SQUAMOUS CELL CARCINOMA,3
ES,SUBARACHNOID HAEMORRHAGE,3
ES,SUICIDAL IDEATION,3
ES,WEIGHT DECREASED,3
ES,ABASIA,2
ES,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,2
ES,ADENOCARCINOMA GASTRIC,2
ES,AGEUSIA,2
ES,ALOPECIA,2
ES,AMNESIA,2
ES,ANAL HAEMORRHAGE,2
ES,ANGINA UNSTABLE,2
ES,ANURIA,2
ES,APATHY,2
ES,APHASIA,2
ES,ASTHMA,2
ES,AUTOIMMUNE HEPATITIS,2
ES,BASAL CELL CARCINOMA,2
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0,2
ES,BLOOD CATECHOLAMINES INCREASED,2
ES,BLOOD CHOLESTEROL INCREASED,2
ES,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
ES,BLOOD GLUCOSE INCREASED,2
ES,BLOOD LACTATE DEHYDROGENASE INCREASED,2
ES,BONE PAIN,2
ES,BRONCHITIS,2
ES,BRONCHOPULMONARY ASPERGILLOSIS,2
ES,C-REACTIVE PROTEIN INCREASED,2
ES,CARDIAC FAILURE CONGESTIVE,2
ES,CARDIOMEGALY,2
ES,CHOKING,2
ES,CHOLECYSTITIS,2
ES,CHOLESTASIS,2
ES,CHRONIC LYMPHOCYTIC LEUKAEMIA,2
ES,CLOSTRIDIUM DIFFICILE COLITIS,2
ES,COLITIS,2
ES,COLITIS ISCHAEMIC,2
ES,COLON CANCER,2
ES,CONDUCT DISORDER,2
ES,CONTRAINDICATED DRUG ADMINISTERED,2
ES,CORONARY ARTERY OCCLUSION,2
ES,DEMENTIA,2
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,2
ES,DERMATITIS,2
ES,DIABETES MELLITUS INADEQUATE CONTROL,2
ES,DIVERTICULUM,2
ES,DRY SKIN,2
ES,DYSPEPSIA,2
ES,DYSPNOEA EXERTIONAL,2
ES,ELECTROCARDIOGRAM ABNORMAL,2
ES,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,2
ES,ELECTROLYTE IMBALANCE,2
ES,EOSINOPHILIA,2
ES,ERECTILE DYSFUNCTION,2
ES,ESCHERICHIA URINARY TRACT INFECTION,2
ES,FALSE POSITIVE INVESTIGATION RESULT,2
ES,GASTROENTERITIS,2
ES,GASTROOESOPHAGEAL REFLUX DISEASE,2
ES,GLOMERULAR FILTRATION RATE DECREASED,2
ES,GLYCOSYLATED HAEMOGLOBIN INCREASED,2
ES,GOUTY TOPHUS,2
ES,HAEMATOCRIT DECREASED,2
ES,HAEMATURIA,2
ES,HAEMORRHAGE,2
ES,HAEMORRHOIDS,2
ES,HALLUCINATION_ VISUAL,2
ES,HANGOVER,2
ES,HEAD INJURY,2
ES,HIATUS HERNIA,2
ES,HOT FLUSH,2
ES,HYPERCALCAEMIA,2
ES,HYPERTHYROIDISM,2
ES,HYPOACUSIS,2
ES,HYPOTHYROIDISM,2
ES,HYPOVOLAEMIC SHOCK,2
ES,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
ES,IMMUNOSUPPRESSION,2
ES,INFECTION,2
ES,INJECTION SITE HAEMORRHAGE,2
ES,INJECTION SITE PRURITUS,2
ES,INJURY,2
ES,INTRA-ABDOMINAL HAEMATOMA,2
ES,ISCHAEMIC CARDIOMYOPATHY,2
ES,ISCHAEMIC CEREBRAL INFARCTION,2
ES,KETOACIDOSIS,2
ES,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,2
ES,LABORATORY TEST ABNORMAL,2
ES,LACUNAR INFARCTION,2
ES,LEUKOCYTOSIS,2
ES,LIVER DISORDER,2
ES,LUNG ADENOCARCINOMA,2
ES,MANIA,2
ES,MELAENA,2
ES,MEMORY IMPAIRMENT,2
ES,METABOLIC DISORDER,2
ES,METASTASES TO LIVER,2
ES,MOBILITY DECREASED,2
ES,MOTOR DYSFUNCTION,2
ES,MUCOSAL INFLAMMATION,2
ES,MULTIPLE DRUG THERAPY,2
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
ES,MULTIPLE SCLEROSIS RELAPSE,2
ES,MUSCLE HAEMORRHAGE,2
ES,MUSCULOSKELETAL STIFFNESS,2
ES,MYELODYSPLASTIC SYNDROME,2
ES,NASAL POLYPS,2
ES,NASOPHARYNGITIS,2
ES,NEPHROLITHIASIS,2
ES,NEPHROPATHY TOXIC,2
ES,NERVOUSNESS,2
ES,OEDEMA,2
ES,ORAL HERPES,2
ES,OROPHARYNGEAL PAIN,2
ES,PALPITATIONS,2
ES,PANCREATITIS,2
ES,PANCREATITIS NECROTISING,2
ES,PERIPHERAL SWELLING,2
ES,PHARYNGITIS,2
ES,PHOTOPHOBIA,2
ES,PNEUMONITIS,2
ES,POLLAKIURIA,2
ES,POOR PERIPHERAL CIRCULATION,2
ES,POST PROCEDURAL HAEMORRHAGE,2
ES,PRESYNCOPE,2
ES,PROCTITIS,2
ES,PRODUCT QUALITY ISSUE,2
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,2
ES,PROSTATIC SPECIFIC ANTIGEN INCREASED,2
ES,PROTEINURIA,2
ES,PULMONARY INFARCTION,2
ES,PULMONARY OEDEMA,2
ES,RASH MACULO-PAPULAR,2
ES,RENAL DISORDER,2
ES,RESTLESSNESS,2
ES,ROAD TRAFFIC ACCIDENT,2
ES,SENSE OF OPPRESSION,2
ES,SKIN ULCER,2
ES,STAPHYLOCOCCAL INFECTION,2
ES,STAPHYLOCOCCAL SEPSIS,2
ES,STEVENS-JOHNSON SYNDROME,2
ES,STOMATITIS,2
ES,SUPRAVENTRICULAR TACHYCARDIA,2
ES,SWELLING,2
ES,SWOLLEN TONGUE,2
ES,TACHYPNOEA,2
ES,TEARFULNESS,2
ES,TENDON RUPTURE,2
ES,THROMBOTIC THROMBOCYTOPENIC PURPURA,2
ES,TOBACCO USER,2
ES,TRANSIENT GLOBAL AMNESIA,2
ES,TREMOR,2
ES,UROSEPSIS,2
ES,VARICOSE VEIN,2
ES,VITAMIN D DEFICIENCY,2
ES,ABDOMINAL INFECTION,1
ES,ABDOMINAL PAIN UPPER,1
ES,ABDOMINAL WALL HAEMATOMA,1
ES,ABNORMAL BEHAVIOUR,1
ES,ACCIDENT,1
ES,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
ES,ACTIVITIES OF DAILY LIVING IMPAIRED,1
ES,ACUTE INTERSTITIAL PNEUMONITIS,1
ES,ACUTE LYMPHOCYTIC LEUKAEMIA,1
ES,ACUTE PHASE REACTION,1
ES,ACUTE PRERENAL FAILURE,1
ES,ACUTE PULMONARY OEDEMA,1
ES,ADVERSE EVENT,1
ES,AFFECTIVE DISORDER,1
ES,AGGRESSION,1
ES,AGNOSIA,1
ES,ALTERED STATE OF CONSCIOUSNESS,1
ES,ALVEOLAR OSTEITIS,1
ES,AMPUTATION,1
ES,AMYLASE INCREASED,1
ES,ANAL ABSCESS,1
ES,ANAPHYLACTIC REACTION,1
ES,ANAPHYLACTIC SHOCK,1
ES,ANHEDONIA,1
ES,ANISAKIASIS,1
ES,ANKYLOSING SPONDYLITIS,1
ES,ANOSMIA,1
ES,ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC,1
ES,ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC,1
ES,ARRHYTHMIA,1
ES,ARTHROPOD BITE,1
ES,ASCITES,1
ES,ASPIRATION,1
ES,ATAXIA,1
ES,ATELECTASIS,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,ATYPICAL FIBROXANTHOMA,1
ES,AXONAL NEUROPATHY,1
ES,BALANCE DISORDER,1
ES,BASAL GANGLIA HAEMORRHAGE,1
ES,BLADDER DYSFUNCTION,1
ES,BLADDER PAIN,1
ES,BLADDER TRANSITIONAL CELL CARCINOMA STAGE III,1
ES,BLEEDING VARICOSE VEIN,1
ES,BLINDNESS,1
ES,BLISTER,1
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,1
ES,BLOOD DISORDER,1
ES,BLOOD GLUCOSE DECREASED,1
ES,BLOOD GROWTH HORMONE INCREASED,1
ES,BLOOD HOMOCYSTEINE INCREASED,1
ES,BLOOD PARATHYROID HORMONE INCREASED,1
ES,BLOOD POTASSIUM INCREASED,1
ES,BLOOD PRESSURE DECREASED,1
ES,BLOOD PRESSURE FLUCTUATION,1
ES,BLOOD PRESSURE SYSTOLIC DECREASED,1
ES,BLOOD SODIUM INCREASED,1
ES,BLOOD UREA INCREASED,1
ES,BONE ABSCESS,1
ES,BONE DISORDER,1
ES,BONE MARROW FAILURE,1
ES,BRAIN MASS,1
ES,BREAST ENLARGEMENT,1
ES,BREAST INFLAMMATION,1
ES,BREAST OPERATION,1
ES,BREAST PAIN,1
ES,BREATH SOUNDS ABNORMAL,1
ES,BRONCHIECTASIS,1
ES,BRONCHIOLITIS,1
ES,C-REACTIVE PROTEIN DECREASED,1
ES,CAPILLARY FRAGILITY,1
ES,CARDIAC FAILURE ACUTE,1
ES,CARDIAC TAMPONADE,1
ES,CARDIOACTIVE DRUG LEVEL INCREASED,1
ES,CARDIOGENIC SHOCK,1
ES,CARDIOPULMONARY FAILURE,1
ES,CAROTID ARTERIOSCLEROSIS,1
ES,CARTILAGE INJURY,1
ES,CEREBELLAR HAEMATOMA,1
ES,CEREBRAL ARTERY OCCLUSION,1
ES,CEREBRAL INFARCTION,1
ES,CHEST DISCOMFORT,1
ES,CHILLS,1
ES,CHOKING SENSATION,1
ES,CHOLANGITIS,1
ES,CHOLANGITIS ACUTE,1
ES,CHOLECYSTITIS ACUTE,1
ES,CHRONIC RESPIRATORY FAILURE,1
ES,CLOSTRIDIUM DIFFICILE INFECTION,1
ES,COAGULOPATHY,1
ES,COMA,1
ES,COMMINUTED FRACTURE,1
ES,COMPLETED SUICIDE,1
ES,CONDUCTION DISORDER,1
ES,CONJUNCTIVITIS,1
ES,CONTINUOUS HAEMODIAFILTRATION,1
ES,CONTRAINDICATED PRODUCT ADMINISTERED,1
ES,CONTUSION,1
ES,CORONARY ARTERY DISEASE,1
ES,CORONARY ARTERY RESTENOSIS,1
ES,CREATININE RENAL CLEARANCE DECREASED,1
ES,CREPITATIONS,1
ES,CRYING,1
ES,CYSTITIS,1
ES,DEAFNESS UNILATERAL,1
ES,DECUBITUS ULCER,1
ES,DEEP VEIN THROMBOSIS,1
ES,DELUSION OF REFERENCE,1
ES,DENTAL CARIES,1
ES,DERMATITIS EXFOLIATIVE,1
ES,DERMATITIS PSORIASIFORM,1
ES,DERMATOMYOSITIS,1
ES,DEVICE ISSUE,1
ES,DIABETIC HYPEROSMOLAR COMA,1
ES,DIABETIC METABOLIC DECOMPENSATION,1
ES,DIARRHOEA HAEMORRHAGIC,1
ES,DIFFUSE ALVEOLAR DAMAGE,1
ES,DISEASE PROGRESSION,1
ES,DISEASE RECURRENCE,1
ES,DISORGANISED SPEECH,1
ES,DISTURBANCE IN ATTENTION,1
ES,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
ES,DROWNING,1
ES,DRUG ADMINISTRATION ERROR,1
ES,DRUG EFFECT DELAYED,1
ES,DRUG PRESCRIBING ERROR,1
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
ES,DRUG-DISEASE INTERACTION,1
ES,DYSKINESIA,1
ES,DYSPLASIA,1
ES,DYSPNOEA AT REST,1
ES,EAR PAIN,1
ES,EARLY SATIETY,1
ES,EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED,1
ES,ECTHYMA,1
ES,ECZEMA,1
ES,ELECTROCARDIOGRAM QRS COMPLEX SHORTENED,1
ES,EMPYEMA,1
ES,ENCEPHALITIS,1
ES,ENTERITIS,1
ES,ENTEROCUTANEOUS FISTULA,1
ES,ENTHESOPATHY,1
ES,EPILEPSY,1
ES,ERYTHEMA MULTIFORME,1
ES,ESCHERICHIA BACTERAEMIA,1
ES,ESCHERICHIA INFECTION,1
ES,ESCHERICHIA PYELONEPHRITIS,1
ES,EXCESSIVE CERUMEN PRODUCTION,1
ES,EXPOSED BONE IN JAW,1
ES,EXPOSURE DURING PREGNANCY,1
ES,EXTENSOR PLANTAR RESPONSE,1
ES,EXTRASYSTOLES,1
ES,EXTREMITY NECROSIS,1
ES,EYE DISORDER,1
ES,EYELID CONTUSION,1
ES,EYELID OEDEMA,1
ES,FACE INJURY,1
ES,FACIAL PARALYSIS,1
ES,FAECALOMA,1
ES,FEAR OF INJECTION,1
ES,FEELING HOT,1
ES,FIBROMYALGIA,1
ES,FISTULA,1
ES,FLANK PAIN,1
ES,FLATULENCE,1
ES,FLUID INTAKE REDUCED,1
ES,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
ES,FRACTURE MALUNION,1
ES,GASTRIC BYPASS,1
ES,GASTRIC CANCER,1
ES,GASTRIC DISORDER,1
ES,GASTRIC ULCER HAEMORRHAGE,1
ES,GASTRITIS,1
ES,GASTRITIS EROSIVE,1
ES,GASTROENTERITIS VIRAL,1
ES,GASTROINTESTINAL HYPOMOTILITY,1
ES,GASTROINTESTINAL INFLAMMATION,1
ES,GASTROINTESTINAL TRACT ADENOMA,1
ES,GAZE PALSY,1
ES,GENERALISED TONIC-CLONIC SEIZURE,1
ES,GINGIVAL BLEEDING,1
ES,GINGIVAL POLYP,1
ES,GINGIVITIS,1
ES,GLOSSITIS,1
ES,GLOSSODYNIA,1
ES,GOUT,1
ES,GYNAECOMASTIA,1
ES,H1N1 INFLUENZA,1
ES,HAEMANGIOMA,1
ES,HAEMATEMESIS,1
ES,HAEMATOSPERMIA,1
ES,HAEMOPTYSIS,1
ES,HAEMOTHORAX,1
ES,HALLUCINATION_ AUDITORY,1
ES,HALLUCINATIONS_ MIXED,1
ES,HEART RATE INCREASED,1
ES,HELICOBACTER INFECTION,1
ES,HEMIPARESIS,1
ES,HEPATIC CIRRHOSIS,1
ES,HEPATIC CYST,1
ES,HEPATIC ENCEPHALOPATHY,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATIC STEATOSIS,1
ES,HEPATITIS C,1
ES,HEPATITIS CHOLESTATIC,1
ES,HEPATOCELLULAR CARCINOMA,1
ES,HEPATOCELLULAR INJURY,1
ES,HEPATOMEGALY,1
ES,HERBAL INTERACTION,1
ES,HERPES VIRUS INFECTION,1
ES,HIP FRACTURE,1
ES,HUMERUS FRACTURE,1
ES,HYDRONEPHROSIS,1
ES,HYPERCHOLESTEROLAEMIA,1
ES,HYPERPARATHYROIDISM,1
ES,HYPERTENSIVE EMERGENCY,1
ES,HYPOAESTHESIA,1
ES,HYPOCHROMIC ANAEMIA,1
ES,HYPOGLYCAEMIC COMA,1
ES,HYPOPHYSITIS,1
ES,HYPOPROTEINAEMIA,1
ES,HYPOTONIA,1
ES,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,1
ES,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
ES,IMMUNODEFICIENCY,1
ES,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
ES,INCORRECT DOSE ADMINISTERED,1
ES,INCORRECT DRUG ADMINISTRATION DURATION,1
ES,INFARCTION,1
ES,INJECTION SITE CELLULITIS,1
ES,INJECTION SITE INDURATION,1
ES,INJECTION SITE INJURY,1
ES,INJECTION SITE MASS,1
ES,INJECTION SITE PAPULE,1
ES,INJECTION SITE SWELLING,1
ES,INSULIN-LIKE GROWTH FACTOR INCREASED,1
ES,INTENTIONAL PRODUCT MISUSE,1
ES,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
ES,INTESTINAL GANGRENE,1
ES,INTESTINAL HAEMORRHAGE,1
ES,INTESTINAL ISCHAEMIA,1
ES,INTESTINAL OBSTRUCTION,1
ES,INTESTINAL PERFORATION,1
ES,INTESTINAL POLYP,1
ES,INTESTINAL STENOSIS,1
ES,INTRA-ABDOMINAL HAEMORRHAGE,1
ES,INTRACRANIAL PRESSURE INCREASED,1
ES,INTRAVENTRICULAR HAEMORRHAGE,1
ES,IRON DEFICIENCY,1
ES,IRON DEFICIENCY ANAEMIA,1
ES,IRRITABILITY,1
ES,ISCHAEMIA,1
ES,ISCHAEMIC PANCREATITIS,1
ES,JOINT SWELLING,1
ES,KLEBSIELLA TEST POSITIVE,1
ES,LARGE INTESTINE POLYP,1
ES,LARYNGEAL POLYP,1
ES,LEUKOPENIA,1
ES,LIBIDO DECREASED,1
ES,LICHENOID KERATOSIS,1
ES,LIMB INJURY,1
ES,LIP SWELLING,1
ES,LIPASE INCREASED,1
ES,LISTERIOSIS,1
ES,LOCALISED INFECTION,1
ES,LOSS OF LIBIDO,1
ES,LUNG DISORDER,1
ES,LUNG INFECTION,1
ES,LUNG NEOPLASM MALIGNANT,1
ES,LUNG TRANSPLANT REJECTION,1
ES,LYMPHOPENIA,1
ES,MACULAR OEDEMA,1
ES,MACULE,1
ES,MACULOPATHY,1
ES,MALE SEXUAL DYSFUNCTION,1
ES,MALIGNANT MELANOMA,1
ES,MASS,1
ES,MATERNAL EXPOSURE DURING PREGNANCY,1
ES,MEDICATION ERROR,1
ES,MEDICATION RESIDUE PRESENT,1
ES,MENINGITIS LISTERIA,1
ES,MENTAL IMPAIRMENT,1
ES,METAMORPHOPSIA,1
ES,METASTASES TO BONE,1
ES,MICTURITION URGENCY,1
ES,MITRAL VALVE INCOMPETENCE,1
ES,MOOD SWINGS,1
ES,MORPHOEA,1
ES,MOUTH HAEMORRHAGE,1
ES,MULTI-ORGAN FAILURE,1
ES,MUSCLE DISORDER,1
ES,MUSCLE NECROSIS,1
ES,MUSCLE RIGIDITY,1
ES,MUSCLE RUPTURE,1
ES,MUSCLE SPASTICITY,1
ES,MYOCARDIAC ABSCESS,1
ES,MYOCARDIAL ISCHAEMIA,1
ES,MYOCARDITIS,1
ES,NASAL OBSTRUCTION,1
ES,NECK PAIN,1
ES,NECROSIS,1
ES,NECROTISING FASCIITIS,1
ES,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,1
ES,NEPHROANGIOSCLEROSIS,1
ES,NEPHROPATHY,1
ES,NERVE COMPRESSION,1
ES,NERVOUS SYSTEM DISORDER,1
ES,NEUROLEPTIC MALIGNANT SYNDROME,1
ES,NEUROPATHY PERIPHERAL,1
ES,NIGHT SWEATS,1
ES,NODAL RHYTHM,1
ES,NUCHAL RIGIDITY,1
ES,OBESITY,1
ES,OCULAR DISCOMFORT,1
ES,OEDEMATOUS PANCREATITIS,1
ES,OPPORTUNISTIC INFECTION,1
ES,ORAL DISCOMFORT,1
ES,ORAL INFECTION,1
ES,ORAL MUCOSA EROSION,1
ES,ORAL MUCOSAL BLISTERING,1
ES,ORAL MUCOSAL ERUPTION,1
ES,ORCHITIS,1
ES,OROPHARYNGEAL SWELLING,1
ES,OSTEITIS,1
ES,OSTEOARTHRITIS,1
ES,OSTEONECROSIS OF JAW,1
ES,OXYGEN SATURATION DECREASED,1
ES,PAIN OF SKIN,1
ES,PALATAL DISORDER,1
ES,PALLOR,1
ES,PANCREATIC ABSCESS,1
ES,PANCREATIC CARCINOMA,1
ES,PANCREATIC CARCINOMA METASTATIC,1
ES,PANCREATIC DISORDER,1
ES,PAPILLARY RENAL CELL CARCINOMA,1
ES,PARAESTHESIA,1
ES,PARALYSIS,1
ES,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,1
ES,PEPTIC ULCER,1
ES,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
ES,PERIPHERAL COLDNESS,1
ES,PERIPHERAL VENOUS DISEASE,1
ES,PERITONEAL HAEMORRHAGE,1
ES,PERSONALITY DISORDER,1
ES,PHAEOCHROMOCYTOMA,1
ES,PHARYNGEAL DISORDER,1
ES,PHARYNGEAL OEDEMA,1
ES,PHLEBITIS,1
ES,PLASMA CELL MYELOMA,1
ES,PNEUMONIA LEGIONELLA,1
ES,PNEUMONIA PNEUMOCOCCAL,1
ES,POLYP,1
ES,POLYURIA,1
ES,PORTAL VEIN THROMBOSIS,1
ES,POST PROCEDURAL COMPLICATION,1
ES,POST PROCEDURAL DISCOMFORT,1
ES,POTENTIATING DRUG INTERACTION,1
ES,PREMATURE AGEING,1
ES,PREMATURE RUPTURE OF MEMBRANES,1
ES,PRERENAL FAILURE,1
ES,PRESCRIBED OVERDOSE,1
ES,PROCEDURAL HAEMORRHAGE,1
ES,PROSTATE CANCER STAGE IV,1
ES,PROSTATIC ADENOMA,1
ES,PROSTATISM,1
ES,PROTEIN TOTAL INCREASED,1
ES,PROTHROMBIN TIME PROLONGED,1
ES,PSEUDOMONAS INFECTION,1
ES,PULMONARY ALVEOLAR HAEMORRHAGE,1
ES,PULMONARY CALCIFICATION,1
ES,PULMONARY FIBROSIS,1
ES,PULMONARY GRANULOMA,1
ES,PULMONARY HAEMORRHAGE,1
ES,PULMONARY HILAR ENLARGEMENT,1
ES,PULMONARY TOXICITY,1
ES,PULSE ABSENT,1
ES,PYELONEPHRITIS ACUTE,1
ES,RALES,1
ES,RASH ERYTHEMATOUS,1
ES,RASH PRURITIC,1
ES,RASH PUSTULAR,1
ES,RED BLOOD CELL COUNT DECREASED,1
ES,RED BLOOD CELL SEDIMENTATION RATE DECREASED,1
ES,RENAL COLIC,1
ES,RENAL CYST,1
ES,RENAL FAILURE CHRONIC,1
ES,RENAL NEOPLASM,1
ES,RENAL PAIN,1
ES,RESPIRATORY DISORDER,1
ES,RESPIRATORY DISTRESS,1
ES,RETINAL ARTERY EMBOLISM,1
ES,RETINAL ARTERY THROMBOSIS,1
ES,RETROGRADE EJACULATION,1
ES,RETROPERITONEAL ABSCESS,1
ES,RHEUMATOID ARTHRITIS,1
ES,RHEUMATOID FACTOR INCREASED,1
ES,RIB FRACTURE,1
ES,RICHTER^S SYNDROME,1
ES,SALIVARY GLAND DISORDER,1
ES,SECRETION DISCHARGE,1
ES,SENSITISATION,1
ES,SENSITIVITY OF TEETH,1
ES,SENSORY LOSS,1
ES,SHOCK,1
ES,SHOCK HAEMORRHAGIC,1
ES,SIALOADENITIS,1
ES,SINOATRIAL BLOCK,1
ES,SINUS TACHYCARDIA,1
ES,SKIN BURNING SENSATION,1
ES,SKIN DISORDER,1
ES,SKIN LESION,1
ES,SKIN MASS,1
ES,SKIN WARM,1
ES,SKIN WRINKLING,1
ES,SKULL FRACTURE,1
ES,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,1
ES,SMALL CELL LUNG CANCER,1
ES,SPEECH DISORDER,1
ES,SPINAL COLUMN STENOSIS,1
ES,SPIROMETRY ABNORMAL,1
ES,SPONDYLITIS,1
ES,SUBCUTANEOUS ABSCESS,1
ES,SUBDURAL HAEMORRHAGE,1
ES,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
ES,SUICIDE ATTEMPT,1
ES,SUPRAVENTRICULAR EXTRASYSTOLES,1
ES,TENDON CALCIFICATION,1
ES,TESTICULAR PAIN,1
ES,THERAPEUTIC RESPONSE UNEXPECTED,1
ES,THROAT IRRITATION,1
ES,THROMBOCYTOPENIC PURPURA,1
ES,THROMBOSIS MESENTERIC VESSEL,1
ES,THYROID OPERATION,1
ES,TIBIA FRACTURE,1
ES,TINNITUS,1
ES,TOE AMPUTATION,1
ES,TONGUE DISCOMFORT,1
ES,TOOTH EXTRACTION,1
ES,TOOTH FRACTURE,1
ES,TOOTH LOSS,1
ES,TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA,1
ES,TRICUSPID VALVE INCOMPETENCE,1
ES,TYMPANIC MEMBRANE PERFORATION,1
ES,UNDERDOSE,1
ES,UPPER LIMB FRACTURE,1
ES,URETERIC STENOSIS,1
ES,URINARY BLADDER ATROPHY,1
ES,URINARY BLADDER POLYP,1
ES,URINARY INCONTINENCE,1
ES,URINARY TRACT DISORDER,1
ES,URINARY TRACT INFECTION BACTERIAL,1
ES,USE OF ACCESSORY RESPIRATORY MUSCLES,1
ES,VARICELLA,1
ES,VASCULAR GRAFT,1
ES,VASCULITIS,1
ES,VASOPLEGIA SYNDROME,1
ES,VENOUS INJURY,1
ES,VENTRICULAR ARRHYTHMIA,1
ES,VERTIGO,1
ES,VESSEL PUNCTURE SITE HAEMATOMA,1
ES,VIITH NERVE PARALYSIS,1
ES,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
ES,VISION BLURRED,1
ES,VISUAL ACUITY REDUCED,1
ES,VISUAL IMPAIRMENT,1
ES,WEIGHT BEARING DIFFICULTY,1
ES,WHITE BLOOD CELL COUNT DECREASED,1
ES,WITHDRAWAL SYNDROME,1
ES,WRIST FRACTURE,1
ES,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
LK,COGNITIVE DISORDER,2
SE,DIZZINESS,35
SE,MYALGIA,34
SE,MUSCULAR WEAKNESS,33
SE,FATIGUE,32
SE,ACUTE KIDNEY INJURY,26
SE,DIARRHOEA,26
SE,NAUSEA,25
SE,TOXICITY TO VARIOUS AGENTS,24
SE,DYSPNOEA,23
SE,RHABDOMYOLYSIS,22
SE,ARTHRALGIA,21
SE,HEADACHE,21
SE,CONFUSIONAL STATE,17
SE,ASTHENIA,16
SE,CHEST PAIN,16
SE,HYPOAESTHESIA,16
SE,MUSCLE SPASMS,16
SE,PAIN,16
SE,PAIN IN EXTREMITY,16
SE,PRURITUS,16
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,15
SE,PARAESTHESIA,15
SE,VOMITING,15
SE,ATRIAL FIBRILLATION,14
SE,HYPOTENSION,14
SE,DYSPHAGIA,13
SE,URINARY TRACT INFECTION,13
SE,WEIGHT DECREASED,13
SE,ABDOMINAL PAIN,12
SE,BACK PAIN,12
SE,CEREBROVASCULAR ACCIDENT,12
SE,DRUG INEFFECTIVE,12
SE,FALL,12
SE,SLEEP DISORDER,12
SE,CONSTIPATION,11
SE,MALAISE,11
SE,MEMORY IMPAIRMENT,11
SE,NIGHTMARE,11
SE,PYREXIA,11
SE,ANAEMIA,10
SE,ANXIETY,10
SE,BALANCE DISORDER,10
SE,COUGH,10
SE,MUSCULOSKELETAL STIFFNESS,10
SE,PNEUMONIA,10
SE,GAIT DISTURBANCE,9
SE,LACTIC ACIDOSIS,9
SE,RASH,9
SE,AGGRESSION,8
SE,AMNESIA,8
SE,DECREASED APPETITE,8
SE,DEPRESSION,8
SE,MUSCULOSKELETAL PAIN,8
SE,TRANSIENT ISCHAEMIC ATTACK,8
SE,ALOPECIA,7
SE,BRADYCARDIA,7
SE,HYPERSENSITIVITY,7
SE,HYPOTONIA,7
SE,MYOCARDIAL INFARCTION,7
SE,RENAL FAILURE,7
SE,SYNCOPE,7
SE,BLOOD CREATININE INCREASED,6
SE,C-REACTIVE PROTEIN INCREASED,6
SE,DEHYDRATION,6
SE,DEPRESSED MOOD,6
SE,DIABETES MELLITUS,6
SE,DRY MOUTH,6
SE,GENERAL PHYSICAL HEALTH DETERIORATION,6
SE,HAEMATURIA,6
SE,HYPERHIDROSIS,6
SE,HYPONATRAEMIA,6
SE,INSOMNIA,6
SE,OEDEMA PERIPHERAL,6
SE,POISONING,6
SE,POLYNEUROPATHY,6
SE,SEPSIS,6
SE,URINARY RETENTION,6
SE,WEIGHT INCREASED,6
SE,CEREBRAL HAEMORRHAGE,5
SE,EPISTAXIS,5
SE,ERECTILE DYSFUNCTION,5
SE,ERYTHEMA,5
SE,FLATULENCE,5
SE,FOETAL EXPOSURE DURING PREGNANCY,5
SE,GASTRIC HAEMORRHAGE,5
SE,HEART RATE INCREASED,5
SE,HEPATITIS,5
SE,ISCHAEMIC STROKE,5
SE,JOINT SWELLING,5
SE,MUSCLE ATROPHY,5
SE,MYOSITIS,5
SE,NEURALGIA,5
SE,PERIPHERAL SWELLING,5
SE,PERONEAL NERVE PALSY,5
SE,PULMONARY EMBOLISM,5
SE,RASH PRURITIC,5
SE,RENAL FAILURE ACUTE,5
SE,ABDOMINAL PAIN UPPER,4
SE,ANGIOEDEMA,4
SE,APHASIA,4
SE,BLOOD CREATINE PHOSPHOKINASE INCREASED,4
SE,BLOOD GLUCOSE INCREASED,4
SE,CARDIAC FAILURE,4
SE,CARDIAC FIBRILLATION,4
SE,CEREBRAL INFARCTION,4
SE,CHILLS,4
SE,DEATH,4
SE,DEEP VEIN THROMBOSIS,4
SE,DISORIENTATION,4
SE,DISTURBANCE IN ATTENTION,4
SE,FEELING ABNORMAL,4
SE,HAEMATOMA,4
SE,HEAD INJURY,4
SE,HEPATIC CIRRHOSIS,4
SE,INFLUENZA LIKE ILLNESS,4
SE,MYOGLOBIN BLOOD INCREASED,4
SE,OXYGEN SATURATION DECREASED,4
SE,PALPITATIONS,4
SE,RHEUMATOID ARTHRITIS,4
SE,SPEECH DISORDER,4
SE,SWELLING FACE,4
SE,TACHYCARDIA,4
SE,TREMOR,4
SE,UNRESPONSIVE TO STIMULI,4
SE,VERTIGO,4
SE,ARRHYTHMIA,3
SE,ATRIOVENTRICULAR BLOCK COMPLETE,3
SE,BLINDNESS TRANSIENT,3
SE,CARDIAC DISORDER,3
SE,CHEST DISCOMFORT,3
SE,CHOLESTASIS,3
SE,COGNITIVE DISORDER,3
SE,DRUG LEVEL INCREASED,3
SE,DUODENAL ULCER,3
SE,DYSARTHRIA,3
SE,DYSGEUSIA,3
SE,GASTRIC ULCER,3
SE,HALLUCINATION,3
SE,HOT FLUSH,3
SE,HYDRONEPHROSIS,3
SE,HYPERGLYCAEMIA,3
SE,HYPERTENSION,3
SE,INCORRECT DOSE ADMINISTERED,3
SE,INFECTION,3
SE,INFLAMMATION,3
SE,JOINT STIFFNESS,3
SE,LOSS OF CONSCIOUSNESS,3
SE,MOOD ALTERED,3
SE,MUSCLE CONTRACTIONS INVOLUNTARY,3
SE,NEPHROTIC SYNDROME,3
SE,OVERDOSE,3
SE,PANCREATITIS,3
SE,PERIORBITAL OEDEMA,3
SE,PHARYNGEAL OEDEMA,3
SE,PHOTOPHOBIA,3
SE,PHOTOSENSITIVITY REACTION,3
SE,POLYMYALGIA RHEUMATICA,3
SE,POLYMYOSITIS,3
SE,PULMONARY OEDEMA,3
SE,RESTLESS LEGS SYNDROME,3
SE,SKIN ULCER,3
SE,SOMNOLENCE,3
SE,STEVENS-JOHNSON SYNDROME,3
SE,SUICIDE ATTEMPT,3
SE,TENDONITIS,3
SE,THROMBOCYTOPENIA,3
SE,TIC,3
SE,TINNITUS,3
SE,TONGUE OEDEMA,3
SE,VENTRICULAR TACHYCARDIA,3
SE,VISUAL IMPAIRMENT,3
SE,ABDOMINAL DISCOMFORT,2
SE,ACCIDENTAL OVERDOSE,2
SE,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
SE,ACUTE MYOCARDIAL INFARCTION,2
SE,AGEUSIA,2
SE,AGITATION,2
SE,AMYOTROPHIC LATERAL SCLEROSIS,2
SE,ANAPHYLACTIC REACTION,2
SE,AORTIC ANEURYSM RUPTURE,2
SE,ARTHRITIS,2
SE,ATRIAL FLUTTER,2
SE,ATRIAL SEPTAL DEFECT,2
SE,AZOTAEMIA,2
SE,BLISTER,2
SE,BLOOD PRESSURE DECREASED,2
SE,BLOOD PRESSURE INCREASED,2
SE,BRAIN STEM HAEMORRHAGE,2
SE,BRONCHITIS,2
SE,BRONCHOSPASM,2
SE,CARDIAC ARREST,2
SE,CARDIAC FAILURE CONGESTIVE,2
SE,CARDIOVERSION,2
SE,CATARACT,2
SE,CELLULITIS,2
SE,CHROMATURIA,2
SE,COLITIS,2
SE,COLITIS ULCERATIVE,2
SE,COLORECTAL CANCER,2
SE,CONDITION AGGRAVATED,2
SE,CORONARY ARTERY STENOSIS,2
SE,DEMYELINATION,2
SE,DEVICE DISLOCATION,2
SE,DIABETIC KETOACIDOSIS,2
SE,DIARRHOEA HAEMORRHAGIC,2
SE,DIVERTICULUM,2
SE,DRUG EFFECT DECREASED,2
SE,DRUG EFFECT INCOMPLETE,2
SE,DRY EYE,2
SE,DYSPEPSIA,2
SE,EMBOLISM ARTERIAL,2
SE,ENCEPHALITIS,2
SE,EOSINOPHILIA,2
SE,EPILEPSY,2
SE,ERUCTATION,2
SE,EXTRAPYRAMIDAL DISORDER,2
SE,EYE HAEMORRHAGE,2
SE,EYELID DISORDER,2
SE,EYELID OEDEMA,2
SE,FAECAL INCONTINENCE,2
SE,FLUSHING,2
SE,GASTROENTERITIS VIRAL,2
SE,GASTROINTESTINAL DISORDER,2
SE,GASTROINTESTINAL INFLAMMATION,2
SE,GENERALISED TONIC-CLONIC SEIZURE,2
SE,GINGIVITIS,2
SE,HAEMORRHAGE,2
SE,HAIR TEXTURE ABNORMAL,2
SE,HALLUCINATION_ VISUAL,2
SE,HYPERACUSIS,2
SE,HYPERCALCAEMIA,2
SE,HYPERKALAEMIA,2
SE,HYPOKALAEMIA,2
SE,HYPOXIA,2
SE,INJECTION SITE BRUISING,2
SE,INJECTION SITE REACTION,2
SE,INTESTINAL PERFORATION,2
SE,IRON DEFICIENCY ANAEMIA,2
SE,JOINT DISLOCATION,2
SE,LISTERIA SEPSIS,2
SE,LISTLESS,2
SE,LIVER FUNCTION TEST ABNORMAL,2
SE,LUNG DISORDER,2
SE,LUNG NEOPLASM MALIGNANT,2
SE,MELAENA,2
SE,MENINGITIS ASEPTIC,2
SE,MENTAL IMPAIRMENT,2
SE,MYOPATHY,2
SE,NASAL CONGESTION,2
SE,NASOPHARYNGITIS,2
SE,NEOPLASM,2
SE,NEPHROLITHIASIS,2
SE,OEDEMA,2
SE,OESOPHAGITIS,2
SE,OROPHARYNGEAL PAIN,2
SE,OSTEOARTHRITIS,2
SE,OVARIAN CANCER,2
SE,PALLOR,2
SE,PANIC DISORDER,2
SE,PARALYSIS,2
SE,PEMPHIGOID,2
SE,PETIT MAL EPILEPSY,2
SE,PLEURISY,2
SE,POLLAKIURIA,2
SE,POST PROCEDURAL INFECTION,2
SE,PRODUCT QUALITY ISSUE,2
SE,PRODUCT SUBSTITUTION ISSUE,2
SE,PRODUCT USE ISSUE,2
SE,PROSTATIC DISORDER,2
SE,PSORIASIS,2
SE,PULMONARY THROMBOSIS,2
SE,PURPURA,2
SE,RENAL IMPAIRMENT,2
SE,RESPIRATORY FAILURE,2
SE,RETINAL DETACHMENT,2
SE,RETINAL HAEMORRHAGE,2
SE,RIB FRACTURE,2
SE,SECRETION DISCHARGE,2
SE,SEIZURE,2
SE,SENSORY DISTURBANCE,2
SE,SENSORY LOSS,2
SE,SINUSITIS,2
SE,SKIN CANCER,2
SE,SPINAL COLUMN STENOSIS,2
SE,STUPOR,2
SE,SUDDEN HEARING LOSS,2
SE,SUICIDAL IDEATION,2
SE,SURGERY,2
SE,TACHYPNOEA,2
SE,TOOTH DISORDER,2
SE,TOXIC SKIN ERUPTION,2
SE,TROPONIN INCREASED,2
SE,TUBULOINTERSTITIAL NEPHRITIS,2
SE,UTERINE CANCER,2
SE,VENTRICULAR SEPTAL DEFECT,2
SE,VIITH NERVE PARALYSIS,2
SE,VISION BLURRED,2
SE,VISUAL ACUITY REDUCED,2
SE,WHEEZING,2
SE,WITHDRAWAL SYNDROME,2
SE,ABDOMINAL ABSCESS,1
SE,ABDOMINAL DISTENSION,1
SE,ABDOMINAL SYMPTOM,1
SE,ABNORMAL DREAMS,1
SE,ABNORMAL SENSATION IN EYE,1
SE,ACETABULUM FRACTURE,1
SE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
SE,ACUTE PRERENAL FAILURE,1
SE,ACUTE PSYCHOSIS,1
SE,ADENOCARCINOMA OF COLON,1
SE,ADVERSE DRUG REACTION,1
SE,ADVERSE EVENT,1
SE,AGRANULOCYTOSIS,1
SE,ALANINE AMINOTRANSFERASE INCREASED,1
SE,ALTERED STATE OF CONSCIOUSNESS,1
SE,ALVEOLITIS,1
SE,ANAL ABSCESS,1
SE,ANAL PROLAPSE,1
SE,ANAL ULCER,1
SE,ANAPHYLACTIC SHOCK,1
SE,ANGINA PECTORIS,1
SE,ANGIOPATHY,1
SE,ANOSOGNOSIA,1
SE,APATHY,1
SE,APPENDICITIS,1
SE,APRAXIA,1
SE,ARTERIAL HAEMORRHAGE,1
SE,ARTHROPATHY,1
SE,ASPARTATE AMINOTRANSFERASE INCREASED,1
SE,ASTHENOPIA,1
SE,ASTHMA,1
SE,ATAXIA,1
SE,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
SE,BACTERIAL INFECTION,1
SE,BASAL GANGLIA INFARCTION,1
SE,BIOPSY KIDNEY,1
SE,BLADDER CANCER,1
SE,BLEPHAROSPASM,1
SE,BLOOD ALBUMIN DECREASED,1
SE,BLOOD BILIRUBIN DECREASED,1
SE,BLOOD BILIRUBIN INCREASED,1
SE,BLOOD CALCIUM ABNORMAL,1
SE,BLOOD CREATINE PHOSPHOKINASE,1
SE,BLOOD CREATINE PHOSPHOKINASE ABNORMAL,1
SE,BLOOD CREATINE PHOSPHOKINASE BB INCREASED,1
SE,BLOOD CREATININE DECREASED,1
SE,BLOOD PH INCREASED,1
SE,BLOOD POTASSIUM INCREASED,1
SE,BLOOD TEST ABNORMAL,1
SE,BLOOD URIC ACID INCREASED,1
SE,BLUNTED AFFECT,1
SE,BONE MARROW FAILURE,1
SE,BONE PAIN,1
SE,BORRELIA INFECTION,1
SE,BRAIN ABSCESS,1
SE,BRAIN INJURY,1
SE,BRAIN NEOPLASM,1
SE,BREAST CANCER,1
SE,BREAST CANCER METASTATIC,1
SE,BRONCHIAL HYPERREACTIVITY,1
SE,BURNING SENSATION MUCOSAL,1
SE,C-REACTIVE PROTEIN DECREASED,1
SE,CARDIAC VALVE DISEASE,1
SE,CARDIAC VALVE VEGETATION,1
SE,CARDIOVASCULAR INSUFFICIENCY,1
SE,CAROTID ARTERY STENOSIS,1
SE,CARPAL TUNNEL DECOMPRESSION,1
SE,CARPAL TUNNEL SYNDROME,1
SE,CATHETER PLACEMENT,1
SE,CENTRAL NERVOUS SYSTEM INFLAMMATION,1
SE,CEREBELLAR INFARCTION,1
SE,CEREBRAL DISORDER,1
SE,CEREBRAL ISCHAEMIA,1
SE,CHEILITIS,1
SE,CHOLECYSTITIS,1
SE,CHRONIC FATIGUE SYNDROME,1
SE,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
SE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
SE,CIRCULATORY COLLAPSE,1
SE,CLEFT PALATE,1
SE,CLOSTRIDIUM DIFFICILE INFECTION,1
SE,COLD SWEAT,1
SE,COLORECTAL CANCER METASTATIC,1
SE,COMPRESSION FRACTURE,1
SE,CONCOMITANT DISEASE PROGRESSION,1
SE,CONGENITAL CARDIOVASCULAR ANOMALY,1
SE,CONGENITAL HYDRONEPHROSIS,1
SE,CONJUNCTIVAL HAEMORRHAGE,1
SE,CONJUNCTIVITIS ALLERGIC,1
SE,CONTUSION,1
SE,CONVULSION,1
SE,CONVULSIONS LOCAL,1
SE,CORNEAL EROSION,1
SE,CYANOSIS,1
SE,DAYDREAMING,1
SE,DECREASED ACTIVITY,1
SE,DECUBITUS ULCER,1
SE,DELUSION,1
SE,DEMENTIA,1
SE,DENTAL CARIES,1
SE,DEVICE COMPONENT ISSUE,1
SE,DEVICE ISSUE,1
SE,DIABETES MELLITUS INADEQUATE CONTROL,1
SE,DIABETIC COMPLICATION,1
SE,DIPLEGIA,1
SE,DIPLOPIA,1
SE,DISCOMFORT,1
SE,DISSOCIATION,1
SE,DRUG ERUPTION,1
SE,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
SE,DRUG WITHDRAWAL SYNDROME,1
SE,DRUG-DISEASE INTERACTION,1
SE,DRUG-INDUCED LIVER INJURY,1
SE,DRY GANGRENE,1
SE,DRY SKIN,1
SE,DRY THROAT,1
SE,DYSKINESIA,1
SE,DYSLIPIDAEMIA,1
SE,DYSPHONIA,1
SE,DYSURIA,1
SE,ECZEMA,1
SE,ECZEMA NUMMULAR,1
SE,ELECTROCARDIOGRAM QT PROLONGED,1
SE,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
SE,ELECTROLYTE IMBALANCE,1
SE,EMBOLIC STROKE,1
SE,EMBOLISM,1
SE,EMOTIONAL DISORDER,1
SE,EMOTIONAL DISTRESS,1
SE,ENCEPHALOPATHY,1
SE,ERYTHEMA MULTIFORME,1
SE,ERYTHEMA OF EYELID,1
SE,ESCHERICHIA SEPSIS,1
SE,EXERCISE ELECTROCARDIOGRAM ABNORMAL,1
SE,EXOPHTHALMOS,1
SE,EXPOSURE DURING PREGNANCY,1
SE,EXTRADURAL HAEMATOMA,1
SE,EXTREMITY NECROSIS,1
SE,EYE PRURITUS,1
SE,EYE SWELLING,1
SE,FACE OEDEMA,1
SE,FEELING HOT,1
SE,FLUID RETENTION,1
SE,FOETAL HAEMOGLOBIN,1
SE,FOOT OPERATION,1
SE,FOREIGN BODY SENSATION IN EYES,1
SE,FREQUENT BOWEL MOVEMENTS,1
SE,FURUNCLE,1
SE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
SE,GASTRIC DISORDER,1
SE,GASTRIC ULCER HAEMORRHAGE,1
SE,GASTRITIS EROSIVE,1
SE,GASTROENTERITIS,1
SE,GASTROINTESTINAL HAEMORRHAGE,1
SE,GASTROINTESTINAL INJURY,1
SE,GASTROOESOPHAGEAL REFLUX DISEASE,1
SE,GENERAL PHYSICAL CONDITION ABNORMAL,1
SE,GENITAL INFECTION FUNGAL,1
SE,GINGIVAL BLISTER,1
SE,GLAUCOMA,1
SE,GLOMERULONEPHRITIS,1
SE,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,1
SE,GROWTH OF EYELASHES,1
SE,GUILLAIN-BARRE SYNDROME,1
SE,GYNAECOMASTIA,1
SE,HAEMATEMESIS,1
SE,HAEMATOCHEZIA,1
SE,HAEMOGLOBIN ABNORMAL,1
SE,HAEMOGLOBIN DECREASED,1
SE,HAEMORRHAGIC DISORDER,1
SE,HAEMORRHAGIC EROSIVE GASTRITIS,1
SE,HAIR GROWTH ABNORMAL,1
SE,HEARING IMPAIRED,1
SE,HEART RATE DECREASED,1
SE,HEART RATE IRREGULAR,1
SE,HEPATIC FAILURE,1
SE,HEPATITIS TOXIC,1
SE,HEPATOCELLULAR CARCINOMA,1
SE,HEPATOMEGALY,1
SE,HERPES ZOSTER CUTANEOUS DISSEMINATED,1
SE,HIATUS HERNIA,1
SE,HICCUPS,1
SE,HIP FRACTURE,1
SE,HOSPITALISATION,1
SE,HYPERKERATOSIS,1
SE,HYPERSOMNIA,1
SE,HYPERTHYROIDISM,1
SE,HYPERVENTILATION,1
SE,HYPOCALCAEMIA,1
SE,HYPOPHAGIA,1
SE,HYPOPHOSPHATAEMIA,1
SE,IDIOPATHIC PULMONARY FIBROSIS,1
SE,IMMUNE THROMBOCYTOPENIC PURPURA,1
SE,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
SE,INCONTINENCE,1
SE,INCORRECT PRODUCT STORAGE,1
SE,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
SE,INFERTILITY,1
SE,INFLAMMATORY BOWEL DISEASE,1
SE,INJECTION SITE ATROPHY,1
SE,INJECTION SITE MASS,1
SE,INJECTION SITE NODULE,1
SE,INTENTIONAL DRUG MISUSE,1
SE,INTENTIONAL OVERDOSE,1
SE,INTERNATIONAL NORMALISED RATIO INCREASED,1
SE,INTERSTITIAL LUNG DISEASE,1
SE,INTESTINAL HAEMORRHAGE,1
SE,IRIS HYPERPIGMENTATION,1
SE,JAUNDICE,1
SE,KERATOPATHY,1
SE,KETOACIDOSIS,1
SE,KIDNEY FIBROSIS,1
SE,LARGE INTESTINAL ULCER HAEMORRHAGE,1
SE,LARYNGEAL PAPILLOMA,1
SE,LATERAL MEDULLARY SYNDROME,1
SE,LEFT VENTRICULAR DYSFUNCTION,1
SE,LEUKOCYTOSIS,1
SE,LEUKOPENIA,1
SE,LEUKOPLAKIA,1
SE,LIMB DEFORMITY,1
SE,LIMB INJURY,1
SE,LIP DRY,1
SE,LIP SWELLING,1
SE,LIVER DISORDER,1
SE,LIVER TRANSPLANT,1
SE,LOCAL SWELLING,1
SE,LUMBAR PUNCTURE ABNORMAL,1
SE,LUNG NEOPLASM SURGERY,1
SE,MALIGNANT NEOPLASM PROGRESSION,1
SE,MASTITIS,1
SE,MEDICATION ERROR,1
SE,MENIERE^S DISEASE,1
SE,MENSTRUAL DISORDER,1
SE,MENTAL DISORDER,1
SE,MENTAL STATUS CHANGES,1
SE,MESENTERIC VEIN THROMBOSIS,1
SE,METASTASES TO BONE,1
SE,MIGRAINE WITH AURA,1
SE,MITRAL VALVE DISEASE,1
SE,MONOPLEGIA,1
SE,MORAXELLA INFECTION,1
SE,MUCOSAL ULCERATION,1
SE,MUCOUS STOOLS,1
SE,MUSCLE HAEMORRHAGE,1
SE,MUSCLE RUPTURE,1
SE,MUSCLE TWITCHING,1
SE,MUSCULOSKELETAL CHEST PAIN,1
SE,MUSCULOSKELETAL DISORDER,1
SE,MYCOSIS FUNGOIDES,1
SE,N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED,1
SE,NASAL CAVITY PACKING,1
SE,NECK MASS,1
SE,NERVOUS SYSTEM DISORDER,1
SE,NEUROPATHY PERIPHERAL,1
SE,NEUTROPENIA,1
SE,NEUTROPHIL COUNT ABNORMAL,1
SE,NIGHT SWEATS,1
SE,NOCTURNAL DYSPNOEA,1
SE,OCULAR ISCHAEMIC SYNDROME,1
SE,ODYNOPHAGIA,1
SE,OESOPHAGEAL OBSTRUCTION,1
SE,OESOPHAGEAL ULCER,1
SE,ON AND OFF PHENOMENON,1
SE,OPTIC ATROPHY,1
SE,ORAL DISCOMFORT,1
SE,ORAL MUCOSAL BLISTERING,1
SE,ORAL PAIN,1
SE,ORTHOSTATIC HYPOTENSION,1
SE,ORTHOSTATIC INTOLERANCE,1
SE,OSCILLOPSIA,1
SE,OSTEONECROSIS OF JAW,1
SE,PANCREATIC CARCINOMA,1
SE,PANCREATIC CARCINOMA METASTATIC,1
SE,PANIC ATTACK,1
SE,PAPILLOEDEMA,1
SE,PARAPARESIS,1
SE,PARKINSONIAN GAIT,1
SE,PARKINSONISM,1
SE,PATHOLOGICAL FRACTURE,1
SE,PCO2 ABNORMAL,1
SE,PERICARDIAL EFFUSION,1
SE,PERIPHERAL COLDNESS,1
SE,PERIPHERAL PARALYSIS,1
SE,PERSONALITY DISORDER,1
SE,PLEURAL EFFUSION,1
SE,PNEUMONIA ASPIRATION,1
SE,PNEUMONITIS,1
SE,PO2 ABNORMAL,1
SE,POLYOMAVIRUS-ASSOCIATED NEPHROPATHY,1
SE,POLYURIA,1
SE,POOR PERIPHERAL CIRCULATION,1
SE,POST PROCEDURAL HAEMORRHAGE,1
SE,PREMATURE BABY,1
SE,PRERENAL FAILURE,1
SE,PRESCRIBED UNDERDOSE,1
SE,PROCEDURAL HAEMORRHAGE,1
SE,PROCEDURAL HYPOTENSION,1
SE,PROCEDURAL PAIN,1
SE,PRODUCT USE IN UNAPPROVED INDICATION,1
SE,PROTEINURIA,1
SE,PTERYGIUM,1
SE,PULMONARY FIBROSIS,1
SE,PULMONARY HAEMORRHAGE,1
SE,PUSTULAR PSORIASIS,1
SE,QUALITY OF LIFE DECREASED,1
SE,RADIUS FRACTURE,1
SE,RASH ERYTHEMATOUS,1
SE,RECTAL ADENOCARCINOMA,1
SE,RECTAL HAEMORRHAGE,1
SE,REFLUX GASTRITIS,1
SE,RENAL FAILURE CHRONIC,1
SE,RENAL TUBULAR ATROPHY,1
SE,RENAL TUBULAR NECROSIS,1
SE,RESPIRATORY DISTRESS,1
SE,RETINAL ARTERY OCCLUSION,1
SE,RETINAL ARTERY THROMBOSIS,1
SE,RHEUMATOID NODULE,1
SE,ROAD TRAFFIC ACCIDENT,1
SE,SCREAMING,1
SE,SELF ESTEEM DECREASED,1
SE,SENSATION OF HEAVINESS,1
SE,SERUM FERRITIN INCREASED,1
SE,SEXUAL DYSFUNCTION,1
SE,SICK SINUS SYNDROME,1
SE,SINUS ARREST,1
SE,SINUS BRADYCARDIA,1
SE,SINUS NODE DYSFUNCTION,1
SE,SKIN ATROPHY,1
SE,SKIN EXFOLIATION,1
SE,SKIN HAEMORRHAGE,1
SE,SKIN LESION,1
SE,SKIN REACTION,1
SE,SKULL FRACTURE,1
SE,SMALL INTESTINAL HAEMORRHAGE,1
SE,SMALL INTESTINAL PERFORATION,1
SE,SOCIAL AVOIDANT BEHAVIOUR,1
SE,SPINAL FRACTURE,1
SE,STOMATITIS,1
SE,STRESS,1
SE,SUBCUTANEOUS ABSCESS,1
SE,SUBDURAL HAEMATOMA,1
SE,SUDDEN DEATH,1
SE,SUDDEN VISUAL LOSS,1
SE,SUICIDAL BEHAVIOUR,1
SE,SUPRAVENTRICULAR EXTRASYSTOLES,1
SE,SUPRAVENTRICULAR TACHYCARDIA,1
SE,SWELLING,1
SE,SWOLLEN TONGUE,1
SE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
SE,TEETH BRITTLE,1
SE,TENDON DISCOMFORT,1
SE,TENDON RUPTURE,1
SE,TENSION,1
SE,THERAPEUTIC RESPONSE UNEXPECTED,1
SE,THORACIC HAEMORRHAGE,1
SE,THROAT IRRITATION,1
SE,THROMBOTIC MICROANGIOPATHY,1
SE,TONGUE BLISTERING,1
SE,TONGUE DISORDER,1
SE,TOOTH LOSS,1
SE,TOOTHACHE,1
SE,TORSADE DE POINTES,1
SE,TOXIC GOITRE,1
SE,TRAUMATIC HAEMORRHAGE,1
SE,TRAUMATIC INTRACRANIAL HAEMORRHAGE,1
SE,TRISMUS,1
SE,TYPE IV HYPERSENSITIVITY REACTION,1
SE,UNEVALUABLE EVENT,1
SE,UPPER RESPIRATORY TRACT INFECTION,1
SE,URINARY TRACT DISORDER,1
SE,URINE OUTPUT DECREASED,1
SE,URTICARIA,1
SE,VASCULAR DEMENTIA,1
SE,VASCULAR GRAFT,1
SE,VASCULAR INJURY,1
SE,VASCULAR STENT THROMBOSIS,1
SE,VENTRICULAR EXTRASYSTOLES,1
SE,VESSEL PUNCTURE SITE HAEMORRHAGE,1
SE,VISUAL FIELD DEFECT,1
SE,VITAMIN D DEFICIENCY,1
SE,VOCAL CORD PARALYSIS,1
SE,WHITE BLOOD CELL COUNT ABNORMAL,1
SE,WHITE BLOOD CELL DISORDER,1
SE,WHITE BLOOD CELLS URINE POSITIVE,1
SE,WRONG DRUG ADMINISTERED,1
SE,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SE,YELLOW SKIN,1
CH,ACUTE KIDNEY INJURY,23
CH,RHABDOMYOLYSIS,22
CH,FALL,13
CH,TOXICITY TO VARIOUS AGENTS,13
CH,ANAEMIA,12
CH,ACUTE MYOCARDIAL INFARCTION,10
CH,CONFUSIONAL STATE,9
CH,GASTROINTESTINAL HAEMORRHAGE,9
CH,THROMBOCYTOPENIA,9
CH,VOMITING,9
CH,DELIRIUM,8
CH,EXPOSURE DURING PREGNANCY,8
CH,RENAL FAILURE ACUTE,8
CH,AGITATION,6
CH,AGRANULOCYTOSIS,6
CH,DIARRHOEA,6
CH,DRUG-INDUCED LIVER INJURY,6
CH,DYSPHAGIA,6
CH,DYSPNOEA,6
CH,HEPATOCELLULAR INJURY,6
CH,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,6
CH,NAUSEA,6
CH,PANCYTOPENIA,6
CH,PRESCRIBED OVERDOSE,6
CH,PYREXIA,6
CH,RENAL FAILURE,6
CH,BRADYCARDIA,5
CH,CEREBRAL HAEMORRHAGE,5
CH,CHROMATOPSIA,5
CH,DYSKINESIA,5
CH,ELECTROCARDIOGRAM QT PROLONGED,5
CH,FATIGUE,5
CH,HALLUCINATION_ VISUAL,5
CH,IMMUNE-MEDIATED NECROTISING MYOPATHY,5
CH,MELAENA,5
CH,OBESITY,5
CH,PAIN IN EXTREMITY,5
CH,PARAESTHESIA,5
CH,PEMPHIGUS,5
CH,PNEUMONIA,5
CH,THROMBOCYTOPENIC PURPURA,5
CH,WEIGHT DECREASED,5
CH,WEIGHT INCREASED,5
CH,ACCIDENTAL OVERDOSE,4
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,4
CH,ANXIETY,4
CH,APLASTIC ANAEMIA,4
CH,BONE MARROW FAILURE,4
CH,CONDITION AGGRAVATED,4
CH,HAEMORRHAGIC ANAEMIA,4
CH,LEUKOPENIA,4
CH,MUSCLE HAEMORRHAGE,4
CH,MYALGIA,4
CH,PRESYNCOPE,4
CH,QUADRIPLEGIA,4
CH,SOMNOLENCE,4
CH,SUDDEN CARDIAC DEATH,4
CH,SYNCOPE,4
CH,THERAPEUTIC RESPONSE INCREASED,4
CH,TRANSAMINASES INCREASED,4
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,4
CH,ABDOMINAL PAIN UPPER,3
CH,ATRIAL FIBRILLATION,3
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CH,BONE DENSITY DECREASED,3
CH,CARDIAC FAILURE,3
CH,DECREASED APPETITE,3
CH,DEHYDRATION,3
CH,DEPRESSION,3
CH,EOSINOPHILIA,3
CH,GAIT DISTURBANCE,3
CH,GENERAL PHYSICAL HEALTH DETERIORATION,3
CH,GENERALISED TONIC-CLONIC SEIZURE,3
CH,HAEMOPTYSIS,3
CH,HALLUCINATION_ AUDITORY,3
CH,HYPERGLYCAEMIA,3
CH,HYPERHIDROSIS,3
CH,HYPOCHROMIC ANAEMIA,3
CH,HYPONATRAEMIA,3
CH,HYPOTENSION,3
CH,INSOMNIA,3
CH,INTERNATIONAL NORMALISED RATIO INCREASED,3
CH,MALAISE,3
CH,MUSCULAR WEAKNESS,3
CH,OVERDOSE,3
CH,PAIN,3
CH,PELVIC FRACTURE,3
CH,PREMATURE BABY,3
CH,REBOUND EFFECT,3
CH,SINUS BRADYCARDIA,3
CH,SPINAL FRACTURE,3
CH,SUBDURAL HAEMATOMA,3
CH,ANGINA PECTORIS,2
CH,APHASIA,2
CH,APNOEA,2
CH,ARRHYTHMIA,2
CH,C-REACTIVE PROTEIN INCREASED,2
CH,CARDIAC DISORDER,2
CH,CARDIOACTIVE DRUG LEVEL INCREASED,2
CH,CHEST PAIN,2
CH,CHILLS,2
CH,CHROMATURIA,2
CH,CHRONIC KIDNEY DISEASE,2
CH,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,2
CH,COGNITIVE DISORDER,2
CH,COLITIS,2
CH,CONGENITAL ANOMALY,2
CH,CONGENITAL INGUINAL HERNIA,2
CH,DIABETES MELLITUS,2
CH,DISEASE PROGRESSION,2
CH,DIZZINESS,2
CH,DRUG ABUSE,2
CH,DRUG CLEARANCE DECREASED,2
CH,EPILEPSY,2
CH,FOETAL EXPOSURE DURING PREGNANCY,2
CH,FOETAL GROWTH RESTRICTION,2
CH,HAEMATOCHEZIA,2
CH,HAEMOGLOBIN DECREASED,2
CH,HAEMORRHAGE INTRACRANIAL,2
CH,HEADACHE,2
CH,HEMIPLEGIA,2
CH,HEPARIN-INDUCED THROMBOCYTOPENIA,2
CH,HYPERKALAEMIA,2
CH,HYPERSENSITIVITY VASCULITIS,2
CH,HYPERTENSION,2
CH,HYPOCALCAEMIA,2
CH,HYPOKALAEMIA,2
CH,HYPOMAGNESAEMIA,2
CH,HYPOPARATHYROIDISM SECONDARY,2
CH,ILEUS PARALYTIC,2
CH,ILLUSION,2
CH,IMMUNE THROMBOCYTOPENIC PURPURA,2
CH,INFLAMMATION,2
CH,INTENTIONAL OVERDOSE,2
CH,ISCHAEMIC STROKE,2
CH,LIVER INJURY,2
CH,LOBAR PNEUMONIA,2
CH,MEDICATION ERROR,2
CH,METABOLIC ACIDOSIS,2
CH,NORMOCHROMIC NORMOCYTIC ANAEMIA,2
CH,PANCREATITIS ACUTE,2
CH,PHOTOPSIA,2
CH,PNEUMONIA BACTERIAL,2
CH,PNEUMONITIS,2
CH,PRODUCT USE IN UNAPPROVED INDICATION,2
CH,PRURITUS,2
CH,PSYCHOMOTOR RETARDATION,2
CH,RECTAL HAEMORRHAGE,2
CH,RESPIRATORY FAILURE,2
CH,SHOCK HAEMORRHAGIC,2
CH,SLEEP APNOEA SYNDROME,2
CH,SUDDEN DEATH,2
CH,TACHYPNOEA,2
CH,TREMOR,2
CH,VISION BLURRED,2
CH,VISUAL IMPAIRMENT,2
CH,ABDOMINAL PAIN,1
CH,ABORTION SPONTANEOUS,1
CH,ACQUIRED HAEMOPHILIA,1
CH,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,1
CH,ACUTE MYELOID LEUKAEMIA,1
CH,AGE-RELATED MACULAR DEGENERATION,1
CH,AGGRESSION,1
CH,ANGIOEDEMA,1
CH,AORTIC ANEURYSM,1
CH,APRAXIA,1
CH,ARTHRALGIA,1
CH,ASCITES,1
CH,ASTHENIA,1
CH,ATRIOVENTRICULAR BLOCK COMPLETE,1
CH,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
CH,AUTOIMMUNE COLITIS,1
CH,AUTOIMMUNE DERMATITIS,1
CH,AUTOIMMUNE HEPATITIS,1
CH,BALANCE DISORDER,1
CH,BLINDNESS,1
CH,BLOOD BLISTER,1
CH,BLOOD CREATININE INCREASED,1
CH,BLOOD PRESSURE INCREASED,1
CH,BREAST CANCER,1
CH,BREAST CANCER METASTATIC,1
CH,BURSITIS,1
CH,CARCINOID TUMOUR,1
CH,CARDIOMEGALY,1
CH,CAROTID ARTERY STENOSIS,1
CH,CATARACT,1
CH,CEREBRAL HAEMATOMA,1
CH,CHARLES BONNET SYNDROME,1
CH,CHOLECYSTITIS,1
CH,CHOLESTASIS,1
CH,CHOLESTATIC LIVER INJURY,1
CH,CHONDROCALCINOSIS PYROPHOSPHATE,1
CH,CIRCULATORY COLLAPSE,1
CH,COAGULATION TIME PROLONGED,1
CH,COAGULOPATHY,1
CH,COLITIS ISCHAEMIC,1
CH,COLITIS MICROSCOPIC,1
CH,CONGENITAL CHOROID PLEXUS CYST,1
CH,CONGENITAL UMBILICAL HERNIA,1
CH,CONJUNCTIVAL HAEMORRHAGE,1
CH,CONTRAINDICATED PRODUCT ADMINISTERED,1
CH,CONTUSION,1
CH,CONVULSION,1
CH,COUGH,1
CH,DEATH,1
CH,DEMENTIA,1
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CH,DIARRHOEA HAEMORRHAGIC,1
CH,DRUG INTOLERANCE,1
CH,DRUG WITHDRAWAL CONVULSIONS,1
CH,DYSCHROMATOPSIA,1
CH,ECCHYMOSIS,1
CH,ECZEMA,1
CH,ELECTROLYTE IMBALANCE,1
CH,EPISTAXIS,1
CH,EPSTEIN-BARR VIRUS INFECTION,1
CH,ERYTHEMA,1
CH,EXTRASYSTOLES,1
CH,FANCONI SYNDROME,1
CH,FANCONI SYNDROME ACQUIRED,1
CH,FEELING HOT,1
CH,FEMUR FRACTURE,1
CH,FLANK PAIN,1
CH,FOAMING AT MOUTH,1
CH,FUNGAL INFECTION,1
CH,GASTROINTESTINAL DISORDER,1
CH,GASTROINTESTINAL NECROSIS,1
CH,GENERALISED ERYTHEMA,1
CH,GLUCOCORTICOID DEFICIENCY,1
CH,GYNAECOMASTIA,1
CH,HAEMATEMESIS,1
CH,HAEMATOLOGY TEST ABNORMAL,1
CH,HAEMORRHAGE,1
CH,HEAD DISCOMFORT,1
CH,HEMIPARESIS,1
CH,HEPATIC CANCER,1
CH,HEPATIC ENZYME INCREASED,1
CH,HEPATITIS CHOLESTATIC,1
CH,HYDROCELE,1
CH,HYPERLACTACIDAEMIA,1
CH,HYPERNATRAEMIA,1
CH,HYPERPROLACTINAEMIA,1
CH,HYPNAGOGIC HALLUCINATION,1
CH,HYPOAESTHESIA,1
CH,HYPOAESTHESIA ORAL,1
CH,HYPOGONADISM,1
CH,HYPOTHYROIDISM,1
CH,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
CH,INFECTION,1
CH,INTERSTITIAL LUNG DISEASE,1
CH,JAUNDICE,1
CH,JOINT DISLOCATION,1
CH,JOINT STIFFNESS,1
CH,JOINT SWELLING,1
CH,LABORATORY TEST ABNORMAL,1
CH,LACTIC ACIDOSIS,1
CH,LEUKOCYTOSIS,1
CH,LICHEN PLANUS,1
CH,LIPASE INCREASED,1
CH,LOSS OF CONSCIOUSNESS,1
CH,LUNG CONSOLIDATION,1
CH,LUNG DISORDER,1
CH,LUNG INFILTRATION,1
CH,MALIGNANT NEOPLASM PROGRESSION,1
CH,MATERNAL EXPOSURE DURING PREGNANCY,1
CH,METHAEMOGLOBINAEMIA,1
CH,MIXED LIVER INJURY,1
CH,MUSCLE RIGIDITY,1
CH,MUSCULOSKELETAL STIFFNESS,1
CH,MYOCARDIAL INFARCTION,1
CH,MYOGLOBINURIA,1
CH,MYOPATHY,1
CH,NEPHROTIC SYNDROME,1
CH,NERVOUS SYSTEM DISORDER,1
CH,OCCIPITAL NEURALGIA,1
CH,OCULAR TOXICITY,1
CH,OPTIC NERVE INJURY,1
CH,ORTHOSTATIC HYPOTENSION,1
CH,ORTHOSTATIC INTOLERANCE,1
CH,OSTEONECROSIS OF JAW,1
CH,PALPABLE PURPURA,1
CH,PARASITE STOOL TEST POSITIVE,1
CH,PEMPHIGOID,1
CH,PERICARDIAL HAEMORRHAGE,1
CH,PERIPHERAL ARTERY THROMBOSIS,1
CH,PERIPHERAL SWELLING,1
CH,PETECHIAE,1
CH,PHARYNGEAL OEDEMA,1
CH,PLEURAL EFFUSION,1
CH,PNEUMONIA VIRAL,1
CH,POLYARTHRITIS,1
CH,POST PROCEDURAL HAEMORRHAGE,1
CH,POTENTIATING DRUG INTERACTION,1
CH,PREMATURE LABOUR,1
CH,PRODUCT USE ISSUE,1
CH,PROSTATE CANCER,1
CH,PSYCHOMOTOR HYPERACTIVITY,1
CH,PULMONARY EMBOLISM,1
CH,QUADRIPARESIS,1
CH,RASH,1
CH,RENAL CELL CARCINOMA,1
CH,RENAL TUBULAR NECROSIS,1
CH,RESPIRATORY ACIDOSIS,1
CH,RESPIRATORY ALKALOSIS,1
CH,RESPIRATORY DISTRESS,1
CH,RESPIRATORY TRACT INFECTION,1
CH,RETINOPATHY,1
CH,RHONCHI,1
CH,RICHTER^S SYNDROME,1
CH,SCLERITIS,1
CH,SEPSIS,1
CH,SKIN LESION,1
CH,SKIN MASS,1
CH,SKIN NECROSIS,1
CH,SKIN REACTION,1
CH,SLEEP DISORDER,1
CH,SOFT TISSUE INFECTION,1
CH,SOMATIC HALLUCINATION,1
CH,SPINAL DEFORMITY,1
CH,SUBDURAL HAEMORRHAGE,1
CH,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CH,TETANY,1
CH,THROMBOSIS,1
CH,TOOTH INJURY,1
CH,TOXIC EPIDERMAL NECROLYSIS,1
CH,TUBULOINTERSTITIAL NEPHRITIS,1
CH,TYPE III IMMUNE COMPLEX MEDIATED REACTION,1
CH,UMBILICAL CORD ABNORMALITY,1
CH,VENOUS THROMBOSIS,1
CH,VERTEBRAL ARTERY STENOSIS,1
CH,VISUAL ACUITY REDUCED,1
TW,ACUTE KIDNEY INJURY,4
TW,DRUG-INDUCED LIVER INJURY,4
TW,RHABDOMYOLYSIS,4
TW,MUSCULAR WEAKNESS,3
TW,OLIGURIA,2
TW,ARTHRALGIA,1
TW,CARDIAC ARREST,1
TW,COARCTATION OF THE AORTA,1
TW,EJECTION FRACTION DECREASED,1
TW,HYPERTENSION,1
TW,INCONTINENCE,1
TW,LEFT VENTRICULAR HYPERTROPHY,1
TW,MUSCLE SPASMS,1
TW,MYALGIA,1
TW,PNEUMOTHORAX,1
TW,PULSE ABSENT,1
TW,RENAL IMPAIRMENT,1
TW,RESPIRATORY ACIDOSIS,1
TW,RESPIRATORY ARREST,1
TW,SINUS TACHYCARDIA,1
TW,T-CELL LYMPHOMA,1
TH,STOMATITIS,5
TH,FATIGUE,4
TH,PNEUMONIA,4
TH,STEVENS-JOHNSON SYNDROME,4
TH,ACUTE KIDNEY INJURY,3
TH,HYPOKALAEMIA,3
TH,SEPSIS,3
TH,ASTHMA,2
TH,BLOOD CREATININE INCREASED,2
TH,DECREASED APPETITE,2
TH,DEMENTIA,2
TH,DIABETES MELLITUS,2
TH,DIARRHOEA,2
TH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
TH,DYSPHAGIA,2
TH,ERYTHEMA,2
TH,FEBRILE NEUTROPENIA,2
TH,HYPONATRAEMIA,2
TH,IMMUNE-MEDIATED NECROTISING MYOPATHY,2
TH,INSOMNIA,2
TH,IRON DEFICIENCY ANAEMIA,2
TH,ISCHAEMIC STROKE,2
TH,MEMORY IMPAIRMENT,2
TH,NEUTROPENIA,2
TH,OVERDOSE,2
TH,STRESS,2
TH,ACUTE MYOCARDIAL INFARCTION,1
TH,ACUTE PULMONARY OEDEMA,1
TH,ACUTE RESPIRATORY FAILURE,1
TH,ADRENAL INSUFFICIENCY,1
TH,ALTERED STATE OF CONSCIOUSNESS,1
TH,ANAEMIA,1
TH,ANGER,1
TH,ARTHRALGIA,1
TH,ARTHRITIS BACTERIAL,1
TH,ASPHYXIA,1
TH,ASTHENIA,1
TH,BACK PAIN,1
TH,BLADDER CANCER,1
TH,BLOOD CREATINE INCREASED,1
TH,BLOOD OSMOLARITY INCREASED,1
TH,BRONCHIAL WALL THICKENING,1
TH,CANDIDA INFECTION,1
TH,CARDIAC ARREST,1
TH,CARDIAC FAILURE CHRONIC,1
TH,CARDIAC FAILURE CONGESTIVE,1
TH,CEREBRAL ARTERY THROMBOSIS,1
TH,CEREBRAL INFARCTION,1
TH,CHRONIC KIDNEY DISEASE,1
TH,COAGULOPATHY,1
TH,CONFUSIONAL STATE,1
TH,CYTOMEGALOVIRUS INFECTION,1
TH,DEPRESSION,1
TH,DIABETIC KETOACIDOSIS,1
TH,DISEASE PROGRESSION,1
TH,DISTURBANCE IN ATTENTION,1
TH,DIZZINESS,1
TH,DUODENAL ULCER HAEMORRHAGE,1
TH,ELECTROLYTE IMBALANCE,1
TH,ENTEROCOLITIS,1
TH,FEMORAL NECK FRACTURE,1
TH,FOOD INTERACTION,1
TH,FRUSTRATION TOLERANCE DECREASED,1
TH,GAIT DISTURBANCE,1
TH,GASTRIC POLYPS,1
TH,GOUTY ARTHRITIS,1
TH,HEADACHE,1
TH,HEART RATE DECREASED,1
TH,HEPATITIS,1
TH,HIP FRACTURE,1
TH,HYPERGLYCAEMIA,1
TH,HYPERKALAEMIA,1
TH,HYPERNATRAEMIA,1
TH,HYPOCALCAEMIA,1
TH,HYPOGLYCAEMIA,1
TH,HYPOMAGNESAEMIA,1
TH,HYPOPHOSPHATAEMIA,1
TH,HYPOPHYSITIS,1
TH,HYPOTHYROIDISM,1
TH,HYPOVOLAEMIA,1
TH,HYPOVOLAEMIC SHOCK,1
TH,IGA NEPHROPATHY,1
TH,JOINT RANGE OF MOTION DECREASED,1
TH,MOOD SWINGS,1
TH,MUCOSAL INFLAMMATION,1
TH,NECROTISING FASCIITIS,1
TH,ORAL LICHEN PLANUS,1
TH,PAIN IN EXTREMITY,1
TH,PANCREATIC CARCINOMA,1
TH,PLASMA CELL MYELOMA,1
TH,PLATELET COUNT DECREASED,1
TH,POLYNEUROPATHY,1
TH,PRODUCT USE IN UNAPPROVED INDICATION,1
TH,PROTEINURIA,1
TH,PYREXIA,1
TH,RENAL FAILURE ACUTE,1
TH,RENAL TUBULAR DYSFUNCTION,1
TH,RESPIRATORY FAILURE,1
TH,RHABDOMYOLYSIS,1
TH,SEPTIC SHOCK,1
TH,SINUSITIS,1
TH,SINUSITIS FUNGAL,1
TH,SKIN HAEMORRHAGE,1
TH,SOMNOLENCE,1
TH,SUSPICIOUSNESS,1
TH,TOXICITY TO VARIOUS AGENTS,1
TH,TRANSPLANT REJECTION,1
TH,UPPER GASTROINTESTINAL HAEMORRHAGE,1
TH,URETERIC STENOSIS,1
TH,VOMITING,1
TH,WEIGHT DECREASED,1
TH,WHITE BLOOD CELL COUNT INCREASED,1
TT,ANGINA PECTORIS,1
TT,BLOOD GLUCOSE DECREASED,1
TT,BLOOD GLUCOSE INCREASED,1
TT,CATARACT,1
TT,CHEST DISCOMFORT,1
TT,DRUG DOSE OMISSION,1
TT,DYSPNOEA,1
TT,HILAR LYMPHADENOPATHY,1
TT,LYMPHADENOPATHY MEDIASTINAL,1
TT,NAUSEA,1
TT,WEIGHT DECREASED,1
TN,ACUTE MYOCARDIAL INFARCTION,8
TN,CARDIOGENIC SHOCK,8
TN,VASCULAR STENT THROMBOSIS,7
TN,KOUNIS SYNDROME,6
TN,ANAPHYLACTIC SHOCK,3
TN,CARDIAC ARREST,3
TN,CHEST PAIN,3
TN,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
TN,DEATH,2
TN,ATRIAL FIBRILLATION,1
TN,DEPRESSED LEVEL OF CONSCIOUSNESS,1
TN,DIZZINESS,1
TN,DYSPNOEA,1
TN,FACE OEDEMA,1
TN,FLUSHING,1
TN,HYPOTENSION,1
TN,PRURITUS,1
TN,SKIN WARM,1
TN,TACHYCARDIA,1
TN,TROPONIN I INCREASED,1
TN,URTICARIA,1
TR,GASTROINTESTINAL HAEMORRHAGE,5
TR,PNEUMONIA CYTOMEGALOVIRAL,5
TR,GASTROINTESTINAL ULCER,3
TR,RESPIRATORY DISTRESS,3
TR,CARDIAC DISORDER,2
TR,CYTOMEGALOVIRUS INFECTION,2
TR,HEADACHE,2
TR,NAUSEA,2
TR,TREMOR,2
TR,ARTERY DISSECTION,1
TR,BLOOD CREATININE INCREASED,1
TR,C-REACTIVE PROTEIN INCREASED,1
TR,CARDIO-RESPIRATORY DISTRESS,1
TR,CARDIOPULMONARY FAILURE,1
TR,CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION,1
TR,DRUG LEVEL INCREASED,1
TR,ESCHERICHIA INFECTION,1
TR,HAEMATOMA,1
TR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,1
UG,TRANSIENT ISCHAEMIC ATTACK,1
UA,HYPERTENSIVE CRISIS,1
UA,RENAL FAILURE,1
UA,THROMBOCYTOPENIA,1
AE,BLOOD GLUCOSE INCREASED,1
AE,BLOOD UREA INCREASED,1
AE,DELIRIUM,1
AE,DRY SKIN,1
AE,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
AE,OROPHARYNGEAL PAIN,1
AE,PNEUMONIA,1
AE,PULMONARY FIBROSIS,1
AE,SUBDURAL HAEMATOMA,1
GB,MYALGIA,1103
GB,FATIGUE,868
GB,MALAISE,785
GB,DYSPNOEA,696
GB,PAIN IN EXTREMITY,574
GB,DIARRHOEA,553
GB,DIZZINESS,536
GB,ARTHRALGIA,534
GB,CONFUSIONAL STATE,533
GB,VOMITING,492
GB,ACUTE KIDNEY INJURY,475
GB,FALL,473
GB,NAUSEA,433
GB,HEADACHE,429
GB,MUSCULAR WEAKNESS,396
GB,BALANCE DISORDER,389
GB,ASTHENIA,379
GB,MUSCLE SPASMS,371
GB,PAIN,357
GB,INSOMNIA,355
GB,HYPOTENSION,325
GB,CHEST PAIN,313
GB,HYPONATRAEMIA,307
GB,FEELING ABNORMAL,301
GB,PARAESTHESIA,300
GB,QUALITY OF LIFE DECREASED,300
GB,RENAL FAILURE ACUTE,291
GB,ABDOMINAL PAIN,283
GB,LETHARGY,282
GB,RASH,282
GB,BACK PAIN,277
GB,RHABDOMYOLYSIS,252
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,248
GB,COUGH,239
GB,PRURITUS,228
GB,PSYCHIATRIC SYMPTOM,224
GB,SEPSIS,222
GB,AMNESIA,218
GB,DEPRESSION,216
GB,PYREXIA,216
GB,GAIT DISTURBANCE,213
GB,PALPITATIONS,202
GB,SOMNOLENCE,201
GB,CONSTIPATION,200
GB,CONDITION AGGRAVATED,197
GB,TENDERNESS,195
GB,SYNCOPE,184
GB,LIVER FUNCTION TEST ABNORMAL,183
GB,BRADYCARDIA,181
GB,LOWER RESPIRATORY TRACT INFECTION,181
GB,GASTROINTESTINAL HAEMORRHAGE,178
GB,DECREASED APPETITE,176
GB,PNEUMONIA,174
GB,TREMOR,172
GB,HYPERHIDROSIS,170
GB,ABDOMINAL DISTENSION,169
GB,WHITE BLOOD CELL COUNT INCREASED,169
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,167
GB,HYPOAESTHESIA,167
GB,DEHYDRATION,166
GB,ATRIAL FIBRILLATION,164
GB,IMPAIRED WORK ABILITY,164
GB,LOSS OF CONSCIOUSNESS,161
GB,MYOCARDIAL INFARCTION,157
GB,RENAL IMPAIRMENT,156
GB,SELF ESTEEM DECREASED,156
GB,CIRCULATORY COLLAPSE,153
GB,DEATH,153
GB,NIGHTMARE,151
GB,URINARY TRACT INFECTION,151
GB,HAEMATEMESIS,149
GB,MUSCULOSKELETAL PAIN,149
GB,ANAEMIA,144
GB,MOBILITY DECREASED,144
GB,SWELLING FACE,144
GB,HAEMOGLOBIN DECREASED,143
GB,CEREBROVASCULAR ACCIDENT,140
GB,ANXIETY,139
GB,ABDOMINAL PAIN UPPER,138
GB,DRUG INEFFECTIVE,138
GB,LIP SWELLING,138
GB,ERYTHEMA,136
GB,HYPERKALAEMIA,136
GB,PERIPHERAL SWELLING,130
GB,MUSCLE ATROPHY,128
GB,TOXICITY TO VARIOUS AGENTS,127
GB,SOCIAL AVOIDANT BEHAVIOUR,125
GB,ABNORMAL DREAMS,124
GB,VISION BLURRED,124
GB,MELAENA,123
GB,MUSCULOSKELETAL STIFFNESS,123
GB,SLEEP DISORDER,122
GB,DYSPHAGIA,120
GB,EPISTAXIS,120
GB,FRUSTRATION,119
GB,NEUTROPENIA,119
GB,SOCIAL PROBLEM,118
GB,SUICIDAL IDEATION,117
GB,JOINT SWELLING,116
GB,CARDIAC ARREST,115
GB,MEMORY IMPAIRMENT,115
GB,INTERNATIONAL NORMALISED RATIO INCREASED,114
GB,SWOLLEN TONGUE,112
GB,ELECTROCARDIOGRAM QT PROLONGED,111
GB,AGGRESSION,109
GB,DRUG INTOLERANCE,109
GB,WEIGHT DECREASED,109
GB,DYSPEPSIA,108
GB,LOCAL SWELLING,106
GB,CONTUSION,105
GB,DISTURBANCE IN ATTENTION,105
GB,HYPERSENSITIVITY,105
GB,NEUTROPHIL COUNT INCREASED,105
GB,VISUAL IMPAIRMENT,105
GB,FLATULENCE,104
GB,AGITATION,103
GB,TACHYCARDIA,103
GB,HYPERTENSION,102
GB,OVERDOSE,102
GB,PULMONARY EMBOLISM,100
GB,ABDOMINAL DISCOMFORT,99
GB,ANGIOEDEMA,97
GB,HYPOGLYCAEMIA,97
GB,OEDEMA PERIPHERAL,97
GB,ALANINE AMINOTRANSFERASE INCREASED,96
GB,NEUROPATHY PERIPHERAL,95
GB,HALLUCINATION,94
GB,PLATELET COUNT DECREASED,94
GB,ABNORMAL LOSS OF WEIGHT,90
GB,BLISTER,89
GB,UNRESPONSIVE TO STIMULI,89
GB,CELLULITIS,88
GB,CHEST DISCOMFORT,88
GB,HYPOKALAEMIA,88
GB,MOVEMENT DISORDER,88
GB,NECK PAIN,86
GB,NEUTROPENIC SEPSIS,84
GB,COGNITIVE DISORDER,83
GB,DEEP VEIN THROMBOSIS,83
GB,DRY MOUTH,83
GB,HEART RATE INCREASED,83
GB,WHEEZING,83
GB,INFECTION,82
GB,DIABETIC KETOACIDOSIS,81
GB,GENERAL PHYSICAL HEALTH DETERIORATION,80
GB,BLOOD GLUCOSE INCREASED,79
GB,DYSARTHRIA,79
GB,SEIZURE,78
GB,ALOPECIA,77
GB,RASH PRURITIC,77
GB,BLOOD CREATININE INCREASED,76
GB,MYOSITIS,75
GB,POLLAKIURIA,75
GB,FLUSHING,74
GB,MOUTH ULCERATION,74
GB,DISCOMFORT,73
GB,MYOPATHY,73
GB,BURNING SENSATION,72
GB,IRRITABILITY,72
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,71
GB,PULMONARY FIBROSIS,71
GB,WHITE BLOOD CELL COUNT DECREASED,71
GB,BLOOD PRESSURE INCREASED,70
GB,PANCYTOPENIA,70
GB,URINARY RETENTION,70
GB,RASH ERYTHEMATOUS,69
GB,SPEECH DISORDER,69
GB,TINNITUS,68
GB,OESOPHAGITIS,67
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,67
GB,HAEMORRHAGE,66
GB,CONVULSION,65
GB,DIABETES MELLITUS,65
GB,MYOCARDIAL ISCHAEMIA,65
GB,CARDIAC DISORDER,64
GB,CHILLS,62
GB,GASTROINTESTINAL DISORDER,62
GB,RENAL FAILURE,62
GB,WITHDRAWAL SYNDROME,62
GB,LACTIC ACIDOSIS,61
GB,RASH GENERALISED,61
GB,SKIN EXFOLIATION,61
GB,DEPRESSED MOOD,60
GB,HAEMATURIA,60
GB,OROPHARYNGEAL PAIN,60
GB,VERTIGO,60
GB,DRUG PRESCRIBING ERROR,59
GB,JAUNDICE,58
GB,FEELING HOT,57
GB,HYPERGLYCAEMIA,57
GB,LIMB DISCOMFORT,57
GB,NEUTROPHIL COUNT DECREASED,57
GB,ANAPHYLACTIC REACTION,56
GB,CHROMATURIA,56
GB,DYSKINESIA,56
GB,OEDEMA,56
GB,WEIGHT INCREASED,56
GB,ACUTE MYOCARDIAL INFARCTION,55
GB,ARTHRITIS,55
GB,FAECES DISCOLOURED,55
GB,GASTROOESOPHAGEAL REFLUX DISEASE,55
GB,MUSCLE TWITCHING,55
GB,TUBULOINTERSTITIAL NEPHRITIS,54
GB,DELIRIUM,53
GB,DYSGEUSIA,53
GB,INTERSTITIAL LUNG DISEASE,53
GB,ORTHOSTATIC HYPOTENSION,53
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,52
GB,RECTAL HAEMORRHAGE,52
GB,DRUG HYPERSENSITIVITY,51
GB,URTICARIA,51
GB,EMOTIONAL DISTRESS,50
GB,ERECTILE DYSFUNCTION,50
GB,VISUAL ACUITY REDUCED,50
GB,DERMATITIS EXFOLIATIVE,49
GB,EYE SWELLING,49
GB,HEMIPARESIS,49
GB,HYPOPHAGIA,49
GB,UROSEPSIS,49
GB,C-REACTIVE PROTEIN INCREASED,48
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,47
GB,CARDIAC FAILURE,47
GB,GYNAECOMASTIA,47
GB,HEPATIC FUNCTION ABNORMAL,47
GB,PANCREATITIS ACUTE,47
GB,APHASIA,46
GB,PALLOR,46
GB,POOR QUALITY SLEEP,46
GB,BLOOD POTASSIUM INCREASED,45
GB,CEREBRAL HAEMORRHAGE,45
GB,TRANSIENT ISCHAEMIC ATTACK,45
GB,PANCREATITIS,44
GB,PULMONARY OEDEMA,44
GB,BLOOD BILIRUBIN INCREASED,43
GB,ELECTROCARDIOGRAM ABNORMAL,43
GB,MOOD ALTERED,43
GB,NEUROLEPTIC MALIGNANT SYNDROME,43
GB,THROMBOCYTOPENIA,43
GB,COORDINATION ABNORMAL,42
GB,GOUT,42
GB,INFLAMMATION,42
GB,ORAL PAIN,42
GB,ECZEMA,41
GB,INFLUENZA LIKE ILLNESS,41
GB,LIVER INJURY,41
GB,PLATELET COUNT INCREASED,41
GB,TENDONITIS,41
GB,CEREBRAL INFARCTION,40
GB,METABOLIC ACIDOSIS,40
GB,PLEURAL EFFUSION,40
GB,RENAL DISORDER,40
GB,RESPIRATORY FAILURE,40
GB,URINARY INCONTINENCE,40
GB,BLOOD URINE PRESENT,39
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,39
GB,EXTRASYSTOLES,39
GB,GASTRITIS,39
GB,MEDICATION ERROR,39
GB,NASOPHARYNGITIS,39
GB,PRODUCT SUBSTITUTION ISSUE,39
GB,ABNORMAL WEIGHT GAIN,38
GB,ANGER,38
GB,ARRHYTHMIA,38
GB,GLOMERULAR FILTRATION RATE DECREASED,38
GB,HEPATITIS,38
GB,MULTI-ORGAN FAILURE,38
GB,NIGHT SWEATS,38
GB,PERIPHERAL COLDNESS,38
GB,PRURITUS GENERALISED,38
GB,ABNORMAL BEHAVIOUR,37
GB,ADVERSE EVENT,37
GB,DRUG-INDUCED LIVER INJURY,37
GB,HAEMORRHAGE INTRACRANIAL,37
GB,HYPOMAGNESAEMIA,37
GB,PIGMENTATION DISORDER,37
GB,RASH MACULAR,37
GB,RESTLESS LEGS SYNDROME,37
GB,DERMATITIS ALLERGIC,36
GB,GLUCOSE TOLERANCE IMPAIRED,36
GB,HAEMOPTYSIS,36
GB,INHIBITORY DRUG INTERACTION,36
GB,ANGINA PECTORIS,35
GB,BLOOD PRESSURE DECREASED,35
GB,COMPLETED SUICIDE,35
GB,DEAFNESS,35
GB,EPILEPSY,35
GB,GINGIVITIS,35
GB,PARANOIA,35
GB,RESTLESSNESS,35
GB,TYPE 2 DIABETES MELLITUS,35
GB,BODY TEMPERATURE INCREASED,34
GB,CONTRAINDICATED PRODUCT ADMINISTERED,34
GB,DYSPNOEA EXERTIONAL,34
GB,DYSURIA,34
GB,FEBRILE NEUTROPENIA,34
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,34
GB,HALLUCINATION_ VISUAL,34
GB,HOT FLUSH,34
GB,MENTAL IMPAIRMENT,34
GB,PRESYNCOPE,34
GB,CLOSTRIDIUM DIFFICILE INFECTION,33
GB,GASTRIC ULCER,33
GB,HEPATOMEGALY,33
GB,PSORIASIS,33
GB,COLD SWEAT,32
GB,DUODENAL ULCER,32
GB,EYE PAIN,32
GB,HEPATIC STEATOSIS,32
GB,SPLENOMEGALY,32
GB,SUBDURAL HAEMATOMA,32
GB,SWELLING,32
GB,ATRIOVENTRICULAR BLOCK FIRST DEGREE,31
GB,DRUG DISPENSING ERROR,31
GB,HIATUS HERNIA,31
GB,MUSCLE TIGHTNESS,31
GB,ASTHMA,30
GB,BLINDNESS,30
GB,BLOOD CHOLESTEROL INCREASED,30
GB,DIABETES MELLITUS INADEQUATE CONTROL,30
GB,GENERALISED TONIC-CLONIC SEIZURE,30
GB,HYPERSOMNIA,30
GB,ISCHAEMIC STROKE,30
GB,LIVER DISORDER,30
GB,LOOSE TOOTH,30
GB,MICTURITION URGENCY,30
GB,MUSCLE RIGIDITY,30
GB,TOXIC EPIDERMAL NECROLYSIS,30
GB,URINE OUTPUT DECREASED,30
GB,ANAL INCONTINENCE,29
GB,DRUG DOSE OMISSION,29
GB,HEART RATE DECREASED,29
GB,MOOD SWINGS,29
GB,PAIN IN JAW,29
GB,FEELING COLD,28
GB,HYPERCALCAEMIA,28
GB,OCULAR HYPERAEMIA,28
GB,PERSONALITY CHANGE,28
GB,PSYCHOTIC DISORDER,28
GB,STEVENS-JOHNSON SYNDROME,28
GB,VIITH NERVE PARALYSIS,28
GB,AGEUSIA,27
GB,CATARACT,27
GB,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,27
GB,GLOSSODYNIA,27
GB,INCORRECT DOSE ADMINISTERED,27
GB,OXYGEN SATURATION DECREASED,27
GB,PANIC ATTACK,27
GB,PARTNER STRESS,27
GB,PERITONITIS,27
GB,ATAXIA,26
GB,CREPITATIONS,26
GB,DIZZINESS POSTURAL,26
GB,DRY SKIN,26
GB,EXTRAPYRAMIDAL DISORDER,26
GB,HYPOTHERMIA,26
GB,HYPOXIA,26
GB,BLOOD MAGNESIUM DECREASED,25
GB,EATING DISORDER,25
GB,ERUCTATION,25
GB,GINGIVAL BLEEDING,25
GB,IRRITABLE BOWEL SYNDROME,25
GB,JOINT STIFFNESS,25
GB,OEDEMA MOUTH,25
GB,PARALYSIS,25
GB,PNEUMONITIS,25
GB,SALIVARY HYPERSECRETION,25
GB,SMALL INTESTINAL OBSTRUCTION,25
GB,SUBDURAL HAEMORRHAGE,25
GB,ACCIDENTAL OVERDOSE,24
GB,BLOOD CALCIUM DECREASED,24
GB,CARDIAC FAILURE CONGESTIVE,24
GB,CHOLELITHIASIS,24
GB,DRUG LEVEL INCREASED,24
GB,FAECES PALE,24
GB,FEELING DRUNK,24
GB,HAEMATOCHEZIA,24
GB,HYPOCALCAEMIA,24
GB,IMMUNE THROMBOCYTOPENIC PURPURA,24
GB,LEUKOPENIA,24
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,24
GB,PRODUCT USE ISSUE,24
GB,SKIN DISCOLOURATION,24
GB,BLADDER CANCER,23
GB,DRY EYE,23
GB,FEMUR FRACTURE,23
GB,GASTROENTERITIS,23
GB,MYELOFIBROSIS,23
GB,NOCTURIA,23
GB,OSTEONECROSIS OF JAW,23
GB,PHARYNGEAL OEDEMA,23
GB,PHOTOSENSITIVITY REACTION,23
GB,POLYURIA,23
GB,PRODUCTIVE COUGH,23
GB,SCHIZOPHRENIA,23
GB,SEXUAL DYSFUNCTION,23
GB,SINUS BRADYCARDIA,23
GB,TENDON RUPTURE,23
GB,ABASIA,22
GB,ARTERIOSCLEROSIS CORONARY ARTERY,22
GB,DISORIENTATION,22
GB,DUODENAL ULCER HAEMORRHAGE,22
GB,ELECTROLYTE IMBALANCE,22
GB,EYELID OEDEMA,22
GB,GINGIVAL SWELLING,22
GB,INFLUENZA,22
GB,LIVER FUNCTION TEST INCREASED,22
GB,MUSCLE FATIGUE,22
GB,OCULAR DISCOMFORT,22
GB,ORAL MUCOSAL BLISTERING,22
GB,OSTEOARTHRITIS,22
GB,POLYDIPSIA,22
GB,ACIDOSIS,21
GB,ATRIOVENTRICULAR BLOCK COMPLETE,21
GB,CYSTITIS,21
GB,ERYTHEMA MULTIFORME,21
GB,FLUID RETENTION,21
GB,FURUNCLE,21
GB,GASTRIC ULCER HAEMORRHAGE,21
GB,HEPATIC FAILURE,21
GB,HERPES ZOSTER,21
GB,MUSCLE INJURY,21
GB,PHOTOPHOBIA,21
GB,PULMONARY HYPERTENSION,21
GB,ANTIPSYCHOTIC DRUG LEVEL INCREASED,20
GB,BLOOD UREA INCREASED,20
GB,BONE PAIN,20
GB,BRONCHIECTASIS,20
GB,DISTURBANCE IN SOCIAL BEHAVIOUR,20
GB,EPIGLOTTITIS,20
GB,GASTRIC DILATATION,20
GB,GROIN PAIN,20
GB,HAEMORRHAGIC STROKE,20
GB,HICCUPS,20
GB,INTENTIONAL OVERDOSE,20
GB,JOB DISSATISFACTION,20
GB,KIDNEY INFECTION,20
GB,MENTAL DISORDER,20
GB,OBSTRUCTIVE AIRWAYS DISORDER,20
GB,PAPULE,20
GB,PETECHIAE,20
GB,RASH MACULO-PAPULAR,20
GB,RENAL TUBULAR NECROSIS,20
GB,SEDATION,20
GB,ABDOMINAL SEPSIS,19
GB,DYSPHONIA,19
GB,EOSINOPHIL COUNT INCREASED,19
GB,FLUID OVERLOAD,19
GB,GINGIVAL HYPERPLASIA,19
GB,HALLUCINATIONS_ MIXED,19
GB,LUNG NEOPLASM MALIGNANT,19
GB,MOTOR NEURONE DISEASE,19
GB,NEURALGIA,19
GB,OESOPHAGEAL CARCINOMA,19
GB,RENAL FAILURE CHRONIC,19
GB,SNEEZING,19
GB,TEMPORAL ARTERITIS,19
GB,VASCULITIC RASH,19
GB,ANTIPSYCHOTIC DRUG LEVEL DECREASED,18
GB,BLOOD SODIUM DECREASED,18
GB,BREAST CANCER,18
GB,CHOLECYSTITIS,18
GB,COMA SCALE ABNORMAL,18
GB,CONTRAINDICATED DRUG ADMINISTERED,18
GB,CYANOSIS,18
GB,DELUSION,18
GB,DERMATITIS,18
GB,DIPLOPIA,18
GB,DYSSTASIA,18
GB,FOETAL EXPOSURE DURING PREGNANCY,18
GB,HYPERAESTHESIA,18
GB,HYPOACUSIS,18
GB,HYPOKINESIA,18
GB,IDIOPATHIC PULMONARY FIBROSIS,18
GB,INTERVERTEBRAL DISC DEGENERATION,18
GB,LARGE INTESTINE PERFORATION,18
GB,MICROPHTHALMOS,18
GB,OBESITY,18
GB,OESOPHAGEAL ULCER,18
GB,PARAESTHESIA ORAL,18
GB,PEMPHIGOID,18
GB,PNEUMONIA ASPIRATION,18
GB,PRESCRIBED OVERDOSE,18
GB,PRODUCT QUALITY ISSUE,18
GB,SCLERODERMA,18
GB,TEARFULNESS,18
GB,WOUND INFECTION,18
GB,AFFECT LABILITY,17
GB,APHAGIA,17
GB,BASAL CELL CARCINOMA,17
GB,CARDIOMYOPATHY,17
GB,CARTILAGE INJURY,17
GB,CHRONIC KIDNEY DISEASE,17
GB,CLOSTRIDIUM DIFFICILE COLITIS,17
GB,COAGULATION TIME PROLONGED,17
GB,COLITIS ULCERATIVE,17
GB,CONJUNCTIVAL HAEMORRHAGE,17
GB,DERMATITIS BULLOUS,17
GB,EJACULATION FAILURE,17
GB,FIBROMYALGIA,17
GB,HEAD INJURY,17
GB,HEPATOTOXICITY,17
GB,INFLAMMATORY MARKER INCREASED,17
GB,INTESTINAL ISCHAEMIA,17
GB,LUNG CONSOLIDATION,17
GB,LUNG INFECTION,17
GB,OBSESSIVE THOUGHTS,17
GB,PROTEINURIA,17
GB,PSYCHOMOTOR HYPERACTIVITY,17
GB,SHOCK,17
GB,SKIN REACTION,17
GB,SKIN TIGHTNESS,17
GB,TENSION HEADACHE,17
GB,TONGUE OEDEMA,17
GB,TREATMENT NONCOMPLIANCE,17
GB,VULVOVAGINAL DISCOMFORT,17
GB,ARTERIOSCLEROSIS,16
GB,BLOOD LACTIC ACID INCREASED,16
GB,BRONCHOSPASM,16
GB,COLITIS,16
GB,DEPRESSIVE SYMPTOM,16
GB,DRUG ERUPTION,16
GB,FASCIITIS,16
GB,HEMIPLEGIA,16
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,16
GB,JAUNDICE CHOLESTATIC,16
GB,LICHENOID KERATOSIS,16
GB,LYMPHOMA,16
GB,MOUTH SWELLING,16
GB,MUCOSAL INFLAMMATION,16
GB,MUSCULOSKELETAL DISORDER,16
GB,ORAL DISCOMFORT,16
GB,PLEUROTHOTONUS,16
GB,PROCTALGIA,16
GB,RENAL CYST,16
GB,RHINORRHOEA,16
GB,SCAB,16
GB,SCLERAL DISCOLOURATION,16
GB,SELF-INJURIOUS IDEATION,16
GB,SKIN BURNING SENSATION,16
GB,SLEEP TERROR,16
GB,STOMATITIS,16
GB,SUBARACHNOID HAEMORRHAGE,16
GB,ABDOMINAL PAIN LOWER,15
GB,ACUTE HEPATIC FAILURE,15
GB,ASCITES,15
GB,BLOOD CREATINE INCREASED,15
GB,BLOOD POTASSIUM DECREASED,15
GB,DISEASE PROGRESSION,15
GB,DRUG WITHDRAWAL SYNDROME,15
GB,DUODENITIS,15
GB,FLANK PAIN,15
GB,HEAD DISCOMFORT,15
GB,IRON DEFICIENCY ANAEMIA,15
GB,LISTLESS,15
GB,LYMPHADENOPATHY,15
GB,MALIGNANT NEOPLASM PROGRESSION,15
GB,MYOCLONUS,15
GB,OESOPHAGEAL PERFORATION,15
GB,OTITIS EXTERNA,15
GB,PERIARTHRITIS,15
GB,PNEUMOTHORAX,15
GB,PURPURA,15
GB,VASODILATATION,15
GB,WOUND,15
GB,ANURIA,14
GB,ASPARTATE AMINOTRANSFERASE INCREASED,14
GB,BLOOD GLUCOSE ABNORMAL,14
GB,CHOKING,14
GB,CRYING,14
GB,DEFAECATION URGENCY,14
GB,ELECTROCARDIOGRAM T WAVE ABNORMAL,14
GB,EXERCISE TOLERANCE DECREASED,14
GB,EYELID PTOSIS,14
GB,GRANULOMA ANNULARE,14
GB,INCORRECT DRUG ADMINISTRATION DURATION,14
GB,INTERNATIONAL NORMALISED RATIO FLUCTUATION,14
GB,LUMBAR VERTEBRAL FRACTURE,14
GB,MUSCULOSKELETAL DISCOMFORT,14
GB,NASAL DRYNESS,14
GB,NERVOUSNESS,14
GB,OCULAR MYASTHENIA,14
GB,OLIGURIA,14
GB,PERIORBITAL OEDEMA,14
GB,RENAL PAIN,14
GB,RESPIRATORY TRACT INFECTION,14
GB,RETCHING,14
GB,SCIATICA,14
GB,SKIN HAEMORRHAGE,14
GB,STRESS,14
GB,SUDDEN DEATH,14
GB,SUICIDE ATTEMPT,14
GB,THINKING ABNORMAL,14
GB,VENTRICULAR TACHYCARDIA,14
GB,VIRAL INFECTION,14
GB,VOLVULUS,14
GB,ACUTE ABDOMEN,13
GB,ATRIAL FLUTTER,13
GB,ATRIAL TACHYCARDIA,13
GB,ATRIOVENTRICULAR BLOCK,13
GB,ATYPICAL FEMUR FRACTURE,13
GB,AUTOIMMUNE HEPATITIS,13
GB,BOWEL MOVEMENT IRREGULARITY,13
GB,CHANGE OF BOWEL HABIT,13
GB,DIVERTICULUM,13
GB,DYSPNOEA AT REST,13
GB,EAR DISCOMFORT,13
GB,EAR INFECTION,13
GB,FEMORAL NECK FRACTURE,13
GB,FLUID INTAKE REDUCED,13
GB,GENERALISED OEDEMA,13
GB,HIRSUTISM,13
GB,HYPEROSMOLAR STATE,13
GB,LIBIDO DECREASED,13
GB,LOWER LIMB FRACTURE,13
GB,LYMPHOCYTE COUNT DECREASED,13
GB,MIDDLE INSOMNIA,13
GB,MIOSIS,13
GB,MUCOUS STOOLS,13
GB,MUSCLE CONTRACTURE,13
GB,NASAL CONGESTION,13
GB,OSTEOMYELITIS,13
GB,PAIN OF SKIN,13
GB,PARKINSONISM,13
GB,PAROSMIA,13
GB,PERONEAL NERVE PALSY,13
GB,PLEURITIC PAIN,13
GB,PROSTATE CANCER,13
GB,RESPIRATORY RATE INCREASED,13
GB,SEROTONIN SYNDROME,13
GB,SINUS ARREST,13
GB,SINUS NODE DYSFUNCTION,13
GB,SKIN IRRITATION,13
GB,SKIN LESION,13
GB,STRESS FRACTURE,13
GB,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,13
GB,THROAT IRRITATION,13
GB,TOOTHACHE,13
GB,UPPER RESPIRATORY TRACT INFECTION,13
GB,URINE OUTPUT INCREASED,13
GB,VASCULITIS,13
GB,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,12
GB,AMYLOIDOSIS,12
GB,ANAPHYLACTIC SHOCK,12
GB,BLINDNESS CORTICAL,12
GB,BLOOD ALBUMIN DECREASED,12
GB,BRAIN INJURY,12
GB,CANDIDA INFECTION,12
GB,CARDIAC FLUTTER,12
GB,DEMENTIA ALZHEIMER^S TYPE,12
GB,ELECTROCARDIOGRAM T WAVE INVERSION,12
GB,EOSINOPHILIA,12
GB,GASTROINTESTINAL CARCINOMA,12
GB,HEARING IMPAIRED,12
GB,HYPOTHYROIDISM,12
GB,IMPAIRED HEALING,12
GB,INDURATION,12
GB,INGUINAL HERNIA,12
GB,INTERNATIONAL NORMALISED RATIO ABNORMAL,12
GB,IRIS COLOBOMA,12
GB,ISCHAEMIA,12
GB,LEFT VENTRICULAR DYSFUNCTION,12
GB,METASTASES TO LIVER,12
GB,NEPHROLITHIASIS,12
GB,RASH VESICULAR,12
GB,RETINAL COLOBOMA,12
GB,SENSORY LOSS,12
GB,SKIN NECROSIS,12
GB,SKIN PLAQUE,12
GB,SKIN WARM,12
GB,STAPHYLOCOCCAL SCALDED SKIN SYNDROME,12
GB,TONGUE DISCOLOURATION,12
GB,VEIN DISORDER,12
GB,APHONIA,11
GB,ARTERIAL THROMBOSIS,11
GB,BLOOD PHOSPHORUS DECREASED,11
GB,CEREBRAL ARTERIOSCLEROSIS,11
GB,CHOKING SENSATION,11
GB,COMPARTMENT SYNDROME,11
GB,CONJUNCTIVAL DISCOLOURATION,11
GB,DRUG DEPENDENCE,11
GB,ENURESIS,11
GB,ESCHERICHIA SEPSIS,11
GB,HEPATIC CIRRHOSIS,11
GB,HYPERSENSITIVITY VASCULITIS,11
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,11
GB,INTESTINAL PERFORATION,11
GB,JOINT INSTABILITY,11
GB,LID LAG,11
GB,LIP DISORDER,11
GB,LUPUS-LIKE SYNDROME,11
GB,MICROCYTIC ANAEMIA,11
GB,NECROSIS,11
GB,NERVOUS SYSTEM DISORDER,11
GB,ONYCHOMYCOSIS,11
GB,PARKINSON^S DISEASE,11
GB,PARTIAL SEIZURES,11
GB,PERICARDITIS,11
GB,PROCEDURAL HAEMORRHAGE,11
GB,RASH PUSTULAR,11
GB,RESPIRATORY ARREST,11
GB,RHEUMATOID ARTHRITIS,11
GB,SKIN ATROPHY,11
GB,SPINAL PAIN,11
GB,THIRST,11
GB,VASCULAR INJURY,11
GB,VENTRICULAR EXTRASYSTOLES,11
GB,ACUTE MYELOID LEUKAEMIA,10
GB,ALVEOLAR PROTEINOSIS,10
GB,ALVEOLITIS ALLERGIC,10
GB,ANGIOPATHY,10
GB,AORTIC ARTERIOSCLEROSIS,10
GB,AVOIDANT PERSONALITY DISORDER,10
GB,AXONAL NEUROPATHY,10
GB,BLOOD PH DECREASED,10
GB,BODY TEMPERATURE ABNORMAL,10
GB,BREAST ATROPHY,10
GB,BRONCHIAL IRRITATION,10
GB,CARDIOVASCULAR DISORDER,10
GB,COAGULOPATHY,10
GB,CORONARY ARTERY STENOSIS,10
GB,DEAFNESS UNILATERAL,10
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,10
GB,DUODENAL ULCER PERFORATION,10
GB,DUODENAL ULCER REPAIR,10
GB,ENCEPHALOPATHY,10
GB,EXFOLIATIVE RASH,10
GB,FACIAL PARALYSIS,10
GB,FREQUENT BOWEL MOVEMENTS,10
GB,GASTRIC HAEMORRHAGE,10
GB,GASTROINTESTINAL MOTILITY DISORDER,10
GB,GINGIVAL EROSION,10
GB,HYPERPROTEINAEMIA,10
GB,HYPOMANIA,10
GB,HYPOVOLAEMIC SHOCK,10
GB,INCREASED TENDENCY TO BRUISE,10
GB,INJURY,10
GB,INTERVERTEBRAL DISC PROTRUSION,10
GB,JOINT CREPITATION,10
GB,KETOACIDOSIS,10
GB,LARGE INTESTINE POLYP,10
GB,LUNG CANCER METASTATIC,10
GB,LUNG DISORDER,10
GB,MASS,10
GB,MUSCLE STRAIN,10
GB,NERVE INJURY,10
GB,NEUROPATHY_ ATAXIA_ RETINITIS PIGMENTOSA SYNDROME,10
GB,OCCUPATIONAL PROBLEM ENVIRONMENTAL,10
GB,PANIC REACTION,10
GB,PERSECUTORY DELUSION,10
GB,PO2 INCREASED,10
GB,PROCEDURAL PAIN,10
GB,PROTEIN TOTAL DECREASED,10
GB,PROTEIN URINE PRESENT,10
GB,RALES,10
GB,RAYNAUD^S PHENOMENON,10
GB,RENAL CANCER,10
GB,RHINITIS,10
GB,SENSORY DISTURBANCE,10
GB,SINUS TACHYCARDIA,10
GB,SQUAMOUS CELL CARCINOMA,10
GB,STRIDOR,10
GB,SUPRAVENTRICULAR TACHYCARDIA,10
GB,SYMPTOM MASKED,10
GB,SYSTEMIC LUPUS ERYTHEMATOSUS,10
GB,TENDON PAIN,10
GB,TOOTH DISORDER,10
GB,TOOTH EROSION,10
GB,TOOTH LOSS,10
GB,TOTAL LUNG CAPACITY DECREASED,10
GB,WALKING DISABILITY,10
GB,ABDOMINAL RIGIDITY,9
GB,ACNE,9
GB,ACOUSTIC NEUROMA,9
GB,ACUTE CORONARY SYNDROME,9
GB,ACUTE PSYCHOSIS,9
GB,AFFECTIVE DISORDER,9
GB,ANTISOCIAL BEHAVIOUR,9
GB,APLASTIC ANAEMIA,9
GB,AUTONOMIC NERVOUS SYSTEM IMBALANCE,9
GB,BLOOD PRESSURE ABNORMAL,9
GB,BLOOD TEST ABNORMAL,9
GB,BLOODY DISCHARGE,9
GB,BREAST TENDERNESS,9
GB,BURNING FEET SYNDROME,9
GB,CAMPYLOBACTER INFECTION,9
GB,CARDIAC MURMUR,9
GB,CLAUDICATION OF JAW MUSCLES,9
GB,COATING IN MOUTH,9
GB,CONVULSIVE THRESHOLD LOWERED,9
GB,DISSEMINATED INTRAVASCULAR COAGULATION,9
GB,DIVERTICULITIS,9
GB,ELECTROCARDIOGRAM QRS COMPLEX PROLONGED,9
GB,ENCEPHALOCELE,9
GB,FACIAL PAIN,9
GB,FEAR,9
GB,FIBRIN D DIMER INCREASED,9
GB,FRACTURE,9
GB,GENITAL RASH,9
GB,HAEMARTHROSIS,9
GB,HAEMATOMA,9
GB,HAND DEFORMITY,9
GB,HAND FRACTURE,9
GB,HEART RATE IRREGULAR,9
GB,HEPATORENAL SYNDROME,9
GB,HYPERTONIA,9
GB,HYPERTRIGLYCERIDAEMIA,9
GB,INCONTINENCE,9
GB,INTESTINAL OBSTRUCTION,9
GB,LARYNGEAL OEDEMA,9
GB,LIBIDO DISORDER,9
GB,LIGAMENT PAIN,9
GB,LOCALISED INFECTION,9
GB,LYMPH NODE PALPABLE,9
GB,MALABSORPTION,9
GB,MANIA,9
GB,METASTASES TO BONE,9
GB,MYASTHENIA GRAVIS,9
GB,MYELITIS,9
GB,OSTEOPOROSIS,9
GB,PANCREATIC CARCINOMA,9
GB,PARAKERATOSIS,9
GB,PCO2 DECREASED,9
GB,PERICARDIAL EFFUSION,9
GB,POLYMYALGIA RHEUMATICA,9
GB,POST-TRAUMATIC STRESS DISORDER,9
GB,RESPIRATORY DISTRESS,9
GB,SKIN DEPIGMENTATION,9
GB,SKIN ULCER,9
GB,SOCIAL FEAR,9
GB,SPINAL OSTEOARTHRITIS,9
GB,SYNOVITIS,9
GB,THROAT LESION,9
GB,THROMBOSIS,9
GB,TONGUE BLISTERING,9
GB,TUMOUR LYSIS SYNDROME,9
GB,TUNNEL VISION,9
GB,ULCER,9
GB,YELLOW SKIN,9
GB,ABDOMINAL SYMPTOM,8
GB,ASOCIAL BEHAVIOUR,8
GB,BLOOD GLUCOSE DECREASED,8
GB,BLOOD UREA DECREASED,8
GB,BODY TEMPERATURE DECREASED,8
GB,BREAST PAIN,8
GB,CARDIOPULMONARY FAILURE,8
GB,CENTRAL PAIN SYNDROME,8
GB,CHOLECYSTITIS CHRONIC,8
GB,COLOBOMA,8
GB,DEMENTIA,8
GB,DRUG MONITORING PROCEDURE NOT PERFORMED,8
GB,DRY THROAT,8
GB,EMPHYSEMA,8
GB,EMPYEMA,8
GB,EROSIVE DUODENITIS,8
GB,EYE COLOUR CHANGE,8
GB,EYE PRURITUS,8
GB,EYELID PAIN,8
GB,FEAR OF DEATH,8
GB,FEAR OF DISEASE,8
GB,FIBROSIS,8
GB,FOAMING AT MOUTH,8
GB,FOOD INTERACTION,8
GB,GENERALISED ERYTHEMA,8
GB,GINGIVAL HYPERTROPHY,8
GB,GLYCOSYLATED HAEMOGLOBIN INCREASED,8
GB,HAND-EYE COORDINATION IMPAIRED,8
GB,HEPATITIS A,8
GB,HEPATITIS E,8
GB,HIP FRACTURE,8
GB,HODGKIN^S DISEASE,8
GB,HYPOCHONDRIASIS,8
GB,HYPOGAMMAGLOBULINAEMIA,8
GB,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,8
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,8
GB,INFUSION RELATED REACTION,8
GB,INJECTION SITE URTICARIA,8
GB,LACRIMATION INCREASED,8
GB,LEFT VENTRICULAR FAILURE,8
GB,LYMPHOCYTIC INFILTRATION,8
GB,MENIERE^S DISEASE,8
GB,MOTOR DYSFUNCTION,8
GB,MUSCLE CONTRACTIONS INVOLUNTARY,8
GB,MUSCLE DISORDER,8
GB,ORAL CANDIDIASIS,8
GB,OSTEONECROSIS OF EXTERNAL AUDITORY CANAL,8
GB,PALINDROMIC RHEUMATISM,8
GB,PAPILLOEDEMA,8
GB,PERIPHERAL ISCHAEMIA,8
GB,PERIPROSTHETIC FRACTURE,8
GB,PNEUMOPERITONEUM,8
GB,POLIOMYELITIS,8
GB,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,8
GB,PRURITUS GENITAL,8
GB,PYELONEPHRITIS,8
GB,RESPIRATORY DEPRESSION,8
GB,SECRETION DISCHARGE,8
GB,SEPTIC SHOCK,8
GB,SUCROSE INTOLERANCE,8
GB,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,8
GB,TEMPERATURE INTOLERANCE,8
GB,TRANSIENT GLOBAL AMNESIA,8
GB,TREATMENT FAILURE,8
GB,WEIGHT BEARING DIFFICULTY,8
GB,ALPHA 1 FOETOPROTEIN INCREASED,7
GB,AMYLASE INCREASED,7
GB,ANAL ULCER,7
GB,ATYPICAL FRACTURE,7
GB,AZOTAEMIA,7
GB,BLOOD BILIRUBIN ABNORMAL,7
GB,CALCIPHYLAXIS,7
GB,CARBUNCLE,7
GB,CARPAL TUNNEL SYNDROME,7
GB,CEREBELLAR HAEMORRHAGE,7
GB,CEREBRAL ISCHAEMIA,7
GB,CONJUNCTIVAL DEPOSIT,7
GB,CROHN^S DISEASE,7
GB,DENERVATION ATROPHY,7
GB,DEREALISATION,7
GB,DRUG ADMINISTRATION ERROR,7
GB,ELECTROLYTE DEPLETION,7
GB,ENCEPHALITIS,7
GB,ENDOCARDITIS,7
GB,ESCHERICHIA URINARY TRACT INFECTION,7
GB,ESSENTIAL HYPERTENSION,7
GB,EYE HAEMORRHAGE,7
GB,FAECALOMA,7
GB,FOOD POISONING,7
GB,FOREIGN BODY,7
GB,GAMBLING DISORDER,7
GB,GASTROINTESTINAL ULCER HAEMORRHAGE,7
GB,GRIP STRENGTH DECREASED,7
GB,HAEMATOCRIT DECREASED,7
GB,HAEMORRHAGE URINARY TRACT,7
GB,HEPATIC ENZYME INCREASED,7
GB,HEPATITIS ACUTE,7
GB,HISTOPLASMOSIS,7
GB,HUNGER,7
GB,HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL,7
GB,HYPERLIPIDAEMIA,7
GB,HYPERPARATHYROIDISM,7
GB,HYPERTHYROIDISM,7
GB,IMMOBILE,7
GB,INCREASED UPPER AIRWAY SECRETION,7
GB,INSULIN RESISTANCE,7
GB,INTENTIONAL SELF-INJURY,7
GB,JOINT DISLOCATION,7
GB,JOINT EFFUSION,7
GB,JOINT WARMTH,7
GB,LEFT VENTRICULAR HYPERTROPHY,7
GB,MAST CELL DEGRANULATION PRESENT,7
GB,MEDICATION MONITORING ERROR,7
GB,METAMORPHOPSIA,7
GB,MITOCHONDRIAL MYOPATHY,7
GB,MOUTH HAEMORRHAGE,7
GB,MULTIPLE ENDOCRINE NEOPLASIA,7
GB,NAEVUS FLAMMEUS,7
GB,NECROTISING FASCIITIS,7
GB,NEOPLASM MALIGNANT,7
GB,NIPPLE DISORDER,7
GB,NITRITE URINE PRESENT,7
GB,NUCHAL RIGIDITY,7
GB,OSTEOPENIA,7
GB,PANCREATITIS NECROTISING,7
GB,PARVOVIRUS B19 INFECTION,7
GB,PHOTOPSIA,7
GB,POLYARTHRITIS,7
GB,POST PROCEDURAL HAEMORRHAGE,7
GB,PYELONEPHRITIS ACUTE,7
GB,RECTAL TENESMUS,7
GB,REPETITIVE STRAIN INJURY,7
GB,RET GENE MUTATION,7
GB,RETINAL ARTERY OCCLUSION,7
GB,RHINITIS ALLERGIC,7
GB,RIGHT VENTRICULAR FAILURE,7
GB,ROTATOR CUFF SYNDROME,7
GB,SKIN FISSURES,7
GB,SLEEP ATTACKS,7
GB,SPASMODIC DYSPHONIA,7
GB,SPERMATOZOA ABNORMAL,7
GB,SPUTUM DISCOLOURED,7
GB,SQUAMOUS CELL CARCINOMA OF SKIN,7
GB,SYNOVIAL DISORDER,7
GB,TEMPOROMANDIBULAR JOINT SYNDROME,7
GB,TENDON DISCOMFORT,7
GB,TORSADE DE POINTES,7
GB,TRANSAMINASES INCREASED,7
GB,TRIGGER FINGER,7
GB,UVEITIS,7
GB,VARICES OESOPHAGEAL,7
GB,VASCULAR DEMENTIA,7
GB,VENTRICULAR FIBRILLATION,7
GB,VERTIGO POSITIONAL,7
GB,ANORECTAL DISCOMFORT,6
GB,APHTHOUS STOMATITIS,6
GB,ASPHYXIA,6
GB,BLADDER DYSFUNCTION,6
GB,BLAST CELLS PRESENT,6
GB,BLEEDING TIME PROLONGED,6
US,DRUG INEFFECTIVE,4154
US,FATIGUE,3340
US,DIARRHOEA,2827
US,NAUSEA,2728
US,DYSPNOEA,2557
US,PAIN,2187
US,DIZZINESS,2180
US,FALL,2026
US,HEADACHE,1988
US,ASTHENIA,1903
US,PAIN IN EXTREMITY,1713
US,MALAISE,1633
US,ARTHRALGIA,1563
US,DRUG DOSE OMISSION,1563
US,WEIGHT DECREASED,1504
US,PNEUMONIA,1421
US,DEATH,1400
US,GASTROINTESTINAL HAEMORRHAGE,1394
US,VOMITING,1373
US,RASH,1370
US,DRUG HYPERSENSITIVITY,1288
US,COUGH,1259
US,INSOMNIA,1241
US,CONSTIPATION,1185
US,BACK PAIN,1158
US,PRURITUS,1127
US,DECREASED APPETITE,1118
US,ANAEMIA,1111
US,GAIT DISTURBANCE,1089
US,FEELING ABNORMAL,1047
US,MYALGIA,1035
US,MUSCLE SPASMS,1032
US,BLOOD GLUCOSE INCREASED,982
US,DEPRESSION,956
US,MYOCARDIAL INFARCTION,956
US,ANXIETY,952
US,CEREBROVASCULAR ACCIDENT,937
US,HYPERTENSION,937
US,INJECTION SITE PAIN,915
US,CHEST PAIN,913
US,PRODUCT QUALITY ISSUE,892
US,WEIGHT INCREASED,850
US,URINARY TRACT INFECTION,832
US,PRODUCT USE ISSUE,796
US,ABDOMINAL PAIN UPPER,790
US,ALOPECIA,784
US,PERIPHERAL SWELLING,773
US,CARDIAC FAILURE CONGESTIVE,755
US,ABDOMINAL DISCOMFORT,747
US,SOMNOLENCE,744
US,NASOPHARYNGITIS,726
US,HYPOTENSION,708
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,708
US,PYREXIA,706
US,DEHYDRATION,705
US,MUSCULAR WEAKNESS,695
US,HYPOAESTHESIA,691
US,TREMOR,688
US,INCORRECT DOSE ADMINISTERED,686
US,CONDITION AGGRAVATED,683
US,ABDOMINAL PAIN,669
US,PARAESTHESIA,666
US,CONTUSION,662
US,MEMORY IMPAIRMENT,662
US,ATRIAL FIBRILLATION,654
US,CONFUSIONAL STATE,647
US,ACUTE KIDNEY INJURY,622
US,BLOOD PRESSURE INCREASED,621
US,GASTROOESOPHAGEAL REFLUX DISEASE,613
US,OEDEMA PERIPHERAL,584
US,FLUSHING,556
US,VISION BLURRED,545
US,BALANCE DISORDER,543
US,SINUSITIS,540
US,DYSPEPSIA,539
US,BRONCHITIS,506
US,EPISTAXIS,505
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,504
US,INTENTIONAL PRODUCT MISUSE,502
US,ERYTHEMA,499
US,ARTHRITIS,487
US,PSORIASIS,484
US,NEUROPATHY PERIPHERAL,475
US,DYSGEUSIA,471
US,DRY MOUTH,470
US,HYPERSENSITIVITY,450
US,HYPERHIDROSIS,445
US,RENAL FAILURE,441
US,HAEMOGLOBIN DECREASED,430
US,DYSPHAGIA,427
US,JOINT SWELLING,425
US,OROPHARYNGEAL PAIN,423
US,MUSCULOSKELETAL PAIN,420
US,BLOOD CHOLESTEROL INCREASED,413
US,CATARACT,412
US,URTICARIA,411
US,VISUAL IMPAIRMENT,406
US,CHILLS,403
US,LOSS OF CONSCIOUSNESS,401
US,INFLUENZA,400
US,DEEP VEIN THROMBOSIS,396
US,ABDOMINAL DISTENSION,392
US,RECTAL HAEMORRHAGE,391
US,DYSPHONIA,390
US,SYNCOPE,387
US,OSTEOARTHRITIS,383
US,THROMBOSIS,373
US,PLATELET COUNT DECREASED,370
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,370
US,CHEST DISCOMFORT,367
US,HAEMORRHAGE,367
US,DIABETES MELLITUS,361
US,OSTEOPOROSIS,361
US,CORONARY ARTERY DISEASE,357
US,WHITE BLOOD CELL COUNT DECREASED,355
US,AMNESIA,350
US,PALPITATIONS,348
US,DISEASE PROGRESSION,347
US,SEPSIS,343
US,RENAL FAILURE ACUTE,340
US,BURNING SENSATION,337
US,CARDIAC DISORDER,336
US,INJECTION SITE ERYTHEMA,336
US,PULMONARY EMBOLISM,331
US,RHINORRHOEA,327
US,DRY SKIN,326
US,INFECTION,326
US,MUSCULOSKELETAL STIFFNESS,322
US,HAEMORRHAGIC ANAEMIA,317
US,UNDERDOSE,316
US,NECK PAIN,311
US,INJECTION SITE HAEMORRHAGE,310
US,NASAL CONGESTION,305
US,UPPER GASTROINTESTINAL HAEMORRHAGE,305
US,DRUG EFFECT INCOMPLETE,303
US,HOT FLUSH,303
US,INJECTION SITE BRUISING,301
US,HEART RATE INCREASED,300
US,DRUG EFFECT DECREASED,299
US,INCORRECT DRUG ADMINISTRATION DURATION,299
US,THERAPEUTIC RESPONSE UNEXPECTED,299
US,ARTHROPATHY,297
US,RESPIRATORY FAILURE,297
US,CELLULITIS,296
US,RHABDOMYOLYSIS,295
US,FLATULENCE,291
US,INFLUENZA LIKE ILLNESS,291
US,POLLAKIURIA,291
US,OVERDOSE,287
US,RHEUMATOID ARTHRITIS,287
US,COMPLETED SUICIDE,286
US,SWELLING,283
US,ASTHMA,280
US,PLEURAL EFFUSION,280
US,TRANSIENT ISCHAEMIC ATTACK,278
US,HERPES ZOSTER,273
US,ADVERSE EVENT,272
US,HAEMATURIA,271
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,268
US,SEIZURE,266
US,THROMBOCYTOPENIA,265
US,PANCREATITIS,262
US,STOMATITIS,262
US,STRESS,254
US,INJURY,253
US,UNEVALUABLE EVENT,250
US,FLUID RETENTION,249
US,BLISTER,247
US,HALLUCINATION,247
US,RASH PRURITIC,247
US,UPPER RESPIRATORY TRACT INFECTION,247
US,DRUG INTOLERANCE,245
US,MIGRAINE,245
US,NERVOUSNESS,245
US,TYPE 2 DIABETES MELLITUS,245
US,ACUTE MYOCARDIAL INFARCTION,244
US,BLOOD PRESSURE DECREASED,242
US,HAEMATOCHEZIA,242
US,BONE PAIN,240
US,BLOOD GLUCOSE DECREASED,238
US,SWELLING FACE,237
US,MALIGNANT NEOPLASM PROGRESSION,235
US,MOBILITY DECREASED,235
US,TOXICITY TO VARIOUS AGENTS,235
US,LOCAL SWELLING,234
US,BLOOD CREATININE INCREASED,232
US,COAGULOPATHY,232
US,INJECTION SITE PRURITUS,232
US,SKIN DISCOLOURATION,229
US,MULTIPLE SCLEROSIS RELAPSE,228
US,PRODUCTIVE COUGH,228
US,FEELING HOT,227
US,CARDIAC ARREST,225
US,OEDEMA,224
US,ADVERSE DRUG REACTION,219
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,217
US,SKIN EXFOLIATION,212
US,INTENTIONAL PRODUCT USE ISSUE,210
US,LETHARGY,210
US,CEREBRAL HAEMORRHAGE,209
US,DEVICE MALFUNCTION,209
US,HEPATIC ENZYME INCREASED,209
US,EYE IRRITATION,208
US,SLEEP DISORDER,208
US,DYSURIA,207
US,EMOTIONAL DISTRESS,207
US,DYSPNOEA EXERTIONAL,206
US,HIP FRACTURE,206
US,WHEEZING,205
US,DRUG ADMINISTRATION ERROR,204
US,GASTROINTESTINAL DISORDER,204
US,PRODUCT USE IN UNAPPROVED INDICATION,202
US,ABASIA,201
US,NEPHROLITHIASIS,201
US,VISUAL ACUITY REDUCED,201
US,CYSTITIS,200
US,BONE DISORDER,197
US,RENAL IMPAIRMENT,196
US,EYE PAIN,194
US,VERTIGO,193
US,ACTIVITIES OF DAILY LIVING IMPAIRED,192
US,AGITATION,192
US,ORAL PAIN,192
US,BLOOD POTASSIUM DECREASED,189
US,HOSPITALISATION,188
US,SLEEP APNOEA SYNDROME,188
US,PLASMA CELL MYELOMA,185
US,PULMONARY OEDEMA,185
US,SPEECH DISORDER,185
US,FEMUR FRACTURE,184
US,BODY HEIGHT DECREASED,182
US,IRRITABILITY,182
US,LOWER GASTROINTESTINAL HAEMORRHAGE,182
US,ROAD TRAFFIC ACCIDENT,181
US,NEUTROPENIA,180
US,BLOOD URINE PRESENT,178
US,HAEMOPTYSIS,178
US,DIVERTICULITIS,177
US,INTERVERTEBRAL DISC PROTRUSION,177
US,IMPAIRED HEALING,176
US,LIMB DISCOMFORT,174
US,SUICIDAL IDEATION,173
US,DRUG WITHDRAWAL SYNDROME,170
US,RENAL DISORDER,170
US,THERAPY CESSATION,170
US,THROAT IRRITATION,170
US,DRY EYE,169
US,MENTAL STATUS CHANGES,169
US,GENERAL PHYSICAL HEALTH DETERIORATION,168
US,HEAD INJURY,167
US,CARDIAC FAILURE,166
US,PAIN IN JAW,166
US,GASTRIC DISORDER,163
US,INJECTION SITE SWELLING,163
US,TINNITUS,163
US,EXPIRED PRODUCT ADMINISTERED,162
US,HAEMORRHOIDS,162
US,NO ADVERSE EVENT,161
US,COGNITIVE DISORDER,160
US,RIB FRACTURE,160
US,URINARY INCONTINENCE,159
US,THERAPEUTIC RESPONSE DECREASED,158
US,CHOLELITHIASIS,157
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,156
US,UPPER LIMB FRACTURE,156
US,STAPHYLOCOCCAL INFECTION,155
US,INTERNATIONAL NORMALISED RATIO INCREASED,154
US,LUNG DISORDER,152
US,DEVICE ISSUE,151
US,DYSSTASIA,150
US,FUNGAL INFECTION,150
US,HYPONATRAEMIA,149
US,TREATMENT NONCOMPLIANCE,149
US,HYPOACUSIS,148
US,PANCYTOPENIA,148
US,WHITE BLOOD CELL COUNT INCREASED,148
US,AGEUSIA,147
US,DISCOMFORT,147
US,HYPOKALAEMIA,147
US,OCULAR HYPERAEMIA,147
US,ACUTE RESPIRATORY FAILURE,146
US,CONVULSION,146
US,FOOT FRACTURE,146
US,OXYGEN SATURATION DECREASED,146
US,INJECTION SITE MASS,144
US,HYPERLIPIDAEMIA,143
US,HYPERSOMNIA,143
US,HYPOXIA,143
US,PRURITUS GENERALISED,143
US,INTERVERTEBRAL DISC DEGENERATION,142
US,NIGHT SWEATS,142
US,OSTEOPENIA,142
US,EYE SWELLING,141
US,TACHYCARDIA,141
US,HYPERKALAEMIA,140
US,SUBDURAL HAEMATOMA,140
US,CHRONIC KIDNEY DISEASE,139
US,JOINT INJURY,138
US,INJECTION SITE REACTION,137
US,DEPRESSED MOOD,136
US,DISTURBANCE IN ATTENTION,136
US,DYSKINESIA,136
US,HYPOGLYCAEMIA,136
US,MEDICATION ERROR,136
US,SPINAL OSTEOARTHRITIS,136
US,BLOOD TESTOSTERONE DECREASED,134
US,DISORIENTATION,134
US,DYSARTHRIA,134
US,FULL BLOOD COUNT DECREASED,134
US,LUNG NEOPLASM MALIGNANT,134
US,RED BLOOD CELL COUNT DECREASED,134
US,URINARY RETENTION,134
US,ANGINA PECTORIS,133
US,BREAST CANCER,133
US,COLITIS,133
US,VITAMIN D DEFICIENCY,133
US,GASTRITIS,132
US,LACRIMATION INCREASED,132
US,PANIC ATTACK,132
US,NEOPLASM MALIGNANT,131
US,PULMONARY MASS,130
US,HYPOTHYROIDISM,129
US,LIMB INJURY,128
US,MALABSORPTION,128
US,MOVEMENT DISORDER,128
US,APHASIA,127
US,HAEMATOMA,127
US,MENTAL DISORDER,127
US,DRUG PRESCRIBING ERROR,126
US,LIP SWELLING,126
US,PULMONARY HYPERTENSION,126
US,SURGERY,126
US,PERICARDIAL EFFUSION,125
US,SKIN ULCER,125
US,DEMENTIA,124
US,EYE DISORDER,124
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,124
US,INTERNAL HAEMORRHAGE,124
US,CARDIO-RESPIRATORY ARREST,123
US,TOOTH DISORDER,123
US,CLOSTRIDIUM DIFFICILE INFECTION,122
US,FAECES DISCOLOURED,122
US,GOUT,122
US,HIATUS HERNIA,122
US,ROTATOR CUFF SYNDROME,122
US,ANKLE FRACTURE,121
US,CHROMATURIA,121
US,CORONARY ARTERY OCCLUSION,121
US,HEART RATE DECREASED,121
US,RASH MACULAR,121
US,CROHN^S DISEASE,120
US,GLAUCOMA,120
US,APPLICATION SITE ERYTHEMA,119
US,BRADYCARDIA,119
US,HEART RATE IRREGULAR,119
US,SKIN DISORDER,119
US,ACNE,118
US,MULTIPLE FRACTURES,118
US,PRODUCT SUBSTITUTION ISSUE,118
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,118
US,CRYING,117
US,INTENTIONAL DRUG MISUSE,117
US,ARRHYTHMIA,116
US,CARPAL TUNNEL SYNDROME,116
US,MUSCULOSKELETAL DISCOMFORT,116
US,NEURALGIA,116
US,OSTEONECROSIS OF JAW,115
US,IRRITABLE BOWEL SYNDROME,114
US,LACERATION,114
US,OSTEOMYELITIS,114
US,RASH ERYTHEMATOUS,114
US,ABNORMAL BEHAVIOUR,113
US,ABNORMAL LOSS OF WEIGHT,113
US,BACK DISORDER,112
US,FEELING COLD,112
US,HYPOPHAGIA,112
US,SINUS DISORDER,112
US,DIVERTICULUM,111
US,SWOLLEN TONGUE,111
US,BLOOD COUNT ABNORMAL,110
US,HAIR COLOUR CHANGES,110
US,NIGHTMARE,109
US,PRODUCT ADHESION ISSUE,109
US,VAGINAL HAEMORRHAGE,109
US,WRIST FRACTURE,109
US,BLOOD TRIGLYCERIDES INCREASED,108
US,FEELING JITTERY,108
US,LABORATORY TEST ABNORMAL,108
US,PROSTATE CANCER,108
US,SCIATICA,108
US,SKIN LESION,108
US,AGGRESSION,107
US,DIPLOPIA,107
US,VIRAL INFECTION,107
US,ABNORMAL DREAMS,106
US,BLINDNESS,106
US,GASTRIC ULCER,106
US,LIVER DISORDER,106
US,HAEMORRHAGE INTRACRANIAL,105
US,HAIR TEXTURE ABNORMAL,105
US,LYMPHADENOPATHY,105
US,RASH GENERALISED,105
US,DEAFNESS,104
US,JOINT STIFFNESS,103
US,RESTLESS LEGS SYNDROME,103
US,WOUND,103
US,EAR INFECTION,102
US,FREQUENT BOWEL MOVEMENTS,102
US,GLOSSODYNIA,102
US,INFLAMMATION,102
US,LOCALISED INFECTION,102
US,FIBROMYALGIA,101
US,LOWER LIMB FRACTURE,101
US,RESPIRATORY TRACT CONGESTION,101
US,RETCHING,101
US,EXTRA DOSE ADMINISTERED,100
US,MOOD ALTERED,100
US,SKIN BURNING SENSATION,99
US,ALANINE AMINOTRANSFERASE INCREASED,98
US,BLOOD POTASSIUM INCREASED,98
US,CANDIDA INFECTION,98
US,MICTURITION URGENCY,98
US,SEPTIC SHOCK,98
US,ANGIOEDEMA,97
US,EXOSTOSIS,97
US,LIVER FUNCTION TEST ABNORMAL,97
US,MULTIPLE SCLEROSIS,97
US,NOCTURIA,97
US,ATELECTASIS,96
US,PSORIATIC ARTHROPATHY,96
US,SPINAL FRACTURE,96
US,GALLBLADDER DISORDER,95
US,LEUKOCYTOSIS,95
US,MYOPATHY,95
US,PHARYNGEAL OEDEMA,95
US,TOOTHACHE,95
US,APPLICATION SITE PRURITUS,94
US,SNEEZING,94
US,ASPARTATE AMINOTRANSFERASE INCREASED,92
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,92
US,EAR PAIN,92
US,EATING DISORDER,92
US,ERECTILE DYSFUNCTION,92
US,BASAL CELL CARCINOMA,91
US,FLUID OVERLOAD,91
US,IRON DEFICIENCY ANAEMIA,91
US,PRESCRIBED OVERDOSE,91
US,SPINAL COLUMN STENOSIS,91
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,90
US,HAEMATOCRIT DECREASED,90
US,POOR QUALITY SLEEP,90
US,RESPIRATORY DISTRESS,90
US,DIABETIC KETOACIDOSIS,89
US,INCREASED TENDENCY TO BRUISE,89
US,RESTLESSNESS,89
US,SKIN CANCER,89
US,DRUG DISPENSING ERROR,88
US,ERUCTATION,88
US,HYPERGLYCAEMIA,88
US,MACULAR DEGENERATION,88
US,SKIN IRRITATION,88
US,WITHDRAWAL SYNDROME,88
US,HAEMATEMESIS,87
US,HAEMORRHAGIC STROKE,87
US,HEMIPARESIS,87
US,INJECTION SITE NODULE,87
US,KNEE ARTHROPLASTY,87
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,86
US,DIABETIC NEUROPATHY,86
US,EMPHYSEMA,86
US,FEBRILE NEUTROPENIA,86
US,LARGE INTESTINE POLYP,86
US,MELAENA,86
US,RENAL FAILURE CHRONIC,86
US,LUNG INFECTION,85
US,MENTAL IMPAIRMENT,85
US,PANCREATIC CARCINOMA,85
US,APPLICATION SITE PAIN,84
US,BLOOD SODIUM DECREASED,84
US,CARDIOVASCULAR DISORDER,84
US,GASTROENTERITIS VIRAL,84
US,PRE-EXISTING CONDITION IMPROVED,84
US,CARDIOMYOPATHY,83
US,EYE PRURITUS,83
US,INTESTINAL OBSTRUCTION,83
US,LEUKOPENIA,83
US,MUSCULOSKELETAL CHEST PAIN,83
US,THROAT TIGHTNESS,83
US,DELIRIUM,82
US,EYE HAEMORRHAGE,82
US,PRESYNCOPE,82
US,RESPIRATORY DISORDER,81
US,TENDONITIS,81
US,CHOKING,80
US,INCORRECT PRODUCT STORAGE,80
US,KIDNEY INFECTION,80
US,BLOOD GLUCOSE ABNORMAL,79
US,HYPERCHOLESTEROLAEMIA,79
US,SINUS CONGESTION,79
US,CEREBRAL INFARCTION,78
US,HAIR DISORDER,78
US,HERNIA,78
US,VITAMIN D DECREASED,78
US,BLOOD PRESSURE ABNORMAL,77
US,BLOOD PRESSURE FLUCTUATION,77
US,ISCHAEMIC STROKE,77
US,PULMONARY CONGESTION,77
US,STENT PLACEMENT,77
US,TOOTH INFECTION,77
US,RASH PAPULAR,76
US,DENTAL CARIES,75
US,LACTIC ACIDOSIS,75
US,UNRESPONSIVE TO STIMULI,75
US,ORAL DISCOMFORT,74
US,ORTHOSTATIC HYPOTENSION,74
US,ASCITES,73
US,COLITIS ULCERATIVE,73
US,RENAL CYST,73
US,HYPOAESTHESIA ORAL,72
US,INJECTION SITE EXTRAVASATION,72
US,MUSCLE STRAIN,72
US,MUSCULOSKELETAL DISORDER,72
US,PNEUMONIA ASPIRATION,72
US,POST PROCEDURAL HAEMORRHAGE,72
US,BLADDER DISORDER,71
US,BLOOD CALCIUM INCREASED,71
US,MIDDLE INSOMNIA,71
US,ABDOMINAL PAIN LOWER,70
US,GINGIVAL BLEEDING,70
US,METABOLIC ACIDOSIS,70
US,MUSCLE DISORDER,70
US,OBESITY,70
US,BLOOD MAGNESIUM DECREASED,69
US,ECCHYMOSIS,69
US,FEAR,69
US,MUSCLE TIGHTNESS,69
US,PANCREATITIS ACUTE,69
US,THYROID DISORDER,69
US,BLOOD GLUCOSE FLUCTUATION,68
US,HYPOKINESIA,68
US,MENISCUS INJURY,68
US,NEOPLASM PROGRESSION,68
US,PROCEDURAL PAIN,68
US,SCAR,68
US,SPINAL COMPRESSION FRACTURE,68
US,ANGER,67
US,ARTERIOSCLEROSIS CORONARY ARTERY,67
US,BLINDNESS UNILATERAL,67
US,BURSITIS,67
US,DIABETES MELLITUS INADEQUATE CONTROL,67
US,HEAD DISCOMFORT,67
US,METASTASES TO LIVER,67
US,MUSCLE TWITCHING,67
US,NERVOUS SYSTEM DISORDER,67
US,NEUTROPHIL COUNT DECREASED,67
US,SUICIDE ATTEMPT,67
US,THINKING ABNORMAL,67
US,ACCIDENTAL EXPOSURE TO PRODUCT,66
US,NERVE COMPRESSION,66
US,NERVE INJURY,66
US,PRODUCT PHYSICAL ISSUE,66
US,SENSORY DISTURBANCE,66
US,ANHEDONIA,65
US,ARTERIOSCLEROSIS,65
US,ENCEPHALOPATHY,65
US,HEPATIC FAILURE,65
US,INCREASED APPETITE,65
US,NODULE,65
US,ANAPHYLACTIC REACTION,64
US,INFUSION RELATED REACTION,64
US,MASS,64
US,MUSCLE ATROPHY,64
US,CARDIOMEGALY,63
US,INTENTIONAL OVERDOSE,63
US,LARYNGITIS,63
US,ORAL CANDIDIASIS,63
US,SUBARACHNOID HAEMORRHAGE,63
US,TOOTH ABSCESS,63
US,COLD SWEAT,62
US,DRUG-INDUCED LIVER INJURY,62
US,ILL-DEFINED DISORDER,62
US,RESPIRATORY TRACT INFECTION,62
US,SEASONAL ALLERGY,62
US,BACK INJURY,61
US,BONE DENSITY DECREASED,61
US,EMOTIONAL DISORDER,61
US,HEPATIC STEATOSIS,61
US,SHOCK,61
US,TOOTH FRACTURE,61
US,VITREOUS FLOATERS,61
US,CORONARY ARTERIAL STENT INSERTION,60
US,INJECTION SITE RASH,60
US,OESOPHAGITIS,60
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,60
US,PARKINSON^S DISEASE,60
US,POOR QUALITY DRUG ADMINISTERED,60
US,IMPAIRED DRIVING ABILITY,59
US,ARTERIAL OCCLUSIVE DISEASE,58
US,BLOOD UREA INCREASED,58
US,CORONARY ARTERY BYPASS,58
US,DRY THROAT,58
US,INTRAOCULAR PRESSURE INCREASED,58
US,LUNG INFILTRATION,58
US,MOOD SWINGS,58
US,PERIPHERAL VASCULAR DISORDER,58
US,SKIN FISSURES,58
US,WALKING AID USER,58
US,BLADDER CANCER,57
US,CLOSTRIDIUM DIFFICILE COLITIS,57
US,FOOT DEFORMITY,57
US,LOWER RESPIRATORY TRACT INFECTION,57
US,PULMONARY ARTERIAL HYPERTENSION,57
US,SCOLIOSIS,57
US,TRANSFUSION,57
US,ATRIAL FLUTTER,56
US,HAND FRACTURE,56
US,PSYCHOLOGICAL TRAUMA,56
US,SMALL INTESTINAL OBSTRUCTION,56
US,ULCER,56
US,UPPER-AIRWAY COUGH SYNDROME,56
US,VENTRICULAR TACHYCARDIA,56
US,ACUTE HEPATIC FAILURE,55
US,MITRAL VALVE INCOMPETENCE,55
US,BLOOD CHOLESTEROL ABNORMAL,54
US,GROIN PAIN,54
US,HEARING IMPAIRED,54
US,HEPATITIS,54
US,JOINT RANGE OF MOTION DECREASED,54
US,METASTASES TO BONE,54
US,PHOTOPHOBIA,54
US,PLATELET COUNT INCREASED,54
US,POLYP,54
US,SECRETION DISCHARGE,54
US,TENDERNESS,54
US,THIRST,54
US,UROSEPSIS,54
US,ACCIDENTAL OVERDOSE,53
US,BEDRIDDEN,53
US,DECUBITUS ULCER,53
US,DEFORMITY,53
US,DISABILITY,53
US,IMPAIRED WORK ABILITY,53
US,INCONTINENCE,53
US,MADAROSIS,53
US,PALLOR,53
US,PARANOIA,53
US,PERIPHERAL COLDNESS,53
US,PSYCHOTIC DISORDER,53
US,SKIN HAEMORRHAGE,53
US,TENDON RUPTURE,53
US,CYST,52
US,INTERSTITIAL LUNG DISEASE,52
US,MEDICATION RESIDUE PRESENT,52
US,NO THERAPEUTIC RESPONSE,52
US,TOOTH EXTRACTION,52
US,ACUTE CORONARY SYNDROME,51
US,CENTRAL NERVOUS SYSTEM LESION,51
US,FRACTURE,51
US,ORAL HERPES,51
US,RESPIRATORY ARREST,51
US,APHONIA,50
US,HIP ARTHROPLASTY,50
US,JOINT DISLOCATION,50
US,LOW TURNOVER OSTEOPATHY,50
US,LYMPHOMA,50
US,MOUTH HAEMORRHAGE,50
US,MYELODYSPLASTIC SYNDROME,50
US,PAIN OF SKIN,50
US,POST PROCEDURAL COMPLICATION,50
US,PRESCRIBED UNDERDOSE,50
US,TOOTH LOSS,50
US,ULCER HAEMORRHAGE,50
US,ANGINA UNSTABLE,49
US,AORTIC ANEURYSM,49
US,COLON CANCER,49
US,ECZEMA,49
US,HUNGER,49
US,INJECTION SITE URTICARIA,49
US,LIGAMENT SPRAIN,49
US,MALIGNANT MELANOMA,49
US,PERSONALITY CHANGE,49
US,PNEUMOTHORAX,49
US,PROSTATOMEGALY,49
US,SPINAL DISORDER,49
US,SPLENOMEGALY,49
US,BLOOD BILIRUBIN INCREASED,48
US,CONCUSSION,48
US,DERMATITIS,48
US,EYELID OEDEMA,48
US,GASTROENTERITIS,48
US,GINGIVAL PAIN,48
US,GLUCOSE TOLERANCE IMPAIRED,48
US,HYPERCALCAEMIA,48
US,JOINT EFFUSION,48
US,LUMBAR SPINAL STENOSIS,48
US,MYOCARDIAL ISCHAEMIA,48
US,PRODUCT TASTE ABNORMAL,48
US,PULMONARY FIBROSIS,48
US,SHOCK HAEMORRHAGIC,48
US,TRANSAMINASES INCREASED,48
US,DEVICE USE ERROR,47
US,DIZZINESS POSTURAL,47
US,HAIR GROWTH ABNORMAL,47
US,INITIAL INSOMNIA,47
US,JAUNDICE,47
US,MULTIPLE INJURIES,47
US,PARAESTHESIA ORAL,47
US,PHOTOSENSITIVITY REACTION,47
US,BLOOD ALKALINE PHOSPHATASE INCREASED,46
US,BONE LESION,46
US,CATARACT OPERATION,46
US,COELIAC DISEASE,46
US,DEMENTIA ALZHEIMER^S TYPE,46
US,DEVICE RELATED INFECTION,46
US,DIARRHOEA HAEMORRHAGIC,46
US,EYE DISCHARGE,46
US,FLANK PAIN,46
US,FOREIGN BODY,46
US,GLOMERULAR FILTRATION RATE DECREASED,46
US,HALLUCINATION_ VISUAL,46
US,MANIA,46
US,MOUTH ULCERATION,46
US,MULTIPLE ALLERGIES,46
US,PARALYSIS,46
US,PELVIC FRACTURE,46
US,SCAB,46
US,APPLICATION SITE RASH,45
US,CARDIAC MURMUR,45
US,DECREASED INTEREST,45
US,FEEDING DISORDER,45
US,HAEMORRHOIDAL HAEMORRHAGE,45
US,MUSCLE SPASTICITY,45
US,MYOSITIS,45
US,ORAL DISORDER,45
US,PNEUMONITIS,45
US,RENAL INJURY,45
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,45
US,ATAXIA,44
US,BIPOLAR DISORDER,44
US,BREAST PAIN,44
US,CHOLECYSTITIS,44
US,DERMATITIS CONTACT,44
US,DIVERTICULUM INTESTINAL,44
US,ELECTROCARDIOGRAM QT PROLONGED,44
US,ESSENTIAL HYPERTENSION,44
US,FEELING DRUNK,44
US,HYPERAESTHESIA,44
US,MUCOSAL INFLAMMATION,44
US,NON-CARDIAC CHEST PAIN,44
US,PANCREATIC CARCINOMA METASTATIC,44
US,ABSCESS,43
US,COORDINATION ABNORMAL,43
US,GAIT INABILITY,43
US,INJECTION SITE WARMTH,43
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,43
US,SKIN ABRASION,43
US,BLOOD CALCIUM DECREASED,42
US,CAROTID ARTERY OCCLUSION,42
US,CHOLECYSTECTOMY,42
US,COLITIS ISCHAEMIC,42
US,DELUSION,42
US,DYSGRAPHIA,42
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,42
US,SQUAMOUS CELL CARCINOMA OF SKIN,42
US,STRESS FRACTURE,42
US,ARTHROPOD BITE,41
US,BLINDNESS TRANSIENT,41
US,COMA,41
US,DYSLIPIDAEMIA,41
US,EXERCISE TOLERANCE DECREASED,41
US,HYPERKERATOSIS,41
US,INJURY ASSOCIATED WITH DEVICE,41
US,INTRAMEDULLARY ROD INSERTION,41
US,LIBIDO DECREASED,41
US,MALNUTRITION,41
US,NAIL DISORDER,41
US,RENAL CANCER,41
US,SEDATION,41
US,SLUGGISHNESS,41
US,THYROID NEOPLASM,41
US,BACTERAEMIA,40
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,40
US,BLOOD PRESSURE SYSTOLIC INCREASED,40
US,FACIAL PAIN,40
US,LYMPHOCYTE COUNT DECREASED,40
US,MULTI-ORGAN FAILURE,40
US,ONYCHOCLASIS,40
US,PELVIC PAIN,40
US,PROTEINURIA,40
US,SKIN INFECTION,40
US,BENIGN PROSTATIC HYPERPLASIA,39
US,BLOOD IRON DECREASED,39
US,BLOOD TEST ABNORMAL,39
US,CALCIUM DEFICIENCY,39
US,CARDIOGENIC SHOCK,39
US,EAR DISCOMFORT,39
US,EYE INFECTION,39
US,IMMUNE SYSTEM DISORDER,39
US,LOW DENSITY LIPOPROTEIN INCREASED,39
US,SCRATCH,39
US,SINUS BRADYCARDIA,39
US,SUPRAVENTRICULAR TACHYCARDIA,39
US,APHAGIA,38
US,ATRIOVENTRICULAR BLOCK,38
US,BARRETT^S OESOPHAGUS,38
US,BOWEL MOVEMENT IRREGULARITY,38
US,DEVICE OCCLUSION,38
US,EJECTION FRACTION DECREASED,38
US,HEPATIC CIRRHOSIS,38
US,HUMERUS FRACTURE,38
US,INCREASED UPPER AIRWAY SECRETION,38
US,INTERNATIONAL NORMALISED RATIO DECREASED,38
US,ISCHAEMIC CARDIOMYOPATHY,38
US,RENAL CELL CARCINOMA,38
US,RETINAL HAEMORRHAGE,38
US,SPINAL OPERATION,38
US,TONGUE DISORDER,38
US,TRICUSPID VALVE INCOMPETENCE,38
US,TROPONIN INCREASED,38
US,WRONG DRUG ADMINISTERED,38
US,APPLICATION SITE IRRITATION,37
US,AUTOIMMUNE HEPATITIS,37
US,CARDIAC PACEMAKER INSERTION,37
US,CONJUNCTIVITIS,37
US,DIALYSIS,37
US,DRUG DEPENDENCE,37
US,FAECAL INCONTINENCE,37
US,GASTRIC ULCER HAEMORRHAGE,37
US,GOITRE,37
US,GYNAECOMASTIA,37
US,HYPOVOLAEMIA,37
US,PULMONARY THROMBOSIS,37
US,SENSORY LOSS,37
US,TARDIVE DYSKINESIA,37
US,TUBULOINTERSTITIAL NEPHRITIS,37
US,WOUND INFECTION,37
US,ACCIDENT,36
US,CAROTID ARTERY STENOSIS,36
US,DIVERTICULUM INTESTINAL HAEMORRHAGIC,36
US,FACIAL BONES FRACTURE,36
US,FOREIGN BODY SENSATION IN EYES,36
US,HYDRONEPHROSIS,36
US,HYPOMAGNESAEMIA,36
US,NASAL DISCOMFORT,36
US,RENAL TUBULAR NECROSIS,36
US,SQUAMOUS CELL CARCINOMA,36
US,WEIGHT FLUCTUATION,36
US,BACTERIAL INFECTION,35
US,BLOOD DISORDER,35
US,BLOOD THYROID STIMULATING HORMONE INCREASED,35
US,BODY TEMPERATURE INCREASED,35
US,LIP DRY,35
US,LIVER FUNCTION TEST INCREASED,35
US,RETINAL DETACHMENT,35
US,SPINAL PAIN,35
US,WHEELCHAIR USER,35
US,ACUTE RESPIRATORY DISTRESS SYNDROME,34
US,CARDIAC VALVE DISEASE,34
US,DISEASE RECURRENCE,34
US,GASTROINTESTINAL PAIN,34
US,GENERALISED TONIC-CLONIC SEIZURE,34
US,HYPOCALCAEMIA,34
US,INJECTION SITE INDURATION,34
US,MUSCLE FATIGUE,34
US,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,34
US,PERONEAL NERVE PALSY,34
US,PHARYNGITIS,34
US,PRODUCT PACKAGING ISSUE,34
US,RENAL HAEMORRHAGE,34
US,SYSTEMIC LUPUS ERYTHEMATOSUS,34
US,URINE ODOUR ABNORMAL,34
US,URINE OUTPUT DECREASED,34
US,ABNORMAL FAECES,33
US,DRUG EFFECT DELAYED,33
US,ELECTROLYTE IMBALANCE,33
US,END STAGE RENAL DISEASE,33
US,FAILURE TO THRIVE,33
US,GANGRENE,33
US,GINGIVITIS,33
US,ILEUS,33
US,PHYSICAL DISABILITY,33
US,RHINITIS ALLERGIC,33
US,SINUS TACHYCARDIA,33
US,SYNOVIAL CYST,33
US,TREATMENT FAILURE,33
US,WOUND COMPLICATION,33
US,ANAL INCONTINENCE,32
US,BONE CANCER,32
US,DECREASED ACTIVITY,32
US,DEVICE DISLOCATION,32
US,DEVICE FAILURE,32
US,EUPHORIC MOOD,32
US,HYPERTHYROIDISM,32
US,INTENTIONAL UNDERDOSE,32
US,JAUNDICE CHOLESTATIC,32
US,LUMBAR RADICULOPATHY,32
US,METASTASES TO CENTRAL NERVOUS SYSTEM,32
US,METASTASES TO LUNG,32
US,NASAL DRYNESS,32
US,PAPILLARY THYROID CANCER,32
US,PEPTIC ULCER,32
US,POST PROCEDURAL INFECTION,32
US,RENAL PAIN,32
US,SEXUAL DYSFUNCTION,32
US,SPUTUM DISCOLOURED,32
US,THYROID FUNCTION TEST ABNORMAL,32
US,VARICOSE VEIN,32
US,VENTRICULAR EXTRASYSTOLES,32
US,VISUAL FIELD DEFECT,32
US,ADVERSE REACTION,31
US,AORTIC ARTERIOSCLEROSIS,31
US,APATHY,31
US,BONE LOSS,31
US,CARDIAC FLUTTER,31
US,DEPRESSED LEVEL OF CONSCIOUSNESS,31
US,ENERGY INCREASED,31
US,HAEMARTHROSIS,31
US,HICCUPS,31
US,LIVER INJURY,31
US,METASTATIC RENAL CELL CARCINOMA,31
US,ONYCHOMYCOSIS,31
US,PRODUCT LABEL ISSUE,31
US,PULMONARY HAEMORRHAGE,31
US,SPONDYLOLISTHESIS,31
US,VULVOVAGINAL PRURITUS,31
US,AORTIC STENOSIS,30
US,APPETITE DISORDER,30
US,BRAIN OEDEMA,30
US,CORONARY ARTERY STENOSIS,30
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,30
US,ECONOMIC PROBLEM,30
US,ELECTROCARDIOGRAM ABNORMAL,30
US,EXPIRED DRUG ADMINISTERED,30
US,EXPOSED BONE IN JAW,30
US,IMMUNODEFICIENCY,30
US,INJECTION SITE DISCOLOURATION,30
US,INTERVERTEBRAL DISC DISORDER,30
US,JAW DISORDER,30
US,OESOPHAGEAL DISORDER,30
US,ORAL MUCOSAL BLISTERING,30
US,PETECHIAE,30
US,PRODUCT SIZE ISSUE,30
US,PSYCHOMOTOR HYPERACTIVITY,30
US,THYROID CANCER,30
US,VITAMIN B12 DEFICIENCY,30
US,WOUND HAEMORRHAGE,30
US,ADENOCARCINOMA PANCREAS,29
US,AFFECT LABILITY,29
US,ANOSMIA,29
US,CHOLECYSTITIS CHRONIC,29
US,DERMATITIS ACNEIFORM,29
US,ENDOPHTHALMITIS,29
US,FUNGAL SKIN INFECTION,29
US,HALLUCINATION_ AUDITORY,29
US,HEMIPLEGIA,29
US,LEFT VENTRICULAR HYPERTROPHY,29
US,LUMBAR VERTEBRAL FRACTURE,29
US,LYMPHOEDEMA,29
US,PARANASAL SINUS HYPERSECRETION,29
US,PATHOLOGICAL FRACTURE,29
US,PIGMENTATION DISORDER,29
US,QUALITY OF LIFE DECREASED,29
US,RIGHT VENTRICULAR FAILURE,29
US,SEROTONIN SYNDROME,29
US,SKIN REACTION,29
US,THROMBOTIC THROMBOCYTOPENIC PURPURA,29
US,TONGUE DISCOLOURATION,29
US,TRIGGER FINGER,29
US,APPLICATION SITE DISCOLOURATION,28
US,DUODENAL ULCER,28
US,FACIAL PARALYSIS,28
US,GASTROINTESTINAL INFECTION,28
US,HEART VALVE INCOMPETENCE,28
US,NEEDLE ISSUE,28
US,NEPHROPATHY,28
US,NICOTINE DEPENDENCE,28
US,POST-TRAUMATIC STRESS DISORDER,28
US,POSTOPERATIVE WOUND INFECTION,28
US,PROCTALGIA,28
US,PRODUCT STORAGE ERROR,28
US,SINUS HEADACHE,28
US,THERAPY NON-RESPONDER,28
US,WRONG PATIENT RECEIVED MEDICATION,28
US,ASPIRATION,27
US,CATHETERISATION CARDIAC,27
US,COMPRESSION FRACTURE,27
US,DEVICE LEAKAGE,27
US,DRUG ERUPTION,27
US,DUODENITIS,27
US,EYE INFLAMMATION,27
US,FIBULA FRACTURE,27
US,FRUSTRATION,27
US,GASTRIC HAEMORRHAGE,27
US,HAEMORRHAGIC DIATHESIS,27
US,HYPOVOLAEMIC SHOCK,27
US,IMPAIRED GASTRIC EMPTYING,27
US,IMPAIRED QUALITY OF LIFE,27
US,ISCHAEMIA,27
VE,AORTIC ANEURYSM,1
VE,CELLULITIS,1
VE,CONCOMITANT DISEASE AGGRAVATED,1
VE,DISEASE RECURRENCE,1
VE,EMPHYSEMA,1
VE,FALL,1
VE,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
VE,HEAD INJURY,1
VE,HUMERUS FRACTURE,1
VE,INFLUENZA,1
VE,INJECTION SITE MASS,1
VE,MYCOSIS FUNGOIDES,1
VE,PAIN,1
VE,PNEUMONIA,1
VE,RED BLOOD CELL COUNT INCREASED,1
VE,TYPE 2 DIABETES MELLITUS,1
VE,VIRAL INFECTION,1
VE,WHITE BLOOD CELL COUNT INCREASED,1
VN,ARTHRALGIA,1
VN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
VN,FEMUR FRACTURE,1
VN,HEPATIC ENZYME INCREASED,1
VN,INTERNAL FIXATION OF FRACTURE,1
VN,LIMB OPERATION,1
VN,PAIN,1
VN,PNEUMONIA,1
VN,RESPIRATORY FAILURE,1
VN,WALKING AID USER,1
VI,DRUG EFFECT INCOMPLETE,2
VI,ANXIETY,1
VI,ASTHENIA,1
VI,CONDITION AGGRAVATED,1
VI,PAIN,1
VI,PALPITATIONS,1
